{"meta":{"query_hash":"61c17db8e2f9","filters":{"venue":"Cancer Treatment Reviews"},"cohort_total":188,"direct_labels_cover":0,"predictions_cover":188,"exported":188,"export_cap":100000,"truncated":false,"label_status":"direct model label, unvalidated","prediction_status":"machine_predicted_unvalidated (Codex and Gemma teacher distillation)","score_status":"score_only:v0-immature-baseline","snapshot":{"source":"OpenAlex, pinned release, all 482 partitions","release":"2026-06-24","frame_built":"2026-07-12"},"permalink":"https://metacan.xera.ac/q/61c17db8e2f9","api":"https://metacan.xera.ac/api/v1/cohort?venue=Cancer+Treatment+Reviews"},"results":[{"id":"W1591039646","doi":"10.1016/j.ctrv.2015.05.006","title":"New molecular targets in non clear renal cell carcinoma: An overview of ongoing clinical trials","year":2015,"lang":"en","type":"review","venue":"Cancer Treatment Reviews","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":19,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"Associazione Italiana per la Ricerca sul Cancro","keywords":"Medicine; PI3K/AKT/mTOR pathway; Renal cell carcinoma; Cancer research; Discovery and development of mTOR inhibitors; Targeted therapy; Immunotherapy; Clinical trial; Immunohistochemistry; Pathology; Oncology; Internal medicine; Bioinformatics; Cancer; Signal transduction; Biology","score_opus":0.4860007036524934,"score_gpt":0.528739808086189,"score_spread":0.04273910443369561,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1591039646","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00039226696,0.98687387,0.000018280376,0.00003460109,0.00043831152,0.010385772,0.000096510244,0.000028354143,0.0017320518],"genre_scores_gemma":[0.00004837738,0.9928331,0.002378312,0.000084987565,0.00078081625,0.0014507476,0.00065247493,0.00019430093,0.0015769121],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.98700607,0.004191214,0.0059830816,0.0015103056,0.0006213905,0.0006879568],"domain_scores_gemma":[0.9930764,0.00036925424,0.00325146,0.0020442826,0.00014798854,0.0011106057],"candidate_categories":["metaepi_narrow","metaepi_broad"],"consensus_categories":["metaepi_narrow"],"category_scores_codex":[0.004655639,0.0014803676,0.016723655,0.00043706657,0.000032645195,0.000029623092,0.0003975372,0.0007179903,0.00046177633],"category_scores_gemma":[0.00023447291,0.00091125455,0.0043988274,0.0007414402,0.00007801649,0.00011428284,0.000108591536,0.00060715195,0.00022222108],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00016886939,0.0009422082,0.00030792246,0.026218541,0.000441809,0.0006022964,0.000081098675,0.0000012618484,0.0000108339345,0.000006905777,0.002487056,0.9687312],"study_design_scores_gemma":[0.00529744,0.0040844684,0.00012716542,0.03443948,0.014591288,0.000040772695,0.000007282238,0.0000031308252,0.00016258123,0.000008890213,0.94066966,0.0005678395],"about_ca_topic_score_codex":0.0013222613,"about_ca_topic_score_gemma":0.00013773362,"teacher_disagreement_score":0.9681634,"about_ca_system_score_codex":0.0030433163,"about_ca_system_score_gemma":0.0039372444,"threshold_uncertainty_score":0.99979454},"labels":[],"label_agreement":null},{"id":"W1649073062","doi":"10.1016/j.ctrv.2005.01.010","title":"No clear evidence for adjuvant therapy in people with stage II colon cancer☆, ☆☆, ☆☆☆Abstracted from: Figueredo A, Charette ML, Maroun J et al. Adjuvant therapy for stage II colon cancer: A systematic review from the Cancer Care Ontario Program in evidence-based care’s gastrointestinal cancer disease site group. J Clin Oncol 2004; 22: 3395–407.","year":2005,"lang":"en","type":"review","venue":"Cancer Treatment Reviews","topic":"Genetic factors in colorectal cancer","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Adjuvant therapy; Colorectal cancer; Stage (stratigraphy); Oncology; Adjuvant; Internal medicine; Cancer","score_opus":0.14000114603089833,"score_gpt":0.42623223677067673,"score_spread":0.28623109073977837,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1649073062","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.012107054,0.8530655,0.000009914717,0.002689752,0.0009661108,0.10998067,0.021018226,0.00015468766,0.000008066083],"genre_scores_gemma":[0.0002687724,0.68267065,0.00081020885,0.0051801912,0.0006630857,0.30578908,0.0033143645,0.0003889287,0.00091470213],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.98602414,0.001889939,0.0044214088,0.003894761,0.0016368667,0.0021328765],"domain_scores_gemma":[0.98739994,0.0024368109,0.00493459,0.0029824933,0.0013553376,0.000890828],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":["metaepi_narrow"],"category_scores_codex":[0.0014275005,0.0034177953,0.012176767,0.00034135766,0.00057986466,0.00022683963,0.0015788971,0.0005446733,0.0034103931],"category_scores_gemma":[0.00057752186,0.0020666365,0.0024106335,0.0014589337,0.00031620217,0.0005147449,0.00019745866,0.0016934612,0.000026248033],"study_design_candidate":"systematic_review","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":true,"study_design_scores_codex":[0.010776356,0.001289965,0.028781548,0.3201878,0.0014611292,0.00012655389,0.0027271425,0.00032980932,0.000027619733,4.4559923e-7,0.010106946,0.62418467],"study_design_scores_gemma":[0.006190778,0.0055581713,0.0021703439,0.47670496,0.005810802,0.0000033343324,0.00006820508,0.0000693542,0.000010412853,2.499848e-7,0.5023225,0.0010908963],"about_ca_topic_score_codex":0.366102,"about_ca_topic_score_gemma":0.8109124,"teacher_disagreement_score":0.6230938,"about_ca_system_score_codex":0.037808195,"about_ca_system_score_gemma":0.02370711,"threshold_uncertainty_score":0.9981781},"labels":[],"label_agreement":null},{"id":"W1699998114","doi":"10.1016/j.ctrv.2004.08.003","title":"Adjuvant chemotherapy with uracil–tegafur prolongs overall survival in people with primary adenocarcinoma of the lung☆☆☆☆☆☆Abstracted from: Kato H, Ichinose Y, Ohta M, et al. A randomized trial of adjuvant chemotherapy with uracil–tegafur for adenocarcinoma of the lung. N Engl J Med 2004;350:1713–21.","year":2004,"lang":"en","type":"letter","venue":"Cancer Treatment Reviews","topic":"Medical Imaging and Pathology Studies","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Cancer Care Ontario","funders":"","keywords":"Medicine; Chemotherapy; Tegafur; Adenocarcinoma; Adjuvant; Internal medicine; Oncology; Randomized controlled trial; Lung; Adjuvant chemotherapy; Adenocarcinoma of the lung; Gastroenterology; Lung cancer; Surgery; Cancer; Breast cancer","score_opus":0.02217442976376168,"score_gpt":0.29626116339422165,"score_spread":0.27408673363046,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1699998114","genre_codex":"empirical","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.4493984,0.24994124,0.00015858018,0.2577056,0.00065321475,0.0401927,0.0013046456,0.00008520738,0.00056041416],"genre_scores_gemma":[0.34718618,0.1803704,0.006436401,0.41002434,0.003811414,0.036590733,0.0038957542,0.001384118,0.010300643],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99176985,0.0015524833,0.0026022247,0.0015541045,0.0015380078,0.000983336],"domain_scores_gemma":[0.99202895,0.0012863077,0.0036867429,0.0022648415,0.000530645,0.00020253945],"candidate_categories":["metaepi_narrow"],"consensus_categories":["metaepi_narrow"],"category_scores_codex":[0.0015415037,0.0017693063,0.008689822,0.00025198775,0.00014832453,0.000028069197,0.0007992759,0.000663087,0.0001549954],"category_scores_gemma":[0.00026554568,0.0007434667,0.0014440303,0.00071986846,0.0014955625,0.0001407617,0.0000901759,0.0017581485,0.0000016477002],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.6724416,0.003114156,0.13843964,0.0066544507,0.010057885,0.00035147413,0.010978495,0.00004360933,0.00024148391,0.000013300982,0.15132436,0.006339507],"study_design_scores_gemma":[0.81622803,0.004524421,0.075603776,0.013294348,0.009391358,0.00016431979,0.0001446342,0.000060008493,0.00093415636,0.000033916152,0.07851381,0.00110721],"about_ca_topic_score_codex":0.0035667152,"about_ca_topic_score_gemma":0.0011967449,"teacher_disagreement_score":0.15231875,"about_ca_system_score_codex":0.0009998315,"about_ca_system_score_gemma":0.003076978,"threshold_uncertainty_score":0.9995053},"labels":[],"label_agreement":null},{"id":"W1782889137","doi":"10.1016/s0305-7372(02)00128-7","title":"Annual screening may not decrease breast cancer deaths among women aged 40 to 49 years☆☆☆★Abstracted from: Miller A, To T, Baines C, Wall C. The Canadian National Breast Screening Study-1: breast cancer mortality after 11 to 16 years of follow-up. Annals of Internal Medicine 2002; 137: 306–12.","year":2003,"lang":"en","type":"letter","venue":"Cancer Treatment Reviews","topic":"Global Cancer Incidence and Screening","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Breast cancer; Mammography; Gynecology; Demography; Cancer; Gerontology; Internal medicine","score_opus":0.11389119629263876,"score_gpt":0.37695858823160594,"score_spread":0.26306739193896717,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1782889137","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.79667753,0.013333468,0.000051753937,0.13796055,0.0011697019,0.008456864,0.04182292,0.00006881691,0.0004583757],"genre_scores_gemma":[0.59946436,0.0032363564,0.00043813995,0.3758937,0.0047094407,0.008082308,0.0006953884,0.00030569552,0.007174597],"study_design_codex":"not_applicable","study_design_gemma":"observational","domain_scores_codex":[0.9912604,0.0006300735,0.0022893124,0.0017350302,0.0024114267,0.0016737352],"domain_scores_gemma":[0.9936723,0.00020792395,0.0011549231,0.001367483,0.0015445618,0.0020527816],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":["metaepi_narrow"],"category_scores_codex":[0.0014692254,0.0013938759,0.0032652523,0.0008721406,0.00022248327,0.0000817111,0.00092377426,0.00055575866,0.00883229],"category_scores_gemma":[0.00023494483,0.0010373523,0.00076255755,0.0012989286,0.000278384,0.00031020076,0.00018752375,0.0010211532,0.000047628626],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0023034064,0.00017745781,0.39977354,0.00023063779,0.0026020007,0.0006976131,0.0045842757,0.00015099025,0.000036616104,4.6757285e-7,0.5212248,0.06821819],"study_design_scores_gemma":[0.00230116,0.00036384133,0.6675248,0.006060874,0.001186517,0.000078165016,0.0005289455,0.000004843743,0.00002062079,0.0000015823781,0.3212694,0.0006592378],"about_ca_topic_score_codex":0.87895995,"about_ca_topic_score_gemma":0.79937166,"teacher_disagreement_score":0.26775128,"about_ca_system_score_codex":0.0041956003,"about_ca_system_score_gemma":0.0024737807,"threshold_uncertainty_score":0.99988115},"labels":[],"label_agreement":null},{"id":"W1814699096","doi":"10.1016/j.ctrv.2004.08.002","title":"Gefitinib does not improve survival when combined with paclitaxel and carboplatin chemotherapy in people with advanced non-small-cell lung cancer☆☆☆☆Abstracted from: Herbst RS, Giaccone G, Schiller JH et al. Gefitinib in combination with paclitaxel and carboplatin in advanced non-small-cell lung cancer: a phase III trial – INTACT 2. J Clin Oncol 2004;22:785–94.","year":2004,"lang":"en","type":"letter","venue":"Cancer Treatment Reviews","topic":"Lung Cancer Treatments and Mutations","field":"Medicine","cited_by":406,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Cancer Care Ontario","funders":"","keywords":"Gefitinib; Medicine; Carboplatin; Paclitaxel; Lung cancer; Chemotherapy; Oncology; Internal medicine; Tyrosine-kinase inhibitor; Epidermal growth factor receptor; Cancer; Cisplatin","score_opus":0.01463295194877606,"score_gpt":0.32321337576972325,"score_spread":0.3085804238209472,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1814699096","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8928692,0.042552575,0.00006519874,0.03167735,0.0007036021,0.028970672,0.0025730275,0.00010045723,0.00048796798],"genre_scores_gemma":[0.54010725,0.27169362,0.009373163,0.06727476,0.0019549385,0.08897269,0.01299256,0.0014749808,0.0061560413],"study_design_codex":"observational","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9920209,0.0004654111,0.0023752977,0.0028310195,0.000821693,0.001485663],"domain_scores_gemma":[0.99501663,0.0005798415,0.0023882708,0.0011960436,0.00034529532,0.0004738976],"candidate_categories":["metaepi_narrow"],"consensus_categories":["metaepi_narrow"],"category_scores_codex":[0.00054824055,0.0023990332,0.005096148,0.0007073262,0.00021618648,0.0002321655,0.00031410347,0.0008183024,0.00020684289],"category_scores_gemma":[0.00003022522,0.0015985701,0.00030043806,0.00096049934,0.0002409414,0.00068617135,0.000074577736,0.0021170403,0.0000019780973],"study_design_candidate":"randomized_trial","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.2660007,0.022349657,0.4287684,0.016693415,0.008818368,0.004553122,0.04191408,0.002387171,0.0076030996,0.000015506053,0.011037456,0.18985905],"study_design_scores_gemma":[0.8783428,0.016892921,0.026263006,0.025980389,0.0059937057,0.000025744936,0.0013696476,0.00091509067,0.0026640596,0.000017852439,0.03764297,0.0038918164],"about_ca_topic_score_codex":0.08312356,"about_ca_topic_score_gemma":0.15984346,"teacher_disagreement_score":0.6123421,"about_ca_system_score_codex":0.0063881557,"about_ca_system_score_gemma":0.004141427,"threshold_uncertainty_score":0.9988747},"labels":[],"label_agreement":null},{"id":"W1867786678","doi":"10.1016/j.ctrv.2015.09.007","title":"Identifying an optimal antiemetic regimen for patients receiving anthracycline and cyclophosphamide-based chemotherapy for breast cancer – An inspection of the evidence base informing clinical decision-making","year":2015,"lang":"en","type":"review","venue":"Cancer Treatment Reviews","topic":"Nausea and vomiting management","field":"Medicine","cited_by":13,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Hospital; University of Ottawa","funders":"Canadian Institutes of Health Research","keywords":"Medicine; Antiemetic; Nausea; Breast cancer; Randomized controlled trial; Regimen; Chemotherapy-induced nausea and vomiting; Intensive care medicine; Anthracycline; Cyclophosphamide; Vomiting; Oncology; Internal medicine; Chemotherapy; Cancer","score_opus":0.17517578384422972,"score_gpt":0.49847993703188065,"score_spread":0.32330415318765093,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1867786678","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.016078252,0.9703042,0.0023678332,0.000098602635,0.00056544435,0.010412945,0.00011397397,0.000050714978,0.000008056063],"genre_scores_gemma":[0.0037207478,0.97837,0.014292331,0.00019024668,0.00039272412,0.0028729432,0.00005806684,0.000079013116,0.000023921351],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99649,0.00023854978,0.0018072689,0.00079235126,0.0003148419,0.0003569989],"domain_scores_gemma":[0.99609023,0.0007272089,0.0017510303,0.000846621,0.0003757343,0.00020918908],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.001915323,0.00053823815,0.0024248783,0.00016377647,0.00025449853,0.000061026753,0.00022552213,0.00016039371,0.000024780278],"category_scores_gemma":[0.00052379165,0.00031339505,0.00074992544,0.0004049051,0.00011714092,0.00039349633,0.00005729464,0.00014683144,8.2609347e-7],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00052635715,0.00042560283,0.014580993,0.009172461,0.00018935952,0.0000011244342,0.00008835909,0.00000870477,0.000001262308,0.0000029834075,0.000101733654,0.9749011],"study_design_scores_gemma":[0.009739274,0.003157364,0.018197225,0.23209193,0.008637375,0.000023881152,0.000070894646,0.0012332039,0.0000309959,0.000037197726,0.7259754,0.00080525974],"about_ca_topic_score_codex":0.00007312153,"about_ca_topic_score_gemma":0.00006498384,"teacher_disagreement_score":0.9740958,"about_ca_system_score_codex":0.00086559507,"about_ca_system_score_gemma":0.0005566226,"threshold_uncertainty_score":0.9999318},"labels":[],"label_agreement":null},{"id":"W1964917977","doi":"10.1016/s0305-7372(06)80002-2","title":"Optimizing patient therapy: the role of bone markers?","year":2006,"lang":"en","type":"review","venue":"Cancer Treatment Reviews","topic":"Bone health and treatments","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; Hôpital Notre-Dame","funders":"","keywords":"Medicine; Bone remodeling; Bone disease; Oncology; Disease; Internal medicine; Cancer; Osteoporosis","score_opus":0.07744950362391258,"score_gpt":0.3827776965620042,"score_spread":0.30532819293809166,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1964917977","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00001162148,0.98668516,6.945074e-7,0.000073454925,0.000196084,0.00744706,0.00011442996,0.000028432227,0.005443084],"genre_scores_gemma":[0.000007417044,0.9922808,0.00037484162,0.00015371469,0.00013903048,0.005309957,0.00031992543,0.000080759884,0.0013335575],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9970802,0.00030594977,0.0014285428,0.0005053328,0.0002482877,0.0004317047],"domain_scores_gemma":[0.99746203,0.000101618076,0.0012208563,0.0009781986,0.000053590687,0.00018371],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00017809875,0.0007345749,0.0040844907,0.00011463061,0.00011178539,0.000013362533,0.00010411271,0.00020902902,0.00024353151],"category_scores_gemma":[0.000009959528,0.0003234765,0.001543312,0.00034526642,0.0000743103,0.00003154005,0.00002824692,0.00020495856,0.000090733534],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000044003016,0.00045938315,0.000082311984,0.0064471094,0.00057406496,0.000019766814,0.00007356197,1.5192713e-7,1.5902147e-7,0.000006763442,0.0013237938,0.99096894],"study_design_scores_gemma":[0.0009348973,0.0007463182,0.000013755122,0.020543829,0.003741333,0.000047873367,0.0000087167755,8.3361135e-7,0.0000072638964,0.000005544663,0.9737548,0.00019483615],"about_ca_topic_score_codex":0.0013314368,"about_ca_topic_score_gemma":0.000066290326,"teacher_disagreement_score":0.9907741,"about_ca_system_score_codex":0.0009527881,"about_ca_system_score_gemma":0.00070365483,"threshold_uncertainty_score":0.99992174},"labels":[],"label_agreement":null},{"id":"W1968104780","doi":"10.1016/j.ctrv.2010.01.004","title":"New developments in arc radiation therapy: A review","year":2010,"lang":"en","type":"review","venue":"Cancer Treatment Reviews","topic":"Advanced Radiotherapy Techniques","field":"Physics and Astronomy","cited_by":144,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"Ontario Institute for Cancer Research; Vanderbilt University Medical Center; Varian Medical Systems","keywords":"Medicine; Radiation therapy; Arc (geometry); Medical physics; Radiation oncology; Internal medicine","score_opus":0.062250255176207664,"score_gpt":0.41000702395242117,"score_spread":0.34775676877621353,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1968104780","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[5.3651764e-8,0.99038273,0.0011168816,0.00003615503,0.00024261099,0.0062819035,0.000046685393,0.000053832417,0.0018391431],"genre_scores_gemma":[1.4312143e-8,0.9791653,0.009472138,0.00016851148,0.00056741067,0.008291724,0.000362135,0.00010144682,0.0018713174],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99740756,0.00023475623,0.0011783201,0.0006587093,0.000138424,0.0003822378],"domain_scores_gemma":[0.99811345,0.000051896604,0.00094585464,0.00072300364,0.000020186013,0.0001455808],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00021299966,0.00086149026,0.003414592,0.00015137345,0.000050138155,0.00003004493,0.0003601725,0.00015941048,0.0018229935],"category_scores_gemma":[0.000004087816,0.0005611175,0.0008014329,0.00052309333,0.000020297566,0.00013313656,0.000023245368,0.00038522438,0.000078579775],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0000011608753,0.00006695395,0.00012431736,0.0037330452,0.00013506711,0.000001311546,0.00002444209,2.3266535e-8,3.2081581e-7,0.000077779914,0.0031778822,0.9926577],"study_design_scores_gemma":[0.00035871088,0.00003771018,0.0000033628955,0.056372628,0.00028919757,0.0000014034558,1.9494044e-7,7.70757e-8,0.0000067797155,0.000048484133,0.94242644,0.00045503024],"about_ca_topic_score_codex":0.0003134468,"about_ca_topic_score_gemma":0.000023173647,"teacher_disagreement_score":0.99220264,"about_ca_system_score_codex":0.00081921363,"about_ca_system_score_gemma":0.0009804677,"threshold_uncertainty_score":0.99968404},"labels":[],"label_agreement":null},{"id":"W1971209307","doi":"10.1016/j.ctrv.2013.09.001","title":"HER2 testing: Current status and future directions","year":2013,"lang":"en","type":"review","venue":"Cancer Treatment Reviews","topic":"HER2/EGFR in Cancer Research","field":"Medicine","cited_by":161,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ontario Institute for Cancer Research","funders":"Genentech","keywords":"Medicine; Clinical Oncology; Human Epidermal Growth Factor Receptor 2; Medical physics; Breast cancer; Oncology; Intensive care medicine; Gynecology; Cancer; Internal medicine","score_opus":0.33526958615058944,"score_gpt":0.5178544713757319,"score_spread":0.1825848852251425,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1971209307","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0000020958855,0.98678756,7.317486e-7,0.000226004,0.0012476037,0.008060629,0.00015984353,0.00010230295,0.0034132276],"genre_scores_gemma":[3.0020473e-8,0.9774729,0.0005003219,0.000047874008,0.0033891941,0.014586846,0.00021445875,0.00012932188,0.0036590623],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99655,0.00036281403,0.0009963785,0.0009705487,0.00034913063,0.00077108864],"domain_scores_gemma":[0.997474,0.00017533588,0.00045985304,0.000996841,0.00015682349,0.0007371301],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00023052077,0.0009095986,0.0038680607,0.00024502625,0.00016164828,0.00008780938,0.00014940709,0.0002669213,0.0014958365],"category_scores_gemma":[0.00009705018,0.0005292612,0.00068961876,0.0008778781,0.00012461164,0.00007023862,0.00008368607,0.00067060697,0.0006735604],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0000030258554,0.00016553556,0.00020031404,0.041749854,0.00024163236,0.000012402659,0.000052837753,6.0771503e-9,8.558041e-8,0.000008040383,0.012704704,0.9448616],"study_design_scores_gemma":[0.0004277085,0.00036847207,0.000051130137,0.043917254,0.0031065994,0.000072692004,0.000006395453,7.2416566e-7,3.6927406e-7,0.000003840234,0.9516737,0.0003711474],"about_ca_topic_score_codex":0.0007592016,"about_ca_topic_score_gemma":0.00008299767,"teacher_disagreement_score":0.94449043,"about_ca_system_score_codex":0.0030563727,"about_ca_system_score_gemma":0.0019993074,"threshold_uncertainty_score":0.9997159},"labels":[],"label_agreement":null},{"id":"W1974605771","doi":"10.1016/j.ctrv.2010.02.009","title":"Possibilities of new therapeutic strategies in brain tumors","year":2010,"lang":"en","type":"review","venue":"Cancer Treatment Reviews","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":37,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"SickKids Foundation; Hospital for Sick Children","funders":"","keywords":"Medicine; Intensive care medicine; Medical physics","score_opus":0.1312581474431459,"score_gpt":0.42972007438482407,"score_spread":0.29846192694167817,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1974605771","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00023666394,0.9935341,7.602719e-7,0.00020375662,0.0001914243,0.0045219553,0.000062657076,0.000024465206,0.0012242433],"genre_scores_gemma":[0.000034147462,0.9951114,0.00017696085,0.00008247732,0.0002113332,0.002410008,0.00015007242,0.00006633839,0.0017572591],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9973324,0.00017865867,0.00134775,0.0005930876,0.00018692037,0.0003612036],"domain_scores_gemma":[0.99801826,0.00018720562,0.000677156,0.00089117966,0.000033772216,0.00019241737],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00018235095,0.0007872966,0.005022742,0.0002897209,0.000025645337,0.000031861535,0.00015384429,0.00028273094,0.00057627936],"category_scores_gemma":[0.000026918626,0.00043322114,0.0012991739,0.00043453692,0.000093522205,0.000072900904,0.00002316037,0.000265107,0.00007284447],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000010455986,0.0005351277,0.00039167827,0.013453687,0.0003259822,0.00006517146,0.00023273322,1.5277146e-7,0.0000026537352,0.00022973419,0.0005616112,0.984191],"study_design_scores_gemma":[0.0012294626,0.00052649877,0.00015649633,0.04602882,0.0027621067,0.000047267444,0.00004472281,2.064805e-7,0.0000199586,0.0001304351,0.94879633,0.00025768427],"about_ca_topic_score_codex":0.0017483335,"about_ca_topic_score_gemma":0.001126326,"teacher_disagreement_score":0.9839333,"about_ca_system_score_codex":0.00077804667,"about_ca_system_score_gemma":0.0021638388,"threshold_uncertainty_score":0.99981195},"labels":[],"label_agreement":null},{"id":"W1980359360","doi":"10.1016/j.ctrv.2009.12.008","title":"Ingestion of selenium and other antioxidants during prostate cancer radiotherapy: A good thing?","year":2010,"lang":"en","type":"review","venue":"Cancer Treatment Reviews","topic":"Selenium in Biological Systems","field":"Nursing","cited_by":63,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Sciences Centre; University Health Network; Princess Margaret Cancer Centre; University of Toronto; Sunnybrook Health Science Centre","funders":"","keywords":"Medicine; Prostate cancer; Radiation therapy; Cancer; Oncology; Chemotherapy; Clinical trial; Prostate; Internal medicine; Pharmacology; Bioinformatics; Biology","score_opus":0.06416306169515845,"score_gpt":0.3762800237607115,"score_spread":0.31211696206555306,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1980359360","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.003042941,0.989825,0.0000013395418,0.000055284792,0.0014834092,0.005120254,0.00024380194,0.00009199254,0.00013594051],"genre_scores_gemma":[0.00016766349,0.99468005,0.0003178094,0.000062007384,0.00081822625,0.003338582,0.000028733217,0.0001288827,0.0004580608],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99634403,0.00065561023,0.0013721511,0.0009252786,0.00020122268,0.0005017028],"domain_scores_gemma":[0.9972804,0.00012619013,0.0017514423,0.00063741027,0.00005486591,0.0001496814],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0004058243,0.0009134102,0.0038620185,0.00015266541,0.00013157856,0.000057419988,0.00026600604,0.0006074237,0.00016942894],"category_scores_gemma":[0.000034206183,0.0005357413,0.00061225,0.00038224642,0.00014136688,0.000097878255,0.00003814182,0.00041843185,0.000013703025],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000057143578,0.0001054854,0.0024382044,0.024703508,0.00026318894,0.000001182942,0.00035543158,4.0522116e-7,0.0007632065,0.0000049702717,0.0000704405,0.9712368],"study_design_scores_gemma":[0.00063989096,0.0002039482,0.00011297427,0.03937389,0.0013425811,0.000036923666,0.000004321252,0.0000020869138,0.00041491224,0.0000037791094,0.95737123,0.0004934859],"about_ca_topic_score_codex":0.0010230065,"about_ca_topic_score_gemma":0.00023906451,"teacher_disagreement_score":0.97074336,"about_ca_system_score_codex":0.0010370025,"about_ca_system_score_gemma":0.00011073238,"threshold_uncertainty_score":0.9997094},"labels":[],"label_agreement":null},{"id":"W1986348063","doi":"10.1016/j.ctrv.2012.07.005","title":"MicroRNAs: Novel mediators of resistance to microtubule-targeting agents","year":2012,"lang":"en","type":"review","venue":"Cancer Treatment Reviews","topic":"MicroRNA in disease regulation","field":"Biochemistry, Genetics and Molecular Biology","cited_by":45,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Wellington Medical Research Foundation; University of Victoria","keywords":"microRNA; Paclitaxel; Drug resistance; Cancer research; Medicine; Function (biology); Suppressor; Vincristine; Gene; Bioinformatics; Cell biology; Cancer; Biology; Genetics; Chemotherapy","score_opus":0.06283064558799728,"score_gpt":0.3593625567153348,"score_spread":0.2965319111273375,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1986348063","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000144648,0.9958203,0.00006867103,0.000012180255,0.00045384455,0.0027627058,0.00057061046,0.000009451021,0.00015759333],"genre_scores_gemma":[0.000021228967,0.9934114,0.0013519063,0.000048972255,0.000590532,0.0015379188,0.0013228725,0.00009847697,0.0016166583],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9974891,0.00017454669,0.0010946484,0.0006902824,0.0001247075,0.00042670267],"domain_scores_gemma":[0.99783784,0.00001678937,0.0010059585,0.00084916595,0.000078055404,0.00021220432],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00024844156,0.0006725129,0.0017892017,0.000103411,0.00005478528,0.000014645653,0.00036317096,0.0003082715,0.00013708527],"category_scores_gemma":[0.00004838685,0.0005059842,0.0009187359,0.0002603975,0.000048939448,0.0000048341076,0.000117427015,0.000074962874,0.00011050524],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000021773267,0.0002605015,0.000058995673,0.022074316,0.00064407033,0.0000011072827,0.000055566263,0.0000010495688,0.01604936,0.000002899387,0.021321932,0.93950844],"study_design_scores_gemma":[0.00028805243,0.000046184407,0.000010175085,0.008921644,0.001605715,0.0000025619654,0.0000023786067,2.7488715e-8,0.005902393,2.8405069e-7,0.98280907,0.00041149312],"about_ca_topic_score_codex":0.00001972098,"about_ca_topic_score_gemma":0.000036910234,"teacher_disagreement_score":0.9614872,"about_ca_system_score_codex":0.00043081143,"about_ca_system_score_gemma":0.00034041813,"threshold_uncertainty_score":0.99973917},"labels":[],"label_agreement":null},{"id":"W1988277782","doi":"10.1016/j.ctrv.2011.05.002","title":"Locoregional radiological treatment for hepatocellular carcinoma; Which, when and how?","year":2011,"lang":"en","type":"review","venue":"Cancer Treatment Reviews","topic":"Hepatocellular Carcinoma Treatment and Prognosis","field":"Medicine","cited_by":65,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; University of Alberta; University of Alberta Hospital; Alberta Hospital Edmonton","funders":"","keywords":"Medicine; Hepatocellular carcinoma; Percutaneous ethanol injection; Radiofrequency ablation; Response Evaluation Criteria in Solid Tumors; Liver transplantation; Stage (stratigraphy); Radiological weapon; Milan criteria; Target lesion; Radiology; Sorafenib; Curative treatment; Percutaneous; Oncology; Transplantation; Surgery; Internal medicine; Ablation; Progressive disease; Disease","score_opus":0.3692608274712213,"score_gpt":0.35966202905389855,"score_spread":0.009598798417322751,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1988277782","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00023014261,0.9808455,0.00005065586,0.00034076645,0.0002778397,0.017205331,0.0004349579,0.00010174205,0.00051304017],"genre_scores_gemma":[0.00017338313,0.95788276,0.0016895455,0.000087856955,0.0009770717,0.031030478,0.002517624,0.00018029723,0.0054609813],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99586546,0.0004218802,0.0009991156,0.0016611107,0.00019340038,0.00085904903],"domain_scores_gemma":[0.9971186,0.00023754511,0.0007303998,0.0010800398,0.00013465917,0.0006987496],"candidate_categories":["metaepi_narrow"],"consensus_categories":["metaepi_narrow"],"category_scores_codex":[0.00026508348,0.001846761,0.0069275275,0.0002681667,0.00022354675,0.000074571384,0.00020663992,0.00075778266,0.00041549292],"category_scores_gemma":[0.00003865346,0.0010247931,0.0027562163,0.00028659008,0.0001762317,0.000092521004,0.00005863575,0.00021458606,0.00010550449],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00010356615,0.0005604716,0.01895388,0.011814135,0.0017210525,0.00017464478,0.00018065606,2.971545e-9,6.285404e-7,0.00013098904,0.0029195403,0.9634404],"study_design_scores_gemma":[0.003038537,0.0039363066,0.000032497523,0.0084620705,0.02146999,0.0003382853,0.000007622839,0.000028355425,0.000013609758,0.00003391842,0.96185666,0.0007821309],"about_ca_topic_score_codex":0.00020414384,"about_ca_topic_score_gemma":0.000047019326,"teacher_disagreement_score":0.9626583,"about_ca_system_score_codex":0.0020448072,"about_ca_system_score_gemma":0.00095564144,"threshold_uncertainty_score":0.9994277},"labels":[],"label_agreement":null},{"id":"W1988557714","doi":"10.1016/j.ctrv.2003.10.002","title":"Epidermal growth factor receptor: a promising target in solid tumours","year":2003,"lang":"en","type":"review","venue":"Cancer Treatment Reviews","topic":"HER2/EGFR in Cancer Research","field":"Medicine","cited_by":254,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"Medicine; Epidermal growth factor receptor; Monoclonal antibody; Tyrosine kinase; Cancer research; Cancer; Receptor tyrosine kinase; Signal transduction; Targeted therapy; EGFR inhibitors; Cetuximab; Blockade; Pharmacology; Receptor; Immunology; Antibody; Internal medicine; Biology; Cell biology","score_opus":0.2218575342477881,"score_gpt":0.48518779668646167,"score_spread":0.2633302624386736,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1988557714","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000010353569,0.9832271,0.000005201561,0.0002506722,0.00068928854,0.010952605,0.00025530116,0.00006665038,0.004542847],"genre_scores_gemma":[0.000001971731,0.982815,0.0011000521,0.00022113489,0.0007580787,0.009762565,0.00035632245,0.0002449556,0.0047398764],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99328786,0.0012672376,0.002140364,0.0014232382,0.0005969771,0.001284344],"domain_scores_gemma":[0.99710065,0.00018091834,0.0007959245,0.0011678564,0.00012660588,0.0006280295],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":["metaepi_narrow","insufficient_payload"],"category_scores_codex":[0.000790698,0.0013495771,0.0074592438,0.0005395356,0.00009866651,0.00006892691,0.00036947074,0.00051350804,0.0039162305],"category_scores_gemma":[0.00027531755,0.00088363036,0.0016107925,0.0011373882,0.00013426322,0.00011925014,0.00007191265,0.0009851505,0.0010625252],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000020143476,0.00033247203,0.0008249507,0.045196943,0.00027562713,0.00016903851,0.00012600033,1.3487012e-7,0.000002645503,0.000009127849,0.0105285635,0.94251436],"study_design_scores_gemma":[0.0010756458,0.0003924149,0.000017473149,0.08023968,0.0010157553,0.00009540491,0.000006099575,8.4092346e-7,0.000039376886,0.0000070222245,0.91651666,0.000593631],"about_ca_topic_score_codex":0.00041399742,"about_ca_topic_score_gemma":0.00008933489,"teacher_disagreement_score":0.9419207,"about_ca_system_score_codex":0.009079195,"about_ca_system_score_gemma":0.0040913112,"threshold_uncertainty_score":0.9999255},"labels":[],"label_agreement":null},{"id":"W1992904267","doi":"10.1016/j.ctrv.2012.07.004","title":"Photodynamic therapy of malignant brain tumours: A complementary approach to conventional therapies","year":2012,"lang":"en","type":"review","venue":"Cancer Treatment Reviews","topic":"Photodynamic Therapy Research Studies","field":"Medicine","cited_by":136,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre d'expertise et de recherche en infrastructures urbaines","funders":"Ligue Contre le Cancer; Agence Nationale de la Recherche","keywords":"Medicine; Photodynamic therapy; Oncology","score_opus":0.17740687088413024,"score_gpt":0.4395065235343096,"score_spread":0.2620996526501793,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1992904267","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00017442573,0.984579,0.000017719634,0.0002384367,0.00020541833,0.012987151,0.0009222158,0.00004489641,0.00083068846],"genre_scores_gemma":[0.000031237058,0.9828891,0.00071080256,0.0003876567,0.00034903496,0.012561817,0.001292001,0.00012684651,0.0016515163],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99594575,0.00049759314,0.0014544898,0.0007950567,0.0005428973,0.0007642236],"domain_scores_gemma":[0.9975885,0.00020106514,0.00077108206,0.00097550347,0.000107088665,0.00035676782],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0007384344,0.0010597833,0.005576838,0.00038683013,0.000111272486,0.000017901248,0.00039218503,0.00015526952,0.001058727],"category_scores_gemma":[0.000016301308,0.00060520484,0.0018723417,0.000588625,0.0002097128,0.00006536557,0.00010514022,0.0002656304,0.00009311697],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00012211196,0.0013399564,0.00005019408,0.013757698,0.0033605644,0.00000658669,0.000446165,1.12802915e-7,0.000115804614,0.000057668905,0.002937459,0.9778057],"study_design_scores_gemma":[0.0017789771,0.00087403954,0.000075436124,0.016883707,0.0015828077,0.000057693487,0.000051923103,0.0000012885902,0.000031664087,0.000010166925,0.97821987,0.0004324343],"about_ca_topic_score_codex":0.0003852454,"about_ca_topic_score_gemma":0.000047437054,"teacher_disagreement_score":0.97737324,"about_ca_system_score_codex":0.001670952,"about_ca_system_score_gemma":0.00064913975,"threshold_uncertainty_score":0.99985445},"labels":[],"label_agreement":null},{"id":"W1995994098","doi":"10.1016/j.ctrv.2008.03.039","title":"OC13. Development of the European organization for research and treatment of cancer bone metastases module (BMM) (EORTC QLQ-BM22)","year":2008,"lang":"en","type":"article","venue":"Cancer Treatment Reviews","topic":"Radiopharmaceutical Chemistry and Applications","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Sciences Centre; Sunnybrook Health Science Centre","funders":"","keywords":"Medicine; Cancer; Oncology; Medical physics; Internal medicine","score_opus":0.2803384651569181,"score_gpt":0.45414330770804356,"score_spread":0.17380484255112544,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1995994098","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8939759,0.101146385,0.000079892954,0.0008614839,0.00003293451,0.0028479493,0.00011926994,0.000015201742,0.00092099165],"genre_scores_gemma":[0.8639819,0.13056138,0.0017154496,0.000040379928,0.00013885059,0.0010583644,0.000099105346,0.000031285876,0.002373277],"study_design_codex":"design_other","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9990014,0.000072651776,0.000397863,0.00023367231,0.00013843879,0.00015597194],"domain_scores_gemma":[0.99923974,0.000043417353,0.0001468329,0.000295678,0.00017675501,0.00009760315],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00016019995,0.00014487546,0.0004246171,0.000027078175,0.00020323369,0.0000036441131,0.000061229744,0.000024529629,0.00010679665],"category_scores_gemma":[0.00002776454,0.00007960847,0.00008185109,0.00031430644,0.00016530215,0.00002195656,0.000019623616,0.000033854645,0.000003322565],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00017680832,0.0028871873,0.038422175,0.0012469905,0.00071571383,0.000007693974,0.0021241242,0.000018066294,0.13833152,0.00015120427,0.002011003,0.8139075],"study_design_scores_gemma":[0.0015338605,0.0001940817,0.010253409,0.0002202278,0.00032945746,0.000011791727,0.000022737457,0.000007733064,0.576964,0.000007998658,0.41038513,0.00006956736],"about_ca_topic_score_codex":0.00006039505,"about_ca_topic_score_gemma":0.000020787564,"teacher_disagreement_score":0.81383795,"about_ca_system_score_codex":0.0003625496,"about_ca_system_score_gemma":0.0002105922,"threshold_uncertainty_score":0.32463393},"labels":[],"label_agreement":null},{"id":"W1996168994","doi":"10.1016/j.ctrv.2008.03.098","title":"P72. Dexamethasone for the prophylaxis of radiation-induced pain flare following palliative radiotherapy for bone metastases: A phase II study","year":2008,"lang":"en","type":"article","venue":"Cancer Treatment Reviews","topic":"Management of metastatic bone disease","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; Sunnybrook Health Science Centre","funders":"","keywords":"Medicine; Dexamethasone; Radiation therapy; Flare; Oncology; Surgery; Internal medicine","score_opus":0.1254565380039686,"score_gpt":0.41854004315942855,"score_spread":0.29308350515545994,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1996168994","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.56819266,0.3026494,0.06355722,0.0017262767,0.0003926144,0.06261486,0.0007638257,0.00006802846,0.000035126133],"genre_scores_gemma":[0.8619683,0.054253396,0.02475809,0.0013567819,0.00041016695,0.054732937,0.00050929846,0.00013365263,0.0018774023],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9976091,0.00042200298,0.0008269601,0.000491459,0.00033611356,0.00031438985],"domain_scores_gemma":[0.9977561,0.0007361244,0.00053913,0.0007065552,0.00011611132,0.00014597498],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0016171183,0.0003901532,0.001366863,0.00012908466,0.00031948337,0.000012370853,0.00013601617,0.000037792863,0.00016313574],"category_scores_gemma":[0.00058432895,0.00022317212,0.0008751196,0.00039500147,0.000045907378,0.00008735757,0.000017048713,0.000060421728,0.0000014022565],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.001350542,0.0058122827,0.002851896,0.00074548007,0.0040945355,0.00003153818,0.004916446,0.000009284926,0.0006157748,0.000016261976,0.0035286192,0.9760273],"study_design_scores_gemma":[0.09827261,0.059237916,0.0020323228,0.00083761464,0.01561945,0.000004028421,0.0028947464,0.0021135022,0.0039374726,0.000026296497,0.81433064,0.0006934176],"about_ca_topic_score_codex":0.00019123645,"about_ca_topic_score_gemma":0.00005067119,"teacher_disagreement_score":0.9753339,"about_ca_system_score_codex":0.00041292072,"about_ca_system_score_gemma":0.0002784611,"threshold_uncertainty_score":0.91006947},"labels":[],"label_agreement":null},{"id":"W1998765212","doi":"10.1016/j.ctrv.2008.05.001","title":"Bone markers and their prognostic value in metastatic bone disease: Clinical evidence and future directions","year":2008,"lang":"en","type":"review","venue":"Cancer Treatment Reviews","topic":"Bone health and treatments","field":"Medicine","cited_by":122,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Juravinski Cancer Centre; McMaster University; University of Waterloo","funders":"National Cancer Institute; Cancer Research UK; Novartis Pharmaceuticals Corporation; Novartis","keywords":"Medicine; Oncology; Disease; Value (mathematics); Bone disease; Internal medicine; Intensive care medicine; Osteoporosis","score_opus":0.17814975031118124,"score_gpt":0.4584829651475898,"score_spread":0.28033321483640855,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1998765212","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00017253046,0.98967916,7.842992e-7,0.0007323469,0.00036244164,0.008798476,0.00014743951,0.00004149083,0.00006531059],"genre_scores_gemma":[0.000012229715,0.99173284,0.00037159206,0.0002079162,0.0003281272,0.006419153,0.00017704767,0.00006950924,0.00068157737],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.995805,0.00090261915,0.0016349492,0.0010138152,0.00016600206,0.00047756973],"domain_scores_gemma":[0.9971055,0.00072138215,0.0006140162,0.0006396518,0.00003694344,0.00088249857],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00039561008,0.00087555416,0.0048836307,0.00021586509,0.00014769142,0.000023648046,0.000056380268,0.00019455628,0.000054978667],"category_scores_gemma":[0.00023177799,0.0004813907,0.0007331511,0.0004961078,0.00019054042,0.00010404305,0.000041921572,0.0003931993,0.000032065145],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00009337508,0.00058936514,0.0070367684,0.02229342,0.000442797,0.00040081312,0.00005601945,1.2827852e-8,3.7008214e-9,0.0000047968138,0.00060500466,0.9684776],"study_design_scores_gemma":[0.0013696565,0.00052653946,0.008382971,0.05995452,0.006074502,0.00050765526,0.0000069597854,0.000003548744,1.2368253e-8,0.0000068838863,0.9228831,0.00028365318],"about_ca_topic_score_codex":0.00036998917,"about_ca_topic_score_gemma":0.00017586655,"teacher_disagreement_score":0.96819395,"about_ca_system_score_codex":0.0007320431,"about_ca_system_score_gemma":0.0012867164,"threshold_uncertainty_score":0.9997638},"labels":[],"label_agreement":null},{"id":"W2000127756","doi":"10.1016/j.ctrv.2012.02.001","title":"Biologic rationale and clinical activity of mTOR inhibitors in gynecological cancer","year":2012,"lang":"en","type":"review","venue":"Cancer Treatment Reviews","topic":"PI3K/AKT/mTOR signaling in cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":49,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto","funders":"","keywords":"Medicine; PI3K/AKT/mTOR pathway; Endometrial cancer; Ovarian cancer; Cancer; Cancer research; Sirolimus; Kinase; Protein kinase B; Targeted therapy; Oncology; Bioinformatics; Internal medicine; Signal transduction; Biology","score_opus":0.20128096533366224,"score_gpt":0.45457944599036504,"score_spread":0.2532984806567028,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2000127756","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0038852897,0.992789,0.0000056128183,0.000028989807,0.0007561073,0.0021339797,0.00028133934,0.0000073103784,0.000112394824],"genre_scores_gemma":[0.0005492444,0.9947444,0.00012690021,0.000059526068,0.0010707383,0.0028934195,0.00019147842,0.000036212074,0.0003280809],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9969565,0.0007183616,0.0010837476,0.0007819305,0.00010523282,0.00035417842],"domain_scores_gemma":[0.99827427,0.00015759145,0.00090439635,0.00047484942,0.000045558023,0.00014333458],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00059680076,0.00056472846,0.0023716772,0.00006990547,0.000038720427,0.000010776994,0.00021407778,0.000708783,0.0002157975],"category_scores_gemma":[0.00011079895,0.00035920047,0.0007184269,0.00018094882,0.00022105023,0.000007025714,0.00012402951,0.00022566918,0.00001244318],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000021224405,0.00027407048,0.006058501,0.0022570319,0.00024488068,0.0000013877308,0.0000069668326,0.000001095525,0.00010418406,0.000003056129,0.0006649834,0.99036264],"study_design_scores_gemma":[0.00045301425,0.00046603938,0.0003979735,0.0025747772,0.0008355081,0.0000038906865,0.0000010958413,8.140071e-7,0.00020081596,0.000002550899,0.99472475,0.00033878066],"about_ca_topic_score_codex":0.00014073619,"about_ca_topic_score_gemma":0.00047830192,"teacher_disagreement_score":0.99405974,"about_ca_system_score_codex":0.00042331402,"about_ca_system_score_gemma":0.0006119581,"threshold_uncertainty_score":0.999886},"labels":[],"label_agreement":null},{"id":"W2001948214","doi":"10.1016/j.ctrv.2012.05.004","title":"The evolving landscape of protein kinases in breast cancer: Clinical implications","year":2012,"lang":"en","type":"review","venue":"Cancer Treatment Reviews","topic":"HER2/EGFR in Cancer Research","field":"Medicine","cited_by":23,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Druggability; Medicine; Kinase; Breast cancer; Carcinogenesis; Cancer; Drug discovery; Bioinformatics; Cancer research; Internal medicine; Biology; Gene","score_opus":0.3287504679105725,"score_gpt":0.5473864501181303,"score_spread":0.21863598220755776,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2001948214","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000012635693,0.9872307,8.885619e-7,0.0016799241,0.00027852415,0.009067719,0.0005243339,0.000025108055,0.0011801663],"genre_scores_gemma":[0.000040796633,0.9717134,0.00007885334,0.000045032015,0.0010592927,0.025408281,0.00011237896,0.00009053401,0.0014513935],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99505323,0.00090592675,0.002316475,0.00066979724,0.00034532262,0.0007092312],"domain_scores_gemma":[0.99633336,0.00050666224,0.0010766211,0.0015675924,0.0001807308,0.00033503622],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0015440413,0.0006144379,0.0039129574,0.00018003116,0.0001229293,0.00003417489,0.000471487,0.0003120262,0.0007977727],"category_scores_gemma":[0.00013690119,0.00031059654,0.001220885,0.0009125472,0.00023313913,0.0000686915,0.000109986715,0.000615919,0.00012022209],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000021803897,0.00033204322,0.012979975,0.017466538,0.00028604528,0.000004955747,0.000020881174,5.1092886e-8,6.0793815e-7,0.000039159473,0.004086837,0.9647611],"study_design_scores_gemma":[0.0005650681,0.00014705025,0.0021784634,0.055488724,0.0019830891,0.00003727404,0.0000051191505,9.623194e-7,0.0000013260388,0.000006518656,0.93936396,0.00022245663],"about_ca_topic_score_codex":0.0015241756,"about_ca_topic_score_gemma":0.0010199123,"teacher_disagreement_score":0.96453863,"about_ca_system_score_codex":0.0020061708,"about_ca_system_score_gemma":0.0031145485,"threshold_uncertainty_score":0.9999346},"labels":[],"label_agreement":null},{"id":"W2002036713","doi":"10.1016/j.ctrv.2004.06.006","title":"Autologous tumour cell vaccine may reduce risk of tumour progression in people with primary renal cell carcinoma","year":2004,"lang":"en","type":"article","venue":"Cancer Treatment Reviews","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"Medicine; Renal cell carcinoma; Nephrectomy; Oncology; Cell; Carcinoma; Kidney; Internal medicine","score_opus":0.021932125755524574,"score_gpt":0.2912317810521755,"score_spread":0.26929965529665095,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2002036713","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8636377,0.12868729,0.000015740565,0.00039352255,0.00007903604,0.0034709387,0.000033044686,0.000043300784,0.0036394699],"genre_scores_gemma":[0.96158713,0.03128266,0.0043379264,0.00007087314,0.00013058042,0.0013266325,0.00012758255,0.00007277924,0.001063816],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9970377,0.00022564078,0.0009489926,0.0008151769,0.00039803362,0.00057445146],"domain_scores_gemma":[0.9979933,0.000047503814,0.0007830085,0.00076927623,0.00010397014,0.00030296427],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00025553527,0.00065471703,0.0017517251,0.00022799415,0.000076947894,0.000013248957,0.00016216614,0.00012888275,0.00012365846],"category_scores_gemma":[0.000012188495,0.0003832695,0.00034916683,0.0005951976,0.00005733376,0.00009746983,0.000050841805,0.0002665024,0.000056455934],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0026857005,0.005326623,0.8285605,0.0030798044,0.00017335934,0.0016135785,0.0016921542,0.0003561441,0.09225886,0.0000069881403,0.00077069446,0.06347561],"study_design_scores_gemma":[0.013058953,0.0056327404,0.6023057,0.0017162974,0.001414411,0.00017825513,0.00005796542,0.000006728793,0.3710277,0.00001042155,0.0042411005,0.00034968165],"about_ca_topic_score_codex":0.002647854,"about_ca_topic_score_gemma":0.00069344905,"teacher_disagreement_score":0.27876884,"about_ca_system_score_codex":0.0027168274,"about_ca_system_score_gemma":0.00094018865,"threshold_uncertainty_score":0.9998619},"labels":[],"label_agreement":null},{"id":"W2004606206","doi":"10.1016/s0305-7372(02)00089-0","title":"Management of the menopause in cancer survivors","year":2002,"lang":"en","type":"review","venue":"Cancer Treatment Reviews","topic":"Menopause: Health Impacts and Treatments","field":"Medicine","cited_by":9,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Sunnybrook Health Science Centre","funders":"","keywords":"Medicine; Menopause; Hormone replacement therapy (female-to-male); Cancer; Intensive care medicine; Hormone replacement; Surgical Menopause; Premature Menopause; Hormone therapy; Gynecology; Hormone; Breast cancer; Internal medicine; Testosterone (patch)","score_opus":0.19015083362911708,"score_gpt":0.44554605796313135,"score_spread":0.2553952243340143,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2004606206","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00005650558,0.9847933,2.437304e-7,0.00018347015,0.0006472939,0.010350598,0.0001981356,0.00002009704,0.0037503454],"genre_scores_gemma":[0.000013518339,0.97910315,0.00008399245,0.00012716709,0.00013435693,0.007262155,0.000058314516,0.00009413481,0.013123223],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9962456,0.0003745354,0.0016959592,0.0006948675,0.00036355076,0.0006254785],"domain_scores_gemma":[0.99710006,0.00005595523,0.0011326766,0.0013981168,0.00003665848,0.00027651025],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0002621449,0.00090150745,0.004477731,0.00019618914,0.000077561956,0.000013170629,0.00028418016,0.00022242255,0.001214682],"category_scores_gemma":[0.000008299709,0.0004210996,0.00029721012,0.0009426875,0.000073358526,0.00004783844,0.00008068791,0.00026223584,0.00012158701],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000016355358,0.00062874093,0.00037776414,0.07128067,0.0010533015,0.00009995598,0.000071723895,4.0152997e-7,1.6852749e-7,0.000018429284,0.00074771105,0.9257048],"study_design_scores_gemma":[0.0018975823,0.0006020573,0.00016430956,0.113167316,0.00877514,0.000017079026,0.0000035929527,4.5233014e-7,0.0000016989518,0.000002742472,0.87513065,0.00023738363],"about_ca_topic_score_codex":0.0042972923,"about_ca_topic_score_gemma":0.001480105,"teacher_disagreement_score":0.9254674,"about_ca_system_score_codex":0.0032662153,"about_ca_system_score_gemma":0.0004345171,"threshold_uncertainty_score":0.9998241},"labels":[],"label_agreement":null},{"id":"W2005542697","doi":"10.1016/j.ctrv.2008.01.002","title":"Cancer in pregnancy: Gaps, challenges and solutions","year":2008,"lang":"en","type":"review","venue":"Cancer Treatment Reviews","topic":"Cancer Risks and Factors","field":"Medicine","cited_by":159,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"SickKids Foundation; Hospital for Sick Children; University of Toronto","funders":"","keywords":"Medicine; Cancer; Pregnancy; Intensive care medicine; Oncology; Obstetrics; Internal medicine","score_opus":0.2552469059883008,"score_gpt":0.4302623060746265,"score_spread":0.1750154000863257,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2005542697","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000002264033,0.99346614,4.3363616e-7,0.00025901292,0.00036186088,0.0041053668,0.00021303122,0.00003849947,0.0015533743],"genre_scores_gemma":[0.000001363833,0.98855036,0.00003214423,0.000043563556,0.00039236437,0.009104808,0.0000802117,0.000078222634,0.0017169599],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9975609,0.0001395875,0.0008599494,0.0007891026,0.00015259377,0.0004978722],"domain_scores_gemma":[0.9986738,0.00005258401,0.00040486103,0.00060417183,0.000028464832,0.0002361027],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00006585473,0.00075814046,0.0040845526,0.00022745469,0.00008059469,0.000011437543,0.00009644202,0.000292479,0.00031496017],"category_scores_gemma":[0.000012637279,0.0004725166,0.0007323977,0.00027124447,0.000106778665,0.000064377135,0.00004591874,0.000291406,0.000044757075],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0000052776236,0.00014497145,0.00009661787,0.018343903,0.00025650283,0.000058782643,0.00027883684,1.0174847e-7,5.540417e-8,0.000023740366,0.0010226398,0.9797686],"study_design_scores_gemma":[0.00071011466,0.00015268102,0.00020260017,0.13213171,0.0017800755,0.000082057566,0.000006675052,4.773604e-7,2.0441377e-7,0.000003776422,0.86460495,0.00032471083],"about_ca_topic_score_codex":0.001374434,"about_ca_topic_score_gemma":0.0037622985,"teacher_disagreement_score":0.97944385,"about_ca_system_score_codex":0.0020322402,"about_ca_system_score_gemma":0.0009644513,"threshold_uncertainty_score":0.99977267},"labels":[],"label_agreement":null},{"id":"W2007790489","doi":"10.1016/s0305-7372(03)80005-1","title":"Can we optimise treatment of thrombosis?","year":2003,"lang":"en","type":"review","venue":"Cancer Treatment Reviews","topic":"Venous Thromboembolism Diagnosis and Management","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University; Juravinski Hospital","funders":"","keywords":"Medicine; Thrombosis; Anticoagulant; Concomitant; Low molecular weight heparin; Heparin; Venous thrombosis; Cancer; Surgery; Venous thromboembolism; Anticoagulant therapy; Internal medicine; Intensive care medicine","score_opus":0.19376038456030753,"score_gpt":0.43061406846393824,"score_spread":0.2368536839036307,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2007790489","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0000038301478,0.9826739,0.0000025165095,0.00030934176,0.0005411201,0.009689411,0.00020653565,0.00004963224,0.0065237335],"genre_scores_gemma":[0.000001088016,0.9833057,0.00058717525,0.00013890282,0.00032218482,0.009509991,0.00033782824,0.00014541863,0.0056517418],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9962443,0.00028348077,0.0016428721,0.00095847115,0.00028258085,0.00058827584],"domain_scores_gemma":[0.9968337,0.00007098469,0.0011397232,0.0015350721,0.00006398296,0.00035657204],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":["metaepi_narrow"],"category_scores_codex":[0.00013493262,0.0013135157,0.010291004,0.00027537605,0.00008753685,0.00002509547,0.00018491318,0.0002993669,0.0016219722],"category_scores_gemma":[0.000009586752,0.0007583587,0.002871719,0.00049562776,0.0001017014,0.000038802475,0.000032669846,0.000107263426,0.00021567549],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0000045057764,0.0027303866,0.000018874578,0.028682556,0.0028264928,0.00003349726,0.00018135464,7.07105e-7,2.880068e-7,0.00011028591,0.0065834248,0.9588276],"study_design_scores_gemma":[0.0012957964,0.0020244825,0.000008061934,0.037209507,0.029967012,0.000020192067,0.000014275954,3.289294e-7,0.000010261603,0.0000089832365,0.9289753,0.00046582453],"about_ca_topic_score_codex":0.00053754705,"about_ca_topic_score_gemma":0.00012549284,"teacher_disagreement_score":0.9583618,"about_ca_system_score_codex":0.0032724289,"about_ca_system_score_gemma":0.0008673078,"threshold_uncertainty_score":0.9999616},"labels":[],"label_agreement":null},{"id":"W2010059199","doi":"10.1016/j.ctrv.2013.01.002","title":"HER2-targeted therapy in breast cancer: A systematic review of neoadjuvant trials","year":2013,"lang":"en","type":"review","venue":"Cancer Treatment Reviews","topic":"HER2/EGFR in Cancer Research","field":"Medicine","cited_by":100,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Hospital; University of Ottawa","funders":"","keywords":"Medicine; Lapatinib; Pertuzumab; Trastuzumab; Oncology; Breast cancer; Internal medicine; Neoadjuvant therapy; Clinical trial; Targeted therapy; Chemotherapy; Cancer","score_opus":0.30647694075076715,"score_gpt":0.523487102194639,"score_spread":0.21701016144387186,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2010059199","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0000011974976,0.9419979,7.973655e-7,0.00076476886,0.00045185944,0.055518366,0.0008389103,0.000049193666,0.0003770357],"genre_scores_gemma":[2.663882e-7,0.90732044,0.000091757414,0.0005736791,0.00047570167,0.089308135,0.0002797023,0.00020374083,0.0017465944],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.98434377,0.0051125917,0.0073756026,0.0012476845,0.0009837135,0.00093663955],"domain_scores_gemma":[0.99161756,0.0007375827,0.004275792,0.0024697243,0.00040636928,0.0004929754],"candidate_categories":["metaepi_narrow","metaepi_broad","insufficient_payload"],"consensus_categories":["metaepi_narrow"],"category_scores_codex":[0.0048592133,0.0016194619,0.03128399,0.0005753308,0.000050868726,0.000041973788,0.0006983014,0.0005008341,0.0072481786],"category_scores_gemma":[0.00060249376,0.00083511206,0.00402048,0.0018401105,0.00014675714,0.000102286285,0.00008129886,0.00067542586,0.0004744997],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000017677437,0.00022148446,0.000021317876,0.50589734,0.00083548157,0.000026818341,0.000030981966,3.8320625e-8,9.2402746e-7,0.0000018814698,0.005243374,0.48770267],"study_design_scores_gemma":[0.00092919637,0.00025512697,0.0000032930939,0.50699776,0.005260452,0.000068852845,0.00000371872,5.7566524e-7,0.0000032957007,0.0000010985075,0.48617998,0.0002966801],"about_ca_topic_score_codex":0.004154501,"about_ca_topic_score_gemma":0.00013105941,"teacher_disagreement_score":0.487406,"about_ca_system_score_codex":0.0053990805,"about_ca_system_score_gemma":0.004483171,"threshold_uncertainty_score":0.9996553},"labels":[],"label_agreement":null},{"id":"W2011223682","doi":"10.1016/j.ctrv.2008.01.008","title":"Metastatic breast cancer: The role of pegylated liposomal doxorubicin after conventional anthracyclines","year":2008,"lang":"en","type":"review","venue":"Cancer Treatment Reviews","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":66,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen Elizabeth II Health Sciences Centre; University of Ottawa; Ottawa Regional Cancer Foundation; Ottawa Hospital","funders":"Canadian Institutes of Health Research","keywords":"Medicine; Cardiotoxicity; Anthracycline; Trastuzumab; Doxorubicin; Breast cancer; Metastatic breast cancer; Oncology; Adjuvant; Internal medicine; Regimen; Adjuvant therapy; Chemotherapy; Cancer; Pharmacology","score_opus":0.07097432120529847,"score_gpt":0.42110653563821765,"score_spread":0.3501322144329192,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2011223682","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00015801383,0.99109685,5.7805244e-7,0.00041433977,0.00064951443,0.0052953693,0.0018540625,0.000040805575,0.00049047475],"genre_scores_gemma":[0.00018092532,0.98380643,0.000054347798,0.00018547088,0.00096489285,0.011140593,0.00063539884,0.00010072068,0.002931218],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9963694,0.0004570479,0.0016182374,0.0007268039,0.00032615545,0.0005023295],"domain_scores_gemma":[0.9974799,0.00020630039,0.0012418537,0.0007066212,0.00014156562,0.00022375409],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00012104402,0.0010391689,0.0048924624,0.00019981993,0.00013233704,0.000015512458,0.00023939135,0.00017513128,0.0051071527],"category_scores_gemma":[0.000008203574,0.0005194932,0.0023610075,0.0005945054,0.00033924344,0.00007900608,0.000055364664,0.00031726158,0.000160627],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00024829476,0.0010188458,0.0010350182,0.007513968,0.0037599134,0.00012399408,0.00009513476,5.7106047e-7,0.000006832458,0.000012759077,0.0029362442,0.9832484],"study_design_scores_gemma":[0.002084185,0.00041105613,0.00023960856,0.015987817,0.021102708,0.0010604355,0.000008796152,0.0000039461966,0.000041891704,0.0000076414135,0.9586922,0.00035970338],"about_ca_topic_score_codex":0.0012813089,"about_ca_topic_score_gemma":0.00028157546,"teacher_disagreement_score":0.9828887,"about_ca_system_score_codex":0.0011329942,"about_ca_system_score_gemma":0.0015376821,"threshold_uncertainty_score":0.99972564},"labels":[],"label_agreement":null},{"id":"W2013017791","doi":"10.1016/j.ctrv.2014.08.002","title":"Temporal changes in the efficacy of chemotherapy for recurrent or metastatic squamous cell carcinoma of the head and neck: A systematic review and meta-analysis","year":2014,"lang":"en","type":"review","venue":"Cancer Treatment Reviews","topic":"Head and Neck Cancer Studies","field":"Medicine","cited_by":10,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"London Health Sciences Centre; Western University","funders":"","keywords":"Medicine; Chemotherapy; Oncology; Internal medicine; Cisplatin; Methotrexate; Head and neck cancer; Head and neck squamous-cell carcinoma; Cancer; Surgery","score_opus":0.2098117257612688,"score_gpt":0.4336556581788757,"score_spread":0.2238439324176069,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2013017791","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000035700774,0.97810656,0.0000021911878,0.00088656077,0.000029816734,0.020706745,0.00019857357,0.000003382726,0.000030469571],"genre_scores_gemma":[0.00023995295,0.9862062,0.00011980036,0.0005755959,0.000030078521,0.012417923,0.000033120774,0.000031329255,0.00034602563],"study_design_codex":"systematic_review","study_design_gemma":"meta_analysis","domain_scores_codex":[0.99642235,0.0009624586,0.0016807142,0.00048010022,0.00022363407,0.00023071609],"domain_scores_gemma":[0.99632317,0.0008363811,0.001738735,0.00096232176,0.00007329356,0.00006610316],"candidate_categories":["metaepi_broad"],"consensus_categories":[],"category_scores_codex":[0.0011525905,0.00064448325,0.016560681,0.00014037565,0.00005845295,0.000009285774,0.00020545431,0.0000702118,0.000048724592],"category_scores_gemma":[0.00015634835,0.0002082502,0.0026094893,0.0008009722,0.0001122428,0.000015241277,0.0000328592,0.00012007745,6.039037e-7],"study_design_candidate":"systematic_review","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000026547155,0.00022866922,0.000031727977,0.9174635,0.015812848,0.0000013603071,0.0004031131,1.8262945e-8,4.3819117e-8,0.000002855017,0.00028933014,0.06574002],"study_design_scores_gemma":[0.0009787856,0.001022139,0.00001930485,0.06934213,0.6151064,0.000010253687,0.000017841076,8.343003e-7,0.0000016887416,6.6430863e-7,0.31336892,0.00013107847],"about_ca_topic_score_codex":0.00019455433,"about_ca_topic_score_gemma":0.0013572954,"teacher_disagreement_score":0.84812135,"about_ca_system_score_codex":0.000161906,"about_ca_system_score_gemma":0.00022004725,"threshold_uncertainty_score":0.9980395},"labels":[],"label_agreement":null},{"id":"W2013822060","doi":"10.1016/j.ctrv.2011.11.006","title":"Tissue confirmation of disease recurrence in breast cancer patients: Pooled analysis of multi-centre, multi-disciplinary prospective studies","year":2011,"lang":"en","type":"article","venue":"Cancer Treatment Reviews","topic":"Breast Cancer Treatment Studies","field":"Biochemistry, Genetics and Molecular Biology","cited_by":175,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Health Network; Ottawa Hospital; University of Ottawa; Princess Margaret Cancer Centre; University of Toronto","funders":"","keywords":"Medicine; Biopsy; Breast cancer; Prospective cohort study; Cancer; Internal medicine; Estrogen receptor; Immunohistochemistry; Oncology; Progesterone receptor; Recurrent breast cancer; Pathology","score_opus":0.060037529948947295,"score_gpt":0.36437695089809247,"score_spread":0.3043394209491452,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2013822060","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.7875298,0.20841682,0.00004950856,0.000109729546,0.00021290091,0.0018306932,0.0017967573,0.000009575677,0.00004417578],"genre_scores_gemma":[0.90096676,0.097099654,0.00035715423,0.00002225352,0.00003197559,0.0011913117,0.00023079643,0.000015956366,0.00008412498],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.998376,0.00013785076,0.00062744797,0.0005130909,0.00012066251,0.00022492777],"domain_scores_gemma":[0.9986508,0.000013833657,0.0005436871,0.0003850839,0.0003239862,0.00008263809],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00008215519,0.00033573218,0.00090288295,0.00014863981,0.000047319154,0.000003008514,0.00012948964,0.000056430243,0.00007116605],"category_scores_gemma":[0.000029535546,0.00024437116,0.00025014795,0.0005183193,0.00017404849,0.000015518031,0.00008861922,0.000036211797,0.0000027660606],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00045717738,0.0023122095,0.9589729,0.00023687993,0.0034319032,0.0000013743567,0.002655906,0.000060807517,0.0005908715,0.000005612836,0.00007790434,0.031196479],"study_design_scores_gemma":[0.0028565954,0.000180036,0.98019093,0.0004880744,0.003760476,1.4044073e-7,0.0002545336,0.000039779097,0.0115598,0.0000042315733,0.00043194465,0.00023344865],"about_ca_topic_score_codex":0.001206373,"about_ca_topic_score_gemma":0.003198752,"teacher_disagreement_score":0.11343693,"about_ca_system_score_codex":0.00032835786,"about_ca_system_score_gemma":0.00010326261,"threshold_uncertainty_score":0.99651664},"labels":[],"label_agreement":null},{"id":"W2015277770","doi":"10.1016/j.ctrv.2008.01.005","title":"Meta-analysis of ifosfamide-based combination chemotherapy in advanced soft tissue sarcoma","year":2008,"lang":"en","type":"review","venue":"Cancer Treatment Reviews","topic":"Sarcoma Diagnosis and Treatment","field":"Medicine","cited_by":72,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University; Mount Sinai Hospital; Cancer Care Ontario; Ottawa Hospital","funders":"Canadian Medical Association; Cancer Care Ontario; National Center for Theoretical Sciences","keywords":"Ifosfamide; Medicine; Dacarbazine; Regimen; Soft tissue sarcoma; Doxorubicin; Chemotherapy; Oncology; Sarcoma; Internal medicine; Randomized controlled trial; Adverse effect; Surgery; Urology; Pathology; Etoposide","score_opus":0.203705741555171,"score_gpt":0.43182510487720044,"score_spread":0.22811936332202945,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2015277770","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000043269913,0.9930199,0.0000154872,0.00023869879,0.00006934855,0.006128703,0.00019631653,0.0000317919,0.00025650355],"genre_scores_gemma":[0.00006951697,0.9866253,0.0006702431,0.00025771308,0.000035499583,0.010499323,0.0012760689,0.00008543658,0.00048087683],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99591476,0.00043620385,0.0019840102,0.00090817735,0.00038553058,0.00037134375],"domain_scores_gemma":[0.9967373,0.00036804826,0.0013728861,0.0012566741,0.000100547426,0.0001645586],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00020276745,0.0010364786,0.014312764,0.0010011652,0.000045663834,0.000011663922,0.00018221351,0.00027420145,0.0013182197],"category_scores_gemma":[0.000025334195,0.0006083153,0.0069958637,0.0021581373,0.00007637328,0.000054298685,0.000016894133,0.00016575714,0.000058039357],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00002401858,0.0024387354,0.00077907305,0.003884887,0.100832336,0.00008976326,0.000040626877,0.000008994755,3.81151e-7,0.000009012784,0.00022651834,0.89166564],"study_design_scores_gemma":[0.0017303467,0.0003197852,0.00026101756,0.0021034882,0.36633953,0.000008046378,0.0000011724379,0.000006545016,0.000029183535,0.0000019857946,0.62896353,0.00023537697],"about_ca_topic_score_codex":0.0004551376,"about_ca_topic_score_gemma":0.00025871978,"teacher_disagreement_score":0.89143026,"about_ca_system_score_codex":0.0017868135,"about_ca_system_score_gemma":0.0005277062,"threshold_uncertainty_score":0.9996368},"labels":[],"label_agreement":null},{"id":"W2018470847","doi":"10.1016/j.ctrv.2005.03.002","title":"Brachytherapy improved dysphagia more than stenting in people with inoperable oesophageal cancer","year":2005,"lang":"en","type":"article","venue":"Cancer Treatment Reviews","topic":"Esophageal and GI Pathology","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; Dysphagia; Brachytherapy; Radiation therapy; Palliative care; Cancer; Surgery; Esophageal disease; Esophagus; Radiology; Internal medicine","score_opus":0.025183704885882494,"score_gpt":0.3318005125469733,"score_spread":0.3066168076610908,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2018470847","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.72350186,0.27122086,0.000023263541,0.0024759814,0.00012193267,0.0017954606,0.00002008693,0.000050899896,0.0007896313],"genre_scores_gemma":[0.8622958,0.11645818,0.0017180906,0.0032255999,0.0006982652,0.0031124363,0.000058936435,0.00006789214,0.012364778],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9982907,0.00008546063,0.00047117038,0.00052428606,0.0001303152,0.00049804],"domain_scores_gemma":[0.9991745,0.000022811693,0.00018264269,0.00040302827,0.000051014315,0.00016603225],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00016001133,0.0003711153,0.0009813985,0.00009251099,0.00008159339,0.000018104873,0.00009023904,0.00009826652,0.000808685],"category_scores_gemma":[0.0000071426334,0.0002199042,0.00014737065,0.00035931965,0.000054180444,0.00015350073,0.000018763729,0.00019041599,0.000058874408],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00022170735,0.00037961552,0.58000994,0.00019098591,0.000119758624,0.00011602748,0.0014727521,0.00005972048,0.0012621995,0.000007825517,0.00023679015,0.41592267],"study_design_scores_gemma":[0.017957311,0.0026240137,0.70921683,0.0016752573,0.00087546033,0.0002201052,0.00020102474,0.0013238577,0.008097593,0.000007911575,0.25706077,0.0007398756],"about_ca_topic_score_codex":0.0024278553,"about_ca_topic_score_gemma":0.0099626295,"teacher_disagreement_score":0.41518277,"about_ca_system_score_codex":0.00070464,"about_ca_system_score_gemma":0.00023785912,"threshold_uncertainty_score":0.8967433},"labels":[],"label_agreement":null},{"id":"W2020317271","doi":"10.1016/j.ctrv.2006.11.003","title":"Common cancers in adolescents","year":2007,"lang":"en","type":"review","venue":"Cancer Treatment Reviews","topic":"Acute Lymphoblastic Leukemia research","field":"Medicine","cited_by":15,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University; McMaster University Medical Centre; Health Sciences Centre","funders":"","keywords":"Medicine; Neuroblastoma; Leukemia; Soft tissue; Pathology; Young adult; Oncology; Internal medicine; Biology","score_opus":0.15265555086111882,"score_gpt":0.46625882292106585,"score_spread":0.31360327205994704,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2020317271","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0000054226666,0.9901953,0.0000053796257,0.000031485524,0.00035694512,0.006549092,0.00007238742,0.00003553309,0.0027485036],"genre_scores_gemma":[0.000005426282,0.99300206,0.000094093535,0.00025831553,0.00056114653,0.0030902363,0.0002505304,0.00012666169,0.002611547],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99611306,0.0002849963,0.0014725816,0.00084473955,0.00043501865,0.0008496237],"domain_scores_gemma":[0.9979259,0.00008861161,0.000485983,0.0010337484,0.000044633936,0.0004211169],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00042521203,0.0009157579,0.0056329477,0.00051110203,0.00004648209,0.00002180755,0.0002965979,0.000460937,0.00030981007],"category_scores_gemma":[0.00004143558,0.0005652156,0.0010801577,0.0010386597,0.00011172096,0.00004942128,0.000078496094,0.0005685785,0.00074852025],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000039471284,0.00018867383,0.0006312187,0.04718748,0.00020833265,0.00044521902,0.00003233241,2.2127082e-7,7.4902744e-8,0.000002143558,0.002808781,0.94845605],"study_design_scores_gemma":[0.0017774749,0.00021380316,0.00003435394,0.17880136,0.0016782051,0.00009005907,0.0000031525715,0.0000035699861,9.183091e-7,8.8635505e-7,0.8170901,0.00030614718],"about_ca_topic_score_codex":0.0029378012,"about_ca_topic_score_gemma":0.00159373,"teacher_disagreement_score":0.9481499,"about_ca_system_score_codex":0.03643664,"about_ca_system_score_gemma":0.004560341,"threshold_uncertainty_score":0.9996799},"labels":[],"label_agreement":null},{"id":"W2021777913","doi":"10.1016/j.ctrv.2011.12.002","title":"Controlling angiogenesis in breast cancer: A systematic review of anti-angiogenic trials","year":2012,"lang":"en","type":"review","venue":"Cancer Treatment Reviews","topic":"Angiogenesis and VEGF in Cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":105,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre Hospitalier de l’Université de Montréal; Queen Elizabeth II Health Sciences Centre; BC Cancer Agency; Sunnybrook Health Science Centre; Health Sciences Centre; MacEwan University","funders":"Alberta Health Services","keywords":"Medicine; Sunitinib; Pazopanib; Bevacizumab; Oncology; Clinical trial; Sorafenib; Breast cancer; Internal medicine; Adverse effect; Randomized controlled trial; Chemotherapy; Cancer; Angiogenesis","score_opus":0.10315423392928001,"score_gpt":0.39669616206870056,"score_spread":0.29354192813942054,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2021777913","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0000076137717,0.9892347,0.000014802488,0.00004387232,0.00043477208,0.008667758,0.0015376607,0.000010520066,0.00004830976],"genre_scores_gemma":[0.00001789791,0.9825887,0.000048598486,0.00023177142,0.00089684664,0.015311319,0.00049733405,0.00012810367,0.00027941138],"study_design_codex":"systematic_review","study_design_gemma":"not_applicable","domain_scores_codex":[0.9923657,0.0019525185,0.0039296513,0.0008682599,0.0002559637,0.0006279004],"domain_scores_gemma":[0.9947215,0.00013257284,0.0035407827,0.00127162,0.00013967027,0.00019386574],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0024147998,0.0011211733,0.012865911,0.00020743425,0.000053379386,0.000019253603,0.0005247052,0.00047556031,0.00034231175],"category_scores_gemma":[0.000107454056,0.000684555,0.0056958636,0.00060284266,0.00006907328,0.00000946223,0.00008880011,0.00008831783,0.000038661517],"study_design_candidate":"systematic_review","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0000108037875,0.00012724429,0.00012176864,0.6876527,0.0018232086,0.0000024072483,0.0000068515615,7.9391816e-7,0.000058170317,0.0000026904104,0.00061891845,0.3095744],"study_design_scores_gemma":[0.00034853164,0.000041130068,0.0000034557283,0.44451803,0.017345818,0.000024980794,0.0000016911093,2.1897367e-7,0.000047148947,1.9875864e-7,0.53728914,0.00037966025],"about_ca_topic_score_codex":0.000295173,"about_ca_topic_score_gemma":0.00008166065,"teacher_disagreement_score":0.5366702,"about_ca_system_score_codex":0.00056794414,"about_ca_system_score_gemma":0.0007910438,"threshold_uncertainty_score":0.99956053},"labels":[],"label_agreement":null},{"id":"W2022753648","doi":"10.1016/j.ctrv.2006.01.008","title":"Adding raltitrexed to cisplatin improves overall survival in people with malignant pleural mesothelioma","year":2006,"lang":"en","type":"article","venue":"Cancer Treatment Reviews","topic":"Occupational and environmental lung diseases","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Hospital Foundation","funders":"","keywords":"Raltitrexed; Medicine; Cisplatin; Mesothelioma; Oncology; Pemetrexed; Internal medicine; Cancer research; Chemotherapy; Pathology; Fluorouracil; Thymidylate synthase","score_opus":0.020823836779793926,"score_gpt":0.2937547142645107,"score_spread":0.2729308774847168,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2022753648","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9820442,0.014082979,0.000010087939,0.000531121,0.00006515213,0.0012609147,0.00007602805,0.000023670438,0.001905827],"genre_scores_gemma":[0.98770463,0.003929857,0.001315456,0.00049997756,0.00023383359,0.0009915669,0.00025415092,0.00003250618,0.0050379937],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9990202,0.000033573146,0.00027285915,0.00028895726,0.0001596083,0.00022477815],"domain_scores_gemma":[0.9995968,0.000022323324,0.00007346756,0.00018379804,0.000008210667,0.000115431634],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000047479243,0.00021288388,0.0004533452,0.00006476682,0.000036738584,0.000012419123,0.000039629387,0.000024714811,0.00036868468],"category_scores_gemma":[0.000004642047,0.00012592343,0.00010156331,0.00016042402,0.00001779077,0.000062654144,0.0000151562035,0.00003177129,0.000090332695],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00061250327,0.00048104805,0.9529009,0.00015026885,0.000049136626,0.000049337246,0.00009078854,0.00011490121,0.0056383577,0.00009141462,0.001235915,0.038585436],"study_design_scores_gemma":[0.0020694467,0.00050939526,0.91070694,0.00050083234,0.00015735929,0.0000069951966,0.000015505777,0.00003061798,0.0008407868,0.000009435905,0.084987365,0.00016534285],"about_ca_topic_score_codex":0.002955419,"about_ca_topic_score_gemma":0.002657152,"teacher_disagreement_score":0.08375145,"about_ca_system_score_codex":0.0005519378,"about_ca_system_score_gemma":0.00005531515,"threshold_uncertainty_score":0.51350087},"labels":[],"label_agreement":null},{"id":"W2023295373","doi":"10.1016/j.ctrv.2004.09.008","title":"Using aromatase inhibitors in the neoadjuvant setting: evolution or revolution?","year":2004,"lang":"en","type":"review","venue":"Cancer Treatment Reviews","topic":"Estrogen and related hormone effects","field":"Biochemistry, Genetics and Molecular Biology","cited_by":33,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Sunnybrook Health Science Centre","funders":"","keywords":"Medicine; Aromatase; Neoadjuvant therapy; Oncology; Internal medicine; Breast cancer; Cancer","score_opus":0.06883962482000135,"score_gpt":0.3904823749099029,"score_spread":0.32164275008990156,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2023295373","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000092368726,0.99625,0.000027613089,0.000026573698,0.00031742285,0.0030888822,0.00008647714,0.00001097702,0.00009972088],"genre_scores_gemma":[0.000030188647,0.9969363,0.0002578567,0.000039500177,0.0005633501,0.0011752162,0.00075123104,0.000050083112,0.00019623681],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99746215,0.0006305042,0.0007726327,0.0006205616,0.00013297531,0.00038114598],"domain_scores_gemma":[0.99865,0.000024640687,0.00051540416,0.00071053667,0.000019126272,0.00008029622],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00038224275,0.00061210094,0.0012156988,0.00009395901,0.00013177845,0.000030280333,0.00027287644,0.00046002615,0.000014027734],"category_scores_gemma":[0.00004278863,0.00029690808,0.00071742147,0.00039759095,0.00006769908,0.0000057974044,0.00005443398,0.00024226599,0.000047706715],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000022423887,0.00021222401,0.000020625886,0.0061064777,0.00021231716,0.00006981004,0.000050492174,0.000031166936,0.00007915422,0.000017635442,0.0023710916,0.9908066],"study_design_scores_gemma":[0.0004668335,0.0003010012,0.0000018840058,0.019986164,0.0011477579,0.00018951019,0.000011257407,0.0000029917644,0.000038592938,0.0000067701567,0.977514,0.00033319215],"about_ca_topic_score_codex":0.00021654482,"about_ca_topic_score_gemma":0.00006277753,"teacher_disagreement_score":0.9904734,"about_ca_system_score_codex":0.0010921964,"about_ca_system_score_gemma":0.001017683,"threshold_uncertainty_score":0.9999483},"labels":[],"label_agreement":null},{"id":"W2024588260","doi":"10.1016/j.ctrv.2008.03.090","title":"P64. Skeletal related events (SREs) in patients with bone metastases from breast cancer treated with intravenous (i.v.) bisphosphonates (BPs) in the non-trial setting","year":2008,"lang":"en","type":"article","venue":"Cancer Treatment Reviews","topic":"Bone health and treatments","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Credit Valley Hospital; Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; Breast cancer; Clinical trial; Natural history; Oncology; Internal medicine; Disease; Metastatic breast cancer; Cancer; Bone disease; Surgery; Osteoporosis","score_opus":0.01809548469759504,"score_gpt":0.28630878071063326,"score_spread":0.2682132960130382,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2024588260","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9626838,0.029620517,8.236167e-7,0.0005759716,0.00010188741,0.006316565,0.0005423037,0.000034689718,0.0001234479],"genre_scores_gemma":[0.97051287,0.024457825,0.00019984765,0.00041532167,0.00006080768,0.0030459617,0.0009833861,0.000065425396,0.0002585688],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9969392,0.00029144937,0.0009034949,0.00071865146,0.00046563576,0.0006815583],"domain_scores_gemma":[0.9985667,0.00009933627,0.00045190306,0.0005672788,0.00007875889,0.00023601759],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00019285825,0.00063025457,0.0013917633,0.00016881211,0.00017553222,0.000014720525,0.00012396414,0.00011295784,0.00024509637],"category_scores_gemma":[0.000013077637,0.00030744215,0.00016413716,0.00088361424,0.00010470405,0.00015828262,0.000017997641,0.00029773967,0.000041115913],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.014100056,0.0031683838,0.87068504,0.0000845558,0.0004479533,0.0005875509,0.0008639313,0.0000129540185,0.0000030362771,7.5708573e-7,0.00019275294,0.10985301],"study_design_scores_gemma":[0.10677415,0.0029641094,0.8835705,0.0019126901,0.0009629395,0.00007713703,0.00005194925,0.000015719315,0.00007767464,0.000004478579,0.0032639299,0.00032474886],"about_ca_topic_score_codex":0.05259952,"about_ca_topic_score_gemma":0.009610519,"teacher_disagreement_score":0.10952825,"about_ca_system_score_codex":0.0012331596,"about_ca_system_score_gemma":0.00053631613,"threshold_uncertainty_score":0.9999378},"labels":[],"label_agreement":null},{"id":"W2025769302","doi":"10.1016/j.ctrv.2008.05.007","title":"The kisspeptin (KiSS-1)/GPR54 system in cancer biology","year":2008,"lang":"en","type":"review","venue":"Cancer Treatment Reviews","topic":"Plant Reproductive Biology","field":"Biochemistry, Genetics and Molecular Biology","cited_by":94,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"","keywords":"Kisspeptin; Paracrine signalling; Autocrine signalling; KISS (TNC); Metastasis; Metastasis Suppressor Gene; Cancer; Cancer research; Mechanism (biology); Medicine; Biology; Cell biology; Receptor; Bioinformatics; Internal medicine","score_opus":0.08958089845718112,"score_gpt":0.4000963147817178,"score_spread":0.3105154163245367,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2025769302","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000052506348,0.9946616,0.0000039957804,0.000048674243,0.0010366932,0.0029386422,0.00037939425,0.000021485419,0.00085697236],"genre_scores_gemma":[0.000009057137,0.9871024,0.000043273416,0.00004391329,0.0014458364,0.008218283,0.00085609924,0.00006982192,0.0022113204],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9958344,0.0009144222,0.0011205687,0.0013813,0.00007797563,0.00067130575],"domain_scores_gemma":[0.9976491,0.000066114066,0.0008111357,0.0013051205,0.000055453347,0.000113088056],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00031427894,0.0008913072,0.0025516662,0.00009396123,0.00017371378,0.000019436766,0.00062464626,0.0006144226,0.000025424612],"category_scores_gemma":[0.000068055575,0.00046846402,0.00083225983,0.0002792679,0.00024658206,0.0000028548022,0.00014807821,0.00023721597,0.00012823354],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000017685456,0.000056473844,0.00020779722,0.0018090239,0.00034361822,0.000015347387,0.000009758916,6.27577e-7,0.00011651832,0.000051180432,0.0043645296,0.9930074],"study_design_scores_gemma":[0.00026920455,0.00022837377,0.00001212525,0.003818934,0.0003131974,0.00015351691,0.000005096856,3.1563494e-7,0.000075087446,0.0000015808688,0.9946759,0.00044670206],"about_ca_topic_score_codex":0.000589575,"about_ca_topic_score_gemma":0.0010522046,"teacher_disagreement_score":0.99256074,"about_ca_system_score_codex":0.0010500568,"about_ca_system_score_gemma":0.000814453,"threshold_uncertainty_score":0.9997767},"labels":[],"label_agreement":null},{"id":"W2027713593","doi":"10.1016/j.ctrv.2005.12.009","title":"Effectiveness of stereotactic radiosurgery alone or in combination with whole brain radiotherapy compared to conventional surgery and/or whole brain radiotherapy for the treatment of one or more brain metastases: A systematic review and meta-analysis","year":2006,"lang":"en","type":"review","venue":"Cancer Treatment Reviews","topic":"Brain Metastases and Treatment","field":"Medicine","cited_by":62,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta; Occupational Cancer Research Centre; Institute of Health Economics","funders":"","keywords":"Medicine; Radiosurgery; Radiation therapy; Whole brain radiotherapy; Brain metastasis; Randomized controlled trial; Quality of life (healthcare); Cohort; Meta-analysis; Overall survival; Surgery; Oncology; Metastasis; Internal medicine; Cancer","score_opus":0.13471160289476167,"score_gpt":0.407240938416746,"score_spread":0.27252933552198433,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2027713593","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000089935646,0.9536237,0.00084670796,0.0042265896,0.000040821968,0.038380466,0.0027721485,0.0000188773,7.689081e-7],"genre_scores_gemma":[0.000029480962,0.95864266,0.0016895758,0.000738974,0.000037042497,0.03493696,0.0019503802,0.00012393856,0.0018509742],"study_design_codex":"systematic_review","study_design_gemma":"meta_analysis","domain_scores_codex":[0.9905752,0.004075035,0.0032016165,0.0011391055,0.00052882975,0.00048020808],"domain_scores_gemma":[0.9805972,0.015040089,0.002639758,0.0012897095,0.0001910287,0.00024219889],"candidate_categories":["metaepi_narrow","metaepi_broad"],"consensus_categories":["metaepi_narrow"],"category_scores_codex":[0.0036668493,0.0014029257,0.02419845,0.00080439274,0.00011336206,0.00005419484,0.00016968833,0.00016354265,0.00024465646],"category_scores_gemma":[0.00029409904,0.0005692866,0.0039050826,0.0020518603,0.00022347184,0.0001158446,0.000016806776,0.000111276735,0.0000012694136],"study_design_candidate":"meta_analysis","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.001929985,0.0037610403,0.00008625194,0.6364537,0.2570691,0.000089190165,0.00016502518,0.000012808043,0.000002781483,0.00001008018,0.0018111316,0.09860892],"study_design_scores_gemma":[0.0063946587,0.003888386,0.00009458282,0.08535054,0.5379274,0.00015300924,0.000024458575,0.000020432388,0.000007948426,0.0000012961283,0.365695,0.0004422999],"about_ca_topic_score_codex":0.0008256311,"about_ca_topic_score_gemma":0.00091227074,"teacher_disagreement_score":0.5511031,"about_ca_system_score_codex":0.0015424815,"about_ca_system_score_gemma":0.0008244059,"threshold_uncertainty_score":0.9998721},"labels":[],"label_agreement":null},{"id":"W2030627370","doi":"10.1016/j.ctrv.2007.02.004","title":"The effect of anticoagulants on cancer risk and survival: Systematic review","year":2007,"lang":"en","type":"review","venue":"Cancer Treatment Reviews","topic":"Venous Thromboembolism Diagnosis and Management","field":"Medicine","cited_by":54,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; Jewish General Hospital","funders":"","keywords":"Medicine; Warfarin; Low molecular weight heparin; Cancer; Oncology; Malignancy; Clinical trial; Lung cancer; Anticoagulant; Heparin; Internal medicine; Intensive care medicine; Randomized controlled trial","score_opus":0.07865189832177222,"score_gpt":0.4311788321912527,"score_spread":0.3525269338694805,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2030627370","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0000067041806,0.9770033,0.0000013577908,0.00006580988,0.0004905723,0.02164134,0.00008673044,0.000025041565,0.00067918736],"genre_scores_gemma":[0.000001841875,0.9887623,0.0000063573175,0.00016580553,0.00018382663,0.010043415,0.000040473646,0.00007863616,0.0007173305],"study_design_codex":"systematic_review","study_design_gemma":"not_applicable","domain_scores_codex":[0.9956259,0.0012007094,0.0017715114,0.0005968484,0.0003893538,0.00041564653],"domain_scores_gemma":[0.9955644,0.0010414867,0.0018947007,0.0012738712,0.00004965341,0.00017587622],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.002163536,0.00088343053,0.012147823,0.00011642876,0.00015234438,0.000025824698,0.00021949792,0.00015118885,0.00006938573],"category_scores_gemma":[0.00024386833,0.00035205806,0.0013471601,0.00036892257,0.00009835256,0.000022462493,0.000057742658,0.0002302227,0.000072011724],"study_design_candidate":"systematic_review","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0000054400703,0.00005633867,0.000048495363,0.50412595,0.0011797666,0.000007950655,0.000006694341,2.5591772e-8,9.412242e-9,0.000010447144,0.0013209009,0.49323797],"study_design_scores_gemma":[0.00026786755,0.0005593555,0.00001541406,0.46547893,0.041390333,0.0000051454826,9.5131156e-7,1.5679831e-7,0.0000012037814,3.305021e-7,0.49214932,0.00013099608],"about_ca_topic_score_codex":0.00046523512,"about_ca_topic_score_gemma":0.00013255842,"teacher_disagreement_score":0.493107,"about_ca_system_score_codex":0.0006350764,"about_ca_system_score_gemma":0.0001372008,"threshold_uncertainty_score":0.9998931},"labels":[],"label_agreement":null},{"id":"W2035360235","doi":"10.1016/j.ctrv.2006.01.005","title":"Trastuzumab after primary treatment for early stage HER2-positive breast cancer reduces recurrence","year":2006,"lang":"en","type":"article","venue":"Cancer Treatment Reviews","topic":"HER2/EGFR in Cancer Research","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Sunnybrook Health Science Centre","funders":"","keywords":"Trastuzumab; Medicine; Breast cancer; Oncology; Adjuvant; Internal medicine; Chemotherapy; Stage (stratigraphy); Metastatic breast cancer; Monoclonal antibody; Cancer; Antibody; Immunology","score_opus":0.06632819832425466,"score_gpt":0.4043932864000384,"score_spread":0.3380650880757837,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2035360235","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.47394997,0.49153888,0.00008243247,0.005135572,0.0008629719,0.014920123,0.0061933547,0.00016556769,0.0071511306],"genre_scores_gemma":[0.29041955,0.5820333,0.0016838106,0.0008622535,0.003164763,0.06766719,0.00071411446,0.00023852328,0.0532165],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99666524,0.0001806667,0.00077097554,0.0010454166,0.00044579897,0.000891921],"domain_scores_gemma":[0.9983466,0.00010601426,0.00027013355,0.0006997672,0.00023233512,0.00034514873],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00022912235,0.0006912529,0.0013737868,0.00014396431,0.00016658974,0.00007896041,0.00017318486,0.00015017927,0.0014964868],"category_scores_gemma":[0.000009932557,0.00046285533,0.0006019143,0.0003934772,0.00019220512,0.0001757064,0.000031652267,0.0001602013,0.0001073484],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0019449609,0.0015250278,0.049471717,0.00081126945,0.0004384781,0.0001146462,0.00066282594,0.0000060209913,0.0007766204,0.00002088073,0.011121812,0.93310577],"study_design_scores_gemma":[0.0052924203,0.0030613097,0.17517713,0.0026952273,0.00091937475,0.00004043868,0.00003555267,0.0000119540455,0.008060314,0.000021178623,0.8041495,0.00053558557],"about_ca_topic_score_codex":0.013849682,"about_ca_topic_score_gemma":0.0021059655,"teacher_disagreement_score":0.93257016,"about_ca_system_score_codex":0.008277643,"about_ca_system_score_gemma":0.0013762275,"threshold_uncertainty_score":0.9997823},"labels":[],"label_agreement":null},{"id":"W2041419946","doi":"10.1053/ctrv.2000.0204","title":"Locoregionally recurrent breast cancer: incidence, risk factors and survival","year":2001,"lang":"en","type":"review","venue":"Cancer Treatment Reviews","topic":"Breast Cancer Treatment Studies","field":"Biochemistry, Genetics and Molecular Biology","cited_by":121,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; Incidence (geometry); Breast cancer; Disease; Oncology; Retrospective cohort study; Internal medicine; Cancer; Risk factor","score_opus":0.06059515640962599,"score_gpt":0.3620871464756759,"score_spread":0.30149199006604993,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2041419946","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00022727698,0.9932608,0.000009119759,0.000075123564,0.0008519451,0.0022032927,0.0030566666,0.00003253507,0.00028326927],"genre_scores_gemma":[0.000027554594,0.99222004,0.000053079435,0.00004878452,0.0012809669,0.0045350767,0.0011421246,0.0001259625,0.00056641566],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9961959,0.0004691968,0.00094770995,0.0014989657,0.00025459353,0.00063364994],"domain_scores_gemma":[0.9975378,0.000074220625,0.001111529,0.00088611257,0.00009179648,0.00029853923],"candidate_categories":["metaepi_narrow"],"consensus_categories":["metaepi_narrow"],"category_scores_codex":[0.0001778509,0.0015248448,0.0033477042,0.00012273941,0.0002726806,0.000058606456,0.00035996523,0.0004069737,0.00017372622],"category_scores_gemma":[0.000026126289,0.0009402774,0.0011384429,0.00037777695,0.00023220002,0.000011012395,0.00022968712,0.00023615827,0.000034278597],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000035586727,0.0001661056,0.018351464,0.0022289713,0.0015433619,0.000009457237,0.000036016583,6.99082e-7,4.028852e-7,0.0000057461384,0.003084665,0.97453755],"study_design_scores_gemma":[0.0006240246,0.00019617248,0.0020025966,0.007610315,0.0045778407,0.00007777427,0.000012574026,2.5753644e-7,0.0000028896086,0.000005102188,0.98408484,0.000805579],"about_ca_topic_score_codex":0.0025575007,"about_ca_topic_score_gemma":0.002936379,"teacher_disagreement_score":0.9810002,"about_ca_system_score_codex":0.00090487645,"about_ca_system_score_gemma":0.00065161777,"threshold_uncertainty_score":0.99975},"labels":[],"label_agreement":null},{"id":"W2041834416","doi":"10.1016/j.ctrv.2012.12.006","title":"A contemporary update on rates and management of toxicities of targeted therapies for metastatic renal cell carcinoma","year":2013,"lang":"en","type":"article","venue":"Cancer Treatment Reviews","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":23,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University Health Centre; Université de Montréal","funders":"National Cancer Institute; National Comprehensive Cancer Network","keywords":"Medicine; Renal cell carcinoma; Oncology; Carcinoma; Targeted therapy; Internal medicine; Intensive care medicine; Cancer research; Cancer","score_opus":0.07822416874921215,"score_gpt":0.3204338860142576,"score_spread":0.24220971726504545,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2041834416","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.6839263,0.3097175,0.000019837871,0.00032722947,0.000036672234,0.0042964346,0.00006995652,0.000009347203,0.0015967564],"genre_scores_gemma":[0.9323597,0.05947238,0.003557404,0.0001440846,0.000022597202,0.0030256205,0.00008562737,0.000026072226,0.0013065427],"study_design_codex":"design_other","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99874455,0.00008039072,0.00056250364,0.000291416,0.00013844558,0.000182717],"domain_scores_gemma":[0.9990692,0.00006749174,0.00034143167,0.00034675162,0.00008100459,0.00009410974],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000104509745,0.0002995634,0.0009712125,0.00009318649,0.00003198512,0.000008858041,0.000055365097,0.000027764037,0.00017652984],"category_scores_gemma":[0.000002921072,0.00017612179,0.00024248486,0.0000977294,0.00009422394,0.000061348,0.000016967208,0.000029646268,0.000010168802],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.004706029,0.006614145,0.09105865,0.042981822,0.009839639,0.00023366627,0.0063196626,0.000032301035,0.11197524,0.001451172,0.048981898,0.67580575],"study_design_scores_gemma":[0.015387207,0.011287712,0.0634809,0.0026322522,0.002739946,0.0000099937815,0.0010685588,0.00008325696,0.8098977,0.00028188614,0.092639714,0.00049085624],"about_ca_topic_score_codex":0.00030341817,"about_ca_topic_score_gemma":0.000005508385,"teacher_disagreement_score":0.69792247,"about_ca_system_score_codex":0.00014987776,"about_ca_system_score_gemma":0.000061437786,"threshold_uncertainty_score":0.7182038},"labels":[],"label_agreement":null},{"id":"W2042215902","doi":"10.1016/j.ctrv.2007.11.001","title":"Aromatase inhibitors in adjuvant therapy for hormone receptor positive breast cancer: A systematic review","year":2008,"lang":"en","type":"review","venue":"Cancer Treatment Reviews","topic":"Estrogen and related hormone effects","field":"Biochemistry, Genetics and Molecular Biology","cited_by":87,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Kingston General Hospital; Health Sciences Centre; Cancer Care Ontario; Sunnybrook Health Science Centre","funders":"","keywords":"Anastrozole; Exemestane; Letrozole; Medicine; Tamoxifen; Breast cancer; Aromatase; Oncology; Internal medicine; Adjuvant therapy; Hormonal therapy; Aromatase inhibitor; Randomized controlled trial; Gynecology; Cancer","score_opus":0.023350227821109612,"score_gpt":0.334381716166746,"score_spread":0.3110314883456364,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2042215902","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00001660391,0.97661084,0.0000022878894,0.00008163425,0.00027772732,0.020633591,0.0023257225,0.000018855582,0.000032757805],"genre_scores_gemma":[0.0000011918255,0.9573079,0.00005268496,0.00025213044,0.00043691625,0.03796838,0.00346755,0.00013114893,0.0003821347],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99594337,0.0007286676,0.0016073321,0.0010164597,0.00016292649,0.0005412183],"domain_scores_gemma":[0.99757504,0.00006184311,0.001190956,0.000888329,0.00007795812,0.00020584212],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00029197353,0.0011412858,0.0054260734,0.00011662341,0.00010668657,0.00002255834,0.00034445623,0.0005402476,0.000021424892],"category_scores_gemma":[0.000039406765,0.0006772893,0.0019282788,0.00038458983,0.00007481297,0.0000085197635,0.000051598836,0.00021701714,0.000060674145],"study_design_candidate":"systematic_review","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00005575328,0.00025655303,0.0000027316212,0.34028694,0.0009848045,0.000017301705,0.000020686488,2.2292268e-7,0.000059531463,0.0000010249507,0.02147236,0.6368421],"study_design_scores_gemma":[0.00073825306,0.00046014634,5.480601e-7,0.37497705,0.001759414,0.00012833223,0.0000014935673,2.3634863e-7,0.000079332,2.7387946e-7,0.6213967,0.00045818737],"about_ca_topic_score_codex":0.00012792947,"about_ca_topic_score_gemma":0.000020665726,"teacher_disagreement_score":0.6363839,"about_ca_system_score_codex":0.0007129455,"about_ca_system_score_gemma":0.0006878252,"threshold_uncertainty_score":0.9995678},"labels":[],"label_agreement":null},{"id":"W2043588430","doi":"10.1016/j.ctrv.2014.10.005","title":"Orphan nuclear receptors as drug targets for the treatment of prostate and breast cancers","year":2014,"lang":"en","type":"review","venue":"Cancer Treatment Reviews","topic":"Nuclear Receptors and Signaling","field":"Neuroscience","cited_by":50,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"Office of Naval Research; Canadian Institutes of Health Research; Prostate Cancer Canada","keywords":"Nuclear receptor; Medicine; Tamoxifen; Androgen receptor; Prostate cancer; Receptor; Estrogen receptor; Cancer research; Prostate; Breast cancer; Drug development; Cancer; Internal medicine; Transcription factor; Pharmacology; Biology; Drug; Genetics; Gene","score_opus":0.06341336605189725,"score_gpt":0.3519563982047676,"score_spread":0.28854303215287036,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2043588430","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000064222826,0.9912371,0.0000025008856,0.000114912786,0.0008955563,0.007009373,0.00037943837,0.000039715374,0.00025715528],"genre_scores_gemma":[0.00001884162,0.99300665,0.0000825893,0.00010760741,0.00040142532,0.003103722,0.000030876905,0.00014933775,0.0030989435],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9970161,0.0004099004,0.00094889547,0.00094317493,0.00019833383,0.0004836425],"domain_scores_gemma":[0.99758166,0.00047809552,0.0010589242,0.00065261615,0.000037336737,0.00019138152],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0002367053,0.000847482,0.002925534,0.000096274445,0.00036082423,0.00008872966,0.00033873785,0.00012997795,0.00054944167],"category_scores_gemma":[0.00003852639,0.00041548675,0.0011058147,0.00027663424,0.00023648824,0.000078820965,0.000036217985,0.000103110564,0.00008664842],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000032546694,0.00011313834,0.0000027291935,0.004035024,0.00014681277,0.0000022717106,0.0005705365,0.0000015655211,0.000015863418,0.00008820539,0.0023357242,0.9926556],"study_design_scores_gemma":[0.00061434257,0.00073088193,1.8075566e-7,0.005474751,0.0017114255,0.000031919117,0.000019822339,0.000014211889,0.0001197001,0.000013159351,0.99089754,0.00037209073],"about_ca_topic_score_codex":0.00070916343,"about_ca_topic_score_gemma":0.000086539316,"teacher_disagreement_score":0.99228346,"about_ca_system_score_codex":0.0012457493,"about_ca_system_score_gemma":0.00029330514,"threshold_uncertainty_score":0.9998297},"labels":[],"label_agreement":null},{"id":"W2046320256","doi":"10.1016/j.ctrv.2005.03.007","title":"Neoadjuvant taxanes in the treatment of non-metastatic breast cancer: A systematic review","year":2005,"lang":"en","type":"review","venue":"Cancer Treatment Reviews","topic":"Breast Cancer Treatment Studies","field":"Biochemistry, Genetics and Molecular Biology","cited_by":29,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University; Sunnybrook Health Science Centre","funders":"","keywords":"Medicine; Taxane; Breast cancer; Oncology; Neoadjuvant therapy; Anthracycline; Chemotherapy; Internal medicine; Mastectomy; Metastatic breast cancer; Randomized controlled trial; Clinical trial; Cancer","score_opus":0.05156857427744584,"score_gpt":0.38660226890609795,"score_spread":0.3350336946286521,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2046320256","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0000085619295,0.98459363,0.0000028086704,0.0003002232,0.00022203774,0.0131925,0.0015503691,0.0000116487245,0.00011822758],"genre_scores_gemma":[0.000010957572,0.9506372,0.00007921794,0.00028548937,0.00050006405,0.047337223,0.0006146721,0.00010300927,0.0004321172],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9945868,0.0010046797,0.002356263,0.0010920602,0.00032737243,0.0006327912],"domain_scores_gemma":[0.9957359,0.0001360552,0.0020445934,0.001866622,0.000096558586,0.00012027418],"candidate_categories":["metaepi_narrow"],"consensus_categories":["metaepi_narrow"],"category_scores_codex":[0.0003780122,0.0015776058,0.008086283,0.00015467331,0.000107442924,0.000030480116,0.0006737963,0.00020343816,0.000105831336],"category_scores_gemma":[0.00002733391,0.00076117116,0.0022319695,0.0006346708,0.00015233987,0.000010226676,0.000056604567,0.00011680991,0.000062677376],"study_design_candidate":"systematic_review","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000012318612,0.00082543254,0.000028607808,0.35258085,0.0014377965,0.000018395047,0.00014358963,0.0000012736047,6.9937425e-7,0.0000013143314,0.0009194464,0.6440303],"study_design_scores_gemma":[0.0007244146,0.00038764466,0.000014894405,0.32495582,0.014498537,0.00014600066,0.000023511828,4.0304346e-7,0.0000034926143,5.204897e-7,0.6588317,0.00041306976],"about_ca_topic_score_codex":0.0011061677,"about_ca_topic_score_gemma":0.0016458177,"teacher_disagreement_score":0.65791225,"about_ca_system_score_codex":0.0013806039,"about_ca_system_score_gemma":0.0006792339,"threshold_uncertainty_score":0.9996972},"labels":[],"label_agreement":null},{"id":"W2046702168","doi":"10.1016/j.ctrv.2009.06.006","title":"Management of prostate cancer recurrence after definitive radiation therapy","year":2010,"lang":"en","type":"review","venue":"Cancer Treatment Reviews","topic":"Prostate Cancer Diagnosis and Treatment","field":"Medicine","cited_by":46,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hôpital Maisonneuve-Rosemont","funders":"","keywords":"Medicine; Prostate cancer; Androgen deprivation therapy; Prostatectomy; Brachytherapy; Cryotherapy; Biochemical recurrence; Radiation therapy; Salvage therapy; External beam radiotherapy; Prostate; Urology; Radiology; Surgery; Cancer; Internal medicine; Chemotherapy","score_opus":0.08981952920318581,"score_gpt":0.4027478522663139,"score_spread":0.31292832306312807,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2046702168","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00009468977,0.9850685,9.956767e-7,0.00011647059,0.000846504,0.011664128,0.0011140645,0.000035845,0.0010588102],"genre_scores_gemma":[0.000014581875,0.9349482,0.0002786818,0.00010776002,0.00027780695,0.06250465,0.00060139864,0.00010092295,0.0011660036],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9967937,0.00017564633,0.0012948915,0.0009535471,0.00030358767,0.0004786307],"domain_scores_gemma":[0.9974417,0.00006734812,0.0012113153,0.0009213095,0.00012307406,0.0002352402],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00018279691,0.0010179582,0.0038559625,0.00018733056,0.00006154769,0.000028322997,0.00015748716,0.00029838982,0.00077983085],"category_scores_gemma":[0.0000052816167,0.000603657,0.0012997363,0.0005107388,0.000118609445,0.00009237084,0.000042906453,0.0003167819,0.00011380661],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000103088874,0.00061427546,0.0011418057,0.021365365,0.0016087416,0.00010025574,0.000163862,8.793637e-8,1.304934e-7,0.000026880902,0.00059934397,0.9742762],"study_design_scores_gemma":[0.0018045976,0.00069363427,0.00039873403,0.076193,0.0066477493,0.000013761985,0.0000051090365,1.8535204e-7,0.00004622234,0.000009985668,0.9137794,0.00040763128],"about_ca_topic_score_codex":0.00024154366,"about_ca_topic_score_gemma":0.000052239975,"teacher_disagreement_score":0.97386855,"about_ca_system_score_codex":0.0017260994,"about_ca_system_score_gemma":0.00070542644,"threshold_uncertainty_score":0.9996415},"labels":[],"label_agreement":null},{"id":"W2047332601","doi":"10.1016/j.ctrv.2005.05.001","title":"Major cytogenetic aberrations and typical multidrug resistance phenotype of uveal melanoma: Current views and new therapeutic prospects","year":2005,"lang":"en","type":"review","venue":"Cancer Treatment Reviews","topic":"Ocular Oncology and Treatments","field":"Medicine","cited_by":25,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"Fondation Mérieux; Ligue Contre le Cancer; Fondation pour la Recherche Médicale","keywords":"Monosomy; Melanoma; Medicine; Cancer research; Disease; Metastasis; Cancer; Natural history; Pathology; Oncology; Chromosome; Internal medicine; Gene; Karyotype; Biology; Genetics","score_opus":0.14828088918315627,"score_gpt":0.428477861503706,"score_spread":0.28019697232054974,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2047332601","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00007317469,0.99403965,0.000012164767,0.00016940902,0.0001934935,0.0049676253,0.000067754765,0.00002103669,0.00045568353],"genre_scores_gemma":[0.00006873518,0.9931883,0.0015112914,0.000050046336,0.00033332358,0.0012456726,0.00014855003,0.000052182975,0.003401886],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9977243,0.00024048376,0.0009216396,0.0006798021,0.00014159491,0.00029215863],"domain_scores_gemma":[0.9984711,0.00008065843,0.00058054406,0.0005502717,0.00003976464,0.00027770866],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00011592821,0.0006656491,0.003172186,0.00010724236,0.0001019178,0.000014879436,0.00008399143,0.00024110894,0.00017693284],"category_scores_gemma":[0.000019139483,0.00040243487,0.0004385082,0.00021576732,0.00015171056,0.000045732206,0.00003637829,0.00021784617,0.00005736318],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00005927617,0.00042770972,0.00087923824,0.0082726255,0.0007039404,0.000014091007,0.00012614843,2.2249997e-8,0.0000012186277,0.000087757704,0.00057607185,0.9888519],"study_design_scores_gemma":[0.0021300744,0.00044813572,0.000862866,0.01231648,0.011226647,0.00003941793,0.0000024459234,6.17345e-7,0.0000044409453,0.000030642757,0.97268635,0.00025185526],"about_ca_topic_score_codex":0.000028790953,"about_ca_topic_score_gemma":0.00057738007,"teacher_disagreement_score":0.9886,"about_ca_system_score_codex":0.00045975888,"about_ca_system_score_gemma":0.0006975796,"threshold_uncertainty_score":0.99984276},"labels":[],"label_agreement":null},{"id":"W2048922859","doi":"10.1016/j.ctrv.2014.12.010","title":"A systematic review of factors influencing older adults’ decision to accept or decline cancer treatment","year":2014,"lang":"en","type":"review","venue":"Cancer Treatment Reviews","topic":"Frailty in Older Adults","field":"Medicine","cited_by":263,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; Ontario Council of University Libraries; Université de Montréal; Princess Margaret Cancer Centre; Jewish General Hospital; University Health Network; University of Toronto","funders":"Canadian Institutes of Health Research","keywords":"Medicine; Cancer; Gerontology; MEDLINE; Intensive care medicine; Internal medicine","score_opus":0.08762258422028803,"score_gpt":0.432860757652245,"score_spread":0.345238173431957,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2048922859","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000043655775,0.96111745,0.000040333296,0.00017664583,0.0006721166,0.03727694,0.00045255193,0.00009646434,0.00012385077],"genre_scores_gemma":[0.000002520227,0.9640773,0.00078755774,0.001160688,0.00044186157,0.029182907,0.00044968276,0.000246356,0.0036511468],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.9903146,0.00073206367,0.005632613,0.0016110674,0.00087719655,0.0008324328],"domain_scores_gemma":[0.99137324,0.0009980117,0.003383036,0.0030117142,0.00041115054,0.0008228187],"candidate_categories":["metaepi_narrow","metaepi_broad","insufficient_payload"],"consensus_categories":["metaepi_narrow"],"category_scores_codex":[0.00063079456,0.00225275,0.01991688,0.0004943594,0.00010280249,0.00004314724,0.00065971253,0.00047494224,0.002153229],"category_scores_gemma":[0.0012215372,0.001063881,0.003541146,0.0013888781,0.000070795,0.00011909574,0.00017304451,0.00028555523,0.0004455159],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000034254404,0.00023049717,0.000028046858,0.5079699,0.0009814982,0.00001814748,0.00024199279,2.5471942e-7,1.1050861e-7,4.792098e-7,0.0016288508,0.48886594],"study_design_scores_gemma":[0.0011011363,0.00081827934,0.000008497622,0.50273114,0.02023878,0.000038590344,0.0000140521925,7.2394874e-7,0.0000068202417,2.2859116e-7,0.47462088,0.00042087815],"about_ca_topic_score_codex":0.0017698769,"about_ca_topic_score_gemma":0.0012678854,"teacher_disagreement_score":0.48844507,"about_ca_system_score_codex":0.0070434352,"about_ca_system_score_gemma":0.0018429895,"threshold_uncertainty_score":0.99918115},"labels":[],"label_agreement":null},{"id":"W2052249651","doi":"10.1016/j.ctrv.2014.08.003","title":"Prognostic relevance of receptor tyrosine kinase expression in breast cancer: A meta-analysis","year":2014,"lang":"en","type":"review","venue":"Cancer Treatment Reviews","topic":"HER2/EGFR in Cancer Research","field":"Medicine","cited_by":47,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; Receptor tyrosine kinase; Odds ratio; Oncology; Breast cancer; Internal medicine; Meta-analysis; Confidence interval; Cancer; Fibroblast growth factor receptor; Epidermal growth factor receptor; Receptor; Tyrosine kinase; Cancer research; Fibroblast growth factor","score_opus":0.23622312007243446,"score_gpt":0.4790153302447197,"score_spread":0.24279221017228525,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2052249651","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000007072238,0.98940957,0.000019995054,0.0005343053,0.00019712288,0.008154965,0.0013946521,0.000040816023,0.00024153125],"genre_scores_gemma":[0.000010311599,0.968399,0.00095522683,0.00010047415,0.0003926102,0.026702086,0.00049126113,0.00015284552,0.0027962148],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99264365,0.0013285434,0.002806205,0.0015704352,0.00084143766,0.0008097227],"domain_scores_gemma":[0.9948295,0.00050731644,0.0017641084,0.0021670344,0.00027935967,0.00045271145],"candidate_categories":["metaepi_narrow","metaepi_broad","insufficient_payload"],"consensus_categories":["metaepi_narrow"],"category_scores_codex":[0.001113711,0.0012831396,0.016664924,0.0009322058,0.00006157307,0.000031773256,0.00050551246,0.0004408822,0.0061239647],"category_scores_gemma":[0.0002281432,0.0007288818,0.006258165,0.0034379773,0.00018426264,0.00008390816,0.000121688776,0.0006175871,0.00017393804],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00006349124,0.0004953945,0.0007892434,0.061024416,0.02993627,0.000033663553,0.000047910744,0.0000060615725,0.000012171319,0.0000031110112,0.0042081624,0.9033801],"study_design_scores_gemma":[0.0005394372,0.00020146112,0.000034991313,0.029091313,0.26965058,0.000011970764,0.0000018106317,0.0000051834018,0.000035573627,0.0000012662905,0.7000739,0.0003525172],"about_ca_topic_score_codex":0.0017967739,"about_ca_topic_score_gemma":0.00068013836,"teacher_disagreement_score":0.9030276,"about_ca_system_score_codex":0.003242685,"about_ca_system_score_gemma":0.0017505732,"threshold_uncertainty_score":0.9999921},"labels":[],"label_agreement":null},{"id":"W2054510044","doi":"10.1016/j.ctrv.2014.03.001","title":"Psychosocial predictors of health outcomes in colorectal cancer: A comprehensive review","year":2014,"lang":"en","type":"review","venue":"Cancer Treatment Reviews","topic":"Cancer survivorship and care","field":"Medicine","cited_by":65,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Brain and Cognition Discovery Foundation","funders":"Conselho Nacional de Desenvolvimento Científico e Tecnológico; Coordenação de Aperfeiçoamento de Pessoal de Nível Superior","keywords":"Medicine; Psychosocial; Distress; Personality; Clinical psychology; Psychological intervention; Population; Quality of life (healthcare); Coping (psychology); Mental health; Psychiatry; Psychology","score_opus":0.10006587990176898,"score_gpt":0.4456100506702709,"score_spread":0.3455441707685019,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2054510044","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000026178182,0.98585474,0.0000012819521,0.0007595812,0.0018954353,0.0104433615,0.0005843396,0.000044449247,0.00039060283],"genre_scores_gemma":[0.000004868868,0.9868852,0.000020589388,0.0012245432,0.0004898665,0.010422101,0.00045922806,0.000104250816,0.00038936443],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9941568,0.0010586444,0.0028963403,0.00088803377,0.0004169755,0.0005832391],"domain_scores_gemma":[0.99638283,0.00017685887,0.0023053624,0.00072450045,0.00012891278,0.00028155415],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00048401565,0.0010709068,0.014427596,0.0002589912,0.000057962243,0.000009625539,0.00026811013,0.00030526693,0.000440387],"category_scores_gemma":[0.000043213367,0.00067915104,0.0025705628,0.0008919228,0.00012533819,0.000041686337,0.00004781076,0.00040286442,0.000043491607],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000015276362,0.00019146847,0.0028069005,0.23707484,0.00056726503,0.000005145703,0.00016279817,4.3614666e-8,5.716798e-8,0.000004012159,0.006712029,0.7524602],"study_design_scores_gemma":[0.0008081259,0.00047766863,0.00031500251,0.27077872,0.0030172456,0.00000895098,0.000008165101,8.966364e-8,3.5351607e-7,0.0000010269623,0.7242886,0.00029604926],"about_ca_topic_score_codex":0.006513275,"about_ca_topic_score_gemma":0.005663133,"teacher_disagreement_score":0.7521641,"about_ca_system_score_codex":0.0032947897,"about_ca_system_score_gemma":0.0024642067,"threshold_uncertainty_score":0.99956596},"labels":[],"label_agreement":null},{"id":"W2063000484","doi":"10.1016/j.ctrv.2005.04.007","title":"Radiotherapeutic management of brain metastases: A systematic review and meta-analysis","year":2005,"lang":"en","type":"review","venue":"Cancer Treatment Reviews","topic":"Brain Metastases and Treatment","field":"Medicine","cited_by":172,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University; University of Toronto; Sunnybrook Health Science Centre","funders":"","keywords":"Medicine; Radiosurgery; Radiation therapy; Brain metastasis; Randomized controlled trial; Oncology; Quality of life (healthcare); Dose fractionation; Cancer; Surgery; Metastasis; Internal medicine","score_opus":0.20633974142822736,"score_gpt":0.45643957404128843,"score_spread":0.25009983261306107,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2063000484","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[1.5456337e-8,0.976833,0.000065105545,0.00052165374,0.00002347838,0.0215535,0.0007619569,0.000030654533,0.00021067125],"genre_scores_gemma":[1.0901597e-7,0.9693485,0.0033364967,0.0013412002,0.000033934717,0.019179124,0.0004983619,0.00008980487,0.0061724675],"study_design_codex":"systematic_review","study_design_gemma":"meta_analysis","domain_scores_codex":[0.9938381,0.0013993506,0.0029260232,0.0010543091,0.0003704428,0.0004117746],"domain_scores_gemma":[0.9952283,0.00021743582,0.0021589801,0.0020410006,0.00006297177,0.00029131424],"candidate_categories":["metaepi_narrow","metaepi_broad","insufficient_payload"],"consensus_categories":["metaepi_narrow","metaepi_broad"],"category_scores_codex":[0.0011903209,0.0014049283,0.031564645,0.00042371996,0.000060245602,0.000028353807,0.00022083463,0.00014550367,0.0022183617],"category_scores_gemma":[0.000016823455,0.00067947234,0.01159957,0.0014639315,0.00009083248,0.000057042966,0.0000589767,0.00015019868,0.000068674875],"study_design_candidate":"meta_analysis","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0000017070083,0.00019622434,1.5560065e-7,0.4542869,0.35131383,0.000035577057,0.000007630093,1.01768585e-7,1.9680233e-9,0.000043696025,0.00023988547,0.19387428],"study_design_scores_gemma":[0.00027739094,0.00013598094,8.937773e-8,0.08414658,0.47062677,0.000054152988,0.0000025918978,3.0479066e-7,7.1702864e-8,6.551763e-7,0.4445643,0.00019112017],"about_ca_topic_score_codex":0.000057114532,"about_ca_topic_score_gemma":0.000021502838,"teacher_disagreement_score":0.4443244,"about_ca_system_score_codex":0.0007612049,"about_ca_system_score_gemma":0.00015539676,"threshold_uncertainty_score":0.9998701},"labels":[],"label_agreement":null},{"id":"W2064815063","doi":"10.1016/j.ctrv.2013.11.001","title":"Exercise training for people following lung resection for non-small cell lung cancer – A Cochrane systematic review","year":2013,"lang":"en","type":"review","venue":"Cancer Treatment Reviews","topic":"Lung Cancer Diagnosis and Treatment","field":"Medicine","cited_by":84,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Medicine; Physical therapy; Lung cancer; Confidence interval; Randomized controlled trial; Meta-analysis; Quality of life (healthcare); MEDLINE; Vital capacity; Strictly standardized mean difference; Lung; Internal medicine; Lung function; Diffusing capacity","score_opus":0.080934093989471,"score_gpt":0.4138930445958479,"score_spread":0.3329589506063769,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2064815063","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0000036698978,0.88755465,0.00014364884,0.00022846842,0.0013674964,0.10999032,0.00045759117,0.00008909132,0.00016504228],"genre_scores_gemma":[0.0000016611933,0.6418122,0.0007800177,0.00020371524,0.00055635604,0.35190412,0.00084186567,0.00023290895,0.0036671455],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.99372816,0.00025535535,0.0029061546,0.001638661,0.00040696462,0.0010646787],"domain_scores_gemma":[0.99478346,0.00068082084,0.0022257513,0.0015428078,0.00027835273,0.0004888019],"candidate_categories":["metaepi_narrow","metaepi_broad"],"consensus_categories":["metaepi_narrow"],"category_scores_codex":[0.00089191535,0.0017937198,0.015786283,0.00026759328,0.00033122694,0.00011255945,0.00033579493,0.00044078764,0.00023730921],"category_scores_gemma":[0.000134503,0.00109515,0.00634412,0.00065054774,0.000025202535,0.00015264258,0.000046090376,0.00025346523,0.00004788997],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000023803124,0.000256571,0.000020513859,0.70007217,0.0022401458,0.000008667989,0.0002472187,4.4441282e-7,3.2505176e-7,0.0000020194063,0.01454405,0.28258407],"study_design_scores_gemma":[0.0019193297,0.0004320654,5.090279e-7,0.5253038,0.105638884,0.000011999466,0.0000160489,0.000038033195,0.0000068251043,8.67032e-7,0.36615032,0.00048135276],"about_ca_topic_score_codex":0.0005544832,"about_ca_topic_score_gemma":0.0005293976,"teacher_disagreement_score":0.35160625,"about_ca_system_score_codex":0.0072771097,"about_ca_system_score_gemma":0.0018200472,"threshold_uncertainty_score":0.9994808},"labels":[],"label_agreement":null},{"id":"W2065151790","doi":"10.1016/j.ctrv.2011.06.009","title":"Endometrial cancer and venous thromboembolism in women under age 50 who take tamoxifen for prevention of breast cancer: A systematic review","year":2011,"lang":"en","type":"review","venue":"Cancer Treatment Reviews","topic":"Estrogen and related hormone effects","field":"Biochemistry, Genetics and Molecular Biology","cited_by":87,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen's University; University of Toronto; Women's College Hospital","funders":"","keywords":"Medicine; Tamoxifen; Breast cancer; Endometrial cancer; Internal medicine; Pulmonary embolism; Gynecology; Relative risk; Cancer; Oncology; Deep vein; Placebo; Obstetrics; Thrombosis; Confidence interval; Pathology","score_opus":0.04801220906922657,"score_gpt":0.35870183004189293,"score_spread":0.3106896209726664,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2065151790","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00019181558,0.985947,0.000008227865,0.000017375924,0.00029189282,0.012881119,0.0006018474,0.00000819407,0.000052521616],"genre_scores_gemma":[0.00001745633,0.9697222,0.000038029382,0.0000766177,0.0002789387,0.028858798,0.0002472369,0.000084877836,0.0006758539],"study_design_codex":"systematic_review","study_design_gemma":"not_applicable","domain_scores_codex":[0.9967168,0.0005204958,0.0014364301,0.0007407565,0.00012106298,0.00046444588],"domain_scores_gemma":[0.9976878,0.000052718682,0.0014202532,0.00062234065,0.00006291734,0.00015393224],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0005275621,0.0007443106,0.0058967997,0.00015155476,0.000053893207,0.000018244953,0.00026662127,0.00046513416,0.00004987099],"category_scores_gemma":[0.000043259017,0.0004789722,0.0009465464,0.00033645195,0.000082841994,0.000009173131,0.00006924673,0.00015417312,0.0000040225545],"study_design_candidate":"systematic_review","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0000424909,0.00018877217,0.0000024531803,0.5174105,0.0013115744,0.0000025061788,0.000060832812,3.6277706e-7,0.00003366387,0.000010815072,0.0003109839,0.48062503],"study_design_scores_gemma":[0.0011726319,0.0005890671,0.0000063651523,0.4549372,0.0070586237,0.000028933413,0.0000048058537,2.3224536e-7,0.000031131847,0.000014651817,0.53576195,0.00039443446],"about_ca_topic_score_codex":0.00037016484,"about_ca_topic_score_gemma":0.00014252623,"teacher_disagreement_score":0.53545094,"about_ca_system_score_codex":0.00061493466,"about_ca_system_score_gemma":0.0005210182,"threshold_uncertainty_score":0.9997662},"labels":[],"label_agreement":null},{"id":"W2068928636","doi":"10.1016/j.ctrv.2010.04.006","title":"The safety and effectiveness of endoscopic and non-endoscopic approaches to the management of early esophageal cancer: A systematic review","year":2010,"lang":"en","type":"review","venue":"Cancer Treatment Reviews","topic":"Esophageal Cancer Research and Treatment","field":"Medicine","cited_by":28,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"","keywords":"Medicine; MEDLINE; CINAHL; Cochrane Library; Systematic review; Adverse effect; Meta-analysis; Esophageal cancer; Esophagectomy; English language; Intensive care medicine; Cancer; Internal medicine; Psychological intervention","score_opus":0.09218007709715578,"score_gpt":0.3808785577789474,"score_spread":0.2886984806817916,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2068928636","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00004069286,0.96633214,0.00000882389,0.00018503708,0.00014325777,0.03290916,0.00017414619,0.00001072666,0.00019604265],"genre_scores_gemma":[0.00026733038,0.9718509,0.00012241624,0.000031775322,0.00007321829,0.027082335,0.00003723824,0.000056574954,0.00047825734],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.995929,0.0009602588,0.0014893289,0.00070972857,0.0004538158,0.00045788568],"domain_scores_gemma":[0.9967232,0.0005962437,0.0009443672,0.0013739888,0.000072746574,0.00028948483],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0014806117,0.0007842676,0.0060397857,0.000103670776,0.00022845271,0.000036631303,0.00036596172,0.00013406732,0.000020807507],"category_scores_gemma":[0.000038806596,0.00032005555,0.0006563253,0.00053281797,0.00024441633,0.000045212106,0.00018376125,0.0003251507,0.000012032202],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00004702528,0.00006675298,0.00020022676,0.573596,0.0015837486,0.000018181621,0.00004175612,5.0905545e-8,7.124055e-8,0.000088167806,0.000011662236,0.4243464],"study_design_scores_gemma":[0.0012323152,0.0010051723,0.00076976395,0.78508687,0.020931622,0.000019429739,0.000009086093,5.258407e-7,0.000014205927,0.0000047913404,0.19076674,0.00015949],"about_ca_topic_score_codex":0.0004475848,"about_ca_topic_score_gemma":0.00015918221,"teacher_disagreement_score":0.4241869,"about_ca_system_score_codex":0.00065682794,"about_ca_system_score_gemma":0.00037983543,"threshold_uncertainty_score":0.99992514},"labels":[],"label_agreement":null},{"id":"W2069700598","doi":"10.1016/j.ctrv.2008.03.011","title":"Long-term outcome of laparoscopic surgery for colorectal cancer: A cochrane systematic review of randomised controlled trials","year":2008,"lang":"en","type":"review","venue":"Cancer Treatment Reviews","topic":"Colorectal Cancer Surgical Treatments","field":"Medicine","cited_by":373,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Dalhousie University","funders":"","keywords":"Medicine; Colorectal cancer; Laparoscopic surgery; Hazard ratio; Cochrane Library; Surgery; Randomized controlled trial; Cancer; Laparoscopy; Colectomy; Meta-analysis; Rectum; Internal medicine; Confidence interval","score_opus":0.1825859753002003,"score_gpt":0.467226585925209,"score_spread":0.28464061062500867,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2069700598","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00007400236,0.8972182,0.00000595403,0.00005043046,0.00088744756,0.10037761,0.0012012284,0.00004818263,0.00013694396],"genre_scores_gemma":[0.0000128683705,0.8500035,0.000052285246,0.00010077924,0.00028154958,0.1478514,0.00072920293,0.0001415057,0.00082696025],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.9812574,0.0032723711,0.012941738,0.0010673658,0.00078777835,0.00067339226],"domain_scores_gemma":[0.97267747,0.012153772,0.012962923,0.0012520485,0.000559766,0.00039404866],"candidate_categories":["metaepi_narrow","metaepi_broad"],"consensus_categories":["metaepi_narrow","metaepi_broad"],"category_scores_codex":[0.0035873393,0.0018352966,0.088013664,0.00045409502,0.00008162144,0.000014818154,0.00034357494,0.000481698,0.00081945426],"category_scores_gemma":[0.006594425,0.00093830674,0.020190489,0.00088802044,0.00021957397,0.00006917593,0.0000485171,0.00023109162,0.00002260599],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.003977013,0.00066769344,0.00053814915,0.81059206,0.011252342,0.000050609964,0.000019155075,5.4001255e-8,9.576514e-7,0.0000016123005,0.0005558448,0.17234452],"study_design_scores_gemma":[0.052343957,0.00080312183,0.000015074395,0.77186924,0.113056034,0.000094586045,8.0182576e-7,5.4525304e-7,0.000032419677,4.962858e-7,0.061328832,0.00045490236],"about_ca_topic_score_codex":0.00014886711,"about_ca_topic_score_gemma":0.000055106444,"teacher_disagreement_score":0.17188962,"about_ca_system_score_codex":0.0026956361,"about_ca_system_score_gemma":0.0026082725,"threshold_uncertainty_score":0.9994392},"labels":[],"label_agreement":null},{"id":"W2069702330","doi":"10.1016/s0305-7372(02)00044-0","title":"Cancer and thromboembolic disease: pathogenic mechanisms","year":2002,"lang":"en","type":"review","venue":"Cancer Treatment Reviews","topic":"Venous Thromboembolism Diagnosis and Management","field":"Medicine","cited_by":153,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hamilton Health Sciences","funders":"","keywords":"Medicine; Angiogenesis; Coagulation; Cancer; Tissue factor; Metastasis; Thrombosis; Cancer research; Immunology; Pathology; Internal medicine","score_opus":0.10017798728227666,"score_gpt":0.38186910538659924,"score_spread":0.28169111810432257,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2069702330","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000006091704,0.9896809,0.000009676949,0.00027048745,0.00059010583,0.007875041,0.00033127944,0.00010122529,0.001135196],"genre_scores_gemma":[0.0000018624748,0.9771517,0.00019651049,0.0006342644,0.0006502772,0.01679847,0.00024807974,0.00016952929,0.0041493364],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99660033,0.00017709611,0.0010622608,0.0012034865,0.00030986458,0.00064693653],"domain_scores_gemma":[0.99749225,0.00004678384,0.00063188554,0.0011210032,0.000042824628,0.0006652631],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00016451556,0.0012023873,0.0067881853,0.00021697268,0.00016457094,0.000066754445,0.00019488674,0.00024303173,0.002696415],"category_scores_gemma":[0.000016564385,0.0007488207,0.001461728,0.0003905145,0.000083360064,0.0000761148,0.00011929701,0.00022865245,0.0004205516],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0000031248778,0.00053176295,0.000017675779,0.033901393,0.0012969238,0.0000913588,0.000050872855,1.1890189e-7,3.8920726e-7,0.00037340878,0.010012424,0.95372057],"study_design_scores_gemma":[0.00063948054,0.00022740236,0.00015521674,0.045511365,0.02918235,0.000019896783,0.0000036979645,0.0000024337476,5.1580287e-7,0.000044449782,0.92363966,0.00057356514],"about_ca_topic_score_codex":0.00022952758,"about_ca_topic_score_gemma":0.000068656824,"teacher_disagreement_score":0.953147,"about_ca_system_score_codex":0.0012756453,"about_ca_system_score_gemma":0.0003955198,"threshold_uncertainty_score":0.9994963},"labels":[],"label_agreement":null},{"id":"W2069941849","doi":"10.1016/s0305-7372(03)00165-8","title":"Delaying post-operative radiotherapy may increase risk of local recurrence in people with breast cancer","year":2003,"lang":"en","type":"review","venue":"Cancer Treatment Reviews","topic":"Breast Cancer Treatment Studies","field":"Biochemistry, Genetics and Molecular Biology","cited_by":3,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hôtel-Dieu de Québec","funders":"","keywords":"Medicine; Radiation therapy; Breast cancer; Cancer; Oncology; Internal medicine","score_opus":0.024251541734225966,"score_gpt":0.35027359381570095,"score_spread":0.326022052081475,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2069941849","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0004505868,0.9936977,0.00014258939,0.00004806285,0.00017494391,0.0026900126,0.0026473855,0.000009904577,0.0001387876],"genre_scores_gemma":[0.00024909392,0.9915376,0.00041827516,0.00009702711,0.00020250837,0.0066948365,0.000496197,0.000110020184,0.00019447255],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99631846,0.00082832127,0.0009787063,0.0011502038,0.00019486324,0.00052942283],"domain_scores_gemma":[0.997749,0.00005947731,0.0010419558,0.000835119,0.00015341719,0.00016107786],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00022733102,0.0011562189,0.0033614195,0.00014474167,0.00011272822,0.000021283082,0.00029367188,0.00029839686,0.0002076109],"category_scores_gemma":[0.000011960609,0.00070135936,0.0006734557,0.0004978936,0.00023388205,0.000013543063,0.00006008421,0.00022888425,0.000010555834],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00019013284,0.00034137772,0.009964107,0.0029576372,0.001717604,0.0000115053645,0.00016598181,0.000036056856,0.0000037041307,0.000003806991,0.00031950074,0.9842886],"study_design_scores_gemma":[0.0018818725,0.0005236265,0.0010341405,0.013207595,0.002844099,0.000109287306,0.000059561124,0.0000015350403,0.000045056684,6.045813e-7,0.9795246,0.0007680089],"about_ca_topic_score_codex":0.0086944625,"about_ca_topic_score_gemma":0.011090473,"teacher_disagreement_score":0.98352057,"about_ca_system_score_codex":0.0014068282,"about_ca_system_score_gemma":0.0014404955,"threshold_uncertainty_score":0.9995437},"labels":[],"label_agreement":null},{"id":"W2070095096","doi":"10.1016/j.ctrv.2015.02.001","title":"Primary and secondary bone lymphomas","year":2015,"lang":"en","type":"review","venue":"Cancer Treatment Reviews","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":130,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; Ontario Institute for Cancer Research","funders":"","keywords":"Medicine; Lymphoma; Malignancy; Pathological; Disease; Radiation therapy; Pathology; Radiology","score_opus":0.11476396420634723,"score_gpt":0.3917319352950804,"score_spread":0.27696797108873317,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2070095096","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000007396355,0.97723943,2.6387755e-7,0.00009360124,0.0003126222,0.004871309,0.00024182853,0.00006913987,0.017164383],"genre_scores_gemma":[3.9349604e-7,0.98491836,0.00032296544,0.00038391893,0.0005190721,0.0065369476,0.0010441408,0.000099570505,0.006174631],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9971569,0.00018977109,0.0010603843,0.0009125745,0.00025201848,0.000428349],"domain_scores_gemma":[0.99781704,0.00007752357,0.0005795474,0.00090293953,0.000059066995,0.00056387717],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00022797337,0.001061796,0.0064320806,0.00017152667,0.00008101548,0.000048040052,0.00009136725,0.00032099636,0.000473106],"category_scores_gemma":[0.000013488346,0.00059190544,0.0011137207,0.00026186966,0.000096313495,0.000078355304,0.000082689556,0.00013359166,0.00048281864],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000013869034,0.00049408054,0.00011459153,0.026310692,0.0008493391,0.000328468,0.000038778195,3.5773777e-9,4.166992e-8,0.00003418973,0.018436981,0.953379],"study_design_scores_gemma":[0.002966266,0.0005793899,0.000066003166,0.029980894,0.012983981,0.00078447646,0.00000273308,1.114746e-7,8.8447547e-7,0.000008763896,0.95220244,0.00042408056],"about_ca_topic_score_codex":0.00015052961,"about_ca_topic_score_gemma":0.000019740846,"teacher_disagreement_score":0.9529549,"about_ca_system_score_codex":0.0048272433,"about_ca_system_score_gemma":0.0025285073,"threshold_uncertainty_score":0.9996532},"labels":[],"label_agreement":null},{"id":"W2070849505","doi":"10.1053/ctrv.2000.0174","title":"Breast cancer risk following irradiation for Hodgkin’s disease","year":2000,"lang":"en","type":"review","venue":"Cancer Treatment Reviews","topic":"Breast Cancer Treatment Studies","field":"Biochemistry, Genetics and Molecular Biology","cited_by":114,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; Breast cancer; Disease; Radiation therapy; Cancer; Oncology; Internal medicine; Stage (stratigraphy)","score_opus":0.04497273947181886,"score_gpt":0.37368563754867035,"score_spread":0.3287128980768515,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2070849505","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000022871687,0.98319197,0.000025954101,0.00010417731,0.0008371229,0.004723743,0.010930733,0.00003856114,0.0001248525],"genre_scores_gemma":[0.0000141642095,0.9593732,0.0001625407,0.0001028079,0.0021122925,0.033154264,0.0035987014,0.00017652544,0.0013055226],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9966618,0.00029305703,0.0008789592,0.0013663138,0.0001714346,0.0006284631],"domain_scores_gemma":[0.9978061,0.000053830827,0.0007974775,0.00098811,0.000053002626,0.00030152305],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00015275537,0.0012196779,0.002599422,0.00010284775,0.0003194503,0.000057619887,0.00031674665,0.0003026412,0.00020548495],"category_scores_gemma":[0.000020620502,0.00085103104,0.002850924,0.00022867798,0.00006137546,0.000011484761,0.000059296664,0.00011674115,0.00006750321],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00009014762,0.00016593763,0.000504795,0.0034226943,0.0020835078,0.000004660819,0.000022586632,0.000006622748,3.9128147e-7,0.00000226163,0.006280131,0.98741627],"study_design_scores_gemma":[0.0011301568,0.000097047916,0.00026511197,0.0069319736,0.0129178325,0.00000981729,0.00000247936,0.0000012852412,0.0000023562488,0.000007821034,0.97788185,0.0007522396],"about_ca_topic_score_codex":0.0005268553,"about_ca_topic_score_gemma":0.00037419377,"teacher_disagreement_score":0.986664,"about_ca_system_score_codex":0.0011267917,"about_ca_system_score_gemma":0.0008744696,"threshold_uncertainty_score":0.99939406},"labels":[],"label_agreement":null},{"id":"W2071668211","doi":"10.1016/j.ctrv.2004.03.005","title":"No difference between pamidronate disodium and placebo in relieving bone pain in men with advanced prostate cancer","year":2004,"lang":"en","type":"letter","venue":"Cancer Treatment Reviews","topic":"Bone health and treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University Health Network","funders":"","keywords":"Medicine; Prostate cancer; Bone pain; Bone resorption; Concomitant; Placebo; Osteoclast; Prostate; Bone metastasis; Pain control; Palliative care; Internal medicine; Oncology; Cancer; Surgery; Pathology","score_opus":0.02770496021028831,"score_gpt":0.3182080621686497,"score_spread":0.29050310195836143,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2071668211","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.074246876,0.6121036,0.0000070587307,0.2869831,0.0002719525,0.023474164,0.0006844061,0.00013480592,0.0020940097],"genre_scores_gemma":[0.01096117,0.8602035,0.00085861166,0.08598804,0.0007784583,0.023407415,0.0015368565,0.0002585106,0.016007444],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99620354,0.00032656192,0.0010296162,0.001145475,0.0003245019,0.000970276],"domain_scores_gemma":[0.9983958,0.00014362557,0.0005430545,0.00059958803,0.00005283346,0.00026509815],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00032578083,0.00096126314,0.0025903923,0.00025502386,0.00007364563,0.000027435175,0.00009668369,0.00041052638,0.00006566775],"category_scores_gemma":[0.000035235673,0.0006045337,0.00013466727,0.0003588406,0.000107250955,0.00010117354,0.00003772415,0.0009792555,0.00005374405],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0007374759,0.00022053628,0.480123,0.0047041452,0.00019896329,0.0013673514,0.00041031296,0.000006148463,0.0000062483355,4.691768e-7,0.010565166,0.50166017],"study_design_scores_gemma":[0.016603539,0.001986449,0.087579295,0.023863345,0.0007096879,0.000018285702,0.000011083878,0.000011612547,0.000018351982,0.000025366333,0.8685206,0.00065238366],"about_ca_topic_score_codex":0.008728062,"about_ca_topic_score_gemma":0.0052693393,"teacher_disagreement_score":0.85795546,"about_ca_system_score_codex":0.0039210455,"about_ca_system_score_gemma":0.0008854487,"threshold_uncertainty_score":0.9999027},"labels":[],"label_agreement":null},{"id":"W2072076152","doi":"10.1053/ctrv.2001.0227","title":"Integration of Chinese medicine into supportive cancer care:A modern role for an ancient tradition","year":2001,"lang":"en","type":"review","venue":"Cancer Treatment Reviews","topic":"Complementary and Alternative Medicine Studies","field":"Medicine","cited_by":87,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University; Hamilton Regional Laboratory Medicine Program","funders":"","keywords":"Medicine; MEDLINE; Integrative medicine; Alternative medicine; Traditional Chinese medicine; Evidence-based medicine; Western medicine; Health care; Cancer treatment; Traditional medicine; Cancer; Internal medicine; Pathology","score_opus":0.20861068330316107,"score_gpt":0.4909616684070676,"score_spread":0.28235098510390655,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2072076152","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0005253812,0.98953295,0.00047635223,0.00011246533,0.0006499876,0.0075411927,0.0005397857,0.000027650653,0.00059424306],"genre_scores_gemma":[0.00045601086,0.98226327,0.00030734894,0.00010990741,0.002169387,0.010193617,0.004128472,0.000057513265,0.00031444852],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9971155,0.00017273914,0.0014066056,0.00071229535,0.00029411798,0.0002987729],"domain_scores_gemma":[0.99783885,0.00012346996,0.0010601997,0.00050278474,0.00027432537,0.00020034569],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00022547494,0.0008006867,0.004389003,0.00025171763,0.00012049644,0.0000054637303,0.00015001856,0.00005845302,0.00042495882],"category_scores_gemma":[0.00006613804,0.00041545008,0.0007942581,0.0004194776,0.00016777725,0.00010740926,0.000023575958,0.00015229365,0.0000034655682],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00006624765,0.00024673488,0.00038058747,0.016737144,0.0006493754,0.0000052526016,0.004924014,6.542517e-7,0.000036751226,0.000019474608,0.0006011104,0.97633266],"study_design_scores_gemma":[0.0018731735,0.0043186797,0.00014669167,0.036199845,0.0068658884,0.00001257884,0.0005535666,0.000027249265,0.000017894125,0.00011937301,0.94958395,0.00028111855],"about_ca_topic_score_codex":0.0019979195,"about_ca_topic_score_gemma":0.0022097852,"teacher_disagreement_score":0.9760515,"about_ca_system_score_codex":0.0017462702,"about_ca_system_score_gemma":0.00043342638,"threshold_uncertainty_score":0.9998297},"labels":[],"label_agreement":null},{"id":"W2076971514","doi":"10.1016/s0305-7372(02)00042-7","title":"Managing thromboembolic disease in the cancer patient: efficacy and safety of antithrombotic treatment options in patients with cancer","year":2002,"lang":"en","type":"review","venue":"Cancer Treatment Reviews","topic":"Venous Thromboembolism Diagnosis and Management","field":"Medicine","cited_by":28,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"","keywords":"Medicine; Cancer; Antithrombotic; Thrombosis; Disease; Intensive care medicine; Quality of life (healthcare); Vomiting; Internal medicine; Surgery","score_opus":0.05495761042026679,"score_gpt":0.3476526322073705,"score_spread":0.2926950217871037,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2076971514","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0049623796,0.980454,0.0000010630947,0.0003099687,0.00017772657,0.013421229,0.00034612644,0.000019081288,0.000308382],"genre_scores_gemma":[0.001685004,0.9869425,0.000046628447,0.0001788625,0.000102881866,0.010621147,0.00024825524,0.000091353344,0.00008331396],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9962469,0.0003932464,0.0013780388,0.0010023772,0.0003869067,0.0005925768],"domain_scores_gemma":[0.9977558,0.0001164139,0.00078552053,0.0010689853,0.00005345301,0.00021981512],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00016339192,0.0009996492,0.00488566,0.00040360857,0.0001157419,0.00003861072,0.00023089767,0.0001260676,0.00039470586],"category_scores_gemma":[0.0000127399635,0.0005087684,0.0004881388,0.00091293437,0.00015497472,0.00010793088,0.00006770333,0.0002140496,0.000014294991],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000058927322,0.004271851,0.017529441,0.011593929,0.00090392475,0.00003968667,0.0009170556,0.00009367243,2.0899282e-8,0.000045615045,0.0002443713,0.9643015],"study_design_scores_gemma":[0.004333156,0.0010541325,0.12121606,0.06548687,0.010653701,0.0000013657303,0.000028670232,0.000009727702,1.7143286e-7,0.0000041130515,0.7967581,0.0004539332],"about_ca_topic_score_codex":0.004450662,"about_ca_topic_score_gemma":0.0020508543,"teacher_disagreement_score":0.9638476,"about_ca_system_score_codex":0.002355704,"about_ca_system_score_gemma":0.00036497795,"threshold_uncertainty_score":0.99973637},"labels":[],"label_agreement":null},{"id":"W2078764279","doi":"10.1016/j.ctrv.2009.10.003","title":"Switching from tamoxifen to aromatase inhibitors for adjuvant endocrine therapy in postmenopausal patients with early breast cancer","year":2009,"lang":"en","type":"review","venue":"Cancer Treatment Reviews","topic":"Estrogen and related hormone effects","field":"Biochemistry, Genetics and Molecular Biology","cited_by":18,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Sunnybrook Health Science Centre","funders":"National Cancer Institute; Sanofi; AstraZeneca","keywords":"Anastrozole; Exemestane; Medicine; Tamoxifen; Letrozole; Oncology; Breast cancer; Internal medicine; Aromatase inhibitor; Aromatase; Adjuvant therapy; Hormonal therapy; Randomization; Gynecology; Cancer; Randomized controlled trial","score_opus":0.019433821561315134,"score_gpt":0.32440740210594454,"score_spread":0.3049735805446294,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2078764279","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.031417705,0.9595076,0.0000061007677,0.000043152297,0.00022115774,0.0066622626,0.0021101215,0.0000149040625,0.000017006525],"genre_scores_gemma":[0.00035165952,0.9898608,0.00020180637,0.0001814245,0.00054963323,0.005485857,0.0031708758,0.000106251806,0.00009171934],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9974949,0.00018299875,0.00071252545,0.0009531624,0.00014477367,0.0005116587],"domain_scores_gemma":[0.99865144,0.000025192814,0.0004429935,0.00059544237,0.00005333645,0.00023161253],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00008503206,0.0008793801,0.0019545916,0.000110941066,0.00007213418,0.000040874835,0.0002514098,0.00027709446,0.000020656089],"category_scores_gemma":[0.000007340402,0.00050899957,0.00043327617,0.00022786229,0.000019929617,0.000009628541,0.000044187662,0.00017255358,0.000019118072],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00027464316,0.00034590007,0.0010267425,0.0005403209,0.0004736642,0.000013045248,0.000034565946,0.0000031585987,0.00015668431,4.472013e-7,0.0007916326,0.9963392],"study_design_scores_gemma":[0.0025979523,0.0028122873,0.00072464184,0.010152953,0.0008121041,0.000006484799,0.0000011828332,2.7526653e-7,0.00029297516,0.0000021905091,0.9819675,0.0006294484],"about_ca_topic_score_codex":0.0011810669,"about_ca_topic_score_gemma":0.00021142107,"teacher_disagreement_score":0.9957097,"about_ca_system_score_codex":0.0004055474,"about_ca_system_score_gemma":0.0003215588,"threshold_uncertainty_score":0.9997362},"labels":[],"label_agreement":null},{"id":"W2079118647","doi":"10.1016/j.ctrv.2007.10.003","title":"Biochemotherapy for the treatment of metastatic malignant melanoma: A systematic review","year":2008,"lang":"en","type":"review","venue":"Cancer Treatment Reviews","topic":"Cutaneous Melanoma Detection and Management","field":"Medicine","cited_by":67,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University; Ottawa Hospital; Cancer Care Ontario; Sunnybrook Health Science Centre; Windsor Regional Hospital","funders":"Cancer Care Ontario","keywords":"Medicine; Hazard ratio; Internal medicine; Oncology; Chemotherapy; Confidence interval; Randomized controlled trial; Melanoma; Meta-analysis; Incidence (geometry); Surgery","score_opus":0.11308282804319754,"score_gpt":0.39236118988544927,"score_spread":0.27927836184225174,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2079118647","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[1.9893227e-7,0.9505171,0.00009474641,0.00019639207,0.00034148124,0.048496533,0.00016331836,0.000040912364,0.00014928769],"genre_scores_gemma":[1.2154652e-7,0.94196856,0.00029956418,0.00031334916,0.00018081671,0.04817979,0.00015797949,0.00010020367,0.008799626],"study_design_codex":"systematic_review","study_design_gemma":"not_applicable","domain_scores_codex":[0.9962761,0.00033594912,0.0021425113,0.00062831683,0.00026061365,0.0003565355],"domain_scores_gemma":[0.9960857,0.0004118353,0.0017228631,0.0015438572,0.00009065024,0.0001450832],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00023211131,0.0009879742,0.009233364,0.00016639472,0.00012365202,0.000015250958,0.0002113112,0.00010292043,0.00023241887],"category_scores_gemma":[0.000045442895,0.000407245,0.00400979,0.00043768136,0.000079506965,0.0000187992,0.000012506876,0.00006425226,0.00009791035],"study_design_candidate":"systematic_review","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000012715791,0.00038877226,1.2299346e-7,0.4977924,0.002959103,0.000027865819,0.000043046533,3.5823835e-8,1.7428351e-7,0.000007814398,0.0019220519,0.4968459],"study_design_scores_gemma":[0.0007155738,0.0015209476,3.6494434e-8,0.342255,0.041675076,0.00050332665,0.000006578976,0.000001948679,0.0000060816965,7.3242643e-7,0.61313105,0.00018364057],"about_ca_topic_score_codex":0.00008712952,"about_ca_topic_score_gemma":0.000026760965,"teacher_disagreement_score":0.611209,"about_ca_system_score_codex":0.0015427961,"about_ca_system_score_gemma":0.0003965253,"threshold_uncertainty_score":0.99983793},"labels":[],"label_agreement":null},{"id":"W2080073879","doi":"10.1016/s0305-7372(02)00036-1","title":"Tamoxifen (‘Nolvadex’): a review","year":2002,"lang":"en","type":"review","venue":"Cancer Treatment Reviews","topic":"Estrogen and related hormone effects","field":"Biochemistry, Genetics and Molecular Biology","cited_by":224,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Sunnybrook Health Science Centre","funders":"","keywords":"Tamoxifen; Medicine; Tolerability; Breast cancer; Oncology; Aromatase; Internal medicine; Male breast cancer; Antiestrogen; Gynecology; Cancer; Adverse effect","score_opus":0.06805263237191005,"score_gpt":0.3792060415056269,"score_spread":0.31115340913371686,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2080073879","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[4.4264843e-7,0.991859,0.0000032606363,0.000048274116,0.0003524751,0.0042165685,0.0000860588,0.000028683547,0.003405222],"genre_scores_gemma":[4.7076323e-8,0.98238033,0.00008012032,0.00034415495,0.0007106436,0.004711813,0.00093556615,0.00011764237,0.0107197],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99705917,0.00046040132,0.00094229245,0.0009252593,0.00013856337,0.00047433004],"domain_scores_gemma":[0.99788874,0.000017234352,0.00065865356,0.0011764555,0.00003311456,0.00022577286],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00019341789,0.0009865632,0.0031425662,0.00006465182,0.0000875523,0.000024549043,0.00039235622,0.00058075844,0.00040168714],"category_scores_gemma":[0.000033369615,0.0005984643,0.0020615666,0.0003026049,0.00006377022,0.000003281237,0.00009069889,0.00024487046,0.0010998478],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0000016999114,0.00008517675,8.689548e-7,0.032943103,0.00047702584,0.000016300059,0.0000032373066,4.738793e-8,0.0000045574225,0.0000025081722,0.07413706,0.8923284],"study_design_scores_gemma":[0.00022589401,0.00031324773,5.450205e-8,0.07652655,0.0040062857,0.00009143343,1.9845031e-7,1.5985447e-7,0.000020785374,6.806125e-7,0.9182853,0.0005293893],"about_ca_topic_score_codex":0.000013939282,"about_ca_topic_score_gemma":0.0000040179607,"teacher_disagreement_score":0.89179903,"about_ca_system_score_codex":0.00025308787,"about_ca_system_score_gemma":0.00024944855,"threshold_uncertainty_score":0.9996779},"labels":[],"label_agreement":null},{"id":"W2081176426","doi":"10.1016/j.ctrv.2013.09.009","title":"Major depressive disorder in breast cancer: A critical systematic review of pharmacological and psychotherapeutic clinical trials","year":2013,"lang":"en","type":"review","venue":"Cancer Treatment Reviews","topic":"Cancer survivorship and care","field":"Medicine","cited_by":54,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; University Health Network","funders":"","keywords":"Medicine; Clinical trial; Cancer; Breast cancer; Oncology; Internal medicine","score_opus":0.25156299452656433,"score_gpt":0.5505509218171463,"score_spread":0.29898792729058193,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2081176426","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0000049155014,0.9775064,0.0000060477323,0.0010322907,0.0007623166,0.020034572,0.0005121406,0.000026126883,0.0001151779],"genre_scores_gemma":[0.000004236514,0.9606881,0.000030027471,0.0015116371,0.00044917664,0.036883958,0.00006779906,0.00007897128,0.000286084],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.9872158,0.005365633,0.0055821813,0.001021906,0.000342023,0.00047244967],"domain_scores_gemma":[0.9944708,0.0020314888,0.002100927,0.0008063356,0.00017767209,0.00041280373],"candidate_categories":["metaepi_narrow","metaepi_broad","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0027827444,0.0010037347,0.019021176,0.00017687117,0.000045012257,0.000027894035,0.00025690487,0.000481841,0.0026312703],"category_scores_gemma":[0.00050650624,0.00051641534,0.0027004925,0.0005474544,0.00025633944,0.00007459501,0.000050432485,0.000536412,0.00005177461],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000029347786,0.00028799128,0.00020536053,0.5141415,0.00095871446,0.0000146873845,0.000018962975,3.1115e-9,1.3390245e-7,0.0000074264453,0.00066489074,0.483671],"study_design_scores_gemma":[0.0012190104,0.00015989036,0.000014201698,0.552713,0.040122338,0.00008236877,0.0000074710374,8.314117e-7,1.6964394e-7,0.000004068216,0.40542334,0.0002533108],"about_ca_topic_score_codex":0.0007884607,"about_ca_topic_score_gemma":0.00024908505,"teacher_disagreement_score":0.4834177,"about_ca_system_score_codex":0.0006551231,"about_ca_system_score_gemma":0.00076664623,"threshold_uncertainty_score":0.99972874},"labels":[],"label_agreement":null},{"id":"W2083788852","doi":"10.1016/j.ctrv.2012.05.008","title":"Optimal management of elderly patients with glioblastoma","year":2012,"lang":"en","type":"review","venue":"Cancer Treatment Reviews","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":153,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Sunnybrook Health Science Centre; Princess Margaret Cancer Centre; University of Toronto; Health Sciences Centre; University Health Network","funders":"","keywords":"Medicine; Temozolomide; Cohort; Radiation therapy; Randomized controlled trial; Population; Oncology; Internal medicine; Adjuvant therapy; Glioblastoma; Cancer; Adjuvant; Clinical trial","score_opus":0.05812854951909599,"score_gpt":0.3517011236841146,"score_spread":0.2935725741650186,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2083788852","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00035954625,0.9906723,0.0000024268131,0.000013605267,0.000177738,0.0074319853,0.00015848265,0.000031127656,0.0011527966],"genre_scores_gemma":[0.000044987843,0.9906649,0.0014052405,0.0000147178425,0.00012822611,0.006703373,0.00039572525,0.00010104999,0.0005417914],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9974788,0.0001026682,0.0009970602,0.0006003015,0.00034757904,0.00047363128],"domain_scores_gemma":[0.9977524,0.000033640576,0.00089756824,0.00094698125,0.00008007849,0.00028930933],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.000086041044,0.0009276818,0.004177407,0.00019529815,0.000050015926,0.000014406566,0.0001391333,0.00016835368,0.00053061236],"category_scores_gemma":[0.0000014044678,0.000467906,0.0011007683,0.00044667366,0.00006280637,0.000065335276,0.000047255377,0.00011085488,0.00025212904],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00005651223,0.0023392902,0.0012736521,0.035264093,0.0031601638,0.000066581815,0.000023235772,2.842605e-7,1.3183492e-8,0.000020377343,0.00039455347,0.9574012],"study_design_scores_gemma":[0.0026474337,0.0025244176,0.0002980607,0.05834393,0.032390755,0.00001749085,0.0000034795319,6.930486e-8,0.000004758353,2.063138e-7,0.90345585,0.00031354075],"about_ca_topic_score_codex":0.000036378315,"about_ca_topic_score_gemma":0.0000110312085,"teacher_disagreement_score":0.9570877,"about_ca_system_score_codex":0.0010162975,"about_ca_system_score_gemma":0.00013820661,"threshold_uncertainty_score":0.99977726},"labels":[],"label_agreement":null},{"id":"W2088955344","doi":"10.1016/j.ctrv.2011.05.009","title":"Recent clinical developments and rationale for combining targeted agents in non-small cell lung cancer (NSCLC)","year":2011,"lang":"en","type":"review","venue":"Cancer Treatment Reviews","topic":"Lung Cancer Treatments and Mutations","field":"Medicine","cited_by":36,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Hospital; University of Ottawa","funders":"Merck KGaA; Pfizer","keywords":"Medicine; Epidermal growth factor receptor; Targeted therapy; Growth factor receptor; Lung cancer; Growth factor; Platelet-derived growth factor receptor; Oncology; Growth factor receptor inhibitor; Insulin-like growth factor 1 receptor; Cancer research; Receptor; Cancer; Internal medicine","score_opus":0.2202845222937452,"score_gpt":0.47681434557765334,"score_spread":0.25652982328390816,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2088955344","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0001283583,0.9815449,0.00002351397,0.00007725552,0.00093458884,0.015521499,0.00031206806,0.000027992937,0.001429786],"genre_scores_gemma":[0.0000045150423,0.96307725,0.0025450261,0.00033178367,0.0002771095,0.027960485,0.0015040722,0.0001112706,0.0041885],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99627364,0.00020270528,0.001841635,0.0010232767,0.00014390565,0.0005148326],"domain_scores_gemma":[0.9979848,0.00016994357,0.0009172816,0.00045831833,0.00013589757,0.0003337443],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0003603544,0.00083453394,0.003534736,0.0002234141,0.00014061313,0.00003427715,0.00014506737,0.00033398834,0.00040559913],"category_scores_gemma":[0.000038437916,0.0005642425,0.0006674126,0.00036032326,0.000055425593,0.000081312915,0.000053808806,0.00024570455,0.000032942025],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000041362535,0.0006381977,0.005697898,0.0138717,0.0010814359,0.000016085674,0.00043672556,2.5025608e-7,1.0535901e-7,0.0000064397323,0.004960518,0.97324926],"study_design_scores_gemma":[0.005269689,0.00029084407,0.0008751611,0.030941585,0.008496984,0.0000066992734,0.000014453014,0.000010405026,0.0000021140424,0.0000051345296,0.95364845,0.00043849382],"about_ca_topic_score_codex":0.0002816204,"about_ca_topic_score_gemma":0.00037547434,"teacher_disagreement_score":0.9728108,"about_ca_system_score_codex":0.0024223318,"about_ca_system_score_gemma":0.0026759629,"threshold_uncertainty_score":0.9996809},"labels":[],"label_agreement":null},{"id":"W2089605820","doi":"10.1016/j.ctrv.2013.03.009","title":"Targeting the PI3K/AKT/mTOR and Raf/MEK/ERK pathways in the treatment of breast cancer","year":2013,"lang":"en","type":"article","venue":"Cancer Treatment Reviews","topic":"PI3K/AKT/mTOR signaling in cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":378,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen's University","funders":"","keywords":"PI3K/AKT/mTOR pathway; Protein kinase B; MAPK/ERK pathway; Medicine; Cancer research; Signal transduction; Kinase; Phosphorylation; RPTOR; Cell biology; Biology","score_opus":0.030303178491005927,"score_gpt":0.2958380245302369,"score_spread":0.26553484603923094,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2089605820","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.62439126,0.37132224,0.000022218126,0.0012938856,0.0002717663,0.0021706326,0.00018611891,0.000009767119,0.0003320931],"genre_scores_gemma":[0.69213957,0.30088517,0.00014232707,0.00057790946,0.0006936051,0.0050511756,0.00006504371,0.00003830377,0.00040689146],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9982103,0.00026292139,0.0004978176,0.0004980137,0.00015326832,0.00037765602],"domain_scores_gemma":[0.9988745,0.00005541837,0.00028778228,0.0006332247,0.00007230466,0.00007678556],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00023278572,0.00039196634,0.0005101069,0.000031346364,0.0001272112,0.00004342701,0.00027943673,0.00011164074,0.00027281666],"category_scores_gemma":[0.000014630614,0.0001892164,0.0002134548,0.00016768176,0.00015619639,0.0000108655595,0.000035833207,0.00006815607,0.000015940504],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00016799096,0.0009164265,0.054793045,0.00023837647,0.000562537,0.0000095407495,0.0033904416,0.00025390004,0.24336307,0.000049410744,0.01634146,0.6799138],"study_design_scores_gemma":[0.0026378918,0.0012745893,0.013840389,0.00036500124,0.00037301,0.000025479743,0.0004079004,0.000091349284,0.048579007,0.000050922303,0.93182683,0.0005276406],"about_ca_topic_score_codex":0.002555313,"about_ca_topic_score_gemma":0.0005103512,"teacher_disagreement_score":0.9154854,"about_ca_system_score_codex":0.00027477316,"about_ca_system_score_gemma":0.00016120051,"threshold_uncertainty_score":0.7716021},"labels":[],"label_agreement":null},{"id":"W2095245646","doi":"10.1016/s0305-7372(03)00101-4","title":"Radical prostatectomy may improve disease-specific mortality, but not overall survival compared with watchful waiting in early prostate cancer","year":2003,"lang":"en","type":"letter","venue":"Cancer Treatment Reviews","topic":"Prostate Cancer Diagnosis and Treatment","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Manitoba","funders":"","keywords":"Medicine; Watchful waiting; Prostate cancer; Prostatectomy; Oncology; Disease; Urology; Overall survival; Prostate; Cancer; Internal medicine; Surgery","score_opus":0.07937016260928091,"score_gpt":0.32790578111345015,"score_spread":0.24853561850416922,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2095245646","genre_codex":"empirical","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.491308,0.29606563,0.000004546153,0.18147638,0.0017390003,0.023980478,0.00440217,0.00022583231,0.0007979356],"genre_scores_gemma":[0.06954256,0.6959034,0.00033272634,0.14698456,0.004479266,0.06645441,0.0045665577,0.0007532734,0.010983207],"study_design_codex":"observational","study_design_gemma":"not_applicable","domain_scores_codex":[0.9925876,0.0004948969,0.0017396332,0.0023699447,0.001078686,0.0017292233],"domain_scores_gemma":[0.9964122,0.000120368495,0.0010182253,0.0015486045,0.00021858804,0.0006820197],"candidate_categories":["metaepi_narrow"],"consensus_categories":["metaepi_narrow"],"category_scores_codex":[0.00032120186,0.0019153088,0.0038938154,0.00026300046,0.00017857735,0.0002051207,0.00029057421,0.00046504932,0.0005231786],"category_scores_gemma":[0.000017361373,0.0012383636,0.0007936998,0.00047530484,0.00035227824,0.00023270321,0.00007605925,0.0014119537,0.000092261565],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0034865595,0.002597444,0.61879003,0.009749671,0.004154446,0.016841928,0.0011425862,0.000050168775,0.00019500883,0.000033522352,0.273004,0.069954656],"study_design_scores_gemma":[0.013011312,0.0010728595,0.029700227,0.008559351,0.0025327809,0.000023072682,0.00002225335,0.000017903636,0.001313892,0.00001979892,0.9424218,0.0013047699],"about_ca_topic_score_codex":0.0070666727,"about_ca_topic_score_gemma":0.00093768304,"teacher_disagreement_score":0.6694178,"about_ca_system_score_codex":0.006910811,"about_ca_system_score_gemma":0.001874679,"threshold_uncertainty_score":0.99954534},"labels":[],"label_agreement":null},{"id":"W2099688828","doi":"10.1016/j.ctrv.2007.06.004","title":"Treatments for metastatic melanoma: Synthesis of evidence from randomized trials","year":2007,"lang":"en","type":"review","venue":"Cancer Treatment Reviews","topic":"Cutaneous Melanoma Detection and Management","field":"Medicine","cited_by":171,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"Bristol-Myers Squibb","keywords":"Dacarbazine; Medicine; Jadad scale; Internal medicine; Randomized controlled trial; Meta-analysis; Melanoma; Oncology; Cochrane Library; Chemotherapy; Cancer research","score_opus":0.5073897111193665,"score_gpt":0.5047787779505932,"score_spread":0.002610933168773255,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2099688828","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0000029996318,0.9685754,0.00080951914,0.00006336331,0.000685861,0.028780438,0.00059619953,0.000049931154,0.00043629407],"genre_scores_gemma":[0.0000016291631,0.9596218,0.0046925596,0.000048939393,0.0004061826,0.029171214,0.00026317168,0.000095927164,0.0056985794],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99274266,0.0018312444,0.0038490782,0.0008585617,0.00033119752,0.0003872816],"domain_scores_gemma":[0.98412675,0.011348791,0.0031846545,0.0010038508,0.00010633111,0.00022964916],"candidate_categories":["metaepi_narrow","metaepi_broad","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0032848017,0.0010190349,0.02098105,0.000409595,0.00006682921,0.000026668373,0.00018986057,0.00021176077,0.0010644941],"category_scores_gemma":[0.003023615,0.00048308325,0.0070645204,0.0003572587,0.00010498358,0.000052658394,0.000033247696,0.00010826337,0.00012021502],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0063380986,0.00037121895,0.0000012944345,0.020863164,0.013200436,0.00004696805,0.000044293505,1.2396941e-7,0.0000017636461,0.000008272772,0.0010929169,0.9580315],"study_design_scores_gemma":[0.02466996,0.0003966449,2.61338e-7,0.055949476,0.1536475,0.000029631063,0.00000710192,0.0000031161212,0.0000905895,0.000013553359,0.7649264,0.00026579568],"about_ca_topic_score_codex":0.0006861637,"about_ca_topic_score_gemma":0.00006947254,"teacher_disagreement_score":0.95776564,"about_ca_system_score_codex":0.0014707326,"about_ca_system_score_gemma":0.000454598,"threshold_uncertainty_score":0.99984866},"labels":[],"label_agreement":null},{"id":"W2100502384","doi":"10.1016/j.ctrv.2004.12.003","title":"Androgen suppression therapy, in combination with radiotherapy prolongs overall survival in men with clinically localised prostate cancer","year":2005,"lang":"en","type":"article","venue":"Cancer Treatment Reviews","topic":"Prostate Cancer Diagnosis and Treatment","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; University Health Network; Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; Prostate cancer; Radiation therapy; Androgen suppression; Oncology; Internal medicine; Androgen; Prostate; Androgen deprivation therapy; Combination therapy; Overall survival; Urology; Cancer; Hormone","score_opus":0.03470590341126252,"score_gpt":0.3476175070251087,"score_spread":0.3129116036138462,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2100502384","genre_codex":"empirical","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8501949,0.13371344,0.000014019161,0.0070319506,0.000063488296,0.008262702,0.000044846936,0.00004550582,0.00062918087],"genre_scores_gemma":[0.4440726,0.54390347,0.0006589473,0.0008984283,0.000120166194,0.009544536,0.00011918426,0.000062115374,0.0006205554],"study_design_codex":"observational","study_design_gemma":"not_applicable","domain_scores_codex":[0.9977443,0.00018718961,0.0006864821,0.00065569294,0.0002867824,0.0004395479],"domain_scores_gemma":[0.99898297,0.000053256914,0.00030493003,0.000409848,0.000078196725,0.00017078563],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00028576158,0.00045306227,0.0011121657,0.00012015117,0.000044906697,0.0000314987,0.00008589252,0.00009325874,0.00023657645],"category_scores_gemma":[0.000004329091,0.00024130536,0.00011066704,0.00033313187,0.00008186956,0.00020258913,0.000010641218,0.00015332822,0.0000060288066],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.004877007,0.0018353096,0.60220706,0.0000914686,0.00018881181,0.000068470596,0.0010390151,0.00023417917,0.000100996236,0.0000067904857,0.0003809861,0.38896993],"study_design_scores_gemma":[0.120396644,0.021627905,0.387961,0.0067425156,0.00043686005,0.000022480035,0.00009256142,0.00095987524,0.0065038367,0.000027563035,0.45431957,0.0009091811],"about_ca_topic_score_codex":0.0018229613,"about_ca_topic_score_gemma":0.002765783,"teacher_disagreement_score":0.45393857,"about_ca_system_score_codex":0.0021540232,"about_ca_system_score_gemma":0.0004613495,"threshold_uncertainty_score":0.9840147},"labels":[],"label_agreement":null},{"id":"W2100891604","doi":"10.1016/j.ctrv.2008.03.013","title":"Adjuvant/neoadjuvant trastuzumab therapy in women with HER-2/neu-overexpressing breast cancer: A systematic review","year":2008,"lang":"en","type":"review","venue":"Cancer Treatment Reviews","topic":"HER2/EGFR in Cancer Research","field":"Medicine","cited_by":77,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; McMaster University; Cancer Care Ontario; Sunnybrook Health Science Centre; Kingston General Hospital","funders":"","keywords":"Medicine; Trastuzumab; Oncology; Breast cancer; Internal medicine; Adjuvant; Cochrane Library; Adjuvant therapy; Randomized controlled trial; Clinical trial; Neoadjuvant therapy; Cancer","score_opus":0.11580775246216311,"score_gpt":0.432500353013039,"score_spread":0.3166926005508759,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2100891604","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000015886399,0.966803,0.0000021316293,0.00036936832,0.00022525185,0.03129635,0.0005733471,0.00011701,0.0005976166],"genre_scores_gemma":[0.000004144998,0.91234195,0.00008487021,0.00096724357,0.00048148766,0.084212616,0.00013381476,0.00037907858,0.001394772],"study_design_codex":"design_other","study_design_gemma":"systematic_review","domain_scores_codex":[0.989544,0.0017649268,0.0036117681,0.0019796952,0.0013182233,0.0017814288],"domain_scores_gemma":[0.9939998,0.00026470263,0.0020198934,0.0026520763,0.0002462655,0.0008172964],"candidate_categories":["metaepi_narrow","metaepi_broad","insufficient_payload"],"consensus_categories":["metaepi_narrow"],"category_scores_codex":[0.00092044054,0.0022954026,0.018972032,0.0005496428,0.0001871878,0.00009243819,0.0007872889,0.00046674977,0.0017541472],"category_scores_gemma":[0.00007326105,0.0012342962,0.0014430733,0.002116147,0.00026512612,0.0002051381,0.00009505624,0.0011444535,0.0002719463],"study_design_candidate":"systematic_review","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":true,"study_design_scores_codex":[0.00009318912,0.00033900538,0.000027166101,0.47101685,0.0007439572,0.00037634315,0.0002333798,3.1775375e-7,4.215894e-7,4.0301515e-7,0.0017265115,0.5254425],"study_design_scores_gemma":[0.001486905,0.0006976659,0.00001289613,0.5082056,0.0019844216,0.0011653834,0.000017044795,8.5860466e-7,6.492065e-7,4.4578618e-7,0.48586574,0.00056237995],"about_ca_topic_score_codex":0.0013283481,"about_ca_topic_score_gemma":0.0002483493,"teacher_disagreement_score":0.52488005,"about_ca_system_score_codex":0.017802404,"about_ca_system_score_gemma":0.0064958413,"threshold_uncertainty_score":0.9991584},"labels":[],"label_agreement":null},{"id":"W2105158042","doi":"10.1053/ctrv.2002.9258","title":"Interventional radiology in the treatment of hepatic metastases","year":2002,"lang":"en","type":"review","venue":"Cancer Treatment Reviews","topic":"Hepatocellular Carcinoma Treatment and Prognosis","field":"Medicine","cited_by":19,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St. Thomas Hospital","funders":"","keywords":"Medicine; Radiology; Interventional radiology","score_opus":0.3329101993664592,"score_gpt":0.40761822476070914,"score_spread":0.07470802539424992,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2105158042","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00023146247,0.9918779,0.0000022240567,0.00009175058,0.00017194299,0.006803041,0.00023868443,0.000015669384,0.0005673213],"genre_scores_gemma":[0.00012444169,0.9863272,0.0001610352,0.00003467038,0.00023963959,0.01082503,0.0010644759,0.000048426875,0.0011750831],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99621654,0.0011124494,0.0015243687,0.00057660753,0.00020194451,0.00036808147],"domain_scores_gemma":[0.9980136,0.00031661722,0.00069922354,0.00083344406,0.00003156845,0.00010553081],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0002612134,0.00083061494,0.0050816876,0.00030615382,0.000046746125,0.000014452911,0.00018776458,0.00021342984,0.0014020621],"category_scores_gemma":[0.000018302726,0.00037586188,0.0032403488,0.0005248812,0.000109228866,0.00003591966,0.000011965212,0.00011856123,0.00017656549],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000016973785,0.0031358707,0.0043178345,0.009029265,0.001355686,0.0002494446,0.00023574523,3.403056e-8,8.862748e-8,0.00003229561,0.0006435427,0.9809832],"study_design_scores_gemma":[0.0015382838,0.0038761671,0.00003906047,0.012687837,0.014670638,0.00020095079,0.0000076253154,0.000005314355,0.0000043246273,0.000005408613,0.96674234,0.00022207186],"about_ca_topic_score_codex":0.00030687003,"about_ca_topic_score_gemma":0.00012869554,"teacher_disagreement_score":0.9807612,"about_ca_system_score_codex":0.0013661594,"about_ca_system_score_gemma":0.00023268841,"threshold_uncertainty_score":0.99986935},"labels":[],"label_agreement":null},{"id":"W2107249642","doi":"10.1016/j.ctrv.2004.03.004","title":"Aromatase inhibitors in the adjuvant setting: bringing the gold to a standard?","year":2004,"lang":"en","type":"review","venue":"Cancer Treatment Reviews","topic":"Estrogen and related hormone effects","field":"Biochemistry, Genetics and Molecular Biology","cited_by":131,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Sunnybrook Health Science Centre","funders":"","keywords":"Medicine; Aromatase; Adjuvant; Gold standard (test); Oncology; Internal medicine; Gynecology; Breast cancer; Cancer","score_opus":0.027705599571916328,"score_gpt":0.3521868601886385,"score_spread":0.32448126061672217,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2107249642","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00012994868,0.99494517,0.000004763313,0.00022756608,0.00022403608,0.003961144,0.00012849235,0.000009670849,0.00036918308],"genre_scores_gemma":[0.000042888347,0.9958386,0.000058061793,0.00024956244,0.000410711,0.0026998476,0.0003420212,0.000051245217,0.0003070833],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99778134,0.00047229172,0.0006180353,0.0005726981,0.0001550248,0.00040061737],"domain_scores_gemma":[0.99868494,0.00003965217,0.0002975437,0.0008664547,0.000014980226,0.000096412325],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0005610886,0.0005806857,0.0011628638,0.0000626859,0.0001013505,0.000058184294,0.00044782215,0.00024423853,0.000008846438],"category_scores_gemma":[0.000041799252,0.0002471702,0.0007267799,0.000343887,0.000047817968,0.000002746356,0.00009362872,0.00026644085,0.00006702322],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000009454544,0.00004812832,0.000005279832,0.0020757383,0.00014574284,0.00003553486,0.00012401087,0.000009188854,0.00002101737,0.0000071069726,0.006949614,0.9905692],"study_design_scores_gemma":[0.00031028688,0.00032059714,0.0000013516024,0.014983667,0.0006934907,0.00005986701,0.000016977774,2.0340819e-7,0.00013632677,0.000002627301,0.983198,0.0002766118],"about_ca_topic_score_codex":0.00010043772,"about_ca_topic_score_gemma":0.00006291756,"teacher_disagreement_score":0.99029255,"about_ca_system_score_codex":0.0003995979,"about_ca_system_score_gemma":0.00043052394,"threshold_uncertainty_score":0.99999803},"labels":[],"label_agreement":null},{"id":"W2111003603","doi":"10.1016/j.ctrv.2006.12.002","title":"Chemotherapy dose–response relationships in non-small cell lung cancer and implied resistance mechanisms","year":2007,"lang":"en","type":"review","venue":"Cancer Treatment Reviews","topic":"Lung Cancer Treatments and Mutations","field":"Medicine","cited_by":51,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Children's Hospital of Eastern Ontario; Canadian Agency for Drugs and Technologies in Health; Élisabeth Bruyère Hospital","funders":"","keywords":"Medicine; Lung cancer; Chemotherapy; Drug resistance; Oncology; Cell; Internal medicine; Cancer research; Biology","score_opus":0.08004728811877747,"score_gpt":0.4160621748165402,"score_spread":0.3360148866977627,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2111003603","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00018367867,0.9873037,0.00012041212,0.00031321082,0.0002961966,0.009488107,0.00022636453,0.000054720713,0.0020136386],"genre_scores_gemma":[0.000034830286,0.9701826,0.0023231131,0.00028936123,0.00020650339,0.009913744,0.0002474312,0.00016130644,0.016641142],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99637574,0.00033357486,0.001351395,0.0010860307,0.00022474151,0.00062849285],"domain_scores_gemma":[0.99761534,0.0003505071,0.0007701337,0.0008501514,0.000069885034,0.0003439853],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0006800596,0.001047552,0.0034446367,0.0004628221,0.00019853507,0.000051631174,0.00015351544,0.00045505332,0.00023252754],"category_scores_gemma":[0.00002564774,0.0007106308,0.0006534727,0.0008150166,0.00006569666,0.00008594156,0.000031912834,0.00046959092,0.00003951874],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00031903642,0.000363999,0.000581493,0.018404486,0.0006395915,0.0001024246,0.00074996566,7.8813997e-7,0.000007248003,0.00006318715,0.001418811,0.977349],"study_design_scores_gemma":[0.0039561363,0.00017531685,0.00084589055,0.03149529,0.0061431252,0.000018551664,0.00003290909,0.0000026667656,0.000016414604,0.000023643,0.95675474,0.0005352902],"about_ca_topic_score_codex":0.0004093363,"about_ca_topic_score_gemma":0.0016236119,"teacher_disagreement_score":0.9768137,"about_ca_system_score_codex":0.004882587,"about_ca_system_score_gemma":0.001640795,"threshold_uncertainty_score":0.9995345},"labels":[],"label_agreement":null},{"id":"W2115028635","doi":"10.1016/j.ctrv.2010.03.006","title":"Targeting DNA repair in breast cancer: A clinical and translational update","year":2010,"lang":"en","type":"review","venue":"Cancer Treatment Reviews","topic":"PARP inhibition in cancer therapy","field":"Medicine","cited_by":52,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"DNA repair; Synthetic lethality; Medicine; Breast cancer; Homologous recombination; Poly ADP ribose polymerase; Cancer research; DNA damage; Genome instability; BRCA2 Protein; DNA mismatch repair; Cancer; DNA; Mutation; Germline mutation; Genetics; Polymerase; Biology; Gene; Internal medicine","score_opus":0.12089813744190153,"score_gpt":0.46419491885373404,"score_spread":0.3432967814118325,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2115028635","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000036371042,0.992262,0.0000054325055,0.001446785,0.00075539335,0.003998463,0.0011898143,0.00009228378,0.00021343183],"genre_scores_gemma":[0.0000018570892,0.9899845,0.0008908445,0.0007560059,0.0018284568,0.005630337,0.00044166614,0.00010215124,0.00036417943],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99550647,0.0004756184,0.0022637467,0.0010675428,0.0002470454,0.00043958615],"domain_scores_gemma":[0.9980595,0.00015912662,0.0007901043,0.00060581736,0.00006863511,0.0003168323],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0008057729,0.00080399256,0.004527322,0.00020996353,0.00007910276,0.000019602128,0.00012585483,0.0005531784,0.0014832683],"category_scores_gemma":[0.000020988537,0.0005404011,0.0013348169,0.0004296425,0.00022750825,0.00010313602,0.000023657421,0.0008100875,0.00008499038],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0000604501,0.0002053855,0.0050911447,0.008192714,0.00031852874,0.000038267637,0.00003925909,2.2088639e-7,0.0000010359508,0.000020569198,0.0052396054,0.9807928],"study_design_scores_gemma":[0.002321642,0.000079196376,0.0003760303,0.03652269,0.0020961668,0.00015076138,0.0000016688521,0.000008346043,5.9129366e-7,0.00001486614,0.9580199,0.00040813014],"about_ca_topic_score_codex":0.00017982279,"about_ca_topic_score_gemma":0.00018270957,"teacher_disagreement_score":0.9803847,"about_ca_system_score_codex":0.00055785605,"about_ca_system_score_gemma":0.001443409,"threshold_uncertainty_score":0.9997048},"labels":[],"label_agreement":null},{"id":"W2121576318","doi":"10.1016/j.ctrv.2009.12.012","title":"Lapatinib and HER2 status: Results of a meta-analysis of randomized phase III trials in metastatic breast cancer","year":2010,"lang":"en","type":"review","venue":"Cancer Treatment Reviews","topic":"HER2/EGFR in Cancer Research","field":"Medicine","cited_by":35,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto","funders":"","keywords":"Lapatinib; Medicine; Internal medicine; Metastatic breast cancer; Oncology; Breast cancer; Hazard ratio; Randomized controlled trial; Adverse effect; Cancer; Clinical trial; Discontinuation; Trastuzumab; Confidence interval","score_opus":0.46909519296310337,"score_gpt":0.5766936765117843,"score_spread":0.1075984835486809,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2121576318","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000040166757,0.9683095,0.000008464715,0.00023979596,0.00013182487,0.017673345,0.013252798,0.000013102081,0.00033098852],"genre_scores_gemma":[0.000025661058,0.974455,0.0006489185,0.000048958165,0.00011476966,0.022735998,0.0008453511,0.00008844045,0.0010369046],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9807263,0.0075210864,0.009021831,0.0012042772,0.00086088054,0.00066560355],"domain_scores_gemma":[0.9863501,0.0047238017,0.0064563537,0.0016417715,0.00038302885,0.00044493738],"candidate_categories":["metaepi_narrow","metaepi_broad","insufficient_payload"],"consensus_categories":["metaepi_broad"],"category_scores_codex":[0.0146318115,0.0011608305,0.060307283,0.0016028843,0.000035178746,0.0000292783,0.00028473928,0.0003269775,0.0037340706],"category_scores_gemma":[0.0023464677,0.00058803445,0.012293901,0.0028150412,0.00046138486,0.00007808586,0.00007596121,0.000604945,0.000006864657],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.011952405,0.0007444082,0.000008524059,0.022958089,0.2045764,0.000023385008,0.0003143863,0.0000019364472,0.0000027178423,0.000006666448,0.00034526456,0.7590658],"study_design_scores_gemma":[0.08201721,0.00016831998,0.0000012017348,0.0057706255,0.44184506,0.000005985759,0.000008770611,0.0000110922465,0.000008912219,0.0000025962615,0.4699716,0.00018863742],"about_ca_topic_score_codex":0.017997846,"about_ca_topic_score_gemma":0.0055438713,"teacher_disagreement_score":0.75887716,"about_ca_system_score_codex":0.00098428,"about_ca_system_score_gemma":0.0030388157,"threshold_uncertainty_score":0.9996571},"labels":[],"label_agreement":null},{"id":"W2123420272","doi":"10.1016/j.ctrv.2010.02.012","title":"Langerhans cell histiocytosis: Current concepts and treatments","year":2010,"lang":"en","type":"review","venue":"Cancer Treatment Reviews","topic":"Histiocytic Disorders and Treatments","field":"Medicine","cited_by":274,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children; SickKids Foundation","funders":"","keywords":"Langerhans cell histiocytosis; Medicine; Malignancy; Histiocytosis; Immunotherapy; Salvage therapy; Disease; Immune system; Pathology; Immunology; Chemotherapy; Internal medicine","score_opus":0.11609083667682,"score_gpt":0.4510513757680648,"score_spread":0.3349605390912448,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2123420272","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000028297638,0.9879268,0.0000033062593,0.000032959353,0.0007598001,0.0053446223,0.00041310996,0.00007740631,0.0054137423],"genre_scores_gemma":[0.0000041976978,0.98120195,0.00024740063,0.00005513519,0.00036184574,0.00612919,0.001057396,0.000120901524,0.010821991],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9971259,0.00014625708,0.0009600146,0.0010260314,0.000228828,0.0005129651],"domain_scores_gemma":[0.9978806,0.00006627275,0.00064227456,0.0008752156,0.000047795318,0.00048785933],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.000087169894,0.0012112528,0.00449239,0.00018796197,0.00015706547,0.00004554074,0.0001310271,0.00037694807,0.0005524492],"category_scores_gemma":[0.000016108164,0.0007242393,0.0011108003,0.00025617986,0.00014978617,0.00006120457,0.00004403687,0.0003608087,0.00067189056],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000010383372,0.0009512514,0.00013904925,0.014476247,0.00048312286,0.00006212418,0.00009159033,7.1999837e-9,3.9481262e-7,0.00000911891,0.0023362588,0.9814404],"study_design_scores_gemma":[0.002514287,0.0005075943,0.000010903519,0.019378312,0.019293489,0.00006894877,0.0000047793806,6.145725e-7,0.0000033060735,0.000004419783,0.957746,0.00046731633],"about_ca_topic_score_codex":0.00016158116,"about_ca_topic_score_gemma":0.000063786174,"teacher_disagreement_score":0.9809731,"about_ca_system_score_codex":0.001570754,"about_ca_system_score_gemma":0.0007770034,"threshold_uncertainty_score":0.9995209},"labels":[],"label_agreement":null},{"id":"W2125752165","doi":"10.1016/j.ctrv.2009.11.005","title":"SRC kinase inhibition: Targeting bone metastases and tumor growth in prostate and breast cancer","year":2009,"lang":"en","type":"review","venue":"Cancer Treatment Reviews","topic":"Bone health and treatments","field":"Medicine","cited_by":124,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"Sanofi","keywords":"Medicine; Dasatinib; Prostate cancer; Proto-oncogene tyrosine-protein kinase Src; Bone metastasis; Osteoclast; Prostate; Bone resorption; Breast cancer; Cancer research; Metastasis; Oncology; Internal medicine; Tyrosine kinase; Cancer; Pathology; Receptor","score_opus":0.0557956574279283,"score_gpt":0.37794086484034706,"score_spread":0.32214520741241875,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2125752165","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00039566885,0.9916434,2.5192273e-7,0.0006611608,0.00009941973,0.0061608087,0.00086601876,0.00003920478,0.00013403597],"genre_scores_gemma":[0.00007473075,0.9925598,0.0003122766,0.0005323557,0.00018315125,0.0052841026,0.00055887375,0.000069698064,0.00042500766],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9967472,0.00028482286,0.0012646435,0.0009269994,0.00018388247,0.00059246],"domain_scores_gemma":[0.9983895,0.000061008854,0.00067326624,0.00030554502,0.00006186706,0.00050883857],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0002827657,0.00092674734,0.004288096,0.00025970946,0.00012482466,0.000041231084,0.00003579592,0.00012570005,0.00013099989],"category_scores_gemma":[0.000026202451,0.00056962174,0.0003472756,0.00046630373,0.000090494425,0.0001322681,0.000035259167,0.0002785541,0.000022591603],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00006143818,0.00033926795,0.001617996,0.031637013,0.00017936906,0.0008126415,0.00005381369,2.2702784e-8,3.101929e-7,0.000008361055,0.00089117914,0.96439856],"study_design_scores_gemma":[0.0028140144,0.000386534,0.00057665404,0.064535186,0.004273114,0.00083495147,0.000006582065,6.63396e-7,0.0000042490633,0.000013597261,0.9261666,0.00038786948],"about_ca_topic_score_codex":0.0024177767,"about_ca_topic_score_gemma":0.0004324711,"teacher_disagreement_score":0.9640107,"about_ca_system_score_codex":0.0012169197,"about_ca_system_score_gemma":0.0007309,"threshold_uncertainty_score":0.9996755},"labels":[],"label_agreement":null},{"id":"W2127154017","doi":"10.1016/j.ctrv.2009.08.001","title":"Irreversible pan-ErbB tyrosine kinase inhibitors and breast cancer: Current status and future directions","year":2009,"lang":"en","type":"review","venue":"Cancer Treatment Reviews","topic":"HER2/EGFR in Cancer Research","field":"Medicine","cited_by":53,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"Genentech; Pfizer","keywords":"Lapatinib; Medicine; Trastuzumab; Tyrosine kinase; Receptor tyrosine kinase; Breast cancer; Tyrosine-kinase inhibitor; ErbB; Monoclonal antibody; Cancer research; Cancer; Pharmacology; Internal medicine; Receptor; Immunology; Antibody","score_opus":0.08835437902740187,"score_gpt":0.4363174976594466,"score_spread":0.34796311863204477,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2127154017","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000023762193,0.99,3.9800844e-7,0.0011387636,0.0013633895,0.0056112153,0.0014258875,0.00008709894,0.000349462],"genre_scores_gemma":[0.0000015179044,0.99123573,0.00008468509,0.00010831982,0.003741029,0.0028499952,0.0004047716,0.00011582621,0.0014581309],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9959797,0.0003494605,0.0010576113,0.0012725798,0.0004366808,0.0009039633],"domain_scores_gemma":[0.9975273,0.00007831456,0.0005105413,0.0008544147,0.0001488652,0.0008805487],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00027850928,0.0011360057,0.0040463917,0.0003923787,0.00026171328,0.000105872576,0.00014091577,0.00034270424,0.0006545746],"category_scores_gemma":[0.00001876416,0.0007380182,0.00061719184,0.0009881448,0.00020462577,0.00013256955,0.00009885655,0.0007524151,0.00006257434],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00002711262,0.00026629167,0.0005707325,0.028223643,0.00028616568,0.000033485874,0.00010403792,2.2402528e-8,5.60484e-7,0.000008983382,0.01670652,0.9537724],"study_design_scores_gemma":[0.0010685286,0.00031510904,0.00055567146,0.05066307,0.0044891387,0.00016203972,0.000016071433,5.846521e-7,0.0000021211497,0.0000032180615,0.9421912,0.0005332504],"about_ca_topic_score_codex":0.0018827834,"about_ca_topic_score_gemma":0.00058365555,"teacher_disagreement_score":0.9532392,"about_ca_system_score_codex":0.004031075,"about_ca_system_score_gemma":0.0020380593,"threshold_uncertainty_score":0.9997923},"labels":[],"label_agreement":null},{"id":"W2131562428","doi":"10.1016/s0305-7372(03)00102-6","title":"Overall, watchful waiting and radical prostatectomy have similar quality of life in localised prostate cancer","year":2003,"lang":"en","type":"letter","venue":"Cancer Treatment Reviews","topic":"Prostate Cancer Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Manitoba","funders":"","keywords":"Medicine; Watchful waiting; Prostatectomy; Prostate cancer; Quality of life (healthcare); Prostate; Urology; Prostate disease; Cancer; Oncology; Internal medicine; Nursing","score_opus":0.07722641572436362,"score_gpt":0.3626080971760545,"score_spread":0.2853816814516909,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2131562428","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.096551515,0.61332554,0.0000037721616,0.27518636,0.00041554475,0.012385398,0.0014788419,0.00006316164,0.0005898536],"genre_scores_gemma":[0.007313591,0.76255125,0.0003145552,0.21258454,0.0008721948,0.013492354,0.0009799758,0.00018353072,0.0017080222],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9944849,0.0005785983,0.0020959938,0.0013530714,0.0005572753,0.0009301746],"domain_scores_gemma":[0.99722856,0.0002043627,0.0012068816,0.0008393037,0.00015859728,0.00036228966],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00047751935,0.0011420024,0.0040036817,0.00021675427,0.000082697494,0.00004818381,0.00013616278,0.00059544673,0.00049180153],"category_scores_gemma":[0.00010557075,0.0007786598,0.00057660165,0.00027360965,0.000318148,0.00013181435,0.00005761326,0.00088605867,0.000010166409],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0008978844,0.0012166767,0.35517895,0.016895076,0.0019017116,0.0009772708,0.0012854612,0.000024308278,0.000104318206,0.000016905004,0.45861143,0.16289],"study_design_scores_gemma":[0.011218526,0.0007918991,0.0051740096,0.006796818,0.00113298,0.000012042998,0.00004049194,0.000030075915,0.00092920644,0.000055985933,0.9731276,0.0006903495],"about_ca_topic_score_codex":0.006320206,"about_ca_topic_score_gemma":0.00061219075,"teacher_disagreement_score":0.5145162,"about_ca_system_score_codex":0.0027796407,"about_ca_system_score_gemma":0.0013041061,"threshold_uncertainty_score":0.9994664},"labels":[],"label_agreement":null},{"id":"W2133493764","doi":"10.1016/j.ctrv.2010.05.006","title":"5-Azacytidine in myelodysplastic syndromes: A clinical practice guideline","year":2010,"lang":"en","type":"review","venue":"Cancer Treatment Reviews","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":35,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University Health Network; Health Sciences Centre; Sunnybrook Health Science Centre; University of Toronto","funders":"","keywords":"Medicine; Myelodysplastic syndromes; Context (archaeology); Guideline; Intensive care medicine; Clinical trial; Disease; Internal medicine; Palliative care; Oncology; Pathology; Bone marrow","score_opus":0.21304195759432804,"score_gpt":0.5385010240775383,"score_spread":0.32545906648321027,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2133493764","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0000031942086,0.9841724,0.000025472094,0.0010883303,0.00091694936,0.00924717,0.000105022926,0.000077479395,0.0043639913],"genre_scores_gemma":[1.1788088e-7,0.9762684,0.009078813,0.00092305563,0.0019121469,0.005723192,0.0007718328,0.0002075343,0.0051148986],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99082285,0.0012529342,0.004834004,0.001571147,0.0005753652,0.00094369677],"domain_scores_gemma":[0.9935655,0.0017942588,0.0015669034,0.0020822454,0.00028036517,0.0007107406],"candidate_categories":["metaepi_narrow","research_integrity","insufficient_payload"],"consensus_categories":["metaepi_narrow","insufficient_payload"],"category_scores_codex":[0.0029299215,0.0013079421,0.009239726,0.00056763884,0.00007216327,0.000052934145,0.0005133124,0.001103554,0.0013162836],"category_scores_gemma":[0.004164997,0.0007829164,0.0020225702,0.0013282185,0.00021187445,0.00017750546,0.00018477268,0.002558428,0.0026570235],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":true,"study_design_scores_codex":[0.000075046424,0.000716218,0.00004619052,0.013817163,0.0005701695,0.0015057616,0.000019332852,1.08419236e-7,2.4851448e-7,0.000012989936,0.030825553,0.95241123],"study_design_scores_gemma":[0.0026114124,0.0008810778,0.000006657956,0.044949684,0.007850849,0.001525288,0.000007917001,0.000011010824,2.2574794e-7,0.0000025070397,0.9416317,0.0005217107],"about_ca_topic_score_codex":0.00039129154,"about_ca_topic_score_gemma":0.00017264961,"teacher_disagreement_score":0.9518895,"about_ca_system_score_codex":0.0050092395,"about_ca_system_score_gemma":0.0066444566,"threshold_uncertainty_score":0.9999672},"labels":[],"label_agreement":null},{"id":"W2135258573","doi":"10.1016/j.ctrv.2009.12.003","title":"Bevacizumab as a treatment option in advanced renal cell carcinoma: An analysis and interpretation of clinical trial data","year":2010,"lang":"en","type":"review","venue":"Cancer Treatment Reviews","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":26,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Canadian Centre for Applied Research in Cancer Control","keywords":"Medicine; Bevacizumab; Renal cell carcinoma; Oncology; Targeted therapy; Combination therapy; Internal medicine; Kidney cancer; Context (archaeology); Alpha interferon; Cancer; Chemotherapy; Immunology; Interferon","score_opus":0.23586084353472192,"score_gpt":0.4972069989666378,"score_spread":0.26134615543191586,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2135258573","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.054773673,0.93476945,0.000021305415,0.000016858598,0.00032759283,0.009312991,0.00040610027,0.00002266256,0.0003493367],"genre_scores_gemma":[0.006522716,0.9799685,0.0015522925,0.000015005712,0.00040416772,0.00318437,0.007722929,0.000081173326,0.0005488389],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9924528,0.0011708105,0.0036213791,0.0019749152,0.0003630835,0.00041699669],"domain_scores_gemma":[0.9937976,0.0003212179,0.0022861208,0.0030498747,0.000092203656,0.0004529583],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00088871573,0.001137278,0.009072165,0.00075140817,0.000051471674,0.000037496957,0.0003597004,0.0006043329,0.00013828713],"category_scores_gemma":[0.00010927522,0.0006992469,0.0019525052,0.0008816832,0.00013906354,0.0002444493,0.00011850742,0.00042191887,0.000032003867],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0053319037,0.0022765382,0.0011042712,0.0038479709,0.0012066667,0.0001155169,0.00015627948,0.0000020144014,0.000004032651,0.0000026426237,0.0000071494014,0.985945],"study_design_scores_gemma":[0.049178172,0.0155394105,0.00080663187,0.006024896,0.08049524,0.00005376796,0.000026591217,0.00036323085,0.000048566504,0.0000043051145,0.8468575,0.0006017291],"about_ca_topic_score_codex":0.0016522385,"about_ca_topic_score_gemma":0.002201613,"teacher_disagreement_score":0.9853433,"about_ca_system_score_codex":0.0017574084,"about_ca_system_score_gemma":0.0014793351,"threshold_uncertainty_score":0.9995459},"labels":[],"label_agreement":null},{"id":"W2139918385","doi":"10.1053/ctrv.2001.0205","title":"Does treatment at the time of locoregional failure of breast cancer alter prognosis?","year":2001,"lang":"en","type":"review","venue":"Cancer Treatment Reviews","topic":"Breast Cancer Treatment Studies","field":"Biochemistry, Genetics and Molecular Biology","cited_by":29,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; Systemic therapy; Breast cancer; Radiation therapy; Cancer; Oncology; Internal medicine; Intensive care medicine; Surgery","score_opus":0.03658015217378618,"score_gpt":0.3387142203316966,"score_spread":0.30213406815791044,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2139918385","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00014947834,0.9912225,0.0000013413988,0.0005844786,0.00025634802,0.0037547892,0.0038467185,0.000012584537,0.00017177845],"genre_scores_gemma":[0.000041479987,0.9805737,0.000052618067,0.000063877706,0.0008364574,0.011342179,0.001123046,0.00010592226,0.005860728],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99665993,0.00032819243,0.0012107617,0.0010318443,0.0002635619,0.000505686],"domain_scores_gemma":[0.99692297,0.00006665715,0.0015382704,0.0011904188,0.00015417708,0.00012752284],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00009344564,0.0012283281,0.003384714,0.00008417611,0.00014725393,0.000014620169,0.00042888228,0.00032827412,0.0009257308],"category_scores_gemma":[0.000006872551,0.00048576173,0.0020032225,0.00033579112,0.0004301526,0.000007350764,0.00019707196,0.000086887136,0.00006216962],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00009333349,0.00059010705,0.0015044974,0.0037617024,0.0041159783,0.000005731918,0.0000987525,0.0000027869812,0.00005943278,0.0000031824814,0.008663679,0.9811008],"study_design_scores_gemma":[0.0009438903,0.00035467854,0.00012727696,0.007438895,0.0061934795,0.00006386923,0.000013306741,2.1397295e-7,0.0007915419,0.0000023219752,0.98361474,0.0004557988],"about_ca_topic_score_codex":0.0008686909,"about_ca_topic_score_gemma":0.0016656938,"teacher_disagreement_score":0.980645,"about_ca_system_score_codex":0.0012087104,"about_ca_system_score_gemma":0.0006669189,"threshold_uncertainty_score":0.99998754},"labels":[],"label_agreement":null},{"id":"W2139955444","doi":"10.1016/s0305-7372(02)00045-2","title":"What is the role for antithrombotics in cancer care?","year":2002,"lang":"en","type":"article","venue":"Cancer Treatment Reviews","topic":"Venous Thromboembolism Diagnosis and Management","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"","keywords":"Medicine; Cancer; Intensive care medicine; Oncology; Internal medicine","score_opus":0.0713271157303598,"score_gpt":0.3630805981750084,"score_spread":0.2917534824446486,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2139955444","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.022521125,0.9582888,0.000008970931,0.0107986685,0.00070900214,0.0047645713,0.000027069409,0.000023338453,0.002858449],"genre_scores_gemma":[0.059222277,0.9286323,0.00017310491,0.0045614447,0.00030107165,0.004848962,0.000013173232,0.00002819118,0.0022194395],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99891925,0.000032679585,0.00031697066,0.00031482457,0.00011780637,0.00029849095],"domain_scores_gemma":[0.9993056,0.000030880088,0.000107418375,0.0004415274,0.000043718883,0.000070856055],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.000081470054,0.00022223894,0.00071240705,0.0000463524,0.0000877367,0.00004994543,0.00009639487,0.00004640746,0.0010992564],"category_scores_gemma":[0.0000059908366,0.00012312089,0.00024090761,0.00017134415,0.00003752979,0.00010880594,0.000020818592,0.0000547916,0.00007774904],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000009412988,0.00056660554,0.012832304,0.0004065975,0.0001974887,0.0000052220576,0.005477741,0.00001959875,0.000035594938,0.00015280402,0.035154708,0.9451419],"study_design_scores_gemma":[0.0012415533,0.00029401726,0.0050556553,0.0010298863,0.00069737,0.0000010083284,0.000756041,0.00015300392,0.0006675483,0.00003276569,0.9899415,0.00012966248],"about_ca_topic_score_codex":0.00093398953,"about_ca_topic_score_gemma":0.00127987,"teacher_disagreement_score":0.9547868,"about_ca_system_score_codex":0.000626373,"about_ca_system_score_gemma":0.00003638718,"threshold_uncertainty_score":0.99981385},"labels":[],"label_agreement":null},{"id":"W2140583113","doi":"10.1016/j.ctrv.2014.10.002","title":"Navigating later lines of treatment for advanced colorectal cancer – Optimizing targeted biological therapies to improve outcomes","year":2014,"lang":"en","type":"review","venue":"Cancer Treatment Reviews","topic":"Colorectal Cancer Treatments and Studies","field":"Medicine","cited_by":18,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Sunnybrook Health Science Centre; Alzheimer Society of Canada; Foothills Medical Centre; Queen Elizabeth II Health Sciences Centre; BC Cancer Agency","funders":"","keywords":"Medicine; Regorafenib; Cetuximab; Panitumumab; Bevacizumab; Aflibercept; Colorectal cancer; Oncology; Targeted therapy; Internal medicine; Randomized controlled trial; Clinical trial; Cancer; Chemotherapy","score_opus":0.10275960320422338,"score_gpt":0.44091157697765077,"score_spread":0.3381519737734274,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2140583113","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.004136739,0.9792988,0.000019502439,0.0003307398,0.0008481388,0.0139218075,0.0012714124,0.000089394314,0.00008350148],"genre_scores_gemma":[0.00025222087,0.9448167,0.004069504,0.0001601313,0.0005335898,0.04894626,0.00035290973,0.00012984591,0.0007388381],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99594665,0.00018586796,0.001722571,0.0012250977,0.00018521215,0.00073461735],"domain_scores_gemma":[0.997341,0.00043433806,0.001153311,0.0005802747,0.00021407615,0.0002769956],"candidate_categories":["metaepi_narrow"],"consensus_categories":["metaepi_narrow"],"category_scores_codex":[0.00018251846,0.0015361211,0.008747769,0.00010658558,0.0002090139,0.000031458447,0.0001962514,0.00033326403,0.00014467948],"category_scores_gemma":[0.000088901594,0.0007525739,0.002676237,0.00034469026,0.00012221531,0.000057556186,0.00007889206,0.00018185699,0.000017852948],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00031590875,0.00037002243,0.0011551363,0.0065565356,0.0038681687,0.0000057970105,0.0006008288,0.0000059204317,0.000092737624,0.00000478188,0.000096281256,0.98692787],"study_design_scores_gemma":[0.0031787173,0.008256839,0.00011203414,0.018759824,0.0063646818,0.000006477312,0.000050053262,0.0000053082117,0.0005021313,0.00000447849,0.9621102,0.0006492496],"about_ca_topic_score_codex":0.0005057879,"about_ca_topic_score_gemma":0.0004009992,"teacher_disagreement_score":0.98627865,"about_ca_system_score_codex":0.0032783516,"about_ca_system_score_gemma":0.00051402004,"threshold_uncertainty_score":0.99973875},"labels":[],"label_agreement":null},{"id":"W2143715586","doi":"10.1016/j.ctrv.2015.07.003","title":"Obinutuzumab in hematologic malignancies: Lessons learned to date","year":2015,"lang":"en","type":"review","venue":"Cancer Treatment Reviews","topic":"Chronic Lymphocytic Leukemia Research","field":"Medicine","cited_by":62,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; BC Cancer Agency","funders":"Pfizer; F. Hoffmann-La Roche; Amgen","keywords":"Medicine; Obinutuzumab; Hematologic Neoplasms; Oncology; Intensive care medicine; Internal medicine; Cancer; Leukemia; Chronic lymphocytic leukemia","score_opus":0.4738322693286079,"score_gpt":0.5435361784067422,"score_spread":0.06970390907813429,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2143715586","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000022132277,0.9868294,0.0000034725533,0.00040949628,0.00025175777,0.008805663,0.000101371275,0.000071544804,0.0035051866],"genre_scores_gemma":[0.0000025732659,0.97694963,0.00035835162,0.00021255287,0.00026525295,0.010678738,0.00034773568,0.00012428682,0.011060882],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9951132,0.0005113779,0.0015337074,0.0013203642,0.0005195815,0.0010017798],"domain_scores_gemma":[0.9967492,0.00015464754,0.00044986614,0.001841691,0.00011089419,0.00069370394],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0008420106,0.0010288017,0.007252051,0.0004598905,0.00005300785,0.00004663126,0.0004809168,0.0004441658,0.0005613858],"category_scores_gemma":[0.0002602616,0.00061216566,0.00097178575,0.0013720435,0.0000954481,0.00006215469,0.00022125972,0.00041401575,0.0035800051],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":true,"study_design_scores_codex":[0.000036544156,0.00013726609,0.0000025342376,0.029762823,0.00021178421,0.0009501651,0.00017018562,0.0000019869046,4.460452e-7,0.000052075422,0.013446594,0.9552276],"study_design_scores_gemma":[0.004478018,0.00041886783,3.085538e-7,0.06569,0.0015401336,0.00049450074,0.000019359666,0.0000097145585,0.0000038791304,0.000013154338,0.92688644,0.00044559178],"about_ca_topic_score_codex":0.001622718,"about_ca_topic_score_gemma":0.00034991693,"teacher_disagreement_score":0.954782,"about_ca_system_score_codex":0.12776534,"about_ca_system_score_gemma":0.041347396,"threshold_uncertainty_score":0.99963295},"labels":[],"label_agreement":null},{"id":"W2147226575","doi":"10.1016/j.ctrv.2015.03.007","title":"Role of CD154 in cancer pathogenesis and immunotherapy","year":2015,"lang":"en","type":"review","venue":"Cancer Treatment Reviews","topic":"Immunotherapy and Immune Responses","field":"Immunology and Microbiology","cited_by":28,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre Hospitalier de l’Université de Montréal","funders":"Canadian Institutes of Health Research; Pfizer","keywords":"CD154; Medicine; Immunology; Cancer; Immunotherapy; Immune system; Cancer immunotherapy; Cancer research; Immunogenicity; Immunosurveillance; CD40; Inflammation; Cancer cell; Cytotoxic T cell; Biology; In vitro; Internal medicine","score_opus":0.06984839867788352,"score_gpt":0.3702846875741137,"score_spread":0.3004362888962302,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2147226575","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00024094322,0.99660647,5.2449883e-7,0.000012538482,0.0004049113,0.002213376,0.0003068952,0.000020356358,0.00019398374],"genre_scores_gemma":[0.0000082153365,0.9929578,0.000020368363,0.00003077695,0.000040577324,0.0034618503,0.00015259416,0.000073539566,0.0032543368],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9965646,0.0011638822,0.0012613477,0.0005424694,0.000041667583,0.00042602245],"domain_scores_gemma":[0.9982708,0.00014236126,0.0008442035,0.00066463696,0.00005071404,0.00002725085],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0004508068,0.0007602664,0.004274631,0.0002893974,0.000065694316,0.000012513463,0.00030459772,0.00053170184,0.0008097958],"category_scores_gemma":[0.000014541494,0.00048964086,0.0006506736,0.00036453558,0.0002543544,0.000072872695,0.000050893224,0.00023149118,0.00010828627],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000120311866,0.0002109959,0.00008301012,0.0023370483,0.00076568086,0.000002010323,0.0003745259,1.1228606e-7,0.0014817049,0.000013924991,0.00021395944,0.9943967],"study_design_scores_gemma":[0.0013553621,0.00037856805,0.000046376652,0.011768237,0.0007594282,0.000028694967,0.000028864964,4.4098417e-8,0.00031041796,0.000010099297,0.9849067,0.00040723232],"about_ca_topic_score_codex":0.0014230881,"about_ca_topic_score_gemma":0.0001360695,"teacher_disagreement_score":0.99398947,"about_ca_system_score_codex":0.0006137275,"about_ca_system_score_gemma":0.00075531687,"threshold_uncertainty_score":0.9997555},"labels":[],"label_agreement":null},{"id":"W2148122717","doi":"10.1016/s0305-7372(03)00020-3","title":"Marimastat may not improve survival over placebo following induction therapy for small-cell lung cancer Abstracted from: Shepherd F, Giaccone G, Seymour L et al. Prospective, randomized, double-blind, placebo-controlled trial of marimastat after response to first-line chemotherapy in patients with small-cell lung cancer: a trial of the National Cancer Institute of Canada-Clinical Trials Group and the European Organization for Research and Treatment of Cancer. J Clin Oncol 2002; 20(22): 4434–39.","year":2003,"lang":"en","type":"letter","venue":"Cancer Treatment Reviews","topic":"Peptidase Inhibition and Analysis","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Lung cancer; Matrix metalloproteinase; Placebo; Oncology; Internal medicine; Randomized controlled trial; Cancer; Surgery; Gastroenterology; Pathology","score_opus":0.0863161860194505,"score_gpt":0.3984681189588007,"score_spread":0.3121519329393502,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2148122717","genre_codex":"empirical","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8678745,0.00966047,0.00007963566,0.034513026,0.0010939114,0.08210862,0.004591934,0.000010539544,0.000067341636],"genre_scores_gemma":[0.30679905,0.36994973,0.0021761658,0.047155656,0.008472282,0.24170817,0.0040269108,0.0011260046,0.018586013],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9898808,0.004089543,0.0034800898,0.0010648161,0.0009844651,0.00050030084],"domain_scores_gemma":[0.9912945,0.0033929688,0.0034551802,0.00050998834,0.0011882681,0.0001590781],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.008070183,0.00082618406,0.0053206305,0.00034184547,0.0001714256,0.00005254774,0.0002096626,0.00036231734,0.00028507784],"category_scores_gemma":[0.00062214636,0.00044586006,0.0010302874,0.0006711331,0.0003272482,0.00012286677,0.000043817297,0.00051570626,9.107354e-8],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.9709168,0.0020086102,0.005011287,0.00055097486,0.0048176544,0.0000041192584,0.00047903278,0.0001353966,0.00044332346,0.0000010977607,0.008943964,0.006687724],"study_design_scores_gemma":[0.9572146,0.0026199988,0.0011303691,0.002058451,0.0040540695,2.1505683e-7,0.000025143492,0.000110149456,0.001720827,0.0000028604895,0.030696819,0.00036647342],"about_ca_topic_score_codex":0.12672697,"about_ca_topic_score_gemma":0.19045827,"teacher_disagreement_score":0.56107545,"about_ca_system_score_codex":0.002888017,"about_ca_system_score_gemma":0.004331103,"threshold_uncertainty_score":0.9997993},"labels":[],"label_agreement":null},{"id":"W2148918407","doi":"10.1016/j.ctrv.2005.09.008","title":"Radical prostatectomy for early prostate cancer improves long term survival","year":2005,"lang":"en","type":"article","venue":"Cancer Treatment Reviews","topic":"Prostate Cancer Diagnosis and Treatment","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Toronto Rehabilitation Institute; University Health Network","funders":"","keywords":"Medicine; Watchful waiting; Prostatectomy; Prostate cancer; Prostate; Urology; Cancer; Term (time); Surgery; Oncology; Internal medicine","score_opus":0.046349012118266614,"score_gpt":0.36181457400293515,"score_spread":0.31546556188466857,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2148918407","genre_codex":"empirical","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.6209046,0.35743517,0.000048202786,0.00564559,0.00067962054,0.013886107,0.0005009146,0.00016593364,0.000733879],"genre_scores_gemma":[0.3375508,0.5860398,0.0020509446,0.0016725129,0.0021486592,0.060755573,0.00039738693,0.00018120099,0.009203163],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99732655,0.00006512522,0.0007393742,0.00084417954,0.00025808698,0.00076669874],"domain_scores_gemma":[0.9984909,0.00006755559,0.00030981624,0.0005631471,0.00013247399,0.00043609302],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0001857323,0.0006109309,0.0012669258,0.0000929341,0.00017278426,0.000071843024,0.00011776894,0.00011200708,0.00034639286],"category_scores_gemma":[0.000018847226,0.00039221015,0.00054361316,0.00022409421,0.00013025448,0.00021594025,0.00003101908,0.00012877463,0.00008001948],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00055391155,0.00080318813,0.20234019,0.0006331759,0.00055014284,0.000028062792,0.00042311224,0.0000030331282,0.000761705,0.000034711436,0.0015105546,0.7923582],"study_design_scores_gemma":[0.012562308,0.002499477,0.15712732,0.0016123867,0.0017014961,0.000014330852,0.000012904947,0.000020810714,0.019526912,0.000023119117,0.8043746,0.00052437506],"about_ca_topic_score_codex":0.00043395913,"about_ca_topic_score_gemma":0.00046506216,"teacher_disagreement_score":0.802864,"about_ca_system_score_codex":0.0021560881,"about_ca_system_score_gemma":0.0005188522,"threshold_uncertainty_score":0.99985296},"labels":[],"label_agreement":null},{"id":"W2149388503","doi":"10.1016/j.ctrv.2008.02.003","title":"A meta-analysis and systematic review of thalidomide for patients with previously untreated multiple myeloma","year":2008,"lang":"en","type":"review","venue":"Cancer Treatment Reviews","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":73,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Sunnybrook Health Science Centre; Health Sciences Centre; Sudbury Regional Hospital; McMaster University Medical Centre; Princess Margaret Cancer Centre; Queen's University; McMaster University; Cancer Care Ontario; St. Michael's Hospital","funders":"Cancer Care Ontario; Canadian Institutes of Health Research; American Society of Hematology","keywords":"Thalidomide; Medicine; Multiple myeloma; Internal medicine; Meta-analysis; Relative risk; Randomized controlled trial; Transplantation; Surgery; Oncology; Confidence interval","score_opus":0.1545901539710433,"score_gpt":0.39731009047903815,"score_spread":0.24271993650799484,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2149388503","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000006221063,0.95161194,0.000021066675,0.000024581279,0.00001845164,0.04682463,0.0014055034,0.000032706568,0.000054874887],"genre_scores_gemma":[0.0000051323227,0.9491001,0.0011897065,0.0000773398,0.00003131807,0.045158293,0.0031565994,0.00011169279,0.001169842],"study_design_codex":"systematic_review","study_design_gemma":"meta_analysis","domain_scores_codex":[0.99427444,0.0008228821,0.0025813142,0.001111698,0.00059728516,0.00061239506],"domain_scores_gemma":[0.9941714,0.0008312554,0.0024222764,0.0016216707,0.00046895465,0.00048446652],"candidate_categories":["metaepi_narrow","metaepi_broad"],"consensus_categories":["metaepi_narrow"],"category_scores_codex":[0.00036765402,0.0013835441,0.024791634,0.00051552313,0.00011802528,0.000023235518,0.00021910704,0.00021027663,0.00021037884],"category_scores_gemma":[0.00038705915,0.000611715,0.0073920162,0.0013268199,0.00013638679,0.00008198608,0.000049747523,0.00014677331,0.000025674688],"study_design_candidate":"systematic_review","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000070138216,0.00047754974,0.00047288236,0.63434297,0.26594272,0.000023292529,0.00002078232,2.8672122e-8,8.164438e-9,6.238204e-7,0.00011891922,0.09853008],"study_design_scores_gemma":[0.0020986784,0.0008456973,0.000022061919,0.28128025,0.5507438,0.000027544696,7.923516e-7,0.0000015124203,8.4525493e-7,1.9356776e-7,0.16472341,0.00025517246],"about_ca_topic_score_codex":0.00026881028,"about_ca_topic_score_gemma":0.00012522069,"teacher_disagreement_score":0.35306272,"about_ca_system_score_codex":0.00080005435,"about_ca_system_score_gemma":0.00057512266,"threshold_uncertainty_score":0.9998915},"labels":[],"label_agreement":null},{"id":"W2156954151","doi":"10.1016/j.ctrv.2014.02.007","title":"TCTP as therapeutic target in cancers","year":2014,"lang":"en","type":"review","venue":"Cancer Treatment Reviews","topic":"Cancer, Stress, Anesthesia, and Immune Response","field":"Medicine","cited_by":99,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Medicine; Malignancy; Cancer research; Extracellular; Cellular stress response; Reversion; Cell biology; Biology; Bioinformatics; Fight-or-flight response; Phenotype; Gene; Pathology; Genetics","score_opus":0.0849936651446577,"score_gpt":0.41368490427667604,"score_spread":0.32869123913201836,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2156954151","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000007984778,0.98968333,0.0000038440057,0.00020827701,0.00071128004,0.005196529,0.000039464678,0.00006129764,0.0040879943],"genre_scores_gemma":[0.0000029542325,0.97862965,0.0000671936,0.0007647274,0.0012763719,0.00672554,0.00023762525,0.00016089107,0.012135077],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9958174,0.00068100565,0.0015126974,0.0009719142,0.0002945391,0.0007224026],"domain_scores_gemma":[0.99737304,0.00019044339,0.0007966846,0.0013172355,0.00004675483,0.00027586083],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00041705655,0.001187349,0.006943388,0.00037418303,0.000080865284,0.00004094953,0.00030078273,0.00041749017,0.0015412353],"category_scores_gemma":[0.00005014038,0.0007509186,0.0018844786,0.0006471243,0.00013782979,0.000067911766,0.00003058632,0.00043377484,0.0006826816],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00011505682,0.00014378928,0.00007985452,0.019018436,0.00042690165,0.00007649194,0.000112035115,9.684497e-7,5.386017e-7,0.000012581085,0.0033657453,0.9766476],"study_design_scores_gemma":[0.0013591446,0.000626913,0.000025681638,0.05118907,0.003351987,0.00018298559,0.000011125492,0.0000025694549,0.0000032378716,0.000008747854,0.9426668,0.000571689],"about_ca_topic_score_codex":0.0024675264,"about_ca_topic_score_gemma":0.00041529417,"teacher_disagreement_score":0.9760759,"about_ca_system_score_codex":0.005627145,"about_ca_system_score_gemma":0.003326153,"threshold_uncertainty_score":0.9994942},"labels":[],"label_agreement":null},{"id":"W2157880942","doi":"10.1016/j.ctrv.2007.04.003","title":"Single-agent interleukin-2 in the treatment of metastatic melanoma: A systematic review","year":2007,"lang":"en","type":"review","venue":"Cancer Treatment Reviews","topic":"Immunotherapy and Immune Responses","field":"Immunology and Microbiology","cited_by":90,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University; Ottawa Hospital; Princess Margaret Cancer Centre; Cancer Care Ontario; Sunnybrook Health Science Centre","funders":"Cancer Care Ontario","keywords":"Medicine; Randomized controlled trial; Oncology; Melanoma; Internal medicine; Surgery; Complete response; Meta-analysis; Quality of life (healthcare); Chemotherapy; Cancer research","score_opus":0.1395188464822861,"score_gpt":0.38998317011989747,"score_spread":0.2504643236376114,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2157880942","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000007421639,0.98481977,0.000005667951,0.00004320411,0.0005552794,0.014185051,0.00011898258,0.000021151865,0.00024345184],"genre_scores_gemma":[0.0000028984377,0.9855444,0.000022872104,0.00022059154,0.000025088524,0.010586843,0.0003582522,0.000062891886,0.003176164],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9908607,0.0045795916,0.0032981546,0.0005924651,0.00008947187,0.0005796311],"domain_scores_gemma":[0.9951134,0.0011455928,0.0020728656,0.0015981563,0.000046311077,0.000023725728],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0012228191,0.0011640728,0.009232253,0.0003482364,0.00009454245,0.000021355423,0.00070204586,0.00026732002,0.00053202524],"category_scores_gemma":[0.00007926467,0.0005165637,0.0025612465,0.00069493486,0.00018659534,0.00005774626,0.00002444147,0.00022262079,0.0005873335],"study_design_candidate":"systematic_review","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000030480367,0.00118388,5.7536727e-7,0.36988053,0.0017761146,0.00002632643,0.00053329143,1.3731358e-8,0.00000915284,0.000011412396,0.00028825027,0.62626],"study_design_scores_gemma":[0.0006318437,0.0013263084,2.4906115e-7,0.36878014,0.00893952,0.00017173735,0.00003561708,9.018749e-9,0.000051681593,9.4635453e-7,0.6198188,0.00024312628],"about_ca_topic_score_codex":0.00027392988,"about_ca_topic_score_gemma":0.00011545913,"teacher_disagreement_score":0.62601686,"about_ca_system_score_codex":0.0016757285,"about_ca_system_score_gemma":0.00032058894,"threshold_uncertainty_score":0.9997286},"labels":[],"label_agreement":null},{"id":"W2157976923","doi":"10.1016/j.ctrv.2013.03.004","title":"Fulvestrant for advanced breast cancer: A meta-analysis","year":2013,"lang":"en","type":"review","venue":"Cancer Treatment Reviews","topic":"Estrogen and related hormone effects","field":"Biochemistry, Genetics and Molecular Biology","cited_by":34,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto","funders":"","keywords":"Medicine; Fulvestrant; Meta-analysis; Oncology; Breast cancer; Cancer; Internal medicine; Tamoxifen","score_opus":0.1108819317349053,"score_gpt":0.40657892642387516,"score_spread":0.29569699468896987,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2157976923","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0000063993857,0.99158657,0.0000749431,0.00007367437,0.00020192993,0.006112255,0.0018115706,0.000019379662,0.000113265],"genre_scores_gemma":[0.0000018788238,0.95527935,0.0004916675,0.000075609205,0.00036554193,0.037231743,0.0018043956,0.00009746967,0.004652368],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9970443,0.0002830498,0.0009295936,0.0011116877,0.00011955907,0.0005118098],"domain_scores_gemma":[0.9978233,0.00003622682,0.00081900763,0.001001464,0.00008798529,0.0002320458],"candidate_categories":["metaepi_narrow","metaepi_broad"],"consensus_categories":[],"category_scores_codex":[0.00016817763,0.0010614977,0.0058651445,0.00013345316,0.00011336753,0.000047224756,0.00034468912,0.00052962935,0.0004295413],"category_scores_gemma":[0.000007918988,0.0005780551,0.01006604,0.0004416281,0.00005970158,0.000006172597,0.000047755908,0.00014166262,0.000070102564],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0000127553485,0.0000852699,0.0000013382825,0.0034542151,0.16845551,0.000001999199,0.000004526279,0.000011688253,0.000047072517,0.000004037505,0.002049275,0.8258723],"study_design_scores_gemma":[0.00024625586,0.00016344944,2.0111864e-7,0.00034725285,0.3769248,0.000011759601,7.667599e-7,0.0000012291805,0.000071547605,0.0000010194196,0.62187225,0.00035945015],"about_ca_topic_score_codex":0.00015387521,"about_ca_topic_score_gemma":0.000072993076,"teacher_disagreement_score":0.8255128,"about_ca_system_score_codex":0.0002317392,"about_ca_system_score_gemma":0.00041132595,"threshold_uncertainty_score":0.9998479},"labels":[],"label_agreement":null},{"id":"W2158878352","doi":"10.1016/j.ctrv.2007.10.002","title":"New research findings on zoledronic acid: Survival, pain, and anti-tumour effects","year":2007,"lang":"en","type":"review","venue":"Cancer Treatment Reviews","topic":"Bone health and treatments","field":"Medicine","cited_by":68,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; Hôpital Notre-Dame","funders":"","keywords":"Zoledronic acid; Medicine; Bisphosphonate; Oncology; Prostate cancer; Internal medicine; Renal cell carcinoma; Incidence (geometry); Bone pain; Kidney cancer; Osteonecrosis of the jaw; Cancer; Osteoporosis","score_opus":0.2530439676291371,"score_gpt":0.5097682949917159,"score_spread":0.25672432736257883,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2158878352","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000054513428,0.9878418,0.0000062347444,0.00023059618,0.00051358924,0.009632,0.00003329212,0.00007005091,0.0016179328],"genre_scores_gemma":[0.000014675085,0.9894829,0.00021762257,0.0003592232,0.00053876534,0.0022605862,0.00025659055,0.00015217898,0.0067175],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9944763,0.0012823954,0.0011522293,0.001229731,0.00061009073,0.0012492093],"domain_scores_gemma":[0.9964456,0.00094124425,0.00036934888,0.0009865252,0.00008255759,0.0011747557],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0023076779,0.0011117442,0.005364616,0.00056820776,0.0002815166,0.00005582727,0.00017401487,0.0005249727,0.00022285535],"category_scores_gemma":[0.00022850772,0.0006631828,0.000822352,0.0008865735,0.0000951489,0.000057902816,0.0000617475,0.00084549334,0.0009772085],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00004060773,0.00029672356,0.0005040085,0.04584736,0.00044769238,0.0002701938,0.00003537927,6.0362773e-9,5.0621423e-7,0.000026370895,0.011183945,0.9413472],"study_design_scores_gemma":[0.0022031039,0.0024044793,0.00023149818,0.078548156,0.00270949,0.00006143081,0.0000033688798,1.8690723e-7,0.000011559084,0.0000064632177,0.91346717,0.00035309346],"about_ca_topic_score_codex":0.0014220038,"about_ca_topic_score_gemma":0.00024128171,"teacher_disagreement_score":0.94099414,"about_ca_system_score_codex":0.003033112,"about_ca_system_score_gemma":0.0019963053,"threshold_uncertainty_score":0.9998006},"labels":[],"label_agreement":null},{"id":"W2159062994","doi":"10.1016/j.ctrv.2014.11.001","title":"Wellbeing during Active Surveillance for localised prostate cancer: A systematic review of psychological morbidity and quality of life","year":2014,"lang":"en","type":"review","venue":"Cancer Treatment Reviews","topic":"Prostate Cancer Diagnosis and Treatment","field":"Medicine","cited_by":46,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"Newcastle University; Calvary Mater Newcastle","keywords":"Watchful waiting; Medicine; MEDLINE; Observational study; Cochrane Library; Quality of life (healthcare); Adverse effect; Family medicine; Scopus; Meta-analysis; Psychiatry; Prostate cancer; Cancer; Pathology; Nursing; Internal medicine","score_opus":0.14662539733314683,"score_gpt":0.4552984161023068,"score_spread":0.30867301876916,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2159062994","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00028783453,0.9730071,0.000009503711,0.00012238862,0.00017672752,0.024660097,0.0016569174,0.000026928374,0.000052535637],"genre_scores_gemma":[0.000122006495,0.96596336,0.00013244491,0.00017128847,0.00013605795,0.032972258,0.00029436825,0.000072146875,0.00013608733],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.99393135,0.00093848177,0.0033836868,0.0010002375,0.00031669394,0.00042952457],"domain_scores_gemma":[0.9934721,0.00059995806,0.0042559193,0.0010723233,0.0002857863,0.00031390946],"candidate_categories":["metaepi_narrow","metaepi_broad"],"consensus_categories":[],"category_scores_codex":[0.0010476299,0.00094471005,0.014634562,0.00011202767,0.000071455244,0.000012230413,0.00018089452,0.00022511638,0.000059290956],"category_scores_gemma":[0.00050948444,0.0005350769,0.0017714911,0.000361406,0.00017153933,0.000054721397,0.000054013282,0.00017086117,0.0000036653948],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00011253823,0.0003359448,0.0006029957,0.7891179,0.0012013243,0.000002563359,0.000039534887,1.388169e-7,0.0000018144979,0.000011412428,0.00014189255,0.20843199],"study_design_scores_gemma":[0.0021955746,0.0006756883,0.00035798762,0.7807167,0.0088172825,0.000008302056,0.000004802907,8.1063104e-7,0.00003476855,0.0000029505334,0.20683487,0.00035027566],"about_ca_topic_score_codex":0.00042143514,"about_ca_topic_score_gemma":0.00008546261,"teacher_disagreement_score":0.20808172,"about_ca_system_score_codex":0.0011802581,"about_ca_system_score_gemma":0.00050012337,"threshold_uncertainty_score":0.9999942},"labels":[],"label_agreement":null},{"id":"W2164958520","doi":"10.1016/j.ctrv.2008.03.082","title":"P61. Identification of serum lactate dehydrogenase (LDH) as a significant prognostic variable for survival: Multivariate analysis in women with metastatic breast cancer (BC)","year":2008,"lang":"en","type":"article","venue":"Cancer Treatment Reviews","topic":"Bone health and treatments","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Waterloo","funders":"","keywords":"Medicine; Multivariate analysis; Zoledronic acid; Oncology; Internal medicine; Lactate dehydrogenase; Breast cancer; Metastatic breast cancer; Prognostic variable; Stage (stratigraphy); Multivariate statistics; Overall survival; Cancer; Bone metastasis; Enzyme","score_opus":0.054974949579510775,"score_gpt":0.35844381267195563,"score_spread":0.30346886309244486,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2164958520","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9787523,0.01224864,0.00044487268,0.0005519289,0.00009023383,0.006683052,0.0011150329,0.00003958905,0.00007432099],"genre_scores_gemma":[0.9599635,0.02515471,0.0014020939,0.00015081592,0.000026445005,0.011986414,0.00016202597,0.0000472129,0.0011068095],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9974215,0.00018764983,0.0009916715,0.0005924016,0.00024940495,0.00055737596],"domain_scores_gemma":[0.99822134,0.0001265142,0.00064012996,0.00049729296,0.00018577283,0.00032894695],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0003871732,0.0003865792,0.0015531618,0.0002798174,0.00010433578,0.000010956461,0.00007795506,0.00005491699,0.00028996987],"category_scores_gemma":[0.000043461947,0.000246744,0.0002058493,0.0013241848,0.0000717304,0.00011628346,0.000010249042,0.000074095646,0.000017185013],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.004321192,0.0047505577,0.8851555,0.0028495393,0.00848385,0.00019555807,0.0027475888,0.0010657043,0.0013673207,0.000044160974,0.00008121807,0.08893778],"study_design_scores_gemma":[0.020724583,0.0023917838,0.94431216,0.0015231643,0.016201165,0.00007133493,0.00019801184,0.0026176656,0.0034956879,0.000067492154,0.007772339,0.00062460866],"about_ca_topic_score_codex":0.018062348,"about_ca_topic_score_gemma":0.0021864495,"teacher_disagreement_score":0.08831317,"about_ca_system_score_codex":0.0012524104,"about_ca_system_score_gemma":0.0009307085,"threshold_uncertainty_score":0.9999985},"labels":[],"label_agreement":null},{"id":"W2166580185","doi":"10.1016/j.ctrv.2006.10.005","title":"Rituximab in lymphoma: A systematic review and consensus practice guideline from Cancer Care Ontario","year":2007,"lang":"en","type":"review","venue":"Cancer Treatment Reviews","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":58,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Sunnybrook Health Science Centre; Cancer Care Ontario; Queen's University; Health Sciences Centre; McMaster University","funders":"","keywords":"Rituximab; Medicine; Internal medicine; Lymphoma; Oncology; Follicular lymphoma; Randomized controlled trial; Guideline; Hematology; Chemotherapy; Disease; Pathology","score_opus":0.09197429490376997,"score_gpt":0.43287013386808737,"score_spread":0.3408958389643174,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2166580185","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0000042351326,0.9768231,6.1185347e-7,0.0006977932,0.000298138,0.020315936,0.0005339005,0.00004621231,0.00128007],"genre_scores_gemma":[7.143831e-7,0.9730473,0.0011326021,0.0031604853,0.00022620302,0.019983882,0.0010584113,0.00011092519,0.0012794689],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99325323,0.0006669272,0.0036667872,0.0013765675,0.00040917378,0.0006272911],"domain_scores_gemma":[0.9951859,0.00067305774,0.0020238466,0.0014206776,0.00027553627,0.0004209545],"candidate_categories":["metaepi_narrow"],"consensus_categories":["metaepi_narrow"],"category_scores_codex":[0.00057753816,0.0015356329,0.014066694,0.00024370567,0.00009031638,0.000055245328,0.0001861968,0.00042366964,0.00048418698],"category_scores_gemma":[0.00026781435,0.0008979009,0.0012813215,0.0005325541,0.00008357109,0.00007993036,0.00008039671,0.00022864003,0.00021758357],"study_design_candidate":"systematic_review","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000017179302,0.0008332736,0.000108399436,0.46898928,0.0013838264,0.0006307019,0.0002144472,1.7674518e-8,5.559743e-9,0.0000025972386,0.0035017077,0.5243186],"study_design_scores_gemma":[0.0032086303,0.0001352866,0.00000921951,0.4251833,0.062304243,0.00020676914,0.000029337732,1.1121505e-7,2.2268135e-7,5.0388206e-7,0.508588,0.00033437123],"about_ca_topic_score_codex":0.15434998,"about_ca_topic_score_gemma":0.1042184,"teacher_disagreement_score":0.5239842,"about_ca_system_score_codex":0.017915985,"about_ca_system_score_gemma":0.0035372458,"threshold_uncertainty_score":0.9997392},"labels":[],"label_agreement":null},{"id":"W2205062739","doi":"10.1016/j.ctrv.2015.12.006","title":"Evolution in the eligibility criteria of randomized controlled trials for systemic cancer therapies","year":2015,"lang":"en","type":"review","venue":"Cancer Treatment Reviews","topic":"Statistical Methods in Clinical Trials","field":"Mathematics","cited_by":34,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen's University; Princess Margaret Cancer Centre; University of Toronto","funders":"","keywords":"Medicine; Randomized controlled trial; Generalizability theory; Internal medicine; Logistic regression; Cancer","score_opus":0.8089890578173045,"score_gpt":0.6935839612305341,"score_spread":0.11540509658677034,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2205062739","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0000017183961,0.924657,0.0043258313,0.00010775616,0.0011273096,0.06870759,0.00093842787,0.000022574754,0.00011180613],"genre_scores_gemma":[0.0000018852429,0.84009737,0.023049677,0.000031674284,0.0007993032,0.13579217,0.000017756916,0.000054776472,0.0001553845],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.92770505,0.05841924,0.012268046,0.0007482135,0.00046937953,0.000390095],"domain_scores_gemma":[0.7178442,0.2706521,0.009650513,0.0013480916,0.00040909875,0.00009601514],"candidate_categories":["metaresearch","metaepi_narrow","metaepi_broad"],"consensus_categories":["metaresearch"],"category_scores_codex":[0.114207275,0.0009500683,0.055287104,0.0001578456,0.000049986054,0.0000519256,0.0005788176,0.00047226108,0.00025960422],"category_scores_gemma":[0.20044748,0.00035479353,0.00857206,0.0003630066,0.00025613036,0.00004153787,0.000027922246,0.00022370237,0.0000071601376],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.01424767,0.00033534202,0.0000011601321,0.05453681,0.0029979502,0.0000013249088,0.000267734,1.8841352e-7,4.2134e-7,0.0068493197,0.0030211208,0.91774094],"study_design_scores_gemma":[0.15833063,0.00016954217,1.05562954e-7,0.057337083,0.038600683,0.0000040701866,0.000026200412,0.000010149525,5.2711476e-7,0.16441485,0.5807739,0.00033227616],"about_ca_topic_score_codex":0.00021428266,"about_ca_topic_score_gemma":0.000050841918,"teacher_disagreement_score":0.9174087,"about_ca_system_score_codex":0.001610757,"about_ca_system_score_gemma":0.0011250807,"threshold_uncertainty_score":0.9998904},"labels":[],"label_agreement":null},{"id":"W2277945632","doi":"10.1016/j.ctrv.2016.02.004","title":"Clinical predictors of benefit from fulvestrant in advanced breast cancer: A Meta-analysis of randomized controlled trials","year":2016,"lang":"en","type":"review","venue":"Cancer Treatment Reviews","topic":"Estrogen and related hormone effects","field":"Biochemistry, Genetics and Molecular Biology","cited_by":23,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Manitoba; University of Toronto; CancerCare Manitoba","funders":"","keywords":"Medicine; Fulvestrant; Randomized controlled trial; Meta-analysis; Oncology; Breast cancer; Internal medicine; Clinical trial; Cancer; Tamoxifen","score_opus":0.09100272314250009,"score_gpt":0.42978530423296596,"score_spread":0.3387825810904659,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2277945632","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0006767675,0.98539233,0.0000140721895,0.000029290679,0.00033417004,0.008847921,0.004631273,0.0000058477576,0.0000682994],"genre_scores_gemma":[0.00014387394,0.98839706,0.00008716996,0.000015595548,0.00025798302,0.009874299,0.000797943,0.000049247195,0.00037681355],"study_design_codex":"design_other","study_design_gemma":"meta_analysis","domain_scores_codex":[0.9860431,0.005280824,0.007175719,0.00094771694,0.00023802515,0.00031459113],"domain_scores_gemma":[0.99021786,0.0018108614,0.0066952934,0.0009895968,0.00012426412,0.00016210713],"candidate_categories":["metaepi_narrow","metaepi_broad"],"consensus_categories":["metaepi_broad"],"category_scores_codex":[0.004519354,0.0009595955,0.053152535,0.00031894087,0.000020474956,0.000009155586,0.0003549285,0.00075782306,0.00048165684],"category_scores_gemma":[0.0005105703,0.00039992805,0.036093187,0.0004753463,0.00021176954,0.000005277126,0.00005202432,0.0001707402,0.0000043648715],"study_design_candidate":"meta_analysis","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.010874468,0.00023563422,0.000065662294,0.0009201024,0.46178845,0.0000027582796,0.0000084266885,0.00001276079,0.00005604641,0.0000044525686,0.000039081722,0.52599216],"study_design_scores_gemma":[0.0740203,0.00019090711,0.000007423366,0.0034885376,0.68710816,0.0000010466422,0.0000010130345,0.0000021444125,0.000074650445,0.0000039678966,0.23481753,0.00028432303],"about_ca_topic_score_codex":0.00045723325,"about_ca_topic_score_gemma":0.00017764836,"teacher_disagreement_score":0.52570784,"about_ca_system_score_codex":0.00013247838,"about_ca_system_score_gemma":0.00058540463,"threshold_uncertainty_score":0.99984527},"labels":[],"label_agreement":null},{"id":"W2300932108","doi":"10.1016/j.ctrv.2016.03.009","title":"The impact of brain metastasis on quality of life, resource utilization and survival in patients with non-small-cell lung cancer","year":2016,"lang":"en","type":"review","venue":"Cancer Treatment Reviews","topic":"Brain Metastases and Treatment","field":"Medicine","cited_by":296,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University Health Network","funders":"F. Hoffmann-La Roche","keywords":"Medicine; Quality of life (healthcare); MEDLINE; Lung cancer; Oncology; Radiation therapy; Internal medicine; Disease; Cancer; Population; Brain metastasis; Systematic review; Intensive care medicine; Metastasis","score_opus":0.11609786579068258,"score_gpt":0.42546623710090925,"score_spread":0.30936837131022665,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2300932108","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0045541865,0.98854405,0.000009626905,0.000066194436,0.000053377906,0.00550795,0.0010018989,0.0000059613503,0.00025675065],"genre_scores_gemma":[0.0005123185,0.9974222,0.000049402588,0.000026099318,0.00005368271,0.0013169175,0.00025323205,0.000059177284,0.00030696884],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9964983,0.0009653055,0.0013601836,0.0005503579,0.00030559162,0.00032025846],"domain_scores_gemma":[0.9966177,0.00064340077,0.0016283848,0.0008226952,0.00010518368,0.00018263685],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0007765174,0.00068449846,0.0039231405,0.00014599257,0.000059273523,0.000012430098,0.00012513719,0.00012683393,0.00009657124],"category_scores_gemma":[0.000087578584,0.00026037605,0.00080769934,0.000407466,0.00011157997,0.0000334964,0.000036251637,0.00012806371,0.0000024188432],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00035028337,0.00070484064,0.04135936,0.012210948,0.0016717464,0.000001854352,0.00006207185,0.000002156462,1.1237103e-7,0.00000973247,0.0004483239,0.9431786],"study_design_scores_gemma":[0.008035765,0.0024977531,0.026542325,0.04960751,0.0055280873,7.465551e-7,0.000013602236,0.000002294953,0.0000058077717,0.0000016598918,0.9073992,0.00036528954],"about_ca_topic_score_codex":0.0019519058,"about_ca_topic_score_gemma":0.00044031153,"teacher_disagreement_score":0.9428133,"about_ca_system_score_codex":0.0010760353,"about_ca_system_score_gemma":0.00081724185,"threshold_uncertainty_score":0.99998486},"labels":[],"label_agreement":null},{"id":"W2400707955","doi":"10.1016/j.ctrv.2016.05.003","title":"Diagnosis and management of gastrointestinal neuroendocrine tumors: An evidence-based Canadian consensus","year":2016,"lang":"en","type":"review","venue":"Cancer Treatment Reviews","topic":"Neuroendocrine Tumor Research Advances","field":"Medicine","cited_by":111,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Dalhousie University; Foothills Medical Centre; McGill University Health Centre; University of Ottawa; University of Toronto; Western University; University of Calgary; St Joseph's Health Care; Princess Margaret Cancer Centre; CancerCare Manitoba; Health Sciences Centre; University Health Network; Ottawa Hospital; BC Cancer Agency; St. Boniface Hospital; Sunnybrook Health Science Centre; University of British Columbia","funders":"","keywords":"Medicine; Neuroendocrine tumors; Radionuclide therapy; Everolimus; Medical literature; Disease; Intensive care medicine; Internal medicine; Pathology; Medical physics","score_opus":0.18685091968283943,"score_gpt":0.4382014244135304,"score_spread":0.251350504730691,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2400707955","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00010106868,0.99105847,0.0000010184575,0.0008966068,0.000084879255,0.007257882,0.000315933,0.000041505788,0.00024264657],"genre_scores_gemma":[0.000022814209,0.99070877,0.0012436891,0.00013525003,0.00014976406,0.00668587,0.000066536275,0.00010564253,0.0008816927],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99595356,0.0005326128,0.0012102143,0.001056312,0.00037070323,0.000876616],"domain_scores_gemma":[0.9964632,0.0004198998,0.0006513253,0.0011591193,0.000115695846,0.0011907971],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00016029856,0.0008950933,0.0035575181,0.0004956397,0.00008465426,0.000032314183,0.0002820363,0.0000106770985,0.0005051257],"category_scores_gemma":[0.0001779169,0.000528284,0.0006119509,0.0004313211,0.00029533994,0.00010223589,0.0000684169,0.00022554299,0.00007409603],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000045813067,0.00015787975,0.0010835684,0.059546664,0.0001457889,0.014070425,0.0000013672612,1.470639e-7,6.7002236e-7,0.000017407647,0.00090025325,0.92403],"study_design_scores_gemma":[0.00074859604,0.0014721026,0.00007531099,0.25624225,0.0016544755,0.0033027967,0.0000026597575,7.961981e-7,0.000017003927,0.0000025133133,0.7362447,0.00023679342],"about_ca_topic_score_codex":0.009218032,"about_ca_topic_score_gemma":0.006360679,"teacher_disagreement_score":0.9237932,"about_ca_system_score_codex":0.001274984,"about_ca_system_score_gemma":0.0015481308,"threshold_uncertainty_score":0.9997169},"labels":[],"label_agreement":null},{"id":"W2461489883","doi":"10.1016/j.ctrv.2016.07.003","title":"The prospect of precision therapy for renal cell carcinoma","year":2016,"lang":"en","type":"review","venue":"Cancer Treatment Reviews","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":62,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"","keywords":"Medicine; Renal cell carcinoma; Oncology; Carcinoma; Intensive care medicine; Internal medicine; Medical physics","score_opus":0.1182675649391262,"score_gpt":0.3909652420386356,"score_spread":0.2726976770995094,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2461489883","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000050398325,0.97777456,0.000017240323,0.00009014544,0.00034784077,0.019643908,0.0002335449,0.000023834991,0.0018185028],"genre_scores_gemma":[0.000020861866,0.967739,0.00032156106,0.000021220245,0.0006268937,0.018030247,0.00015073763,0.00012958443,0.012959884],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9964799,0.00029094153,0.001558775,0.0008261264,0.00033003392,0.0005141795],"domain_scores_gemma":[0.9960414,0.00060193735,0.0014138793,0.0015808014,0.00015818595,0.00020377302],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0004429822,0.0009720427,0.004277457,0.000119239325,0.00016521465,0.000027092228,0.0003167786,0.00025021995,0.0001522577],"category_scores_gemma":[0.000034298264,0.00035148842,0.0029749905,0.00024973016,0.00012633532,0.000039075287,0.00004105584,0.00013468624,0.00009918084],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00020273497,0.00027984387,0.000053547195,0.010729083,0.00040213892,0.000011325287,0.000031562286,1.6028359e-8,0.000020064621,0.000015869178,0.0039029538,0.98435086],"study_design_scores_gemma":[0.0025983416,0.003128653,0.00003252903,0.022354197,0.0033390876,0.00003143995,0.000001701456,2.1155371e-7,0.0012158742,0.000019321422,0.9669926,0.000286032],"about_ca_topic_score_codex":0.00003975857,"about_ca_topic_score_gemma":0.000010862899,"teacher_disagreement_score":0.9840648,"about_ca_system_score_codex":0.0018625106,"about_ca_system_score_gemma":0.0010771779,"threshold_uncertainty_score":0.9998937},"labels":[],"label_agreement":null},{"id":"W2496988985","doi":"10.1016/j.ctrv.2016.07.005","title":"How are the kids holding up? A systematic review and meta-analysis on the psychosocial impact of maternal breast cancer on children","year":2016,"lang":"en","type":"review","venue":"Cancer Treatment Reviews","topic":"Family Support in Illness","field":"Social Sciences","cited_by":35,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"","keywords":"Medicine; Psychosocial; Meta-analysis; Breast cancer; Childhood cancer; Cancer; Oncology; Internal medicine; Psychiatry","score_opus":0.1463027417837157,"score_gpt":0.4313877286012478,"score_spread":0.28508498681753214,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2496988985","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000006187373,0.98128456,0.0000012970944,0.0047168205,0.0002349086,0.010576263,0.0029352373,0.000021128344,0.00022361155],"genre_scores_gemma":[0.00015694133,0.98586744,0.0000017831512,0.00053280755,0.00034366053,0.010676489,0.00002313455,0.000056811954,0.0023409142],"study_design_codex":"design_other","study_design_gemma":"meta_analysis","domain_scores_codex":[0.992955,0.0036289345,0.0013387183,0.00078512175,0.0007559397,0.0005362573],"domain_scores_gemma":[0.9939217,0.00065157237,0.0036853107,0.0014330212,0.00012907095,0.00017931503],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0019343817,0.0010263269,0.010623945,0.00016528726,0.0005693137,0.00024736166,0.0010731634,0.00021745579,0.0015350749],"category_scores_gemma":[0.00015037805,0.00032107785,0.0076242294,0.0012175353,0.00036757434,0.00012498681,0.000057637913,0.0002550323,0.000039639715],"study_design_candidate":"meta_analysis","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000009827051,0.00014800401,0.0004184888,0.2837887,0.34708467,0.0000049059695,0.0010567792,7.2866897e-7,1.6537284e-8,0.00054633187,0.008335804,0.35860574],"study_design_scores_gemma":[0.00009701037,0.00004773773,0.00013398344,0.12884122,0.67642844,0.000005763579,0.00004949354,5.2828963e-8,7.6674525e-8,0.000010243571,0.19399786,0.00038814032],"about_ca_topic_score_codex":0.004338129,"about_ca_topic_score_gemma":0.001097603,"teacher_disagreement_score":0.3582176,"about_ca_system_score_codex":0.0017653605,"about_ca_system_score_gemma":0.0004945176,"threshold_uncertainty_score":0.9999241},"labels":[],"label_agreement":null},{"id":"W2520692458","doi":"10.1016/j.ctrv.2016.09.001","title":"Post-gemcitabine therapy for patients with advanced pancreatic cancer – A comparative review of randomized trials evaluating oxaliplatin- and/or irinotecan-containing regimens","year":2016,"lang":"en","type":"review","venue":"Cancer Treatment Reviews","topic":"Pancreatic and Hepatic Oncology Research","field":"Medicine","cited_by":20,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency; University of British Columbia","funders":"","keywords":"Medicine; Irinotecan; Oxaliplatin; Gemcitabine; Internal medicine; Oncology; Pancreatic cancer; Clinical trial; Randomized controlled trial; FOLFIRINOX; Population; Context (archaeology); Progression-free survival; Cancer; Colorectal cancer; Chemotherapy","score_opus":0.30522861975147,"score_gpt":0.5399468667520916,"score_spread":0.2347182470006216,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2520692458","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00033239182,0.94174427,0.000050053197,0.00025912386,0.00014941288,0.056270808,0.00079379516,0.000028973216,0.00037115766],"genre_scores_gemma":[0.0000064526453,0.9264066,0.0034182968,0.00030177282,0.0002471771,0.06601657,0.0004869272,0.00009951211,0.00301664],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.98991585,0.003828307,0.0040293867,0.0010072368,0.000566712,0.0006525033],"domain_scores_gemma":[0.9827788,0.009955685,0.0050137187,0.00085588405,0.0010855988,0.00031031808],"candidate_categories":["metaepi_narrow","metaepi_broad"],"consensus_categories":[],"category_scores_codex":[0.0055201226,0.001203797,0.029426424,0.00024564058,0.0001341525,0.00001787359,0.00020094626,0.00026453286,0.00088749436],"category_scores_gemma":[0.0037838107,0.0004809701,0.0019994548,0.00038460016,0.00040580248,0.00010781758,0.00004701054,0.00023789098,0.000010812167],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.040712453,0.00036888663,0.00021397874,0.1048094,0.005558843,0.0000036339322,0.00023842174,3.5293066e-8,0.000001837195,0.000012324196,0.0003188568,0.84776133],"study_design_scores_gemma":[0.109822564,0.0074766786,0.000016651853,0.3956545,0.02330335,0.000008588369,0.000012474576,0.000005067322,0.0000018879367,0.00000531885,0.4633411,0.00035184313],"about_ca_topic_score_codex":0.00015617734,"about_ca_topic_score_gemma":0.000034690744,"teacher_disagreement_score":0.8474095,"about_ca_system_score_codex":0.0014376761,"about_ca_system_score_gemma":0.004071863,"threshold_uncertainty_score":0.9997642},"labels":[],"label_agreement":null},{"id":"W2521763233","doi":"10.1016/j.ctrv.2016.09.013","title":"Bone-targeted therapy use in patients with bone metastases from lung cancer: A systematic review of randomized controlled trials","year":2016,"lang":"en","type":"review","venue":"Cancer Treatment Reviews","topic":"Bone health and treatments","field":"Medicine","cited_by":47,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Public Health; Ottawa Hospital; University of Ottawa","funders":"","keywords":"Medicine; Lung cancer; Denosumab; Randomized controlled trial; Meta-analysis; Oncology; Internal medicine; Bone pain; Cancer; Population; Surgery; Osteoporosis","score_opus":0.08462681559930937,"score_gpt":0.40857850373297544,"score_spread":0.32395168813366604,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2521763233","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000030204123,0.8750982,0.0000035555795,0.00008691072,0.00027368343,0.121985175,0.0024584914,0.00003595751,0.000027805969],"genre_scores_gemma":[0.0000049533933,0.8847696,0.00017273279,0.00043306142,0.000087832675,0.11220941,0.0015771663,0.000134216,0.00061099813],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.97627884,0.010482429,0.010771399,0.0010478834,0.00076745014,0.00065200275],"domain_scores_gemma":[0.98014855,0.0052348967,0.0122372,0.0015796786,0.00037002398,0.00042964146],"candidate_categories":["metaepi_narrow","metaepi_broad","insufficient_payload"],"consensus_categories":["metaepi_narrow"],"category_scores_codex":[0.0048897313,0.0018327873,0.09400574,0.00049153174,0.00006006562,0.000031860433,0.00017700941,0.00031169804,0.001103825],"category_scores_gemma":[0.0026002652,0.0006555904,0.0073617985,0.0006379248,0.000117542506,0.00015861573,0.000024638624,0.00023733402,0.000040487557],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.028828276,0.00094851304,0.00032089563,0.6756494,0.017265148,0.000038178507,0.000026504864,1.200729e-8,3.697177e-8,0.0000021069689,0.00042825384,0.27649269],"study_design_scores_gemma":[0.2594822,0.00028536373,0.0000067653673,0.55215174,0.08526773,0.0000026268476,5.202919e-7,2.8518556e-7,5.229295e-7,8.2855155e-7,0.102521084,0.00028031602],"about_ca_topic_score_codex":0.0026151312,"about_ca_topic_score_gemma":0.00020043176,"teacher_disagreement_score":0.27621236,"about_ca_system_score_codex":0.0020978686,"about_ca_system_score_gemma":0.001984603,"threshold_uncertainty_score":0.9998093},"labels":[],"label_agreement":null},{"id":"W2523098967","doi":"10.1016/j.ctrv.2016.09.011","title":"Mechanism of drug resistance in relation to site of metastasis: Meta-analyses of randomized controlled trials in advanced breast cancer according to anticancer strategy","year":2016,"lang":"en","type":"review","venue":"Cancer Treatment Reviews","topic":"Breast Cancer Treatment Studies","field":"Biochemistry, Genetics and Molecular Biology","cited_by":13,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Manitoba; CancerCare Manitoba","funders":"","keywords":"Medicine; Oncology; Internal medicine; Breast cancer; Randomized controlled trial; Hazard ratio; Metastatic breast cancer; Meta-analysis; Cancer; Palbociclib; Hormone therapy; Metastasis; Sunitinib; Hormonal therapy; Targeted therapy; Confidence interval","score_opus":0.1498119967717804,"score_gpt":0.44889570713484,"score_spread":0.2990837103630596,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2523098967","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0006051297,0.9849569,0.00019456996,0.00019787443,0.00016964025,0.0114631215,0.0022796225,0.0000055876108,0.00012753828],"genre_scores_gemma":[0.006032555,0.96888965,0.001063759,0.00003519414,0.00010070695,0.023366893,0.00010142926,0.000071698625,0.0003380935],"study_design_codex":"design_other","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9875893,0.004119115,0.006344461,0.0011074253,0.00038660466,0.0004530947],"domain_scores_gemma":[0.99180156,0.0011431621,0.005650189,0.000952354,0.00032465276,0.00012810007],"candidate_categories":["metaepi_narrow","metaepi_broad"],"consensus_categories":[],"category_scores_codex":[0.004645617,0.001138166,0.031405233,0.00067237456,0.00003026905,0.000011953908,0.00032953918,0.000228383,0.00014793884],"category_scores_gemma":[0.0010395081,0.0005863635,0.0060518477,0.0008286425,0.000105109444,0.000020767768,0.00011296293,0.00010165166,0.000004158405],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.05649322,0.0006625651,0.00013592435,0.012995419,0.06831752,0.000007396678,0.0003635591,0.00024423227,0.0039959797,0.00039995974,0.00020474092,0.8561795],"study_design_scores_gemma":[0.29425204,0.0005377943,0.00015289243,0.116839215,0.2939579,0.000006444509,0.00016084168,0.000002300568,0.016614256,0.00033810828,0.27458173,0.0025565007],"about_ca_topic_score_codex":0.0014621008,"about_ca_topic_score_gemma":0.0033483556,"teacher_disagreement_score":0.853623,"about_ca_system_score_codex":0.00067140313,"about_ca_system_score_gemma":0.00071683835,"threshold_uncertainty_score":0.99965876},"labels":[],"label_agreement":null},{"id":"W2548925627","doi":"10.1016/j.ctrv.2016.10.007","title":"Approach to evaluation of fever in ambulatory cancer patients receiving chemotherapy: A systematic review","year":2016,"lang":"en","type":"review","venue":"Cancer Treatment Reviews","topic":"Neutropenia and Cancer Infections","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Juravinski Cancer Centre; University of Windsor; Sinai Health System; Princess Margaret Cancer Centre; Health Sciences Centre; University Health Network; Windsor Regional Hospital; Institute for Clinical Evaluative Sciences; Sunnybrook Health Science Centre; Windsor Clinical Research; McMaster University; Cancer Care Ontario; University of Toronto; Grand River Hospital; Ontario Institute for Cancer Research","funders":"National Institutes of Health","keywords":"Medicine; Febrile neutropenia; Ambulatory; Intensive care medicine; Chemotherapy; MEDLINE; Neutropenia; Systematic review; Population; Cancer; Internal medicine","score_opus":0.15135810267013,"score_gpt":0.43302971880095553,"score_spread":0.28167161613082553,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2548925627","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000010671789,0.96846944,0.00000508927,0.00006786583,0.0002952483,0.029153947,0.00007758219,0.000021357797,0.0018987947],"genre_scores_gemma":[0.0000065166564,0.9426688,0.000057809884,0.00062457216,0.00016017325,0.055430368,0.00007968348,0.00009029143,0.00088178803],"study_design_codex":"design_other","study_design_gemma":"systematic_review","domain_scores_codex":[0.9954546,0.0007891489,0.0020590418,0.00075934234,0.0005988489,0.00033898943],"domain_scores_gemma":[0.9970566,0.00006461648,0.0013510514,0.0010250999,0.00032029653,0.00018234584],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0011474722,0.0007217842,0.0067701307,0.00025205914,0.000039435825,0.000011244378,0.00018961851,0.00017895253,0.00045030503],"category_scores_gemma":[0.00010550451,0.00039066953,0.0012918825,0.0008971958,0.000031628304,0.000082570754,0.000031224743,0.00016085693,0.00010418554],"study_design_candidate":"systematic_review","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0000032079074,0.0002505024,0.000099025165,0.49235815,0.00035610082,2.3634654e-7,0.000048635804,2.5432152e-7,2.5509672e-7,0.0000015417597,0.0014016622,0.5054804],"study_design_scores_gemma":[0.00075412716,0.0000712836,0.000035937916,0.513592,0.010085783,0.000003296595,0.0000010134623,5.466518e-7,0.0000011671508,5.9511825e-7,0.47526842,0.00018582509],"about_ca_topic_score_codex":0.0001767458,"about_ca_topic_score_gemma":0.00006523919,"teacher_disagreement_score":0.5052946,"about_ca_system_score_codex":0.0058561102,"about_ca_system_score_gemma":0.0013159553,"threshold_uncertainty_score":0.9998545},"labels":[],"label_agreement":null},{"id":"W2555449614","doi":"10.1016/j.ctrv.2016.11.009","title":"Statin use and kidney cancer survival outcomes: A systematic review and meta-analysis","year":2016,"lang":"en","type":"review","venue":"Cancer Treatment Reviews","topic":"Cancer, Lipids, and Metabolism","field":"Biochemistry, Genetics and Molecular Biology","cited_by":61,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Sciences Centre; Sunnybrook Health Science Centre; Institute for Clinical Evaluative Sciences; Western University; London Health Sciences Centre; University of Toronto; University Health Network; Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; Hazard ratio; Internal medicine; Kidney cancer; Publication bias; Statin; Meta-analysis; Oncology; Cancer; Randomized controlled trial; Proportional hazards model; Confidence interval","score_opus":0.1656488248597905,"score_gpt":0.41206211989832026,"score_spread":0.24641329503852977,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2555449614","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[3.849117e-7,0.9895205,0.00004067378,0.00021246081,0.0008669347,0.005803871,0.0035070626,0.0000134528555,0.000034661065],"genre_scores_gemma":[5.20954e-8,0.97174877,0.000113483395,0.0013568944,0.0009086041,0.013921002,0.00043257992,0.00008110067,0.011437522],"study_design_codex":"systematic_review","study_design_gemma":"not_applicable","domain_scores_codex":[0.9954555,0.0010611557,0.0016114826,0.0012335279,0.00020562415,0.00043268947],"domain_scores_gemma":[0.99663275,0.00010702678,0.0013510082,0.0013668032,0.000113325965,0.00042908557],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0005945528,0.0011981193,0.0142536545,0.0001414614,0.000093930015,0.00009462692,0.00025513468,0.0002657491,0.00042811254],"category_scores_gemma":[0.00024281317,0.00057542825,0.0037114597,0.00033981068,0.00010620821,0.000015938977,0.00012520632,0.000107537526,0.000016759035],"study_design_candidate":"systematic_review","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0000035699359,0.00004935759,0.000039113394,0.7153904,0.19730446,4.5465137e-7,0.00001902153,5.0386223e-8,0.0000019003415,0.000012367616,0.015145022,0.072034314],"study_design_scores_gemma":[0.00015733381,0.000028311017,0.0000014162108,0.017777031,0.44504565,0.0000037577531,8.888887e-7,3.096455e-8,3.8645808e-7,4.131343e-7,0.5366602,0.0003245929],"about_ca_topic_score_codex":0.0005870304,"about_ca_topic_score_gemma":0.00070620474,"teacher_disagreement_score":0.69761336,"about_ca_system_score_codex":0.00018354817,"about_ca_system_score_gemma":0.00048988155,"threshold_uncertainty_score":0.99966973},"labels":[],"label_agreement":null},{"id":"W2560222145","doi":"10.1016/j.ctrv.2016.11.010","title":"Effects and moderators of exercise on quality of life and physical function in patients with cancer: An individual patient data meta-analysis of 34 RCTs","year":2016,"lang":"en","type":"review","venue":"Cancer Treatment Reviews","topic":"Cancer survivorship and care","field":"Medicine","cited_by":610,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"KWF Kankerbestrijding","keywords":"Medicine; Meta-analysis; PsycINFO; Quality of life (healthcare); Randomized controlled trial; Physical therapy; Moderation; Psychological intervention; CINAHL; Body mass index; Clinical trial; MEDLINE; Internal medicine","score_opus":0.18206724738803673,"score_gpt":0.40623549348465143,"score_spread":0.2241682460966147,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2560222145","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0490553,0.94464326,0.0000025400816,0.0000069701673,0.000058734626,0.002923474,0.003293709,0.0000047399394,0.000011281514],"genre_scores_gemma":[0.02605237,0.9717793,0.000013685572,0.000026230064,0.000029550818,0.0011631633,0.00089455035,0.00003097472,0.000010190469],"study_design_codex":"design_other","study_design_gemma":"meta_analysis","domain_scores_codex":[0.99684364,0.00059960753,0.0011261575,0.000775063,0.00047765207,0.00017788204],"domain_scores_gemma":[0.9969327,0.00021089455,0.0014861224,0.0010627372,0.00012063053,0.00018690681],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00032831111,0.0005555512,0.008363948,0.0003244969,0.000019749474,0.0000069728,0.00013311327,0.000129515,0.00004423592],"category_scores_gemma":[0.000032347703,0.00027010363,0.000737374,0.00062187325,0.00010874568,0.000110527224,0.000075706404,0.000109927816,3.4405463e-7],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0004256287,0.0008492347,0.011123968,0.028348584,0.037754335,5.9978413e-7,0.0004128596,0.0000013902398,2.4811726e-7,0.0000061396036,0.000023236948,0.92105377],"study_design_scores_gemma":[0.0035117215,0.004063141,0.016859097,0.021938259,0.8761592,1.2498288e-7,0.000036946116,0.000005727374,0.000016712702,0.0000039451675,0.07686986,0.0005352946],"about_ca_topic_score_codex":0.002684062,"about_ca_topic_score_gemma":0.001996543,"teacher_disagreement_score":0.92051846,"about_ca_system_score_codex":0.0002187893,"about_ca_system_score_gemma":0.00032670188,"threshold_uncertainty_score":0.99997514},"labels":[],"label_agreement":null},{"id":"W2563522215","doi":"10.1016/j.ctrv.2016.12.002","title":"Cardiovascular toxicity of angiogenesis inhibitors in treatment of malignancy: A systematic review and meta-analysis","year":2016,"lang":"en","type":"review","venue":"Cancer Treatment Reviews","topic":"Chemotherapy-induced cardiotoxicity and mitigation","field":"Medicine","cited_by":254,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Health Network; Princess Margaret Cancer Centre; Women's College Hospital; University of Toronto; Institute for Clinical Evaluative Sciences","funders":"","keywords":"Medicine; Number needed to harm; Angiogenesis; Internal medicine; Cardiology; Ischemia; Pharmacology; Relative risk; Number needed to treat; Confidence interval","score_opus":0.12253469518415144,"score_gpt":0.3725759583253476,"score_spread":0.2500412631411962,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2563522215","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000018540735,0.9862478,0.000012918065,0.000053033567,0.00002646303,0.013173905,0.0003779632,0.000012194847,0.000077204226],"genre_scores_gemma":[0.000055324563,0.9909989,0.00008584824,0.00004939153,0.000047943173,0.0082120225,0.000093198134,0.0000505621,0.0004067715],"study_design_codex":"systematic_review","study_design_gemma":"meta_analysis","domain_scores_codex":[0.99514663,0.00095031655,0.002554974,0.00074486475,0.00034335788,0.00025987395],"domain_scores_gemma":[0.99650234,0.0001431131,0.0015969643,0.0015100567,0.000104865125,0.00014266321],"candidate_categories":["metaepi_narrow","metaepi_broad"],"consensus_categories":["metaepi_broad"],"category_scores_codex":[0.00069900637,0.00088079635,0.02918796,0.00049136905,0.000022760049,0.000006129045,0.00010701405,0.00027023567,0.0001536753],"category_scores_gemma":[0.000044320404,0.00042789025,0.018361427,0.0012830495,0.00008005488,0.00005066526,0.000018738685,0.000051403793,0.0000068031104],"study_design_candidate":"meta_analysis","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0000029751923,0.00017742674,0.000006884005,0.55866724,0.25703,0.000010055736,0.000047880803,1.7222052e-7,0.000010160207,0.0000023423456,0.0000094742645,0.18403539],"study_design_scores_gemma":[0.000444508,0.00022138747,0.0000010271918,0.1534786,0.6828313,0.000021069316,0.0000024841006,6.020438e-8,0.0007942222,0.0000010436692,0.1619996,0.00020468749],"about_ca_topic_score_codex":0.00025047458,"about_ca_topic_score_gemma":0.00006421683,"teacher_disagreement_score":0.4258013,"about_ca_system_score_codex":0.0012091134,"about_ca_system_score_gemma":0.00030524944,"threshold_uncertainty_score":0.9998173},"labels":[],"label_agreement":null},{"id":"W2564183539","doi":"10.1016/j.ctrv.2016.11.013","title":"Toxicity of concurrent stereotactic radiotherapy and targeted therapy or immunotherapy: A systematic review","year":2016,"lang":"en","type":"review","venue":"Cancer Treatment Reviews","topic":"Brain Metastases and Treatment","field":"Medicine","cited_by":205,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Canada Research Chairs","funders":"","keywords":"Medicine; Radiation therapy; Immunotherapy; Stereotactic radiotherapy; Oncology; Toxicity; Targeted therapy; Medical physics; Radiosurgery; Intensive care medicine; Internal medicine; Cancer","score_opus":0.10906969441442799,"score_gpt":0.41843800132175824,"score_spread":0.30936830690733025,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2564183539","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0000032677688,0.97613645,0.000025313435,0.00016999237,0.0002385789,0.022975078,0.0003695185,0.0000403851,0.00004143635],"genre_scores_gemma":[0.0000010960613,0.9874338,0.00021621886,0.0006067093,0.00014377116,0.009896497,0.00012728768,0.00013056422,0.0014440776],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9947596,0.0012357467,0.002453449,0.0008060808,0.0003206719,0.00042442442],"domain_scores_gemma":[0.99552953,0.0004140999,0.0023102183,0.0013984233,0.000093905706,0.0002538128],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0006337117,0.0012751345,0.0128332125,0.00016792583,0.000067612214,0.000024572077,0.00020312445,0.00020318266,0.0016250513],"category_scores_gemma":[0.00006547761,0.0005041313,0.0020046623,0.00038833977,0.00013479027,0.00007005098,0.000024364736,0.00016214371,0.000042246276],"study_design_candidate":"systematic_review","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0000359196,0.00029820984,0.0000032203454,0.4602312,0.0033301075,0.000023558212,0.000028853417,7.838961e-10,0.0000014110796,0.0000063032267,0.00029353125,0.53574765],"study_design_scores_gemma":[0.0017308368,0.0011317062,8.213239e-7,0.4665616,0.007139894,0.00015771958,0.0000013393529,1.1245968e-7,0.000005612593,7.0002585e-7,0.5230354,0.00023427239],"about_ca_topic_score_codex":0.000035696445,"about_ca_topic_score_gemma":0.0000073664055,"teacher_disagreement_score":0.5355134,"about_ca_system_score_codex":0.0012869795,"about_ca_system_score_gemma":0.00070991996,"threshold_uncertainty_score":0.99995446},"labels":[],"label_agreement":null},{"id":"W2576814507","doi":"10.1016/j.ctrv.2017.01.003","title":"Biology and patterns of response to EGFR-inhibition in squamous cell cancers of the lung and head & neck","year":2017,"lang":"en","type":"review","venue":"Cancer Treatment Reviews","topic":"Lung Cancer Treatments and Mutations","field":"Medicine","cited_by":17,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University; University of Ottawa; University of Toronto; University Health Network; Ottawa Hospital; Princess Margaret Cancer Centre; McMaster University; Juravinski Cancer Centre","funders":"","keywords":"Medicine; Epidermal growth factor receptor; Lung cancer; EGFR inhibitors; Head and neck cancer; Biomarker; Oncology; Head and neck squamous-cell carcinoma; Cancer research; Targeted therapy; Cancer; Clinical trial; Squamous carcinoma; Internal medicine; Carcinoma; Biology","score_opus":0.10154198292516915,"score_gpt":0.46727080123517467,"score_spread":0.36572881831000553,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2576814507","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.015002334,0.97938174,0.0000036514484,0.00022852868,0.00016663106,0.004384953,0.00058432383,0.000005405667,0.00024241084],"genre_scores_gemma":[0.004290854,0.9924207,0.00009196205,0.0000719994,0.000059647202,0.0016127863,0.000101125515,0.00003198575,0.0013189836],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9981712,0.00030331718,0.0007650866,0.00045541726,0.00008907127,0.00021589604],"domain_scores_gemma":[0.9982325,0.00012398431,0.00075668853,0.0007204069,0.000044834676,0.00012162483],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00020214645,0.00040362356,0.002297182,0.0001698815,0.000068500514,0.000010084094,0.00007593243,0.00015477845,0.000042684012],"category_scores_gemma":[0.000056233563,0.00021720654,0.0003255781,0.00015480867,0.000093185205,0.00003443808,0.00005806912,0.00011086097,0.0000028907937],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00013684474,0.00015216062,0.011324817,0.020157378,0.00018214101,0.000008981176,0.00060468464,7.904859e-7,0.000021767737,0.000008964168,0.00040998115,0.9669915],"study_design_scores_gemma":[0.001798652,0.00043570914,0.0024438745,0.029286912,0.0030290019,0.000020029409,0.000010784431,3.639539e-7,0.000025182855,0.0000034797092,0.9627915,0.00015452948],"about_ca_topic_score_codex":0.0045612673,"about_ca_topic_score_gemma":0.002990175,"teacher_disagreement_score":0.966837,"about_ca_system_score_codex":0.0013970018,"about_ca_system_score_gemma":0.00084382115,"threshold_uncertainty_score":0.8857426},"labels":[],"label_agreement":null},{"id":"W2588571167","doi":"10.1016/j.ctrv.2017.02.003","title":"A systematic review of smell alterations after radiotherapy for head and neck cancer","year":2017,"lang":"en","type":"review","venue":"Cancer Treatment Reviews","topic":"Olfactory and Sensory Function Studies","field":"Neuroscience","cited_by":46,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"","keywords":"Medicine; Olfaction; Olfactory system; Radiation therapy; CINAHL; Head and neck cancer; MEDLINE; Systematic review; Internal medicine; PsycINFO; Oncology; Neuroscience; Psychiatry","score_opus":0.41662792700825413,"score_gpt":0.4571656062967414,"score_spread":0.04053767928848728,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2588571167","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000001506938,0.98593515,0.0000200824,0.000088369015,0.00057538063,0.012478147,0.0007416652,0.000020098758,0.00013962024],"genre_scores_gemma":[6.090979e-7,0.9599763,0.00006034629,0.000607047,0.00021437963,0.034457166,0.00001527332,0.000047399266,0.004621487],"study_design_codex":"systematic_review","study_design_gemma":"not_applicable","domain_scores_codex":[0.99694026,0.00052706606,0.0014249923,0.0007038085,0.00014717226,0.00025667602],"domain_scores_gemma":[0.9968314,0.0003466935,0.0017396586,0.00092015334,0.0000662997,0.00009578528],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00023847815,0.0006545843,0.0058229943,0.00008611626,0.00026899224,0.00005980398,0.00021862016,0.00010540062,0.0001981756],"category_scores_gemma":[0.00027116376,0.00036714622,0.0011583117,0.00013039577,0.00012440531,0.00012864792,0.00002578647,0.000093647795,0.000020544063],"study_design_candidate":"systematic_review","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000005521842,0.00004359174,0.0000032616276,0.749114,0.00020577865,0.0000018442984,0.000052826894,4.2587246e-8,0.0000013246053,0.000013904213,0.0005922262,0.24996568],"study_design_scores_gemma":[0.00016938082,0.000094317766,5.4765206e-7,0.4430421,0.0028478922,0.0000068656936,6.028214e-7,6.3680756e-7,0.000004563291,0.0000012441361,0.55366683,0.00016502468],"about_ca_topic_score_codex":0.000019811107,"about_ca_topic_score_gemma":0.00004789043,"teacher_disagreement_score":0.5530746,"about_ca_system_score_codex":0.00036798549,"about_ca_system_score_gemma":0.00021631845,"threshold_uncertainty_score":0.99987805},"labels":[],"label_agreement":null},{"id":"W2590461535","doi":"10.1016/j.ctrv.2017.02.005","title":"Ovarian ablation for premenopausal breast cancer: A review of treatment considerations and the impact of premature menopause","year":2017,"lang":"en","type":"review","venue":"Cancer Treatment Reviews","topic":"Estrogen and related hormone effects","field":"Biochemistry, Genetics and Molecular Biology","cited_by":38,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency; University of British Columbia","funders":"","keywords":"Medicine; Menopause; Premature Menopause; Breast cancer; Premature ovarian failure; Gynecology; Cancer; Ablation; Oncology; Internal medicine","score_opus":0.05435239297481958,"score_gpt":0.4056446301276318,"score_spread":0.3512922371528122,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2590461535","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000022575636,0.98918235,0.0000051201987,0.00010427823,0.00009369658,0.008766378,0.0016764447,0.0000044399176,0.0001447065],"genre_scores_gemma":[0.00007068786,0.9926528,0.00010388711,0.000019686195,0.00021778212,0.0059070187,0.000674632,0.000043321084,0.00031018315],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99798584,0.00039073365,0.0008802154,0.00045345572,0.000076733755,0.00021302373],"domain_scores_gemma":[0.99713707,0.00008861701,0.0016815311,0.0008701242,0.00013596803,0.00008667655],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00033826064,0.0005877305,0.0027033812,0.00004169757,0.00015344209,0.000024409546,0.00015025343,0.00028472455,0.00004193202],"category_scores_gemma":[0.00006309143,0.0002655639,0.0010338727,0.00006721101,0.00018888185,0.000007706037,0.000038038972,0.00007873388,0.000001113091],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00012648453,0.00014820261,0.000013490131,0.044715058,0.0037252563,0.000001008606,0.00004024434,0.0000035640016,0.0001552213,0.00007101951,0.0025472709,0.9484532],"study_design_scores_gemma":[0.002020884,0.0014356265,0.000008660465,0.06448527,0.009261444,0.000076887794,7.3045686e-7,0.0000037307066,0.00012251634,0.000015508018,0.9223159,0.0002528769],"about_ca_topic_score_codex":0.0005702884,"about_ca_topic_score_gemma":0.00004545499,"teacher_disagreement_score":0.9482003,"about_ca_system_score_codex":0.000320063,"about_ca_system_score_gemma":0.0011796729,"threshold_uncertainty_score":0.9999797},"labels":[],"label_agreement":null},{"id":"W2591590744","doi":"10.1016/j.ctrv.2017.02.008","title":"Anti-angiogenic treatment for breast cancer?","year":2017,"lang":"en","type":"letter","venue":"Cancer Treatment Reviews","topic":"Angiogenesis and VEGF in Cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Children's Hospital; University of British Columbia; University of Victoria","funders":"","keywords":"Medicine; Breast cancer; Scopus; Oncology; Cancer; Cancer treatment; Internal medicine; MEDLINE","score_opus":0.06379287675606626,"score_gpt":0.35811604205317804,"score_spread":0.2943231652971118,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2591590744","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0013831527,0.8369286,0.00012072536,0.1395281,0.0025996834,0.005092573,0.013549936,0.00004177373,0.0007554657],"genre_scores_gemma":[0.0008037347,0.82611793,0.0002186224,0.07715665,0.026639145,0.01793046,0.004096775,0.0002582838,0.046778403],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9970993,0.000097982214,0.0005690364,0.0013135198,0.00015976057,0.00076043326],"domain_scores_gemma":[0.99727607,0.000017540136,0.0007602954,0.0016806236,0.00013198204,0.00013351967],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.000098669836,0.0010292429,0.0015007784,0.00006790214,0.0003490596,0.00009896838,0.00053383684,0.00085432,0.0004101372],"category_scores_gemma":[0.000007254074,0.00070881407,0.0020452477,0.000054176217,0.00012458318,0.0000069993125,0.0000643696,0.00011568594,0.00005810116],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000044295135,0.00007617304,0.0011611651,0.00022264547,0.0012152857,0.000021407923,0.000012550978,0.0000052930327,0.0014329795,8.2370315e-7,0.74531823,0.25048918],"study_design_scores_gemma":[0.0013516473,0.0005481187,0.00033603286,0.00038279174,0.001618213,0.000035544876,0.0000014957475,0.000003225705,0.005082721,0.0000044426724,0.989896,0.0007397495],"about_ca_topic_score_codex":0.0010920144,"about_ca_topic_score_gemma":0.00050028024,"teacher_disagreement_score":0.24974942,"about_ca_system_score_codex":0.0008616556,"about_ca_system_score_gemma":0.0006996028,"threshold_uncertainty_score":0.9995363},"labels":[],"label_agreement":null},{"id":"W2604383404","doi":"10.1016/j.ctrv.2017.03.011","title":"Efficacy, safety, tolerability and price of newly approved drugs in solid tumors","year":2017,"lang":"en","type":"review","venue":"Cancer Treatment Reviews","topic":"Economic and Financial Impacts of Cancer","field":"Economics, Econometrics and Finance","cited_by":45,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto","funders":"","keywords":"Medicine; Tolerability; Discontinuation; Internal medicine; Hazard ratio; Oncology; Chemotherapy; Immunotherapy; Adverse effect; Cancer; Confidence interval","score_opus":0.14328270882966276,"score_gpt":0.3700561566682588,"score_spread":0.22677344783859604,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2604383404","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0001409354,0.9792648,0.00001618392,0.00008147016,0.00039781834,0.0030307209,0.00062158547,0.000013811865,0.016432682],"genre_scores_gemma":[0.00014146394,0.99700844,0.00013505491,0.00004064506,0.00022923398,0.00087516976,0.000060287544,0.000064756554,0.0014449621],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99522835,0.00007486839,0.0031306446,0.0010322388,0.000033527842,0.00050038274],"domain_scores_gemma":[0.9945608,0.00012694972,0.003843072,0.0012591401,0.00002528576,0.00018475002],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0009360198,0.0007379972,0.007769066,0.00026903985,0.00010251166,0.00007876743,0.0005195506,0.00032945003,0.0002234408],"category_scores_gemma":[0.00019022441,0.00063203217,0.0008834851,0.00018150019,0.0002055873,0.00026900618,0.00012233142,0.0002599935,0.00014482567],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000019999463,0.00017286911,0.0010500192,0.00669141,0.00012799336,0.0000017885712,0.00021913092,0.0000015221423,1.5735525e-8,0.0014219087,0.00022071088,0.9900726],"study_design_scores_gemma":[0.0010263575,0.00013327965,0.00121886,0.008234806,0.0001623965,0.0000028141392,0.000003429143,0.000006547633,4.3884393e-7,0.00045641346,0.9882312,0.0005234741],"about_ca_topic_score_codex":0.0019868512,"about_ca_topic_score_gemma":0.00029661853,"teacher_disagreement_score":0.98954916,"about_ca_system_score_codex":0.0015074164,"about_ca_system_score_gemma":0.00039927356,"threshold_uncertainty_score":0.9996131},"labels":[],"label_agreement":null},{"id":"W2734686113","doi":"10.1016/j.ctrv.2017.06.007","title":"Influence of non-measurable disease on progression-free survival in patients with metastatic breast cancer","year":2017,"lang":"en","type":"review","venue":"Cancer Treatment Reviews","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto","funders":"","keywords":"Medicine; Internal medicine; Breast cancer; Metastatic breast cancer; Hazard ratio; Oncology; Chemotherapy; Disease; Cancer; Clinical trial; Confidence interval; Bone disease; Progression-free survival; Osteoporosis","score_opus":0.10435938010052802,"score_gpt":0.45080077233445087,"score_spread":0.34644139223392284,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2734686113","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0034759021,0.9849728,1.5719495e-7,0.00013085893,0.00026879887,0.008935808,0.0018453964,0.00001954846,0.00035073084],"genre_scores_gemma":[0.0005746347,0.9869437,0.000040188017,0.000069540794,0.00015592984,0.010773775,0.00040594596,0.00009857379,0.00093769096],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9965921,0.00029293218,0.0011036473,0.0008870848,0.000589495,0.0005347065],"domain_scores_gemma":[0.99612826,0.00011459163,0.0015464755,0.0016032517,0.0001819851,0.00042544512],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00024155724,0.0010327746,0.005129432,0.0002797805,0.00010453359,0.000023625635,0.00042016397,0.00010481584,0.00036653987],"category_scores_gemma":[0.000042169195,0.00055000704,0.00069905526,0.0003699065,0.00018766646,0.000139573,0.000068542504,0.00031698126,0.000044198998],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010503436,0.0025148448,0.061272908,0.02511811,0.0011149901,0.00013054322,0.000027192144,0.00002160633,9.109906e-8,0.0000016186711,0.0006482729,0.9080995],"study_design_scores_gemma":[0.00817837,0.001308398,0.047277734,0.11829859,0.011438401,0.0000061154956,8.881542e-7,0.000001122491,0.000001474522,0.0000024786864,0.8130292,0.00045719004],"about_ca_topic_score_codex":0.0010542963,"about_ca_topic_score_gemma":0.00046211897,"teacher_disagreement_score":0.9076423,"about_ca_system_score_codex":0.002106648,"about_ca_system_score_gemma":0.002346607,"threshold_uncertainty_score":0.9996951},"labels":[],"label_agreement":null},{"id":"W2746712977","doi":"10.1016/j.ctrv.2017.08.001","title":"Duration of adjuvant trastuzumab in HER2 positive breast cancer: Overall and disease free survival results from meta-analyses of randomized controlled trials","year":2017,"lang":"en","type":"review","venue":"Cancer Treatment Reviews","topic":"HER2/EGFR in Cancer Research","field":"Medicine","cited_by":38,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Manitoba; CancerCare Manitoba","funders":"","keywords":"Medicine; Trastuzumab; Hazard ratio; Internal medicine; Breast cancer; Oncology; Meta-analysis; Confidence interval; Randomized controlled trial; Odds ratio; Cancer","score_opus":0.47897338594908834,"score_gpt":0.54750043717925,"score_spread":0.06852705123016167,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2746712977","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00004872499,0.9494011,0.00000789157,0.00085262785,0.00027655065,0.02342404,0.025623122,0.000011636636,0.0003543205],"genre_scores_gemma":[0.00030028008,0.9814419,0.00011078684,0.000031269057,0.00044620398,0.015462192,0.0013052839,0.00007844279,0.00082362664],"study_design_codex":"design_other","study_design_gemma":"meta_analysis","domain_scores_codex":[0.9792472,0.009826184,0.008294339,0.0011848274,0.0010032282,0.00044422245],"domain_scores_gemma":[0.9821563,0.0056513017,0.009186146,0.002048348,0.00044042105,0.00051751],"candidate_categories":["metaresearch","metaepi_narrow","metaepi_broad"],"consensus_categories":[],"category_scores_codex":[0.009649669,0.0012156424,0.05782837,0.00047758492,0.00007097647,0.00006022476,0.00043848137,0.00030322978,0.0007922301],"category_scores_gemma":[0.010813495,0.00057984336,0.00973872,0.00027016908,0.00040144147,0.00013354835,0.00010179746,0.0003527837,0.000004915592],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.11784868,0.0005336195,0.000043767162,0.012943467,0.055496138,0.00007698745,0.00016730593,0.0000026052244,0.000009114387,0.000015439016,0.00072734983,0.8121355],"study_design_scores_gemma":[0.3648906,0.0002957665,0.000211711,0.061984647,0.36742562,0.0000064001983,0.000009171366,0.000023677314,0.000022696271,0.00007250869,0.20457236,0.00048484092],"about_ca_topic_score_codex":0.03449089,"about_ca_topic_score_gemma":0.0024482424,"teacher_disagreement_score":0.8116507,"about_ca_system_score_codex":0.0016998794,"about_ca_system_score_gemma":0.0042559304,"threshold_uncertainty_score":0.9996653},"labels":[],"label_agreement":null},{"id":"W2749459964","doi":"10.1016/j.ctrv.2017.08.008","title":"Efficacy of extended adjuvant therapy with aromatase inhibitors in early breast cancer among common clinicopathologically-defined subgroups: A systematic review and meta-analysis","year":2017,"lang":"en","type":"review","venue":"Cancer Treatment Reviews","topic":"Breast Cancer Treatment Studies","field":"Biochemistry, Genetics and Molecular Biology","cited_by":24,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; Aromatase; Meta-analysis; Adjuvant; Oncology; Breast cancer; Internal medicine; Cancer; Gynecology; Adjuvant therapy; Aromatase inhibitor","score_opus":0.11892181173949712,"score_gpt":0.40118202484652005,"score_spread":0.28226021310702293,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2749459964","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0004141833,0.9882617,0.0000012899591,0.0000964023,0.00004172661,0.009152141,0.00198551,0.000015554806,0.000031516745],"genre_scores_gemma":[0.0009908328,0.9775837,0.000059899605,0.00012251346,0.000066836605,0.02039818,0.0005660618,0.000083633975,0.00012832458],"study_design_codex":"systematic_review","study_design_gemma":"meta_analysis","domain_scores_codex":[0.99417436,0.0012298187,0.002392582,0.0014585799,0.0002661195,0.00047851994],"domain_scores_gemma":[0.9936645,0.00013245989,0.0036709455,0.0022376715,0.000115524446,0.0001788716],"candidate_categories":["metaepi_narrow","metaepi_broad"],"consensus_categories":["metaepi_narrow"],"category_scores_codex":[0.00067814987,0.0014712373,0.017136978,0.00021508153,0.00012883941,0.000052932628,0.00054022967,0.00034277083,0.000065605826],"category_scores_gemma":[0.000054740016,0.0007225175,0.003527195,0.00052655704,0.00037790052,0.000018474542,0.00016188266,0.00018342929,0.0000047416065],"study_design_candidate":"meta_analysis","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00024613045,0.0014830889,0.0056222775,0.49793282,0.24762839,0.00010263947,0.00014042384,0.0000016777918,0.0000013837598,0.0000038697053,0.00017701424,0.24666029],"study_design_scores_gemma":[0.0018402976,0.0006011141,0.0045995736,0.09084779,0.85398686,0.00005461661,0.0000051074844,1.241993e-7,0.0000058211826,0.0000014725842,0.04717266,0.0008845925],"about_ca_topic_score_codex":0.0015440356,"about_ca_topic_score_gemma":0.0030019318,"teacher_disagreement_score":0.60635847,"about_ca_system_score_codex":0.00027906548,"about_ca_system_score_gemma":0.00027388864,"threshold_uncertainty_score":0.9998037},"labels":[],"label_agreement":null},{"id":"W2750695770","doi":"10.1016/j.ctrv.2017.08.011","title":"The Notch-3 receptor: A molecular switch to tumorigenesis?","year":2017,"lang":"en","type":"review","venue":"Cancer Treatment Reviews","topic":"Developmental Biology and Gene Regulation","field":"Biochemistry, Genetics and Molecular Biology","cited_by":13,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Trinity College","funders":"","keywords":"Notch signaling pathway; Medicine; Receptor; Cancer research; Carcinogenesis; Bioinformatics; Computational biology; Cancer; Internal medicine; Biology","score_opus":0.09881371528737785,"score_gpt":0.4230899546080199,"score_spread":0.32427623932064203,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2750695770","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000032245476,0.99565196,0.000028049546,0.00015168783,0.0008311208,0.0024119813,0.00006261269,0.000010489695,0.0008198717],"genre_scores_gemma":[0.0000052506753,0.9848306,0.0002161804,0.00012936298,0.00048657236,0.0039739134,0.000723215,0.000051845967,0.009583044],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9978922,0.00026729883,0.00061475276,0.0007424701,0.00009826124,0.0003850438],"domain_scores_gemma":[0.9980059,0.000017789482,0.00053162454,0.0012520346,0.00004347493,0.00014913607],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0003193906,0.0006092433,0.0012647416,0.000040541334,0.00043589468,0.00007174287,0.0005926351,0.00032847808,0.000032726373],"category_scores_gemma":[0.00005046664,0.00033235113,0.000760815,0.00009677967,0.00008074549,0.0000027952287,0.00015321592,0.00008313863,0.0005224729],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000011303614,0.000024097975,0.000012397531,0.0005609716,0.0002995062,0.0000023443476,0.0000073054716,2.7999604e-7,0.00026295334,0.000009977202,0.0071904887,0.9916184],"study_design_scores_gemma":[0.0001298596,0.00016807718,0.000007139071,0.0019887746,0.0004122307,0.000011486362,0.0000014076546,3.7906506e-8,0.0011757001,0.0000044883286,0.99571836,0.00038243958],"about_ca_topic_score_codex":0.000022451411,"about_ca_topic_score_gemma":0.00012434165,"teacher_disagreement_score":0.9912359,"about_ca_system_score_codex":0.00025818768,"about_ca_system_score_gemma":0.0004809432,"threshold_uncertainty_score":0.99991286},"labels":[],"label_agreement":null},{"id":"W2757591860","doi":"10.1016/j.ctrv.2017.09.004","title":"Adjuvant therapy in renal cell carcinoma","year":2017,"lang":"en","type":"review","venue":"Cancer Treatment Reviews","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":45,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"","keywords":"Medicine; Renal cell carcinoma; Adjuvant; Immunotherapy; Targeted therapy; Adjuvant therapy; Clinical trial; Disease; Oncology; Kidney cancer; Internal medicine; Cancer","score_opus":0.2687763931843208,"score_gpt":0.4286284167925947,"score_spread":0.15985202360827394,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2757591860","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00021824914,0.978457,5.057671e-7,0.000058729776,0.0003931357,0.009218228,0.000095669544,0.000040128027,0.011518385],"genre_scores_gemma":[0.00006909841,0.9774724,0.00015969825,0.000078648365,0.00066930027,0.008641526,0.0005027533,0.00017657709,0.012229948],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99549353,0.0004271612,0.0016504353,0.0013212136,0.0003489008,0.00075874705],"domain_scores_gemma":[0.99557316,0.00008291657,0.0013359457,0.002541767,0.000056773988,0.00040940646],"candidate_categories":["metaepi_narrow"],"consensus_categories":["metaepi_narrow"],"category_scores_codex":[0.00031363493,0.0015442703,0.008047035,0.000397479,0.00013008274,0.000067415385,0.0004313117,0.00045188563,0.0006554312],"category_scores_gemma":[0.000017877002,0.00086801697,0.002580272,0.00027923743,0.000107833475,0.00008870819,0.00007050765,0.00045804624,0.0007753427],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000050109,0.0005855649,0.0006300577,0.012895914,0.00023003522,0.0010408948,0.00007200338,8.237181e-8,0.0000024984793,0.0000017157827,0.0014890122,0.9830021],"study_design_scores_gemma":[0.0030940797,0.0015894737,0.00039410885,0.028545342,0.0033744036,0.00014693686,0.0000024425299,4.1916596e-7,0.0000711975,0.0000023304572,0.96218896,0.0005902955],"about_ca_topic_score_codex":0.00089456607,"about_ca_topic_score_gemma":0.00016198317,"teacher_disagreement_score":0.9824118,"about_ca_system_score_codex":0.004213388,"about_ca_system_score_gemma":0.0016618968,"threshold_uncertainty_score":0.9997306},"labels":[],"label_agreement":null},{"id":"W2765083464","doi":"10.1016/j.ctrv.2017.09.009","title":"Risk of adverse events with the addition of targeted agents to endocrine therapy in patients with hormone receptor-positive metastatic breast cancer: A systematic review and meta-analysis","year":2017,"lang":"en","type":"review","venue":"Cancer Treatment Reviews","topic":"Advanced Breast Cancer Therapies","field":"Medicine","cited_by":20,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre intégré de santé et de services sociaux de Chaudière-Appalaches; Hôpital Charles-Le Moyne; Université de Sherbrooke","funders":"European Society for Medical Oncology","keywords":"Medicine; Internal medicine; Odds ratio; Meta-analysis; Adverse effect; Oncology; Breast cancer; Cochrane Library; Neutropenia; Randomized controlled trial; Metastatic breast cancer; Relative risk; Confidence interval; Cancer; Chemotherapy","score_opus":0.0726883789844289,"score_gpt":0.3747771327808193,"score_spread":0.30208875379639044,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2765083464","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000090542046,0.9686185,0.000025225369,0.0001662707,0.000017384742,0.022846809,0.008217924,0.000010232986,0.000007124629],"genre_scores_gemma":[0.00022391696,0.9780358,0.00042262246,0.00017166225,0.000018183284,0.02013714,0.00068921933,0.00008564412,0.00021581506],"study_design_codex":"systematic_review","study_design_gemma":"meta_analysis","domain_scores_codex":[0.9952284,0.0012266118,0.0017844525,0.00080374954,0.00058966037,0.00036714002],"domain_scores_gemma":[0.9925276,0.00016617763,0.0050883074,0.001587285,0.0004419337,0.00018870279],"candidate_categories":["metaepi_narrow","metaepi_broad"],"consensus_categories":[],"category_scores_codex":[0.00048788375,0.0010957387,0.015648916,0.00036965543,0.000093853734,0.0000061641476,0.00032355115,0.00006579875,0.00043063663],"category_scores_gemma":[0.000042604534,0.00044194935,0.0018175436,0.0012396018,0.00016138752,0.00015899238,0.000045064935,0.0002228163,0.0000062035347],"study_design_candidate":"meta_analysis","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00070292375,0.00072163175,0.0007300777,0.37820297,0.36760175,0.000009038443,0.0002733438,0.00001568837,2.0077094e-7,9.80349e-7,0.000067132656,0.25167426],"study_design_scores_gemma":[0.0026087298,0.0012816519,0.002086985,0.13584504,0.8169974,0.0000131993,0.000016263983,4.1214065e-7,0.0000017280817,6.348132e-7,0.040767472,0.0003805084],"about_ca_topic_score_codex":0.000958985,"about_ca_topic_score_gemma":0.0003710978,"teacher_disagreement_score":0.44939563,"about_ca_system_score_codex":0.00090267323,"about_ca_system_score_gemma":0.00033459658,"threshold_uncertainty_score":0.99980325},"labels":[],"label_agreement":null},{"id":"W2766249538","doi":"10.1016/j.ctrv.2017.10.008","title":"Epidermal growth factor receptor overexpression and outcomes in early breast cancer: A systematic review and a meta-analysis","year":2017,"lang":"en","type":"review","venue":"Cancer Treatment Reviews","topic":"HER2/EGFR in Cancer Research","field":"Medicine","cited_by":94,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto; Queen's University","funders":"","keywords":"Medicine; Breast cancer; Meta-analysis; Oncology; Internal medicine; Hazard ratio; Epidermal growth factor receptor; Triple-negative breast cancer; Cancer; Confidence interval","score_opus":0.32236565591717875,"score_gpt":0.5041202922561302,"score_spread":0.18175463633895145,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2766249538","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000006651663,0.97820026,8.367237e-7,0.0013668993,0.00006148267,0.017806368,0.0024364323,0.000031245814,0.000089806366],"genre_scores_gemma":[0.000007292761,0.96470547,0.00008495149,0.00037747985,0.00008933402,0.030236052,0.00010595271,0.00011125501,0.0042821863],"study_design_codex":"systematic_review","study_design_gemma":"meta_analysis","domain_scores_codex":[0.99280524,0.0016612367,0.0026573185,0.0015195826,0.0006371269,0.00071948336],"domain_scores_gemma":[0.9946604,0.0003957934,0.0021149504,0.0020544343,0.00016576558,0.0006086987],"candidate_categories":["metaepi_narrow","metaepi_broad","insufficient_payload"],"consensus_categories":["metaepi_narrow"],"category_scores_codex":[0.0010962108,0.001472753,0.030140743,0.00058743684,0.0001625536,0.00015742579,0.00043670813,0.00037335436,0.0018299973],"category_scores_gemma":[0.00035206173,0.0007323931,0.0041800495,0.0007199388,0.00017203004,0.00021367421,0.00020421104,0.0005747667,0.00007104022],"study_design_candidate":"systematic_review","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000008178262,0.000107152664,0.0014978306,0.80705434,0.06959364,0.000033357635,0.00006668424,8.148913e-9,1.2342805e-7,0.0000024501142,0.0005209585,0.121115275],"study_design_scores_gemma":[0.00035751206,0.0000827144,0.00019968893,0.24757078,0.4791995,0.00004137371,0.0000014592857,3.0185737e-7,2.6085831e-7,8.3320344e-7,0.27218488,0.00036069832],"about_ca_topic_score_codex":0.004465402,"about_ca_topic_score_gemma":0.0005112851,"teacher_disagreement_score":0.5594836,"about_ca_system_score_codex":0.0019088265,"about_ca_system_score_gemma":0.0008059929,"threshold_uncertainty_score":0.9998022},"labels":[],"label_agreement":null},{"id":"W2768374708","doi":"10.1016/j.ctrv.2017.10.015","title":"The lymphatics in infiltrating ductal carcinoma (IDC) of the breast","year":2017,"lang":"en","type":"letter","venue":"Cancer Treatment Reviews","topic":"Cancer, Hypoxia, and Metabolism","field":"Biochemistry, Genetics and Molecular Biology","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute of Population and Public Health; University of British Columbia; University of Victoria","funders":"","keywords":"Medicine; Breast cancer; Ductal carcinoma; Lymphatic system; Invasive ductal carcinoma; Cancer; Carcinoma; Confusion; Oncology; Pathology; Hypoxia (environmental); CA15-3; Internal medicine","score_opus":0.028384465867645762,"score_gpt":0.29382892564442187,"score_spread":0.2654444597767761,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2768374708","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.032744892,0.8861214,0.0000037237785,0.068904445,0.005871883,0.002519292,0.0005449243,0.000006660843,0.003282774],"genre_scores_gemma":[0.020160884,0.85459894,0.00013777844,0.05777034,0.03875891,0.0026112725,0.0006135241,0.00017511673,0.025173254],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.998387,0.0001989174,0.0005110258,0.00040135704,0.00015996564,0.00034175752],"domain_scores_gemma":[0.99776596,0.00002242834,0.0007139995,0.0014061212,0.000057468835,0.000034039054],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00018538568,0.00038181123,0.00061393384,0.000022166832,0.00020517547,0.00004792362,0.00061616715,0.00031659662,0.000015125633],"category_scores_gemma":[0.00004571776,0.0001939095,0.0004650826,0.00006275296,0.00021420854,0.0000038775825,0.00011058642,0.00020919868,0.0000036926322],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000027949276,0.00004794795,0.00860538,0.00032546138,0.00021310245,0.000009413444,0.0001416015,0.0000037225961,0.0047977,0.000007822818,0.775442,0.2103779],"study_design_scores_gemma":[0.0005178832,0.000047801903,0.0025586528,0.00025920305,0.00019763234,0.000058920934,0.000008485188,0.0000014815895,0.0022159049,0.0000092831015,0.993928,0.00019676515],"about_ca_topic_score_codex":0.0008574164,"about_ca_topic_score_gemma":0.0011471282,"teacher_disagreement_score":0.218486,"about_ca_system_score_codex":0.00014422995,"about_ca_system_score_gemma":0.0005194132,"threshold_uncertainty_score":0.79073995},"labels":[],"label_agreement":null},{"id":"W2769738013","doi":"10.1016/j.ctrv.2017.11.005","title":"Balancing the benefits and harms of thyroid cancer surveillance in survivors of Childhood, adolescent and young adult cancer: Recommendations from the international Late Effects of Childhood Cancer Guideline Harmonization Group in collaboration with the PanCareSurFup Consortium","year":2017,"lang":"en","type":"review","venue":"Cancer Treatment Reviews","topic":"Thyroid Cancer Diagnosis and Treatment","field":"Medicine","cited_by":136,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"SickKids Foundation; Hospital for Sick Children; University of Toronto","funders":"KWF Kankerbestrijding","keywords":"Medicine; Guideline; Thyroid cancer; Harmonization; Family medicine; Cancer; Multidisciplinary approach; Thyroid nodules; Thyroid; Pathology; Internal medicine","score_opus":0.029434177617291103,"score_gpt":0.3322134058633581,"score_spread":0.302779228246067,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2769738013","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.02615142,0.9607528,0.000004323132,0.004385589,0.00056054496,0.005745116,0.002377015,0.000008155098,0.000015049435],"genre_scores_gemma":[0.04033146,0.9530977,0.000045805486,0.00023672199,0.00022729005,0.0054405807,0.00054182956,0.000053360913,0.00002523518],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99677867,0.000457202,0.00148218,0.00064984796,0.00035681628,0.00027526467],"domain_scores_gemma":[0.99595594,0.00041596193,0.0024484822,0.0007347655,0.00037017514,0.000074654],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0004958872,0.0006189259,0.0023648608,0.00011781367,0.0001456548,0.00005250156,0.00033045825,0.00014305487,0.00003389689],"category_scores_gemma":[0.00010205799,0.0002846683,0.00022093259,0.00050314923,0.00021228539,0.00012546276,0.00008953101,0.0002739456,3.3628245e-7],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000071723785,0.00034922658,0.23710352,0.0021079516,0.00089688215,0.0000027517935,0.0014071163,0.00007463478,0.000009516299,0.00001697167,0.0008794349,0.75708026],"study_design_scores_gemma":[0.008627221,0.00053273264,0.5049632,0.13166265,0.005095669,0.000009961576,0.00031188244,0.000089192676,0.00028633163,0.0000063989114,0.34779593,0.00061879837],"about_ca_topic_score_codex":0.062732935,"about_ca_topic_score_gemma":0.28051144,"teacher_disagreement_score":0.75646144,"about_ca_system_score_codex":0.00093357736,"about_ca_system_score_gemma":0.000847747,"threshold_uncertainty_score":0.99996054},"labels":[],"label_agreement":null},{"id":"W2771905132","doi":"10.1016/j.ctrv.2017.12.003","title":"Multi-agent chemotherapy in advanced soft tissue sarcoma (STS) – A systematic review and meta-analysis","year":2017,"lang":"en","type":"review","venue":"Cancer Treatment Reviews","topic":"Sarcoma Diagnosis and Treatment","field":"Medicine","cited_by":25,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto","funders":"","keywords":"Medicine; Anthracycline; Internal medicine; Hazard ratio; Meta-analysis; Chemotherapy; Oncology; Doxorubicin; Randomized controlled trial; Soft tissue sarcoma; Confidence interval; Surgery; Cancer; Soft tissue; Breast cancer","score_opus":0.266840350468161,"score_gpt":0.4779336853555634,"score_spread":0.2110933348874024,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2771905132","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[5.308921e-7,0.9730789,0.0000072499793,0.00056844344,0.000054761003,0.025965715,0.00020621688,0.000039243998,0.00007894149],"genre_scores_gemma":[0.0000017955998,0.9431126,0.0009823177,0.00090333045,0.00004071654,0.050825927,0.000295981,0.000113742695,0.0037235594],"study_design_codex":"systematic_review","study_design_gemma":"meta_analysis","domain_scores_codex":[0.99428433,0.00075489597,0.0026373619,0.0014467081,0.00032797176,0.00054872024],"domain_scores_gemma":[0.99416935,0.0002244576,0.0023280033,0.0028454978,0.00007719735,0.00035551013],"candidate_categories":["metaepi_narrow","metaepi_broad"],"consensus_categories":["metaepi_narrow"],"category_scores_codex":[0.000680775,0.0016407146,0.03153847,0.00044656245,0.00012860721,0.00008012321,0.0003496219,0.00026942138,0.00089202164],"category_scores_gemma":[0.00012097191,0.0008377879,0.0064738877,0.0006768291,0.000080174155,0.0000991994,0.00006882132,0.0002374406,0.00021809219],"study_design_candidate":"systematic_review","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0000028720951,0.0006003014,0.00003284082,0.48339027,0.105996884,0.00013918719,0.00002906937,6.6801285e-8,2.9704344e-8,9.567634e-7,0.0001006542,0.40970686],"study_design_scores_gemma":[0.0006953026,0.000095243246,0.000010619634,0.09834196,0.45398495,0.000041434843,0.0000012103582,6.313386e-7,4.4869057e-7,2.7457492e-7,0.44655034,0.00027761149],"about_ca_topic_score_codex":0.0003091203,"about_ca_topic_score_gemma":0.000469531,"teacher_disagreement_score":0.44644967,"about_ca_system_score_codex":0.0015180032,"about_ca_system_score_gemma":0.00027777438,"threshold_uncertainty_score":0.999634},"labels":[],"label_agreement":null},{"id":"W2774652621","doi":"10.1016/j.ctrv.2017.12.006","title":"Staging and surgical approaches in gastric cancer: A systematic review","year":2017,"lang":"en","type":"review","venue":"Cancer Treatment Reviews","topic":"Gastric Cancer Management and Outcomes","field":"Medicine","cited_by":114,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Hotel Dieu Hospital; Princess Margaret Cancer Centre; Ottawa Hospital; Grand River Hospital; Humber River Regional Hospital; McMaster University; Juravinski Cancer Centre; Sunnybrook Health Science Centre","funders":"Ontario Ministry of Health and Long-Term Care","keywords":"Medicine; Cancer; MEDLINE; Intensive care medicine; General surgery; Oncology; Internal medicine","score_opus":0.3244429439331436,"score_gpt":0.4413542188612157,"score_spread":0.11691127492807207,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2774652621","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[7.200285e-7,0.9822517,0.0000014020967,0.00035603455,0.00020722052,0.01562195,0.00004662834,0.000039155337,0.0014752074],"genre_scores_gemma":[6.08858e-7,0.97500145,0.00006277331,0.00014279691,0.00027779548,0.017843915,0.0001156705,0.000074587886,0.006480382],"study_design_codex":"systematic_review","study_design_gemma":"not_applicable","domain_scores_codex":[0.99591374,0.00039759878,0.00188908,0.00094069523,0.00030335333,0.0005555143],"domain_scores_gemma":[0.9967219,0.00012343684,0.0015804046,0.001296663,0.000026957518,0.0002506132],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0007707582,0.0010221147,0.011710049,0.00037246366,0.00010486843,0.00008722866,0.0003077512,0.00017136823,0.00018027473],"category_scores_gemma":[0.000084453066,0.0005861119,0.0012316152,0.00050670205,0.00008357386,0.000108644825,0.00012346651,0.00032740907,0.00004834227],"study_design_candidate":"systematic_review","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0000027785986,0.000042806005,0.0002609055,0.50393337,0.00031602234,0.00011072264,0.000012294243,2.1474259e-8,5.6832944e-10,0.0000066575567,0.00045149642,0.49486288],"study_design_scores_gemma":[0.00054819183,0.0000542899,0.000010184585,0.47042462,0.013766697,0.000075927754,0.0000031277928,0.0000012063186,7.0466126e-9,5.543902e-7,0.51490694,0.00020823702],"about_ca_topic_score_codex":0.00039771508,"about_ca_topic_score_gemma":0.00013623803,"teacher_disagreement_score":0.5144555,"about_ca_system_score_codex":0.0018851442,"about_ca_system_score_gemma":0.0005287182,"threshold_uncertainty_score":0.999659},"labels":[],"label_agreement":null},{"id":"W2792893181","doi":"10.1016/j.ctrv.2018.02.005","title":"Breaking the biomarker code: PD-L1 expression and checkpoint inhibition in advanced NSCLC","year":2018,"lang":"en","type":"review","venue":"Cancer Treatment Reviews","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":66,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; Juravinski Cancer Centre; Montreal General Hospital; University of British Columbia; Royal Victoria Regional Health Centre; University of Alberta; Royal Victoria Hospital; University Health Network; University of Toronto; McMaster University; Princess Margaret Cancer Centre; BC Cancer Agency","funders":"Pfizer Canada; Merck Canada; Pfizer; AstraZeneca Canada; Roche Canada","keywords":"Medicine; Biomarker; Cancer research; Oncology; Code (set theory); Internal medicine; Programming language; Genetics","score_opus":0.10290617840553892,"score_gpt":0.40395395192761063,"score_spread":0.3010477735220717,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2792893181","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00021824615,0.9929266,0.0000085388,0.0002429334,0.00037108845,0.0051717455,0.00006974222,0.00003595784,0.0009551559],"genre_scores_gemma":[0.000035372992,0.99448174,0.00014983796,0.00027597597,0.00031350448,0.0036537277,0.00019102979,0.00007360683,0.00082519435],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99710435,0.00035007257,0.0011939877,0.0007681575,0.00020208655,0.00038135724],"domain_scores_gemma":[0.99821085,0.00010000681,0.00076205283,0.0007768578,0.000040887797,0.00010933647],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.000580113,0.00072695606,0.0024075822,0.00017985326,0.00013650913,0.00004534029,0.00009766691,0.00027921182,0.00032354638],"category_scores_gemma":[0.000028893512,0.00035384714,0.0007782033,0.00051684276,0.00020212684,0.000100860234,0.00006082692,0.0002258466,0.000043108874],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000289136,0.000107256696,0.000022901986,0.007787736,0.00018352905,0.000024949102,0.00014113549,1.6398824e-8,0.00016144449,0.0000013479729,0.00164223,0.9896383],"study_design_scores_gemma":[0.002060945,0.00024468402,0.00010531505,0.112412915,0.0010918559,0.00013194238,0.000015607951,0.0000013711496,0.0001194727,0.0000041228855,0.88350916,0.00030260114],"about_ca_topic_score_codex":0.00019168387,"about_ca_topic_score_gemma":0.000235042,"teacher_disagreement_score":0.9893357,"about_ca_system_score_codex":0.0014006749,"about_ca_system_score_gemma":0.00033925567,"threshold_uncertainty_score":0.99989134},"labels":[],"label_agreement":null},{"id":"W2795044371","doi":"10.1016/j.ctrv.2018.03.006","title":"Outlooks on Epstein-Barr virus associated gastric cancer","year":2018,"lang":"en","type":"review","venue":"Cancer Treatment Reviews","topic":"Viral-associated cancers and disorders","field":"Medicine","cited_by":216,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; St. Michael's Hospital","funders":"National Cancer Institute","keywords":"Medicine; Immunotherapy; Cancer; Epstein–Barr virus; Cancer research; Carcinogenesis; Immunology; Biomarker; Immune system; Immune checkpoint; Epstein–Barr virus infection; Virus; Cancer immunotherapy; Internal medicine; Biology; Genetics","score_opus":0.09538164567364876,"score_gpt":0.3900547197652027,"score_spread":0.2946730740915539,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2795044371","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000015277728,0.9820894,0.0000035718278,0.0001722871,0.0014868898,0.005574851,0.00093120965,0.00017235639,0.009554145],"genre_scores_gemma":[0.0000042946326,0.9722706,0.000040614465,0.0010943111,0.0013241725,0.0077929697,0.0006794375,0.00024247293,0.016551105],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9948725,0.00047844285,0.0016291775,0.0014006965,0.0005565354,0.0010626321],"domain_scores_gemma":[0.99618584,0.00013641013,0.0017944645,0.0012087553,0.0001614966,0.0005130048],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":["metaepi_narrow","insufficient_payload"],"category_scores_codex":[0.00036406802,0.0016172468,0.0067387004,0.00036121733,0.00023832452,0.000068241614,0.00034204294,0.0008137396,0.00265575],"category_scores_gemma":[0.00018467946,0.0010307326,0.002759887,0.0010558537,0.00013691216,0.000064392145,0.00005147543,0.00059160386,0.0015286625],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000048488502,0.0005063447,0.00009929317,0.006322964,0.0020227558,0.00004431556,0.00007732822,5.27491e-7,4.0973956e-7,0.000010155577,0.0604474,0.93042004],"study_design_scores_gemma":[0.0021221228,0.0015201207,0.00001647715,0.06884581,0.012723165,0.00000896792,0.0000083505165,0.0000014948453,0.0000039028655,0.000013327094,0.91400284,0.0007334422],"about_ca_topic_score_codex":0.0018108712,"about_ca_topic_score_gemma":0.00095751527,"teacher_disagreement_score":0.9296866,"about_ca_system_score_codex":0.009810374,"about_ca_system_score_gemma":0.0022784718,"threshold_uncertainty_score":0.9996575},"labels":[],"label_agreement":null},{"id":"W2800540552","doi":"10.1016/j.ctrv.2018.04.005","title":"Molecular analyses in the diagnosis and prediction of prognosis in non-GIST soft tissue sarcomas: A systematic review and meta-analysis","year":2018,"lang":"en","type":"review","venue":"Cancer Treatment Reviews","topic":"Sarcoma Diagnosis and Treatment","field":"Medicine","cited_by":13,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Hospital; McMaster University; Juravinski Cancer Centre; Cancer Care Ontario; Mount Sinai Hospital","funders":"","keywords":"Medicine; Liposarcoma; Soft tissue sarcoma; Hazard ratio; Internal medicine; Sarcoma; Confidence interval; Oncology; Meta-analysis; Fluorescence in situ hybridization; GiST; Pathogenesis; Pathology; Synovial sarcoma; Stromal cell; Gene; Genetics","score_opus":0.2435051499371978,"score_gpt":0.4562480861357726,"score_spread":0.21274293619857482,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2800540552","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000034567445,0.9802403,0.0000031872316,0.0003525009,0.000014281421,0.019009132,0.0002921169,0.000009728026,0.00004417447],"genre_scores_gemma":[0.0003269194,0.93215907,0.00012051446,0.0002778844,0.000022032827,0.066801675,0.00021813408,0.000039776885,0.000033979086],"study_design_codex":"systematic_review","study_design_gemma":"meta_analysis","domain_scores_codex":[0.99467456,0.0012971093,0.0024706428,0.0009027224,0.00034770783,0.000307282],"domain_scores_gemma":[0.99689347,0.000491242,0.0013348041,0.0010764353,0.00007881423,0.00012523634],"candidate_categories":["metaepi_narrow","metaepi_broad"],"consensus_categories":[],"category_scores_codex":[0.0009512172,0.00091275503,0.015264798,0.00061037834,0.000045997564,0.00004048424,0.00019361333,0.00018694016,0.0001200624],"category_scores_gemma":[0.0001517561,0.0004100084,0.0026224009,0.002069379,0.00013348744,0.00006556649,0.000052758773,0.00016063968,0.00000855847],"study_design_candidate":"systematic_review","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0000029773091,0.001066847,0.002739771,0.8169187,0.09329291,0.00013564709,0.00016169035,2.1736837e-7,9.4858606e-8,0.0000033060999,0.00020389176,0.08547396],"study_design_scores_gemma":[0.00035527674,0.000340585,0.00025395968,0.13359584,0.78867465,0.000048671096,0.00001490727,0.0000022799147,0.0000043380787,0.0000018118066,0.076513894,0.00019379015],"about_ca_topic_score_codex":0.0008325885,"about_ca_topic_score_gemma":0.0005344419,"teacher_disagreement_score":0.69538176,"about_ca_system_score_codex":0.00043877822,"about_ca_system_score_gemma":0.0001119758,"threshold_uncertainty_score":0.9998352},"labels":[],"label_agreement":null},{"id":"W2800630992","doi":"10.1016/j.ctrv.2018.04.014","title":"The role of bisphosphonates or denosumab in light of the availability of new therapies for prostate cancer","year":2018,"lang":"en","type":"review","venue":"Cancer Treatment Reviews","topic":"Bone health and treatments","field":"Medicine","cited_by":45,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre Hospitalier de l’Université de Montréal","funders":"Amgen","keywords":"Denosumab; Medicine; Cabazitaxel; Enzalutamide; Abiraterone acetate; Prostate cancer; Radium-223; Zoledronic acid; Oncology; Clinical trial; Docetaxel; Internal medicine; Bisphosphonate; Osteonecrosis of the jaw; Cancer; Osteoporosis; Bone metastasis; Androgen deprivation therapy; Androgen receptor","score_opus":0.08337314094360428,"score_gpt":0.41182926513150525,"score_spread":0.328456124187901,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2800630992","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00024563496,0.98690844,1.8136988e-7,0.00029279414,0.00026955383,0.011781036,0.0003131099,0.0000063202956,0.00018292028],"genre_scores_gemma":[0.000057065346,0.9864556,0.00011957268,0.000033255328,0.00006059833,0.005991103,0.000027444596,0.000047539677,0.0072077783],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9970464,0.00021639714,0.0017458249,0.00042678267,0.00020792938,0.0003566815],"domain_scores_gemma":[0.9966249,0.0002903943,0.0017817573,0.0010282997,0.00016337931,0.00011130259],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00037463597,0.0005155046,0.0033418762,0.000060317503,0.000078231766,0.0000055433047,0.00025807717,0.00017236354,0.00014492762],"category_scores_gemma":[0.00009846208,0.00018141189,0.0009784553,0.0004923041,0.00020855328,0.000029907498,0.000040417748,0.00011670561,0.00000554395],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00036380588,0.00032675758,0.0066348454,0.023207068,0.0006620553,4.5579353e-7,0.000541828,4.1093408e-8,0.0000011381933,0.000014424522,0.00104517,0.9672024],"study_design_scores_gemma":[0.0016372295,0.00076551497,0.0004030535,0.031848494,0.0026449487,0.0000028374268,0.00002184525,5.001652e-7,0.0005293079,0.00007641355,0.96195084,0.000119017954],"about_ca_topic_score_codex":0.0071065687,"about_ca_topic_score_gemma":0.00894656,"teacher_disagreement_score":0.9670834,"about_ca_system_score_codex":0.00079590164,"about_ca_system_score_gemma":0.0034406232,"threshold_uncertainty_score":0.9995052},"labels":[],"label_agreement":null},{"id":"W2803396907","doi":"10.1016/j.ctrv.2018.05.007","title":"Tumor necrosis and clinical outcomes following neoadjuvant therapy in soft tissue sarcoma: A systematic review and meta-analysis","year":2018,"lang":"en","type":"review","venue":"Cancer Treatment Reviews","topic":"Sarcoma Diagnosis and Treatment","field":"Medicine","cited_by":63,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; Hazard ratio; Internal medicine; Radiation therapy; Meta-analysis; Odds ratio; Soft tissue sarcoma; Necrosis; Neoadjuvant therapy; Oncology; Chemotherapy; Surgery; Confidence interval; Soft tissue; Cancer","score_opus":0.2316832925001087,"score_gpt":0.4804624741231427,"score_spread":0.248779181623034,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2803396907","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000019105077,0.98158634,0.0000019193258,0.0005288577,0.00008673122,0.01760275,0.000104483835,0.000036460988,0.000033350654],"genre_scores_gemma":[0.000013446304,0.9828907,0.00040462817,0.0017005678,0.000048193513,0.0140601015,0.00013862942,0.00009225336,0.0006514418],"study_design_codex":"systematic_review","study_design_gemma":"meta_analysis","domain_scores_codex":[0.9929542,0.0013173321,0.003427496,0.0014758338,0.0003250482,0.0005001069],"domain_scores_gemma":[0.99556,0.0008605059,0.0015511556,0.0015793443,0.00005787982,0.00039113572],"candidate_categories":["metaepi_narrow","metaepi_broad"],"consensus_categories":["metaepi_narrow"],"category_scores_codex":[0.0014956822,0.0014435885,0.03330522,0.00031052338,0.0001120384,0.000083952145,0.00020266035,0.00024289888,0.0005989264],"category_scores_gemma":[0.00019666133,0.00068671786,0.009382179,0.0008041339,0.00012338298,0.00007877384,0.000087495464,0.00024793658,0.00012282492],"study_design_candidate":"meta_analysis","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0000033395497,0.00074178405,0.005749935,0.370235,0.25312144,0.00025471588,0.000046327972,4.336411e-9,3.0995504e-9,0.0000015329726,0.00033612462,0.36950982],"study_design_scores_gemma":[0.00084860146,0.00035158504,0.000283094,0.0759152,0.6164098,0.000039604696,0.0000027477424,3.1518638e-7,5.1594554e-8,0.0000026966388,0.30582216,0.00032416408],"about_ca_topic_score_codex":0.00077806396,"about_ca_topic_score_gemma":0.00064735214,"teacher_disagreement_score":0.36918566,"about_ca_system_score_codex":0.00050486467,"about_ca_system_score_gemma":0.00022428727,"threshold_uncertainty_score":0.9998314},"labels":[],"label_agreement":null},{"id":"W2805329954","doi":"10.1016/j.ctrv.2018.05.017","title":"Chemotherapy and cognition: International cognition and cancer task force recommendations for harmonising preclinical research","year":2018,"lang":"en","type":"review","venue":"Cancer Treatment Reviews","topic":"Cancer-related cognitive impairment studies","field":"Medicine","cited_by":58,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Trent University; Baycrest Hospital; University of Toronto","funders":"Canadian Institutes of Health Research; National Institutes of Health; Institut National Du Cancer; Institut de France; Ligue Contre le Cancer; Indonesia Climate Change Trust Fund","keywords":"Medicine; Cognition; Neurochemical; Disease; Task force; Affect (linguistics); Clinical trial; Cancer; Mechanism (biology); Psychiatry; Pathology; Psychology; Internal medicine","score_opus":0.4277431736626132,"score_gpt":0.5675078931782638,"score_spread":0.13976471951565056,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2805329954","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0000109032335,0.9818776,0.000082112936,0.0051477496,0.0007675488,0.009736363,0.0011949354,0.000046641122,0.0011361438],"genre_scores_gemma":[0.000007553807,0.9721251,0.0007056417,0.00061329943,0.002087378,0.01951368,0.0013471653,0.00008995887,0.0035102386],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9969693,0.00029572815,0.0010356422,0.0009903905,0.00027237638,0.0004365835],"domain_scores_gemma":[0.99755144,0.00077375927,0.0005549203,0.00027713267,0.000628813,0.00021392427],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0007746728,0.0005875832,0.0021190015,0.00028169996,0.00043520427,0.00009868649,0.000096118376,0.00028420874,0.00054955174],"category_scores_gemma":[0.00024371379,0.00042755314,0.00047029016,0.0003223921,0.00043206234,0.000139338,0.00008176956,0.000369112,0.000033171018],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0001579014,0.00019014059,0.000033826323,0.0066056494,0.0018130003,0.0000022350434,0.00015126634,5.0689377e-9,0.000001835565,0.000007487403,0.030831514,0.96020514],"study_design_scores_gemma":[0.003378221,0.00089167815,0.000019847746,0.058695532,0.006393487,0.000047070505,0.000037261987,0.0000070661968,0.000015022411,0.00011106321,0.9300855,0.00031827102],"about_ca_topic_score_codex":0.000059009726,"about_ca_topic_score_gemma":0.00007975298,"teacher_disagreement_score":0.95988685,"about_ca_system_score_codex":0.0011850939,"about_ca_system_score_gemma":0.00051464775,"threshold_uncertainty_score":0.9998176},"labels":[],"label_agreement":null},{"id":"W2810728079","doi":"10.1016/j.ctrv.2018.07.001","title":"Tobacco smoking and survival after a prostate cancer diagnosis: A systematic review and meta-analysis","year":2018,"lang":"en","type":"review","venue":"Cancer Treatment Reviews","topic":"Prostate Cancer Diagnosis and Treatment","field":"Medicine","cited_by":57,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"National Health and Medical Research Council; Medical Research Council","keywords":"Medicine; Prostate cancer; Meta-analysis; Hazard ratio; Oncology; Internal medicine; Cancer; Population; Systematic review; MEDLINE; Confidence interval; Environmental health","score_opus":0.14158501726053063,"score_gpt":0.4087204551280374,"score_spread":0.26713543786750676,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2810728079","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0000064637625,0.9747683,6.640818e-7,0.000715645,0.0001325863,0.022359513,0.0018940436,0.00005611393,0.000066664674],"genre_scores_gemma":[0.0000040888885,0.7459623,0.000057757647,0.0010457331,0.00012362847,0.25125775,0.0002046375,0.00010569792,0.0012383716],"study_design_codex":"systematic_review","study_design_gemma":"meta_analysis","domain_scores_codex":[0.9939088,0.0008192787,0.002423859,0.0018004935,0.00036876698,0.00067879574],"domain_scores_gemma":[0.99571604,0.00026513435,0.0017561067,0.001534121,0.00018867529,0.0005399561],"candidate_categories":["metaepi_narrow","metaepi_broad","insufficient_payload"],"consensus_categories":["metaepi_narrow"],"category_scores_codex":[0.00076380925,0.001818398,0.024271686,0.00035405066,0.00014483056,0.00014968545,0.00016951982,0.0002715423,0.0015797329],"category_scores_gemma":[0.000069074384,0.00092061405,0.004966446,0.0011797423,0.0001782245,0.00014996197,0.00014003084,0.0002513933,0.000047069203],"study_design_candidate":"systematic_review","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000008527064,0.00016897042,0.00095374836,0.6427988,0.25710747,0.00007442625,0.000086345346,1.5938857e-8,1.2999075e-9,0.0000027420747,0.00067154155,0.09812745],"study_design_scores_gemma":[0.00027454153,0.00017949777,0.000015432399,0.15225708,0.4589887,0.000019491643,0.0000028429722,7.892785e-8,2.1118974e-7,0.0000012296898,0.38792458,0.0003362927],"about_ca_topic_score_codex":0.00066183327,"about_ca_topic_score_gemma":0.00086058956,"teacher_disagreement_score":0.4905417,"about_ca_system_score_codex":0.0015637967,"about_ca_system_score_gemma":0.00044457763,"threshold_uncertainty_score":0.9994561},"labels":[],"label_agreement":null},{"id":"W2810974217","doi":"10.1016/j.ctrv.2018.06.015","title":"Optimal sequence of adjuvant endocrine and radiation therapy in early-stage breast cancer – A systematic review","year":2018,"lang":"en","type":"review","venue":"Cancer Treatment Reviews","topic":"Breast Cancer Treatment Studies","field":"Biochemistry, Genetics and Molecular Biology","cited_by":23,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University; Ottawa Hospital; University of Ottawa","funders":"","keywords":"Medicine; Tamoxifen; Breast cancer; Oncology; Internal medicine; Radiation therapy; Randomized controlled trial; Aromatase inhibitor; Adjuvant therapy; Cancer; Clinical trial","score_opus":0.056386258084545435,"score_gpt":0.37534734821830956,"score_spread":0.3189610901337641,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2810974217","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00017350566,0.9917545,0.0000019303664,0.00006321334,0.00014795286,0.006297449,0.0015195162,0.000010257103,0.000031725518],"genre_scores_gemma":[0.00003909337,0.9863636,0.00006584525,0.000112140726,0.00024558642,0.012421473,0.00037804825,0.00007128779,0.00030296243],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99663943,0.00049627194,0.001406887,0.0008936961,0.00017333633,0.00039038705],"domain_scores_gemma":[0.99755275,0.000039733306,0.0013468489,0.00085271476,0.00010101253,0.00010693145],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00026592033,0.0008907357,0.0046428023,0.0001088496,0.000055219178,0.000018067545,0.0002681045,0.00017001282,0.00006583907],"category_scores_gemma":[0.00003190906,0.0005543125,0.00064808497,0.0003233538,0.000158882,0.000012396851,0.0000930986,0.000099443176,0.000012585729],"study_design_candidate":"systematic_review","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000025276913,0.00012281576,0.0004973066,0.48570934,0.0009433702,0.000009031005,0.00005553632,4.655485e-7,0.0000062781783,0.0000023651996,0.00028754212,0.51234066],"study_design_scores_gemma":[0.0007427321,0.00028225573,0.00012327846,0.39045715,0.002783811,0.000060109007,0.0000036093347,5.0422693e-7,0.00003009568,3.8076791e-7,0.60510343,0.00041263117],"about_ca_topic_score_codex":0.0012358832,"about_ca_topic_score_gemma":0.00029896482,"teacher_disagreement_score":0.6048159,"about_ca_system_score_codex":0.00055152184,"about_ca_system_score_gemma":0.00040769068,"threshold_uncertainty_score":0.99969083},"labels":[],"label_agreement":null},{"id":"W2883475115","doi":"10.1016/j.ctrv.2018.07.011","title":"Risk factors for loco-regional recurrence after radical cystectomy of muscle-invasive bladder cancer: A systematic-review and framework for adjuvant radiotherapy","year":2018,"lang":"en","type":"review","venue":"Cancer Treatment Reviews","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":42,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Hospital","funders":"National Cancer Institute","keywords":"Medicine; Cystectomy; Bladder cancer; Lymph node; Dissection (medical); Radiation therapy; Systematic review; Oncology; Perioperative; Pathological; Cancer; Internal medicine; MEDLINE; Surgery","score_opus":0.07949940888877625,"score_gpt":0.4023044407904984,"score_spread":0.3228050319017221,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2883475115","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00001304567,0.948265,0.0008738855,0.00015003596,0.000490484,0.04454029,0.005614276,0.000042110194,0.0000108460035],"genre_scores_gemma":[0.0000035295272,0.8992466,0.0034455128,0.00051453966,0.0007463769,0.095189326,0.00037762919,0.00018827041,0.00028824445],"study_design_codex":"systematic_review","study_design_gemma":"not_applicable","domain_scores_codex":[0.9946704,0.00048694623,0.0023709822,0.0014005837,0.0003769348,0.00069416576],"domain_scores_gemma":[0.9941735,0.0013279574,0.0024668686,0.0012526801,0.00031715268,0.00046183384],"candidate_categories":["metaepi_narrow"],"consensus_categories":["metaepi_narrow"],"category_scores_codex":[0.0004353145,0.0015814713,0.011643741,0.00020176043,0.00015441666,0.000034764376,0.0003228933,0.0005632871,0.00047180572],"category_scores_gemma":[0.0003702574,0.00088430784,0.0030159107,0.00041574228,0.0003483443,0.00009043456,0.00003617466,0.00029263375,0.000011617458],"study_design_candidate":"systematic_review","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00011206572,0.00025523713,0.00008911512,0.67679816,0.004652804,0.000004113327,0.00022419676,2.7631641e-8,1.4800281e-7,0.000012643445,0.0022538442,0.31559765],"study_design_scores_gemma":[0.0015285678,0.0012144273,0.000009799497,0.42198175,0.052568994,0.000020819558,0.000007693232,9.295117e-7,0.0000038876096,0.000022433967,0.5222317,0.00040901947],"about_ca_topic_score_codex":0.00028659627,"about_ca_topic_score_gemma":0.0000963365,"teacher_disagreement_score":0.51997787,"about_ca_system_score_codex":0.001465789,"about_ca_system_score_gemma":0.0016858525,"threshold_uncertainty_score":0.99969333},"labels":[],"label_agreement":null},{"id":"W2884829265","doi":"10.1016/j.ctrv.2018.07.012","title":"Systematic review and meta-analysis of distance-based physical activity interventions for cancer survivors (2013–2018): We still haven’t found what we’re looking for","year":2018,"lang":"en","type":"review","venue":"Cancer Treatment Reviews","topic":"Cancer survivorship and care","field":"Medicine","cited_by":94,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Athabasca University","funders":"Canada Research Chairs","keywords":"Medicine; Psychological intervention; Meta-analysis; Haven; Cancer; Systematic review; MEDLINE; Gerontology; Safe haven; Oncology; Internal medicine; Psychiatry","score_opus":0.2767488603845295,"score_gpt":0.4641507615719709,"score_spread":0.18740190118744138,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2884829265","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000002253157,0.9685396,0.0016318985,0.00088660116,0.0004795806,0.023798887,0.004615854,0.000034726047,0.000010625493],"genre_scores_gemma":[0.00001641057,0.92680293,0.00011815099,0.00016403495,0.00020224192,0.069782555,0.0006020005,0.00012539157,0.0021862874],"study_design_codex":"systematic_review","study_design_gemma":"meta_analysis","domain_scores_codex":[0.9949761,0.0007038388,0.0020902997,0.0013035076,0.00038769463,0.0005385669],"domain_scores_gemma":[0.993477,0.00095635076,0.0032082316,0.0016678545,0.00040999826,0.00028056954],"candidate_categories":["metaepi_narrow","metaepi_broad"],"consensus_categories":["metaepi_narrow","metaepi_broad"],"category_scores_codex":[0.00094823155,0.0013107558,0.0224029,0.00037894055,0.00013542226,0.000103921724,0.00031655128,0.00024870655,0.0003648334],"category_scores_gemma":[0.00011371035,0.0007635076,0.017782778,0.0010361157,0.00019496921,0.00023812597,0.000053539152,0.00018804788,0.0000061512824],"study_design_candidate":"systematic_review","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000027869639,0.00033983437,0.0000014906643,0.7168232,0.10231081,9.848621e-7,0.00014661285,5.7369454e-7,4.6249305e-8,0.000012853223,0.00059234805,0.17974335],"study_design_scores_gemma":[0.00022606782,0.00021852019,1.6656084e-7,0.22120947,0.40012553,6.297391e-7,0.00002183428,0.000017660263,0.0000011486496,0.0000041611365,0.37793097,0.00024384173],"about_ca_topic_score_codex":0.0014028193,"about_ca_topic_score_gemma":0.043806177,"teacher_disagreement_score":0.49561378,"about_ca_system_score_codex":0.0016016002,"about_ca_system_score_gemma":0.00054760213,"threshold_uncertainty_score":0.9999644},"labels":[],"label_agreement":null},{"id":"W2888428143","doi":"10.1016/j.ctrv.2018.08.009","title":"Evolution in sites of recurrence over time in breast cancer patients treated with adjuvant endocrine therapy","year":2018,"lang":"en","type":"review","venue":"Cancer Treatment Reviews","topic":"Breast Cancer Treatment Studies","field":"Biochemistry, Genetics and Molecular Biology","cited_by":11,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto","funders":"","keywords":"Medicine; Breast cancer; Adjuvant therapy; Adjuvant; Internal medicine; Cancer; Oncology; Endocrine system; Randomized controlled trial; Surgery; Hormonal therapy; Disease; Hormone","score_opus":0.03017103205909811,"score_gpt":0.33316974438187646,"score_spread":0.30299871232277836,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2888428143","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.010944958,0.984865,3.6075795e-7,0.000017035381,0.00008793812,0.0026211177,0.0013458605,0.000009352862,0.00010839149],"genre_scores_gemma":[0.0012367025,0.99254787,0.000028900824,0.000022552042,0.00021250603,0.0044939467,0.0011954947,0.000063808366,0.00019821293],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9970964,0.0003076501,0.0009468943,0.0009816249,0.00019724767,0.00047014837],"domain_scores_gemma":[0.998319,0.000025495507,0.00080826745,0.0006269946,0.00014046273,0.00007983751],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00010410343,0.0009085717,0.0025489484,0.00020452072,0.00003947807,0.0000108968,0.00024533606,0.00022058433,0.00017668944],"category_scores_gemma":[0.0000096296,0.0005504279,0.0004072534,0.0006079129,0.0001626344,0.000013242522,0.000071318755,0.0001194922,0.0000234023],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00027535114,0.0009220162,0.22137335,0.0018995075,0.0005098108,0.000006154997,0.000040100087,0.0000014156851,0.000020715186,8.6636817e-7,0.0007665867,0.7741841],"study_design_scores_gemma":[0.004148383,0.00093613693,0.06411999,0.024060246,0.0008490617,0.000012759592,0.0000022943996,0.0000011327804,0.00011828304,0.0000015499547,0.90501094,0.00073921995],"about_ca_topic_score_codex":0.0027960849,"about_ca_topic_score_gemma":0.0024975967,"teacher_disagreement_score":0.90424436,"about_ca_system_score_codex":0.0013158013,"about_ca_system_score_gemma":0.00046377192,"threshold_uncertainty_score":0.9996947},"labels":[],"label_agreement":null},{"id":"W2896552420","doi":"10.1016/j.ctrv.2018.10.010","title":"Absolute benefit from adjuvant chemotherapy in contemporary clinical trials: A systemic review and meta-analysis","year":2018,"lang":"en","type":"review","venue":"Cancer Treatment Reviews","topic":"Breast Cancer Treatment Studies","field":"Biochemistry, Genetics and Molecular Biology","cited_by":14,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto","funders":"","keywords":"Medicine; Internal medicine; Breast cancer; Oncology; Meta-analysis; Chemotherapy; Clinical trial; Adjuvant; Estrogen receptor; Disease; Randomized controlled trial; Adjuvant chemotherapy; Proportional hazards model; Cancer","score_opus":0.49227477311335927,"score_gpt":0.5228902450112396,"score_spread":0.03061547189788033,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2896552420","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0000053305125,0.9889409,0.000010350321,0.0002868506,0.00018582247,0.0078462,0.0025728338,0.000018438954,0.00013330749],"genre_scores_gemma":[0.000008480008,0.98025095,0.0001595745,0.0010579274,0.00062183186,0.014911311,0.0021234588,0.00009970232,0.0007667832],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99032927,0.0028115816,0.00424654,0.0020048097,0.00018546417,0.00042235677],"domain_scores_gemma":[0.9947514,0.0003544284,0.0028841235,0.0016952531,0.00009330029,0.00022150019],"candidate_categories":["metaepi_narrow","metaepi_broad"],"consensus_categories":["metaepi_narrow"],"category_scores_codex":[0.0027436512,0.0014574013,0.02277127,0.0001713087,0.0000748027,0.0000421244,0.00040792042,0.00055439654,0.00038396247],"category_scores_gemma":[0.00015834742,0.0008218192,0.008860764,0.0005702122,0.00018145931,0.000009296551,0.00015442754,0.00020186859,0.00006306859],"study_design_candidate":"meta_analysis","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000041626416,0.00020731935,0.00014511935,0.0105217965,0.28746697,0.000011365756,0.00002147381,8.224754e-8,1.8295434e-7,0.0000012864542,0.008011375,0.6935714],"study_design_scores_gemma":[0.0006854232,0.00011876714,0.000026757058,0.00374148,0.4155886,0.0000068807276,0.000002131896,1.3343224e-7,6.644996e-7,0.0000026872935,0.5794511,0.00037540807],"about_ca_topic_score_codex":0.0009800505,"about_ca_topic_score_gemma":0.0010208655,"teacher_disagreement_score":0.693196,"about_ca_system_score_codex":0.0003524467,"about_ca_system_score_gemma":0.0004552305,"threshold_uncertainty_score":0.99981755},"labels":[],"label_agreement":null},{"id":"W2914108875","doi":"10.1016/j.ctrv.2019.02.001","title":"Network meta-analysis of therapies for previously untreated advanced BRAF-mutated melanoma","year":2019,"lang":"en","type":"review","venue":"Cancer Treatment Reviews","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":29,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Juravinski Cancer Centre; McMaster University; Impact","funders":"","keywords":"Medicine; Dabrafenib; Vemurafenib; Trametinib; Dacarbazine; Oncology; Internal medicine; Ipilimumab; Melanoma; Hazard ratio; Nivolumab; Randomized controlled trial; Population; Progression-free survival; Metastatic melanoma; Cancer; Immunotherapy; Chemotherapy; Cancer research; Overall survival; Confidence interval","score_opus":0.20660714001164493,"score_gpt":0.3974582458880378,"score_spread":0.19085110587639287,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2914108875","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000018585393,0.9921441,0.00013408848,0.000015522472,0.00020957783,0.0059858686,0.0011708286,0.00001659037,0.0003048424],"genre_scores_gemma":[0.000012531369,0.98070973,0.0009432868,0.000082174396,0.00020576119,0.0070266933,0.006518159,0.000092985756,0.0044086557],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9965823,0.00045481056,0.0013341988,0.001010527,0.0001224114,0.0004957506],"domain_scores_gemma":[0.99677575,0.00009370467,0.0015271296,0.0013659223,0.00012481723,0.000112674716],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00031223128,0.00096108404,0.008394031,0.00012284378,0.000065941276,0.000022152104,0.0003921131,0.00040354792,0.0003386459],"category_scores_gemma":[0.000024685294,0.00056219305,0.0073051434,0.0006500993,0.000053114916,0.000004962422,0.000060079918,0.00007443108,0.000024045146],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00004055373,0.00009193529,0.000011132702,0.005827496,0.21951368,0.0000017482682,0.000023979197,0.00005743715,0.00004057485,0.00003444337,0.0015965019,0.7727605],"study_design_scores_gemma":[0.00031937167,0.00056780316,9.801831e-7,0.00040944316,0.3666663,0.0000020293633,0.0000012584072,0.0000020140708,0.000081799735,0.000003726936,0.631636,0.0003092526],"about_ca_topic_score_codex":0.000048229504,"about_ca_topic_score_gemma":0.00017426092,"teacher_disagreement_score":0.7724513,"about_ca_system_score_codex":0.00012479014,"about_ca_system_score_gemma":0.00037311338,"threshold_uncertainty_score":0.99968296},"labels":[],"label_agreement":null},{"id":"W2922823095","doi":"10.1016/j.ctrv.2019.03.002","title":"Emerging therapeutic targets for patients with advanced prostate cancer","year":2019,"lang":"en","type":"review","venue":"Cancer Treatment Reviews","topic":"Prostate Cancer Treatment and Research","field":"Medicine","cited_by":38,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre Hospitalier de l’Université de Montréal","funders":"Pfizer","keywords":"Medicine; Prostate cancer; Cancer; Clinical trial; Oncology; Cancer research; EZH2; Disease; Prostate; Internal medicine; Epigenetics","score_opus":0.09584489418431515,"score_gpt":0.4380468469586624,"score_spread":0.3422019527743473,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2922823095","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000013984819,0.9674191,0.00001010121,0.0001716587,0.00060423935,0.030366508,0.0010170655,0.00007580871,0.00032155638],"genre_scores_gemma":[0.0000030613558,0.93587095,0.0003247078,0.00013292654,0.00032199197,0.045540906,0.002699077,0.0002619303,0.014844481],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9961212,0.00015020356,0.0009976211,0.0012827642,0.00043078582,0.0010174158],"domain_scores_gemma":[0.9974384,0.00012223821,0.0008444484,0.0009744782,0.00029438606,0.0003260637],"candidate_categories":["metaepi_narrow"],"consensus_categories":["metaepi_narrow"],"category_scores_codex":[0.00015469296,0.0013128251,0.0049475115,0.00025868317,0.00018839017,0.000052572206,0.00023080538,0.0002467294,0.00046160832],"category_scores_gemma":[0.000013490108,0.0006568351,0.0012675772,0.0005519352,0.00009804888,0.00015615406,0.00004517471,0.0002950915,0.0001360397],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00046836596,0.00050719385,0.0011254598,0.048475254,0.0020945442,0.000009526612,0.00013419759,0.0000015225296,3.3690577e-7,0.0000040484574,0.0012440415,0.9459355],"study_design_scores_gemma":[0.006691817,0.0024088016,0.000044699827,0.04384815,0.009540933,0.0000032617972,0.000008029993,0.0000026740029,0.000005672362,0.0000037473558,0.9368059,0.00063630665],"about_ca_topic_score_codex":0.000056868677,"about_ca_topic_score_gemma":0.00003567123,"teacher_disagreement_score":0.9452992,"about_ca_system_score_codex":0.003129736,"about_ca_system_score_gemma":0.0018863712,"threshold_uncertainty_score":0.99996233},"labels":[],"label_agreement":null},{"id":"W2944914845","doi":"10.1016/j.ctrv.2019.05.002","title":"PD-L1 expression and clinical outcomes in patients with advanced urothelial carcinoma treated with checkpoint inhibitors: A meta-analysis","year":2019,"lang":"en","type":"review","venue":"Cancer Treatment Reviews","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":47,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto; Queen's University","funders":"","keywords":"Medicine; Metastatic Urothelial Carcinoma; Internal medicine; Oncology; Bladder cancer; Context (archaeology); Immunotherapy; Meta-analysis; Odds ratio; PD-L1; Pembrolizumab; Carcinoma; Urothelial carcinoma; Cancer","score_opus":0.1338417283217021,"score_gpt":0.406187911463415,"score_spread":0.2723461831417129,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2944914845","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0048502414,0.9821775,0.0000033600645,0.000039562474,0.00009784819,0.011933333,0.0005592425,0.000048119775,0.00029077585],"genre_scores_gemma":[0.0010672144,0.98963434,0.00048538164,0.00012590781,0.0001185424,0.005945722,0.00075669726,0.00017004869,0.001696165],"study_design_codex":"design_other","study_design_gemma":"meta_analysis","domain_scores_codex":[0.9941661,0.000629295,0.0022194553,0.0018280734,0.0005476725,0.0006094424],"domain_scores_gemma":[0.99635845,0.00018297366,0.0013870177,0.001516657,0.00013201302,0.00042288064],"candidate_categories":["metaepi_narrow","metaepi_broad"],"consensus_categories":["metaepi_narrow"],"category_scores_codex":[0.00026526977,0.0017276078,0.015206681,0.0005298823,0.00007625675,0.00005050945,0.00018333572,0.00041103843,0.0005102094],"category_scores_gemma":[0.000024464178,0.0007464765,0.004338097,0.0010425028,0.00014672476,0.00016581995,0.00006623604,0.00043150893,0.000059183792],"study_design_candidate":"meta_analysis","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00088516,0.0016908878,0.36374,0.004719659,0.10057938,0.00006503405,0.000058271507,9.2861694e-7,1.04131075e-7,3.797327e-7,0.000046502475,0.5282137],"study_design_scores_gemma":[0.010184955,0.0040468755,0.020305205,0.0044986526,0.55645674,0.0000062341746,0.0000053869517,4.59246e-7,0.000004338221,3.0099665e-7,0.4038466,0.0006442501],"about_ca_topic_score_codex":0.0007455763,"about_ca_topic_score_gemma":0.00038293548,"teacher_disagreement_score":0.5275695,"about_ca_system_score_codex":0.0011465251,"about_ca_system_score_gemma":0.00071571546,"threshold_uncertainty_score":0.999547},"labels":[],"label_agreement":null},{"id":"W2947340802","doi":"10.1016/j.ctrv.2019.05.006","title":"Prognostic value of receptor tyrosine kinase-like orphan receptor (ROR) family in cancer: A meta-analysis","year":2019,"lang":"en","type":"review","venue":"Cancer Treatment Reviews","topic":"Wnt/β-catenin signaling in development and cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":18,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto","funders":"Instituto de Salud Carlos III","keywords":"Medicine; Orphan receptor; ROR1; Oncology; Internal medicine; Hazard ratio; Meta-analysis; Subgroup analysis; Confidence interval; Cancer; Lung cancer; Receptor; Gene; Biology; Genetics","score_opus":0.15298336154643505,"score_gpt":0.3828456729642744,"score_spread":0.22986231141783936,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2947340802","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00017133194,0.99416375,0.000020369378,0.00004539669,0.00066197675,0.0038415215,0.0008921569,0.000015841591,0.0001876366],"genre_scores_gemma":[0.000028759676,0.9783234,0.0008115762,0.00014300701,0.00031000315,0.010318352,0.0027528459,0.00012122542,0.0071908496],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9950102,0.00064732914,0.0019242193,0.0014768532,0.00033913058,0.0006022863],"domain_scores_gemma":[0.996857,0.000065091015,0.0015634786,0.0011926077,0.00016044249,0.00016140292],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0005564187,0.0012276291,0.0072417404,0.00036741068,0.000055962788,0.000036381105,0.0006536918,0.00055537676,0.0015122201],"category_scores_gemma":[0.000039618364,0.00080976763,0.0045847534,0.001439493,0.00010917657,0.000009716547,0.00014033164,0.00021093838,0.00013661996],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00007047139,0.0004939212,0.0008186085,0.015326613,0.124539934,0.0000049942814,0.00007794565,0.00010224058,0.0009349108,0.000012930415,0.020682476,0.8369349],"study_design_scores_gemma":[0.00039123485,0.00024309722,0.000010031792,0.0022766467,0.16545622,8.480908e-7,0.0000041168637,0.0000012608867,0.0005062383,9.628285e-7,0.83045816,0.0006511911],"about_ca_topic_score_codex":0.0007653858,"about_ca_topic_score_gemma":0.0003242429,"teacher_disagreement_score":0.83628374,"about_ca_system_score_codex":0.0006940708,"about_ca_system_score_gemma":0.0013537084,"threshold_uncertainty_score":0.9994353},"labels":[],"label_agreement":null},{"id":"W2952944061","doi":"10.1016/j.ctrv.2019.05.001","title":"Androgen receptor plasticity and its implications for prostate cancer therapy","year":2019,"lang":"en","type":"review","venue":"Cancer Treatment Reviews","topic":"Prostate Cancer Treatment and Research","field":"Medicine","cited_by":53,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Simon Fraser University; University of British Columbia","funders":"","keywords":"Enzalutamide; Prostate cancer; Androgen receptor; Medicine; Mechanism (biology); Cancer; Androgen deprivation therapy; Cancer research; Receptor; Drug resistance; Bioinformatics; Oncology; Internal medicine; Genetics; Biology","score_opus":0.2532166580661024,"score_gpt":0.4788837669870904,"score_spread":0.225667108920988,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2952944061","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00005045044,0.9716659,0.0000030972335,0.00076979387,0.00028575544,0.023502573,0.0034704104,0.000055961013,0.00019602636],"genre_scores_gemma":[0.0000018917278,0.9330588,0.00009936254,0.000114794864,0.00048733252,0.050744504,0.0011679055,0.00013084216,0.014194557],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99720764,0.00013457732,0.0008195974,0.0010451893,0.00015646592,0.0006365065],"domain_scores_gemma":[0.99821377,0.00020749393,0.00051789137,0.00051980343,0.00018551969,0.00035550733],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00015897081,0.0008795455,0.0036346824,0.00017950237,0.00019249416,0.000057170582,0.00016233863,0.00028462426,0.00034063472],"category_scores_gemma":[0.00002729984,0.00048730097,0.00089774956,0.00037751955,0.00007666837,0.00009147555,0.000046057907,0.00021018236,0.00012949784],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0001491031,0.00021333797,0.00031509888,0.025832256,0.0012490377,0.0000017698685,0.000077155935,1.054644e-7,0.000014816066,0.00002544868,0.00529414,0.96682775],"study_design_scores_gemma":[0.0030399847,0.000914057,0.000037621405,0.016954456,0.0037308952,0.000016017992,0.0000029327268,0.0000022884722,0.000058336573,0.0000077084815,0.9748243,0.00041138078],"about_ca_topic_score_codex":0.0000794835,"about_ca_topic_score_gemma":0.000028998162,"teacher_disagreement_score":0.96953017,"about_ca_system_score_codex":0.0016464465,"about_ca_system_score_gemma":0.0017282505,"threshold_uncertainty_score":0.9997579},"labels":[],"label_agreement":null},{"id":"W3004630265","doi":"10.1016/j.ctrv.2020.101979","title":"Toxicity management with combination chemotherapy and programmed death 1/programmed death ligand 1 inhibitor therapy in advanced lung cancer","year":2020,"lang":"en","type":"review","venue":"Cancer Treatment Reviews","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":31,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"Merck Sharp and Dohme","keywords":"Medicine; Nivolumab; Pembrolizumab; Atezolizumab; Lung cancer; Chemotherapy; Oncology; Internal medicine; Immunotherapy; Cancer","score_opus":0.05420534162604314,"score_gpt":0.37431323484624324,"score_spread":0.3201078932202001,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3004630265","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.001879622,0.9772495,0.000021555275,0.00063721166,0.00021441576,0.019602858,0.000053487678,0.00011185712,0.00022948535],"genre_scores_gemma":[0.00012910545,0.9741659,0.00080714416,0.0005865383,0.00023942311,0.023010898,0.00026987185,0.0001643023,0.00062677375],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9961753,0.00025252378,0.0012110217,0.001280749,0.00039283032,0.00068759377],"domain_scores_gemma":[0.9981099,0.00005242117,0.00081667706,0.0006436944,0.00007086706,0.00030643572],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0003408762,0.00126905,0.003979611,0.00026042465,0.000115373645,0.00010140192,0.00020134124,0.0002993951,0.00011324418],"category_scores_gemma":[0.0000052805226,0.0007624097,0.0006624773,0.0008748525,0.00010652562,0.00013213097,0.0000373513,0.0003393777,0.0000052980736],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010833652,0.0007631206,0.0028200122,0.015041539,0.0020098926,0.00009572627,0.00024938578,1.5770227e-7,0.0000074050336,0.000011071324,0.00018572083,0.9777326],"study_design_scores_gemma":[0.013044819,0.0021647627,0.00069937564,0.03689497,0.002157124,0.000033279433,0.00002290959,0.000008085197,0.00010686135,0.0000035324279,0.94416517,0.00069910666],"about_ca_topic_score_codex":0.00046207127,"about_ca_topic_score_gemma":0.0003588651,"teacher_disagreement_score":0.9770335,"about_ca_system_score_codex":0.0029943853,"about_ca_system_score_gemma":0.00055737613,"threshold_uncertainty_score":0.9994827},"labels":[],"label_agreement":null},{"id":"W3006060452","doi":"10.1016/j.ctrv.2020.101987","title":"An evidence-based guideline on the application of molecular testing in the diagnosis, prediction of prognosis, and selection of therapy in non-GIST soft tissue sarcomas","year":2020,"lang":"en","type":"review","venue":"Cancer Treatment Reviews","topic":"Gastrointestinal Tumor Research and Treatment","field":"Medicine","cited_by":11,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Hospital; Population Health Research Institute; Cancer Care Ontario; McMaster University; Juravinski Cancer Centre; Mount Sinai Hospital","funders":"Ontario Ministry of Health and Long-Term Care","keywords":"Medicine; Liposarcoma; Guideline; GiST; Sarcoma; Leiomyosarcoma; Soft tissue sarcoma; MEDLINE; Internal medicine; Fluorescence in situ hybridization; Sunitinib; Cochrane Library; Oncology; Cancer; Pathology; Meta-analysis; Stromal cell","score_opus":0.1782895704646649,"score_gpt":0.438689119759938,"score_spread":0.2603995492952731,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3006060452","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0020349415,0.9870609,0.00012326518,0.00057092536,0.000007493562,0.010123926,0.00005469653,0.00000754134,0.000016280668],"genre_scores_gemma":[0.026903078,0.9619774,0.0008890205,0.000059930906,0.000049082406,0.009980711,0.00011422254,0.000025109446,0.0000014215758],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99727386,0.00063252775,0.0011830768,0.00040822197,0.00032184986,0.00018048885],"domain_scores_gemma":[0.9979941,0.00060296676,0.00081784104,0.00038196467,0.0001341727,0.00006892552],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007930238,0.0003505631,0.001534983,0.00016357133,0.000028314096,0.0000089173345,0.00016455968,0.00006144284,0.000012208759],"category_scores_gemma":[0.00036709497,0.00016461358,0.00020278363,0.0009319059,0.000098620396,0.000040402316,0.000012055018,0.00020070338,0.0000011401718],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00007047413,0.00095007085,0.029783888,0.0058349385,0.00006725113,0.000013083684,0.00004440322,0.000010398369,0.00032891045,0.0000074075942,0.000040721134,0.9628484],"study_design_scores_gemma":[0.004145467,0.03695658,0.01843193,0.2284146,0.0031584054,0.0001080699,0.000064412045,0.0016327461,0.009515395,0.000030271836,0.6971392,0.00040292673],"about_ca_topic_score_codex":0.0013378438,"about_ca_topic_score_gemma":0.00011406811,"teacher_disagreement_score":0.9624455,"about_ca_system_score_codex":0.00038317093,"about_ca_system_score_gemma":0.00042851348,"threshold_uncertainty_score":0.67127466},"labels":[],"label_agreement":null},{"id":"W3030007841","doi":"10.1016/j.ctrv.2020.102032","title":"Systemic adjuvant therapy for adult patients at high risk for recurrent melanoma: A systematic review","year":2020,"lang":"en","type":"review","venue":"Cancer Treatment Reviews","topic":"Cutaneous Melanoma Detection and Management","field":"Medicine","cited_by":17,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; University of Ottawa; Health Sciences Centre; Credit Valley Hospital; Sunnybrook Health Science Centre; Juravinski Cancer Centre; Queen's University; McMaster University; Grand River Hospital; Ottawa Hospital; Kingston General Hospital","funders":"Ministry of Health, Ontario","keywords":"Medicine; Melanoma; Adjuvant; Adjuvant therapy; Guideline; Oncology; Systemic therapy; Internal medicine; Targeted therapy; Sentinel lymph node; Dermatology; Cancer; Surgery; Breast cancer; Pathology; Cancer research","score_opus":0.05222711110885997,"score_gpt":0.34799767661670644,"score_spread":0.2957705655078465,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3030007841","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00000166881,0.89610773,0.00007243869,0.00017355884,0.0012688271,0.100770876,0.0014474196,0.00011196423,0.000045507197],"genre_scores_gemma":[0.0000010402139,0.8695149,0.0001855496,0.00079782394,0.00044458822,0.124909654,0.0017860031,0.00016973204,0.0021907468],"study_design_codex":"systematic_review","study_design_gemma":"not_applicable","domain_scores_codex":[0.99452364,0.00055085286,0.0028356053,0.0012241816,0.00034584664,0.00051988737],"domain_scores_gemma":[0.9946379,0.0002854698,0.0030926506,0.0012052323,0.0004202754,0.00035848207],"candidate_categories":["metaepi_narrow"],"consensus_categories":["metaepi_narrow"],"category_scores_codex":[0.00040631954,0.0013065839,0.011125059,0.0001530665,0.00019766942,0.00003487859,0.00027415546,0.00023827098,0.00012663737],"category_scores_gemma":[0.00046184464,0.0007319235,0.003650585,0.00034351143,0.000026414496,0.00003451423,0.00005915742,0.0001817303,0.00031410332],"study_design_candidate":"systematic_review","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00009527223,0.00016110404,0.0000017897314,0.5038853,0.0012441912,0.0000070507135,0.000019323785,1.2956536e-8,2.8235988e-8,0.000008536954,0.008790317,0.48578703],"study_design_scores_gemma":[0.0019396406,0.0022000321,1.8044518e-7,0.43218744,0.02699141,0.000061885235,0.0000028294903,0.000002632399,4.1308778e-7,0.0000012770939,0.53629464,0.00031765457],"about_ca_topic_score_codex":0.000043701046,"about_ca_topic_score_gemma":0.000052499538,"teacher_disagreement_score":0.5275043,"about_ca_system_score_codex":0.004181939,"about_ca_system_score_gemma":0.00029464302,"threshold_uncertainty_score":0.9999686},"labels":[],"label_agreement":null},{"id":"W3043154728","doi":"10.1016/j.ctrv.2020.102084","title":"Impact of high tumor mutational burden in solid tumors and challenges for biomarker application","year":2020,"lang":"en","type":"review","venue":"Cancer Treatment Reviews","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":110,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto","funders":"","keywords":"Medicine; Immunotherapy; Biomarker; Oncology; Cancer; Melanoma; Lung cancer; Clinical trial; Targeted therapy; Circulating tumor cell; Internal medicine; Computational biology; Cancer research; Metastasis","score_opus":0.12482030120339196,"score_gpt":0.42675127690850645,"score_spread":0.3019309757051145,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3043154728","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00009969719,0.9927808,0.000013127829,0.00033796774,0.00005596116,0.006276549,0.00036730853,0.000013740501,0.00005485024],"genre_scores_gemma":[0.00014892925,0.99172693,0.00020655947,0.000028483288,0.00021943849,0.0070759878,0.00049021456,0.00005039865,0.000053051597],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9980738,0.0000934128,0.0009866365,0.0005248877,0.00011584446,0.00020540379],"domain_scores_gemma":[0.9986991,0.00011186634,0.00073359336,0.00030440866,0.000047315298,0.000103692146],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00018918322,0.00047940243,0.003073281,0.00016790912,0.000024582498,0.00000856303,0.00008565154,0.000116232295,0.00007790166],"category_scores_gemma":[0.000023029032,0.0002923156,0.0009183709,0.00027068367,0.00007083163,0.000037657737,0.0000151102795,0.000075373995,0.0000063532175],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00026916224,0.00010193227,0.000035454214,0.02460167,0.00077892997,0.000008669552,0.00009947178,2.1365e-7,0.000010339171,0.000011675605,0.000121408026,0.97396106],"study_design_scores_gemma":[0.0020031824,0.00080189196,0.0009651804,0.017977634,0.0015279629,0.000060883347,0.0000089184605,0.0000119455835,0.0000043011805,0.000015765474,0.9763997,0.00022259861],"about_ca_topic_score_codex":0.0006799557,"about_ca_topic_score_gemma":0.000066446584,"teacher_disagreement_score":0.9762783,"about_ca_system_score_codex":0.0011082496,"about_ca_system_score_gemma":0.00074212486,"threshold_uncertainty_score":0.9999529},"labels":[],"label_agreement":null},{"id":"W3049702673","doi":"10.1016/j.ctrv.2020.102086","title":"Comparison of treatment-related adverse events of different Cyclin-dependent kinase 4/6 inhibitors in metastatic breast cancer: A network meta-analysis","year":2020,"lang":"en","type":"article","venue":"Cancer Treatment Reviews","topic":"Advanced Breast Cancer Therapies","field":"Medicine","cited_by":91,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto","funders":"","keywords":"Palbociclib; Medicine; Fulvestrant; Tolerability; Metastatic breast cancer; Internal medicine; Oncology; Adverse effect; Neutropenia; Discontinuation; Breast cancer; Hazard ratio; Pharmacology; Cancer; Chemotherapy; Estrogen receptor; Confidence interval","score_opus":0.13815874616013846,"score_gpt":0.40500467243691196,"score_spread":0.2668459262767735,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3049702673","genre_codex":"review","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.43160224,0.5591402,0.00021065399,0.0023414397,0.00024204282,0.005309591,0.0009912589,0.000067399786,0.000095163094],"genre_scores_gemma":[0.95754397,0.03928404,0.000516298,0.00017749456,0.0001043726,0.0019572796,0.00013778664,0.000056293673,0.00022249323],"study_design_codex":"observational","study_design_gemma":"meta_analysis","domain_scores_codex":[0.995777,0.00041952948,0.002153955,0.0007610099,0.00040322242,0.000485275],"domain_scores_gemma":[0.9972579,0.00010915861,0.0014986792,0.0006739383,0.00011239663,0.00034795495],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00016001746,0.00074561714,0.0062432336,0.00023499932,0.000045557612,0.000003444625,0.00016876459,0.00009077136,0.0017030896],"category_scores_gemma":[0.000015188223,0.0004596861,0.0026526286,0.0015218586,0.000111002475,0.00010928664,0.000045099983,0.00015827555,0.000012997261],"study_design_candidate":"meta_analysis","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0018399357,0.0035098097,0.57568645,0.00092073984,0.206137,0.00005110854,0.003476573,0.0401513,0.0016121418,0.000025404133,0.000059601334,0.16652994],"study_design_scores_gemma":[0.023287954,0.0043512355,0.061735865,0.0011603336,0.8769237,0.000019107534,0.00076760806,0.0031558273,0.013248621,0.00010403957,0.0140893,0.0011564251],"about_ca_topic_score_codex":0.002328117,"about_ca_topic_score_gemma":0.0018471633,"teacher_disagreement_score":0.6707867,"about_ca_system_score_codex":0.0017069539,"about_ca_system_score_gemma":0.0002749288,"threshold_uncertainty_score":0.9997855},"labels":[],"label_agreement":null},{"id":"W3093476204","doi":"10.1016/j.ctrv.2020.102113","title":"National comprehensive cancer network recommendations for drugs without US food and drug administration approval in metastatic breast cancer: A cross-sectional study","year":2020,"lang":"en","type":"review","venue":"Cancer Treatment Reviews","topic":"HER2/EGFR in Cancer Research","field":"Medicine","cited_by":11,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto","funders":"","keywords":"Medicine; Food and drug administration; Metastatic breast cancer; Cancer; Breast cancer; Drug; Cancer drugs; Oncology; Drug approval; Drug administration; Internal medicine; Intensive care medicine; Pharmacology","score_opus":0.2736387104802975,"score_gpt":0.5247481558783833,"score_spread":0.25110944539808583,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3093476204","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00030482173,0.9720892,0.000015102172,0.0016021968,0.00071099965,0.020104192,0.005020108,0.000048860624,0.00010457001],"genre_scores_gemma":[0.00029585868,0.9270014,0.00077126105,0.00031441392,0.0016670077,0.06790805,0.001294875,0.00013139403,0.0006156917],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99442333,0.0007358426,0.001959512,0.0014700894,0.00074868987,0.00066255475],"domain_scores_gemma":[0.9972267,0.00045264515,0.0009577773,0.00043760863,0.00052546145,0.00039977184],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.000784745,0.0009591407,0.0038012727,0.00027246567,0.00029299274,0.00017809958,0.00023943468,0.00017777662,0.0005042692],"category_scores_gemma":[0.00006115446,0.00072481524,0.00068727497,0.0009957224,0.00015674166,0.00016644792,0.00008912734,0.00060572085,0.000019931498],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":true,"study_design_scores_codex":[0.00029621762,0.00073619117,0.025074415,0.017790437,0.0019363703,0.000014543952,0.00037133126,0.000027263563,1.3462737e-7,0.00003340701,0.00651537,0.9472043],"study_design_scores_gemma":[0.0037673353,0.00096612325,0.0027890662,0.012178623,0.002561439,0.00009129438,0.000059806873,0.00008038731,5.0920664e-7,0.000024032295,0.97697383,0.0005075369],"about_ca_topic_score_codex":0.0017005402,"about_ca_topic_score_gemma":0.00588075,"teacher_disagreement_score":0.97045845,"about_ca_system_score_codex":0.0057561253,"about_ca_system_score_gemma":0.007139547,"threshold_uncertainty_score":0.9995203},"labels":[],"label_agreement":null},{"id":"W3093855610","doi":"10.1016/j.ctrv.2020.102115","title":"Sarcomas: Immune biomarker expression and checkpoint inhibitor trials","year":2020,"lang":"en","type":"review","venue":"Cancer Treatment Reviews","topic":"Sarcoma Diagnosis and Treatment","field":"Medicine","cited_by":71,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Vancouver General Hospital; University of British Columbia","funders":"Terry Fox Research Institute; Canadian Cancer Society","keywords":"Medicine; Biomarker; Immune checkpoint; Cancer research; Immune system; Immunotherapy; Oncology; Immunology; Genetics","score_opus":0.23283391994023742,"score_gpt":0.44218175392257025,"score_spread":0.20934783398233284,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3093855610","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000009983638,0.9889723,0.0000024933524,0.0005174651,0.0004377024,0.009293437,0.00021407312,0.00008386118,0.00046865075],"genre_scores_gemma":[0.0000058210403,0.98651505,0.0005867916,0.0001421331,0.000776374,0.010836609,0.00052355963,0.00013326669,0.00048041975],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9946252,0.00091663614,0.002597755,0.0011463948,0.00027688785,0.00043713246],"domain_scores_gemma":[0.99663264,0.00043582727,0.0014536215,0.0009291522,0.00004224774,0.0005065158],"candidate_categories":["metaepi_narrow"],"consensus_categories":["metaepi_narrow"],"category_scores_codex":[0.0006359332,0.0012984704,0.011005807,0.00019435163,0.000116930816,0.00007066014,0.00013402662,0.00037215804,0.0007268295],"category_scores_gemma":[0.00022549722,0.0006646173,0.0029822963,0.00038122307,0.00008467688,0.00007059884,0.00012268912,0.00023708168,0.00034233247],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00005072356,0.0005765798,0.00007702658,0.016172376,0.0012697955,0.00026387532,0.000054928616,2.1869517e-9,0.000029743353,0.0000046859823,0.0036530583,0.9778472],"study_design_scores_gemma":[0.0026399514,0.0004043794,0.00004495272,0.07745669,0.013833781,0.00014214282,0.0000065807067,4.235836e-7,0.00020689676,0.0000038358976,0.9048234,0.00043696974],"about_ca_topic_score_codex":0.000086687716,"about_ca_topic_score_gemma":0.000006001538,"teacher_disagreement_score":0.97741026,"about_ca_system_score_codex":0.0012576997,"about_ca_system_score_gemma":0.00048144985,"threshold_uncertainty_score":0.9999767},"labels":[],"label_agreement":null},{"id":"W3106231563","doi":"10.1016/j.ctrv.2020.102125","title":"Bugs as drugs: The role of microbiome in cancer focusing on immunotherapeutics","year":2020,"lang":"en","type":"review","venue":"Cancer Treatment Reviews","topic":"Gut microbiota and health","field":"Biochemistry, Genetics and Molecular Biology","cited_by":27,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University Health Network","funders":"Princess Margaret Cancer Foundation","keywords":"Medicine; Microbiome; Cancer; Oncology; Computational biology; Bioinformatics; Internal medicine","score_opus":0.052150591589164796,"score_gpt":0.3979215327201149,"score_spread":0.3457709411309501,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3106231563","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00010219937,0.99684954,8.6989735e-7,0.00018864266,0.00018560688,0.0020241218,0.00020913375,0.000004852185,0.00043502206],"genre_scores_gemma":[0.000039857914,0.9975355,0.000031734595,0.00053129275,0.00032497518,0.0008565001,0.0001891329,0.00006577231,0.00042517876],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99799514,0.00029103,0.00078556134,0.00053843285,0.00007100694,0.00031883214],"domain_scores_gemma":[0.99864644,0.000021863205,0.00061372644,0.0006274226,0.00002796071,0.00006260396],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00014876356,0.00053819537,0.0016940874,0.00006445093,0.00006297985,0.000018013216,0.0003440228,0.0002682398,0.00007718166],"category_scores_gemma":[0.000006197988,0.00030758945,0.0006667709,0.0002617546,0.0000731108,0.0000019517292,0.00006391214,0.00018734754,0.000053478867],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000019317582,0.000093620314,0.000009039837,0.002669217,0.00023841872,0.0000012741249,0.00016308135,5.993183e-7,0.004374989,0.000011255389,0.0002790758,0.9921401],"study_design_scores_gemma":[0.00030826373,0.00029300246,0.0000018764268,0.008427688,0.00053857954,0.0000060114853,0.000018928919,2.1733122e-7,0.0018306362,0.00000473857,0.988315,0.0002550595],"about_ca_topic_score_codex":0.0008220628,"about_ca_topic_score_gemma":0.00022366023,"teacher_disagreement_score":0.99188507,"about_ca_system_score_codex":0.00046270536,"about_ca_system_score_gemma":0.0009245283,"threshold_uncertainty_score":0.9999376},"labels":[],"label_agreement":null},{"id":"W3107738233","doi":"10.1016/j.ctrv.2020.102134","title":"Association between immune-related side effects and efficacy and benefit of immune checkpoint inhibitors – A systematic review and meta-analysis","year":2020,"lang":"en","type":"review","venue":"Cancer Treatment Reviews","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":375,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Lawson Health Research Institute; Western University","funders":"","keywords":"Medicine; Meta-analysis; Immune system; Oncology; Bioinformatics; Immunology; Internal medicine","score_opus":0.05682420004956792,"score_gpt":0.3523567482553131,"score_spread":0.2955325482057452,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3107738233","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000034460805,0.98641926,9.901047e-7,0.0005348553,0.00004319999,0.012733331,0.00015891362,0.000028144521,0.000046850368],"genre_scores_gemma":[0.000034327033,0.9957755,0.000046519603,0.00011240935,0.00003977864,0.002722976,0.0002525842,0.000060031387,0.00095588196],"study_design_codex":"systematic_review","study_design_gemma":"meta_analysis","domain_scores_codex":[0.9944724,0.0005973565,0.0035899794,0.00076588296,0.00029411848,0.00028026468],"domain_scores_gemma":[0.9944415,0.0006182839,0.003969232,0.00069656776,0.00008028635,0.00019410609],"candidate_categories":["metaepi_narrow","metaepi_broad"],"consensus_categories":[],"category_scores_codex":[0.0012569525,0.0009544763,0.021523405,0.00025121402,0.00007764575,0.000037708014,0.00010788288,0.0003296427,0.000075844044],"category_scores_gemma":[0.0002214731,0.00053460285,0.0044280277,0.0011524244,0.0000828157,0.00006627569,0.00007076346,0.00025296403,0.000007166352],"study_design_candidate":"meta_analysis","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000010765964,0.000040507155,0.000027264414,0.5809199,0.2585909,0.0000052578202,0.00006789526,9.72899e-9,0.0000043562527,0.0000010540508,0.000013814682,0.16031824],"study_design_scores_gemma":[0.0010049837,0.0003437199,0.00011915097,0.1465048,0.72657454,0.00001592959,0.0000023932523,2.5587008e-7,0.00001585988,0.0000016839588,0.12513354,0.00028312104],"about_ca_topic_score_codex":0.0003464723,"about_ca_topic_score_gemma":0.000020007328,"teacher_disagreement_score":0.46798366,"about_ca_system_score_codex":0.00084700616,"about_ca_system_score_gemma":0.00012887265,"threshold_uncertainty_score":0.99971056},"labels":[],"label_agreement":null},{"id":"W3129770065","doi":"10.1016/j.ctrv.2021.102167","title":"Fragility index of trials supporting approval of anti-cancer drugs in common solid tumours","year":2021,"lang":"en","type":"review","venue":"Cancer Treatment Reviews","topic":"Statistical Methods in Clinical Trials","field":"Mathematics","cited_by":19,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto","funders":"","keywords":"Medicine; Clinical endpoint; Randomized controlled trial; Statistical significance; Informed consent; Internal medicine; Clinical trial; Sample size determination; Prostate cancer; Surgery; Cancer; Alternative medicine; Pathology","score_opus":0.7670505635966346,"score_gpt":0.678180220305882,"score_spread":0.08887034329075261,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3129770065","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00014306871,0.99028116,0.0004550799,0.000025730644,0.0007612182,0.006639783,0.0013816768,0.000022216938,0.0002900425],"genre_scores_gemma":[0.000019185018,0.9580275,0.037962228,0.000017506822,0.0003786268,0.0032873177,0.000049469712,0.00009949529,0.00015867993],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9732021,0.011873809,0.012699669,0.0010752697,0.00056036114,0.0005887668],"domain_scores_gemma":[0.9470171,0.039342973,0.011731146,0.0015298019,0.00019116708,0.00018786268],"candidate_categories":["metaresearch","metaepi_narrow","metaepi_broad","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.017887358,0.0010006111,0.028387811,0.0002137897,0.000035727804,0.000022193037,0.00058355246,0.0006284071,0.0014044244],"category_scores_gemma":[0.037325576,0.0006438465,0.0035761097,0.00087047607,0.00026830434,0.000053952434,0.0001896161,0.0005971043,0.000007112064],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000021634743,0.0007398632,0.0005821839,0.061359596,0.0006710926,0.0000085822985,0.00010423661,6.345348e-7,0.0000016097384,0.00063328707,0.00035403465,0.9355233],"study_design_scores_gemma":[0.0030447314,0.00031877673,0.000041944,0.17765313,0.014650937,0.0000047838726,0.000051734238,0.000010271184,0.0004197892,0.024851836,0.77785885,0.0010932338],"about_ca_topic_score_codex":0.00043134822,"about_ca_topic_score_gemma":0.00008985487,"teacher_disagreement_score":0.93443,"about_ca_system_score_codex":0.00088978384,"about_ca_system_score_gemma":0.0012729949,"threshold_uncertainty_score":0.9996013},"labels":[],"label_agreement":null},{"id":"W3137251658","doi":"10.1016/j.ctrv.2021.102187","title":"Avelumab first-line maintenance in locally advanced or metastatic urothelial carcinoma: Applying clinical trial findings to clinical practice","year":2021,"lang":"en","type":"review","venue":"Cancer Treatment Reviews","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":62,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"Pfizer Foundation; Merck KGaA; EMD Serono; Pfizer","keywords":"Avelumab; Medicine; Metastatic Urothelial Carcinoma; Carboplatin; Chemotherapy; Oncology; Internal medicine; Maintenance therapy; Cisplatin; Clinical trial; Bladder cancer; Javelin; Cancer; Immunotherapy; Nivolumab; Urothelial carcinoma","score_opus":0.3066253015532885,"score_gpt":0.5286651053873425,"score_spread":0.22203980383405397,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3137251658","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000074984906,0.9642329,0.00021010378,0.0006641616,0.003259556,0.030297222,0.0003566024,0.00007684769,0.00082759996],"genre_scores_gemma":[0.000018461476,0.9512527,0.007831436,0.0021775996,0.0025881762,0.030973354,0.00037107163,0.00027170923,0.004515489],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.98657775,0.002039991,0.006696,0.0027325712,0.00073194806,0.0012217233],"domain_scores_gemma":[0.9927069,0.0023262256,0.0017045868,0.0019429168,0.000309003,0.0010103735],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":["metaepi_narrow"],"category_scores_codex":[0.0025368917,0.0018430845,0.012922156,0.00035157675,0.00017025444,0.00010535656,0.0005318198,0.00064976217,0.0010124648],"category_scores_gemma":[0.003676914,0.0011282978,0.0036975758,0.0015118766,0.00017761966,0.00023018366,0.0002133976,0.0012751108,0.0006361665],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.016521545,0.003503599,0.00019178161,0.0079364795,0.0015447312,0.0022804919,0.00009831563,0.0000019787,4.1155353e-8,0.000010028955,0.0028886113,0.9650224],"study_design_scores_gemma":[0.07407501,0.008125015,0.00002592496,0.044640172,0.013089196,0.00029658817,0.000034869583,0.0000032708688,6.8111865e-7,0.000002651353,0.8588973,0.0008093021],"about_ca_topic_score_codex":0.0004992231,"about_ca_topic_score_gemma":0.00082976517,"teacher_disagreement_score":0.9642131,"about_ca_system_score_codex":0.0034174218,"about_ca_system_score_gemma":0.007226739,"threshold_uncertainty_score":0.99990076},"labels":[],"label_agreement":null},{"id":"W3138024387","doi":"10.1016/j.ctrv.2021.102188","title":"The COVID-19 pandemic: An opportunity to rethink and harmonise the frequency of follow-up visits for patients with early stage breast cancer","year":2021,"lang":"en","type":"review","venue":"Cancer Treatment Reviews","topic":"COVID-19 and healthcare impacts","field":"Medicine","cited_by":13,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"London Health Sciences Centre; Thunder Bay Regional Health Sciences Centre; University of Ottawa; Ottawa Hospital","funders":"","keywords":"Medicine; Randomized controlled trial; Cochrane Library; MEDLINE; Quality of life (healthcare); Cohort; Breast cancer; Cohort study; Pandemic; Internal medicine; Stage (stratigraphy); Adverse effect; Physical therapy; Coronavirus disease 2019 (COVID-19); Cancer; Disease; Nursing","score_opus":0.32922199234492694,"score_gpt":0.49569022118323264,"score_spread":0.1664682288383057,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3138024387","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000655748,0.9799931,0.00001869092,0.0030591306,0.00034621134,0.012492236,0.0033757458,0.0000343594,0.0000247884],"genre_scores_gemma":[0.000068421105,0.9879436,0.000085061845,0.0041313446,0.00031677837,0.0058179647,0.00039887597,0.00008570732,0.0011522659],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9965624,0.00061770034,0.0010975838,0.0007792854,0.00039320634,0.00054982206],"domain_scores_gemma":[0.9949708,0.00066826673,0.0009959895,0.001298936,0.00050162734,0.0015643735],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00087799475,0.0007431447,0.0030754388,0.00009130395,0.00046237858,0.000074023774,0.00028886215,0.0002396737,0.00016360151],"category_scores_gemma":[0.000688052,0.00030985798,0.00057436025,0.00044585177,0.00012861216,0.00010335612,0.00006445555,0.00034180548,0.0000023986613],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00017643294,0.0001406729,0.023083013,0.018561436,0.00052478706,0.000009953907,0.0011179862,1.12999e-7,1.3554502e-7,0.000030424744,0.0015896985,0.9547653],"study_design_scores_gemma":[0.001929491,0.001222278,0.0022068832,0.01636052,0.0040197023,0.000015920037,0.000036600057,2.5319306e-7,2.212844e-7,0.0000068930494,0.9739029,0.00029834907],"about_ca_topic_score_codex":0.009822559,"about_ca_topic_score_gemma":0.009378836,"teacher_disagreement_score":0.97231317,"about_ca_system_score_codex":0.0025403064,"about_ca_system_score_gemma":0.010152742,"threshold_uncertainty_score":0.9999353},"labels":[],"label_agreement":null},{"id":"W3138763072","doi":"10.1016/j.ctrv.2021.102190","title":"Treatment of venous thromboembolism in cancer patients: The dark side of the moon","year":2021,"lang":"en","type":"review","venue":"Cancer Treatment Reviews","topic":"Venous Thromboembolism Diagnosis and Management","field":"Medicine","cited_by":27,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Medicine; Intensive care medicine; Cancer; Thrombosis; Venous thromboembolism; Disease; Population; Venous thrombosis; Internal medicine","score_opus":0.08660830747067964,"score_gpt":0.39007039099869933,"score_spread":0.3034620835280197,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3138763072","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0006883588,0.9862302,2.5568173e-7,0.00027621002,0.000839254,0.00941925,0.000272171,0.000011380223,0.0022629013],"genre_scores_gemma":[0.0002272236,0.99058527,0.000022073016,0.00017253314,0.00025090788,0.007873326,0.00016004003,0.00008491032,0.0006237201],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99608856,0.0005424088,0.0018008102,0.00069301,0.00041479443,0.00046044067],"domain_scores_gemma":[0.99635845,0.00015676835,0.0015536452,0.0017005354,0.0001301647,0.000100425175],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00017705525,0.0008676621,0.0078042173,0.0001406916,0.00009424114,0.00001633188,0.00038052944,0.00021033622,0.0003283244],"category_scores_gemma":[0.000041465126,0.0003685431,0.0021264704,0.0008347111,0.00017431763,0.000042037344,0.00011928159,0.00017578219,0.000017162738],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000006694477,0.005342274,0.00053486746,0.012191195,0.0016588809,0.000011716766,0.00072659494,0.00000464289,7.38229e-7,0.00007686511,0.001948079,0.97749746],"study_design_scores_gemma":[0.0012762912,0.0010074166,0.0020860976,0.042559087,0.012782355,0.0000043532864,0.000037512815,4.2695595e-7,0.00003760308,0.000007628353,0.9399519,0.00024932044],"about_ca_topic_score_codex":0.004773178,"about_ca_topic_score_gemma":0.0013894356,"teacher_disagreement_score":0.97724813,"about_ca_system_score_codex":0.0026380876,"about_ca_system_score_gemma":0.0010938806,"threshold_uncertainty_score":0.9998767},"labels":[],"label_agreement":null},{"id":"W3174377969","doi":"10.1016/j.ctrv.2021.102254","title":"De-escalating adjuvant therapies in older patients with lower risk estrogen receptor-positive breast cancer treated with breast-conserving surgery: A systematic review and meta-analysis","year":2021,"lang":"en","type":"review","venue":"Cancer Treatment Reviews","topic":"Breast Cancer Treatment Studies","field":"Biochemistry, Genetics and Molecular Biology","cited_by":13,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Hospital; University of Ottawa","funders":"","keywords":"Medicine; Meta-analysis; Breast cancer; Oncology; Adjuvant; Estrogen receptor; Breast-conserving surgery; Internal medicine; Gynecology; Cancer; Surgery; Mastectomy","score_opus":0.027057366162339922,"score_gpt":0.30202799814013903,"score_spread":0.2749706319777991,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3174377969","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0005741757,0.98885196,0.000008884205,0.00015469779,0.000024779702,0.0060377787,0.004315757,0.00002079987,0.00001114796],"genre_scores_gemma":[0.0002529518,0.97912157,0.00017356263,0.00021901209,0.000057985904,0.018044587,0.0018126459,0.00014653933,0.00017113371],"study_design_codex":"meta_analysis","study_design_gemma":"meta_analysis","domain_scores_codex":[0.99423325,0.0018138575,0.0013684015,0.0016053459,0.00029722476,0.0006818978],"domain_scores_gemma":[0.9960975,0.00018182097,0.0020409531,0.0011332848,0.00033431555,0.00021211291],"candidate_categories":["metaepi_narrow"],"consensus_categories":["metaepi_narrow"],"category_scores_codex":[0.0004479295,0.001671779,0.012523824,0.00022098528,0.00018644358,0.00009729875,0.00023302218,0.00026187763,0.0002749805],"category_scores_gemma":[0.000032080803,0.0008592812,0.0024858983,0.0012600548,0.00014369059,0.000025543177,0.000113281625,0.00021706367,0.0000040291616],"study_design_candidate":"meta_analysis","study_design_consensus":"meta_analysis","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00011674149,0.0007559279,0.100117244,0.2621636,0.49299997,0.000047922877,0.00016574997,0.0000070539672,3.2047996e-7,0.0000010105715,0.000288846,0.14333561],"study_design_scores_gemma":[0.0007853532,0.00013839334,0.003558583,0.12951982,0.85160965,0.000097071505,0.000027339112,5.6136855e-7,0.0000021240228,1.2977235e-7,0.013242766,0.0010182172],"about_ca_topic_score_codex":0.0022598691,"about_ca_topic_score_gemma":0.0017010792,"teacher_disagreement_score":0.35860968,"about_ca_system_score_codex":0.0009167786,"about_ca_system_score_gemma":0.0006073287,"threshold_uncertainty_score":0.9996029},"labels":[],"label_agreement":null},{"id":"W3196883315","doi":"10.1016/j.ctrv.2021.102283","title":"Platinum-based chemotherapy in early-stage triple negative breast cancer: A meta-analysis","year":2021,"lang":"en","type":"review","venue":"Cancer Treatment Reviews","topic":"Breast Cancer Treatment Studies","field":"Biochemistry, Genetics and Molecular Biology","cited_by":32,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto","funders":"","keywords":"Medicine; Internal medicine; Triple-negative breast cancer; Oncology; Taxane; Hazard ratio; Breast cancer; Anthracycline; Meta-analysis; Neutropenia; Confidence interval; Chemotherapy; Stage (stratigraphy); Cancer; Surgery","score_opus":0.11330154597979047,"score_gpt":0.395675935329519,"score_spread":0.2823743893497285,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3196883315","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000025430836,0.9914629,0.000028695662,0.00026270116,0.0001641596,0.0030647556,0.0048018084,0.000022913802,0.00016662394],"genre_scores_gemma":[0.000038220744,0.97483,0.00032699466,0.0003309356,0.00033149152,0.019872217,0.0016856939,0.00013692169,0.0024475637],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99498844,0.00081286294,0.0013986196,0.0018422304,0.00027718287,0.00068065216],"domain_scores_gemma":[0.9969326,0.000091421585,0.0011960118,0.0014626188,0.00012979147,0.0001875299],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":["metaepi_narrow"],"category_scores_codex":[0.00024821062,0.0016134405,0.009294453,0.00032693145,0.00012655667,0.00007170147,0.00041694893,0.00044787268,0.0015612037],"category_scores_gemma":[0.000020254789,0.0010593017,0.0075944057,0.0017023796,0.00012807938,0.000010163962,0.00009807943,0.00022689032,0.000028366663],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00006599491,0.0005086986,0.00084197253,0.002298754,0.20876119,0.00003726843,0.000112224145,0.000056235313,0.0000014496317,0.0000037947625,0.0010013264,0.7863111],"study_design_scores_gemma":[0.0014006665,0.00008669659,0.00015719114,0.0010243364,0.2184132,0.000004793868,0.00000939876,0.0000018547415,0.000053158983,7.296676e-7,0.7781718,0.0006761661],"about_ca_topic_score_codex":0.0057897167,"about_ca_topic_score_gemma":0.009294413,"teacher_disagreement_score":0.78563493,"about_ca_system_score_codex":0.0012730826,"about_ca_system_score_gemma":0.0011576059,"threshold_uncertainty_score":0.9996613},"labels":[],"label_agreement":null},{"id":"W3200484435","doi":"10.1016/j.ctrv.2021.102294","title":"The role of the tumor primary chemosensitivity relative to the success of the medical-surgical management in patients with advanced ovarian carcinomas","year":2021,"lang":"en","type":"review","venue":"Cancer Treatment Reviews","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":52,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"National Institute for Health and Care Research","keywords":"Debulking; Medicine; Tumor Debulking; Oncology; Bevacizumab; Chemotherapy; Ovarian cancer; Internal medicine; Primary tumor; Clinical trial; Surgery; Cancer; Metastasis","score_opus":0.019109934841371513,"score_gpt":0.3121977706038538,"score_spread":0.29308783576248226,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3200484435","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0010660207,0.9829121,7.138247e-7,0.0019173376,0.0003067175,0.010621084,0.0001104782,0.0000063165103,0.0030592205],"genre_scores_gemma":[0.0027423112,0.9918033,0.000068487054,0.00025316354,0.000102752085,0.0045034396,0.000048127447,0.000051425173,0.00042698695],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9958211,0.0009686752,0.00119708,0.00068915245,0.00093011354,0.00039383437],"domain_scores_gemma":[0.99624896,0.00041689834,0.0010954663,0.0019487219,0.000139506,0.00015047172],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005142552,0.00065609027,0.0028529926,0.000049729766,0.00019647188,0.000019441315,0.0005725106,0.00012311341,0.000073273426],"category_scores_gemma":[0.00006602884,0.00020104728,0.001057872,0.0011218615,0.00025268068,0.000043295146,0.00034199076,0.00038875433,0.0000054922334],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00009240958,0.0007597731,0.014104957,0.0025473798,0.0012325986,0.000049281894,0.00013746602,0.0000021336357,2.5267079e-8,0.00032294248,0.00016562597,0.9805854],"study_design_scores_gemma":[0.0024261062,0.00025804463,0.047315445,0.037841838,0.004046431,0.000015952935,0.000026690339,5.109155e-7,0.000015434658,0.000006973947,0.9078699,0.0001766945],"about_ca_topic_score_codex":0.00030743805,"about_ca_topic_score_gemma":0.0005106437,"teacher_disagreement_score":0.9804087,"about_ca_system_score_codex":0.0018403279,"about_ca_system_score_gemma":0.0010844624,"threshold_uncertainty_score":0.819847},"labels":[],"label_agreement":null},{"id":"W3200782887","doi":"10.1016/j.ctrv.2021.102293","title":"The impact of radiological assessment schedules on progression-free survival in metastatic breast cancer: A systemic review and meta-analysis","year":2021,"lang":"en","type":"review","venue":"Cancer Treatment Reviews","topic":"Breast Cancer Treatment Studies","field":"Biochemistry, Genetics and Molecular Biology","cited_by":9,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto","funders":"","keywords":"Medicine; Confidence interval; Hazard ratio; Metastatic breast cancer; Internal medicine; Breast cancer; Oncology; Meta-analysis; Population; Randomized controlled trial; Subgroup analysis; Cancer","score_opus":0.12793987392326162,"score_gpt":0.46872736857275327,"score_spread":0.34078749464949165,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3200782887","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0000240022,0.99298334,0.0000052818314,0.00034186288,0.000067575194,0.0038178766,0.002704324,0.000007684393,0.00004804662],"genre_scores_gemma":[0.00009727719,0.98300445,0.00016759113,0.00005151965,0.00008376862,0.015919307,0.0005320795,0.000050210012,0.000093821975],"study_design_codex":"design_other","study_design_gemma":"meta_analysis","domain_scores_codex":[0.9943034,0.002163207,0.0015695965,0.0011815124,0.0003003431,0.00048193077],"domain_scores_gemma":[0.9963102,0.00027216,0.0014697611,0.0016626074,0.0001405081,0.00014477469],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00087,0.0011817033,0.010259244,0.0001265048,0.00014126865,0.00004314368,0.00050773553,0.00018864838,0.00015464911],"category_scores_gemma":[0.00007859489,0.000492717,0.0053850138,0.00084374123,0.00020957681,0.0000064406395,0.00025011084,0.00021450024,0.0000022493252],"study_design_candidate":"meta_analysis","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000030605628,0.00047324676,0.0010923542,0.016773893,0.30739444,0.000021936421,0.000011426533,0.000019900044,9.889766e-7,0.000051205505,0.0006902643,0.67343974],"study_design_scores_gemma":[0.00070301956,0.0003982986,0.00054162624,0.0110860765,0.7102593,0.00008633769,0.000014433022,9.907768e-7,0.000001731635,0.0000051309003,0.27632585,0.00057716673],"about_ca_topic_score_codex":0.000662725,"about_ca_topic_score_gemma":0.0006000146,"teacher_disagreement_score":0.6728625,"about_ca_system_score_codex":0.00094026537,"about_ca_system_score_gemma":0.00094877515,"threshold_uncertainty_score":0.99975246},"labels":[],"label_agreement":null},{"id":"W3203279168","doi":"10.1016/j.ctrv.2021.102299","title":"Prognostic factors for relapse in resected gastroenteropancreatic neuroendocrine neoplasms: A systematic review and meta-analysis","year":2021,"lang":"en","type":"review","venue":"Cancer Treatment Reviews","topic":"Neuroendocrine Tumor Research Advances","field":"Medicine","cited_by":11,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto","funders":"","keywords":"Medicine; Perineural invasion; Internal medicine; Lymph node; Oncology; Subgroup analysis; Disease; Cohort; Meta-analysis; Gastroenterology; Surgery; Cancer","score_opus":0.1709972473452934,"score_gpt":0.4411561825446852,"score_spread":0.2701589351993918,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3203279168","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000012463155,0.9596554,0.0000054367756,0.00034693678,0.00004706455,0.03934471,0.0005108345,0.000056099714,0.000021060592],"genre_scores_gemma":[0.0000031335728,0.9314474,0.00028196885,0.00027289343,0.00003274179,0.063256405,0.00094720564,0.00014782486,0.0036104163],"study_design_codex":"systematic_review","study_design_gemma":"meta_analysis","domain_scores_codex":[0.9915175,0.0021233498,0.00318578,0.0017003326,0.000476125,0.000996953],"domain_scores_gemma":[0.9944953,0.0014869138,0.0015038971,0.0017963896,0.0001966274,0.0005208862],"candidate_categories":["metaepi_narrow","metaepi_broad"],"consensus_categories":["metaepi_narrow"],"category_scores_codex":[0.00036878337,0.0015625495,0.030884918,0.0008771543,0.00008311205,0.00008279772,0.00031813668,0.000030820895,0.00038801166],"category_scores_gemma":[0.0028050062,0.000844809,0.0067064343,0.0024996696,0.000098024175,0.00013550206,0.00013257541,0.00048125887,0.000018699973],"study_design_candidate":"systematic_review","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000012884511,0.00027440896,0.00011151764,0.91309947,0.08105821,0.0015944744,0.000009883881,2.766353e-7,8.4807915e-8,0.0000031484547,0.0003340899,0.0035015233],"study_design_scores_gemma":[0.0004677702,0.00055375264,0.0000024087883,0.15431671,0.6106432,0.00078918756,0.0000067893125,0.0000012952818,8.261043e-7,7.5142367e-7,0.2329663,0.0002509668],"about_ca_topic_score_codex":0.00012576683,"about_ca_topic_score_gemma":0.00048311357,"teacher_disagreement_score":0.7587828,"about_ca_system_score_codex":0.000912793,"about_ca_system_score_gemma":0.00048550492,"threshold_uncertainty_score":0.9997123},"labels":[],"label_agreement":null},{"id":"W3210523511","doi":"10.1016/j.ctrv.2021.102310","title":"Genomic sequencing to inform therapy in advanced pancreatic cancer: A systematic review and meta-analysis of prospective studies","year":2021,"lang":"en","type":"review","venue":"Cancer Treatment Reviews","topic":"Pancreatic and Hepatic Oncology Research","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ontario Institute for Cancer Research; McGill University Health Centre; University Health Network; Dalhousie University; Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; Pancreatic cancer; Meta-analysis; Internal medicine; Oncology; Hazard ratio; Targeted therapy; Cancer; Confidence interval; Bioinformatics; Biology","score_opus":0.3355794220963075,"score_gpt":0.520829721966734,"score_spread":0.18525029987042657,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3210523511","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00008960906,0.9741953,0.0000015932901,0.00021531788,0.000025069405,0.025134712,0.00016761996,0.000013323061,0.00015744995],"genre_scores_gemma":[0.0000041527637,0.9352765,0.00041196254,0.00048104083,0.00002112623,0.06166437,0.00006666488,0.00004448788,0.0020296618],"study_design_codex":"systematic_review","study_design_gemma":"meta_analysis","domain_scores_codex":[0.99476796,0.0008414973,0.0027723291,0.0008478002,0.00032717918,0.00044323233],"domain_scores_gemma":[0.99637103,0.0005947923,0.0013895308,0.0010920693,0.00033333956,0.00021921632],"candidate_categories":["metaepi_narrow","metaepi_broad"],"consensus_categories":[],"category_scores_codex":[0.0011746396,0.0008916025,0.04024514,0.0006553949,0.00006830094,0.0000142299195,0.00018687348,0.00016559756,0.00045616372],"category_scores_gemma":[0.00042909782,0.0004558518,0.0029988342,0.0028959133,0.00010907978,0.00006170579,0.00008802938,0.0002467978,0.000014502824],"study_design_candidate":"meta_analysis","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0000110291385,0.000074974894,0.00041037513,0.6370717,0.29285857,0.000030285282,0.000564037,9.257742e-7,4.368713e-7,0.000009817763,0.00003577339,0.06893203],"study_design_scores_gemma":[0.00041053002,0.00040811737,0.000033617576,0.21773225,0.7177107,0.000017407561,0.000085249914,0.0000012908744,8.2485815e-7,0.0000015575209,0.06335894,0.0002395463],"about_ca_topic_score_codex":0.00051420956,"about_ca_topic_score_gemma":0.0007661207,"teacher_disagreement_score":0.4248521,"about_ca_system_score_codex":0.004688288,"about_ca_system_score_gemma":0.0017852326,"threshold_uncertainty_score":0.9997893},"labels":[],"label_agreement":null},{"id":"W4245954238","doi":"10.1016/s0305-7372(04)00144-6","title":"Gefitinib does not improve survival when combined with paclitaxel and carboplatin chemotherapy in people with advanced non-small-cell lung cancer☆, ☆, ☆☆Abstracted from: Herbst RS, Giaccone G, Schiller JH et al. Gefitinib in combination with paclitaxel and carboplatin in advanced non-small-cell lung cancer: a phase III trial – INTACT 2. J Clin Oncol 2004;22:785–94.","year":2004,"lang":"en","type":"article","venue":"Cancer Treatment Reviews","topic":"Lung Cancer Treatments and Mutations","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Cancer Care Ontario","funders":"","keywords":"Gefitinib; Medicine; Carboplatin; Paclitaxel; Lung cancer; Oncology; Chemotherapy; Epidermal growth factor receptor; Internal medicine; Tyrosine-kinase inhibitor; Tyrosine kinase; Cancer research; Cancer; Cisplatin; Receptor","score_opus":0.013877398128715145,"score_gpt":0.32741736364032537,"score_spread":0.31353996551161023,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4245954238","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.94917995,0.027858445,0.000109905886,0.0028347683,0.000363783,0.018246653,0.0008835855,0.00007442847,0.00044848563],"genre_scores_gemma":[0.9181156,0.05876117,0.0040219342,0.0011993513,0.00016403185,0.015904557,0.000907512,0.00022695557,0.0006988614],"study_design_codex":"observational","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9947036,0.0002620396,0.0016430101,0.0018340672,0.0005296123,0.0010276897],"domain_scores_gemma":[0.9968531,0.00033573454,0.0013050662,0.0007868326,0.00024596008,0.00047329962],"candidate_categories":["metaepi_narrow"],"consensus_categories":["metaepi_narrow"],"category_scores_codex":[0.00048265106,0.0013876957,0.0029841794,0.000421349,0.00018681712,0.0001476004,0.00019343906,0.00029049572,0.000120170684],"category_scores_gemma":[0.000027018941,0.00091480534,0.00017302201,0.000848204,0.00017032867,0.0006777824,0.00005063995,0.00074513035,0.0000014283411],"study_design_candidate":"randomized_trial","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.17189841,0.016787529,0.6023797,0.003278898,0.0025592796,0.00072207616,0.033029847,0.003324839,0.017346302,0.000036163143,0.00020736316,0.1484296],"study_design_scores_gemma":[0.86543924,0.014981999,0.08783597,0.011025169,0.0026593017,0.000014443884,0.0026039705,0.0013360117,0.008946413,0.000023607108,0.0029708415,0.0021630211],"about_ca_topic_score_codex":0.06950875,"about_ca_topic_score_gemma":0.2054941,"teacher_disagreement_score":0.6935409,"about_ca_system_score_codex":0.0038726067,"about_ca_system_score_gemma":0.0024411252,"threshold_uncertainty_score":0.99995136},"labels":[],"label_agreement":null},{"id":"W4292253343","doi":"10.1016/j.ctrv.2022.102455","title":"Retrospective observational studies in ultra-rare sarcomas: A consensus paper from the Connective Tissue Oncology Society (CTOS) community of experts on the minimum requirements for the evaluation of activity of systemic treatments","year":2022,"lang":"en","type":"review","venue":"Cancer Treatment Reviews","topic":"Sarcoma Diagnosis and Treatment","field":"Medicine","cited_by":27,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children; Princess Margaret Cancer Centre; University of Toronto; SickKids Foundation; Mount Sinai Hospital","funders":"Connective Tissue Oncology Society","keywords":"Medicine; Observational study; Context (archaeology); Medical physics; Family medicine; Intensive care medicine; Pathology","score_opus":0.668078266631063,"score_gpt":0.5380330149164358,"score_spread":0.1300452517146271,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4292253343","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.028607978,0.9506334,5.409875e-7,0.00058847124,0.00027230594,0.017763825,0.0019961384,0.000006369264,0.00013094032],"genre_scores_gemma":[0.076946676,0.8910536,0.000032711032,0.0001450964,0.00007578026,0.031339753,0.00033923337,0.00003635949,0.00003078864],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99275696,0.0044275834,0.0013998767,0.00048252204,0.00069167383,0.00024140424],"domain_scores_gemma":[0.98270917,0.013182522,0.0024138885,0.0012399217,0.00041668324,0.00003781589],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0022562596,0.00062542426,0.003842751,0.000053367043,0.00032591447,0.000005664068,0.0003192109,0.00016655716,0.00021209389],"category_scores_gemma":[0.0008957179,0.00025715155,0.001287994,0.00040930527,0.00041098698,0.000035904442,0.00007611554,0.00028433226,0.0000012074329],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00030384486,0.0038822244,0.005158556,0.004013588,0.012911752,0.0000041612925,0.010904076,0.0000056370577,0.000069180765,0.00007497051,0.0020351952,0.9606368],"study_design_scores_gemma":[0.01601685,0.00793405,0.018822284,0.08031617,0.07122336,0.000041203166,0.025159862,0.000031327618,0.0010723483,0.00034004796,0.7783634,0.00067909056],"about_ca_topic_score_codex":0.0025617916,"about_ca_topic_score_gemma":0.0008020314,"teacher_disagreement_score":0.9599577,"about_ca_system_score_codex":0.007502869,"about_ca_system_score_gemma":0.0011316936,"threshold_uncertainty_score":0.9999881},"labels":[],"label_agreement":null},{"id":"W4293428565","doi":"10.1016/j.ctrv.2022.102453","title":"Cabozantinib after prior checkpoint inhibitor therapy in patients with solid tumors: A systematic literature review","year":2022,"lang":"en","type":"review","venue":"Cancer Treatment Reviews","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Sunnybrook Health Science Centre; University of Toronto; CancerCare Manitoba","funders":"Ipsen","keywords":"Cabozantinib; Medicine; Renal cell carcinoma; Tolerability; Oncology; Observational study; Clinical trial; Cochrane Library; Internal medicine; Systematic review; Kidney cancer; MEDLINE; Adverse effect; Meta-analysis","score_opus":0.04775146533847868,"score_gpt":0.33780633725682585,"score_spread":0.29005487191834717,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4293428565","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00016037044,0.9567426,1.582085e-7,0.000052503103,0.00022961476,0.042279758,0.00021908229,0.0000574591,0.0002584652],"genre_scores_gemma":[0.000009250078,0.9199754,0.00010507255,0.00048016733,0.00024336137,0.07639917,0.0013549328,0.00023782905,0.0011948228],"study_design_codex":"systematic_review","study_design_gemma":"not_applicable","domain_scores_codex":[0.9925458,0.0012402422,0.0031512745,0.0014941596,0.0008198466,0.000748723],"domain_scores_gemma":[0.99533373,0.00012785685,0.0020036679,0.0020415864,0.00013359773,0.0003595315],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":["metaepi_narrow"],"category_scores_codex":[0.00058379135,0.0019600776,0.012345395,0.00045360083,0.000090381065,0.000075880314,0.0003037539,0.00025277844,0.001251615],"category_scores_gemma":[0.00006648981,0.00095801725,0.0022085812,0.0015661711,0.00006115997,0.00013555586,0.00009395045,0.000707853,0.00016310289],"study_design_candidate":"systematic_review","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00013427185,0.00088355737,0.0003693908,0.56798923,0.00062370807,0.0006698822,0.00013592922,3.0999896e-8,3.0676325e-8,3.6543008e-7,0.00023988534,0.4289537],"study_design_scores_gemma":[0.0019682802,0.0015821534,0.00012623925,0.4950242,0.004372627,0.00009968015,0.000002233639,6.7211516e-8,0.0000011003234,1.3620311e-7,0.49641386,0.00040941784],"about_ca_topic_score_codex":0.000033342407,"about_ca_topic_score_gemma":0.000023398325,"teacher_disagreement_score":0.49617398,"about_ca_system_score_codex":0.0043846625,"about_ca_system_score_gemma":0.0010572161,"threshold_uncertainty_score":0.9996614},"labels":[],"label_agreement":null},{"id":"W4318205427","doi":"10.1016/j.ctrv.2023.102519","title":"A systematic review of eHealth technologies for breast cancer supportive care","year":2023,"lang":"en","type":"review","venue":"Cancer Treatment Reviews","topic":"Cancer survivorship and care","field":"Medicine","cited_by":30,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen's University","funders":"","keywords":"eHealth; Medicine; CINAHL; Psychological intervention; Breast cancer; Context (archaeology); Randomized controlled trial; MEDLINE; Patient satisfaction; Telemedicine; Family medicine; Cancer; Health care; Internal medicine; Nursing","score_opus":0.10151399184867065,"score_gpt":0.44242813454720326,"score_spread":0.3409141426985326,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4318205427","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[9.4256485e-8,0.9602017,0.00000526657,0.00038485313,0.00066898885,0.030905914,0.007452193,0.00024424534,0.00013678208],"genre_scores_gemma":[3.256384e-7,0.9111735,0.000033800876,0.00020928023,0.0002182439,0.08599643,0.00078738935,0.00015865723,0.001422382],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.99514866,0.00027454697,0.0027555863,0.0008977998,0.0003551833,0.0005682003],"domain_scores_gemma":[0.99505556,0.00023180808,0.0026130718,0.0014736564,0.0004595662,0.00016632244],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0004501924,0.0010419637,0.012931233,0.0002920792,0.00007672398,0.000014071163,0.00035551822,0.00038283854,0.00017546517],"category_scores_gemma":[0.00016125664,0.0005931626,0.0032818476,0.0011357053,0.00010389565,0.00004644696,0.000070173955,0.00024763824,0.000065474094],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000007451812,0.00003144633,0.0000036377369,0.53805107,0.0008037438,0.000006858482,0.00011150147,6.119091e-9,1.6335568e-8,0.0000095501355,0.001629724,0.459345],"study_design_scores_gemma":[0.00021518522,0.00017846409,4.332927e-7,0.5111053,0.021293953,0.000030499632,0.00017595921,6.486872e-8,9.0204463e-7,0.0000016345948,0.4667771,0.00022051211],"about_ca_topic_score_codex":0.0009571942,"about_ca_topic_score_gemma":0.0012940916,"teacher_disagreement_score":0.46514735,"about_ca_system_score_codex":0.003486559,"about_ca_system_score_gemma":0.002670844,"threshold_uncertainty_score":0.99965197},"labels":[],"label_agreement":null},{"id":"W4320717817","doi":"10.1016/j.ctrv.2023.102525","title":"nmCRPC, a look in the continuous care of prostate cancer patients: state of art and future perspectives","year":2023,"lang":"en","type":"review","venue":"Cancer Treatment Reviews","topic":"Prostate Cancer Treatment and Research","field":"Medicine","cited_by":21,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Surgical Specialties (Canada)","funders":"Cilag","keywords":"Medicine; Prostate cancer; Incidence (geometry); Clinical trial; Metastasis; Oncology; Adverse effect; Internal medicine; Cancer","score_opus":0.05666846989924946,"score_gpt":0.40249026250732234,"score_spread":0.3458217926080729,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4320717817","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00094040734,0.98651016,5.4564982e-8,0.00026145478,0.00015854137,0.010364181,0.0013170483,0.00001810915,0.00043006067],"genre_scores_gemma":[0.000037356032,0.98950094,0.000017268967,0.000023493685,0.00021612426,0.0070481678,0.0004912066,0.00007844442,0.0025869731],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99694407,0.00039115842,0.0011366942,0.0006723826,0.00041063086,0.00044504867],"domain_scores_gemma":[0.99803996,0.00012567303,0.0008177645,0.0006067458,0.00029112937,0.00011871773],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00026474104,0.0006804602,0.0039123655,0.00030957354,0.00005504381,0.000019930716,0.00019635288,0.00014596609,0.00007848324],"category_scores_gemma":[0.000024724783,0.00032194293,0.00067049405,0.00084971945,0.00026528002,0.000065666005,0.000060879054,0.00031148666,0.00001791645],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000117521406,0.00047631862,0.00311357,0.05019952,0.00072350656,0.000038877843,0.009645677,1.3154578e-7,2.687643e-7,0.0000068118547,0.0011192224,0.9345586],"study_design_scores_gemma":[0.002400053,0.0013083493,0.00060716714,0.03776922,0.0024919563,0.000004621357,0.0016090712,1.7846185e-7,0.000006875649,0.00000511895,0.9535626,0.00023478197],"about_ca_topic_score_codex":0.0004264125,"about_ca_topic_score_gemma":0.00048122325,"teacher_disagreement_score":0.95244336,"about_ca_system_score_codex":0.0012058215,"about_ca_system_score_gemma":0.0010075858,"threshold_uncertainty_score":0.9999233},"labels":[],"label_agreement":null},{"id":"W4322774020","doi":"10.1016/j.ctrv.2023.102526","title":"Clinical consensus statement: Establishing the roles of locoregional and systemic therapies for the treatment of intermediate-stage hepatocellular carcinoma in Canada","year":2023,"lang":"en","type":"review","venue":"Cancer Treatment Reviews","topic":"Hepatocellular Carcinoma Treatment and Prognosis","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of British Columbia; University of New Brunswick; Université de Montréal; University of Toronto; Western University; McGill University; Hôpital du Sacré-Cœur de Montréal; Juravinski Cancer Centre; Vancouver General Hospital; Princess Margaret Cancer Centre; University of Calgary; BC Cancer Agency; Dalhousie University","funders":"","keywords":"Medicine; Systemic therapy; Context (archaeology); Stage (stratigraphy); Hepatocellular carcinoma; Radiation therapy; Intensive care medicine; Internal medicine; Oncology; Surgery; Cancer","score_opus":0.2824124292356557,"score_gpt":0.3892550520759621,"score_spread":0.10684262284030643,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4322774020","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.047524266,0.9385601,0.0000027302049,0.00016006237,0.00031986219,0.012608996,0.000803144,0.000011537856,0.000009273704],"genre_scores_gemma":[0.024900343,0.9658443,0.000029485076,0.000025149442,0.00020861228,0.008305484,0.00030254116,0.000083928084,0.00030018404],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9953434,0.00068239524,0.002609229,0.00063468906,0.000298699,0.00043161647],"domain_scores_gemma":[0.994055,0.003286617,0.001567584,0.00084217446,0.000102369464,0.0001462643],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0008143028,0.00078241545,0.004481938,0.00014841266,0.000098340475,0.000023910126,0.00024509916,0.00017415802,0.000026354446],"category_scores_gemma":[0.00006989944,0.00033766194,0.0012621235,0.00036894483,0.00027008879,0.00003164582,0.000041051546,0.00015954819,0.0000025694246],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000091259746,0.00022209666,0.25102207,0.020594636,0.0018955301,0.00010347387,0.0006678838,7.7012095e-7,3.263366e-7,0.000020269637,0.0001978363,0.72518384],"study_design_scores_gemma":[0.0026027272,0.0012084364,0.00092394097,0.020763148,0.00827099,0.000023624287,0.000729626,0.0003303805,0.000010807879,0.0000036467334,0.96486616,0.00026653745],"about_ca_topic_score_codex":0.22477296,"about_ca_topic_score_gemma":0.3219888,"teacher_disagreement_score":0.9646683,"about_ca_system_score_codex":0.0020598865,"about_ca_system_score_gemma":0.0035685883,"threshold_uncertainty_score":0.99990755},"labels":[],"label_agreement":null},{"id":"W4377969156","doi":"10.1016/j.ctrv.2023.102583","title":"Clinical trial designs for evaluating and exploiting cancer evolution","year":2023,"lang":"en","type":"review","venue":"Cancer Treatment Reviews","topic":"Cancer Genomics and Diagnostics","field":"Biochemistry, Genetics and Molecular Biology","cited_by":18,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute of Cancer Research","funders":"Imperial Experimental Cancer Medicine Centre; National Institute for Health and Care Research; Cancer Research UK","keywords":"Medicine; Clinical trial; Somatic evolution in cancer; Clinical study design; Intensive care medicine; Cancer; Bioinformatics; Internal medicine; Biology","score_opus":0.5524420529314084,"score_gpt":0.5605969373199633,"score_spread":0.00815488438855494,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4377969156","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00013593564,0.99103,0.0004713363,0.000018599161,0.0013615516,0.0064132866,0.0005131814,0.000017295682,0.000038838254],"genre_scores_gemma":[0.0000025404654,0.97511035,0.0008063369,0.00005285048,0.003755635,0.018810784,0.0005813687,0.00010800037,0.00077212945],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9970525,0.0002981266,0.0012672012,0.0009208603,0.00009482499,0.000366501],"domain_scores_gemma":[0.9981485,0.0002988285,0.00085267454,0.00047658582,0.00007687595,0.00014651545],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0009281574,0.00052454794,0.0019380004,0.00005695154,0.00014781431,0.00005258847,0.0001666577,0.0003686086,0.000016079815],"category_scores_gemma":[0.000428176,0.00039499105,0.0010049389,0.00012761707,0.000059979197,0.0000033586894,0.000098153374,0.00010644368,0.00001473833],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00028136317,0.000050509505,0.000018069168,0.004166423,0.00036457318,7.5680225e-7,0.0000079706715,0.0000031377685,0.000008727766,0.000016318927,0.002733699,0.99234843],"study_design_scores_gemma":[0.006403607,0.0013879944,0.0000015475076,0.006420887,0.0028420934,0.0000021515036,0.0000055887112,0.00001709801,0.0000063296416,0.000022743454,0.9825021,0.00038783308],"about_ca_topic_score_codex":0.00014703936,"about_ca_topic_score_gemma":0.0003110899,"teacher_disagreement_score":0.99196064,"about_ca_system_score_codex":0.000446189,"about_ca_system_score_gemma":0.0011717853,"threshold_uncertainty_score":0.9998502},"labels":[],"label_agreement":null},{"id":"W4378530156","doi":"10.1016/j.ctrv.2023.102584","title":"The evolution of immune checkpoint inhibitor combinations in advanced hepatocellular carcinoma – A systematic review","year":2023,"lang":"en","type":"review","venue":"Cancer Treatment Reviews","topic":"Hepatocellular Carcinoma Treatment and Prognosis","field":"Medicine","cited_by":22,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary; University of British Columbia; BC Cancer Agency; Princess Margaret Cancer Centre; Juravinski Cancer Centre; Dalhousie University; University of Toronto; McMaster University","funders":"","keywords":"Sorafenib; Medicine; Bevacizumab; Oncology; Durvalumab; Atezolizumab; Internal medicine; Hepatocellular carcinoma; Clinical trial; Regimen; Immunotherapy; Cancer; Nivolumab; Chemotherapy","score_opus":0.1175993671776607,"score_gpt":0.34778021340634835,"score_spread":0.23018084622868765,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4378530156","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00008645738,0.96970975,0.0000026700702,0.00016266001,0.00029036758,0.029414393,0.00008880139,0.00006440286,0.00018047074],"genre_scores_gemma":[0.0004347801,0.9600026,0.00003501125,0.000015823949,0.00007716877,0.036763072,0.00045204692,0.00012638337,0.002093098],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.9930938,0.0010507876,0.0041616918,0.00072014466,0.00043172386,0.00054184307],"domain_scores_gemma":[0.99536544,0.00041257008,0.0022420713,0.0016325626,0.00017072809,0.00017665171],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0013952564,0.0009839089,0.008380958,0.0003585477,0.00015931833,0.000025482279,0.00033190806,0.00027105844,0.00003816522],"category_scores_gemma":[0.00034447602,0.0005203222,0.003112357,0.0018546348,0.00011188392,0.00007634117,0.00008209089,0.00032179314,0.0002844086],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000009315079,0.00035750272,0.0012232551,0.86627775,0.00054595893,0.00008557326,0.00004853126,2.0104926e-8,0.0000016646854,0.00006834233,0.00008579148,0.1312963],"study_design_scores_gemma":[0.001010311,0.00034194684,0.000021928816,0.6872427,0.01611878,0.000035250763,0.00002234662,0.000025470123,0.000013541784,0.000011097796,0.29485476,0.0003018785],"about_ca_topic_score_codex":0.00053018524,"about_ca_topic_score_gemma":0.00011546561,"teacher_disagreement_score":0.294769,"about_ca_system_score_codex":0.004796758,"about_ca_system_score_gemma":0.0012321349,"threshold_uncertainty_score":0.99972486},"labels":[],"label_agreement":null},{"id":"W4386800011","doi":"10.1016/j.ctrv.2023.102626","title":"Managing postoperative biochemical relapse in prostate cancer, from the perspective of the Francophone group of Urological radiotherapy (GFRU)","year":2023,"lang":"en","type":"review","venue":"Cancer Treatment Reviews","topic":"Prostate Cancer Treatment and Research","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Kelowna General Hospital; Hôpital Charles-Le Moyne","funders":"","keywords":"Medicine; Prostate cancer; Radiation therapy; Androgen deprivation therapy; Radiological weapon; Disease; Positron emission tomography; Clinical trial; Management of prostate cancer; Prostate; Biochemical recurrence; Cancer; Oncology; Radiology; Internal medicine; Prostatectomy","score_opus":0.08208481369047983,"score_gpt":0.4076436679264487,"score_spread":0.32555885423596886,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4386800011","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0012275053,0.9855976,0.0000011560388,0.0028287892,0.00043353095,0.008943644,0.00078517065,0.000025288999,0.0001572934],"genre_scores_gemma":[0.00011031476,0.99248177,0.000060786184,0.0001631763,0.00029935638,0.0055725924,0.00016673908,0.00008985362,0.0010554391],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9961571,0.0007803638,0.0012535402,0.00088057405,0.00043566644,0.00049272634],"domain_scores_gemma":[0.99746233,0.00046372318,0.00080541807,0.0010179075,0.00013334768,0.00011726377],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00039998099,0.0007474295,0.0038339049,0.00012237993,0.00010271271,0.000015866084,0.00047679053,0.00025355557,0.0002441306],"category_scores_gemma":[0.00008050305,0.00029844145,0.0012823174,0.0016719842,0.0005492597,0.000047185746,0.00013213995,0.0006608146,0.00001659062],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005547816,0.000608176,0.0025589445,0.006341281,0.0024475588,0.0000766999,0.0033668175,0.0000028532477,0.00012853058,0.000054554715,0.002694346,0.98116547],"study_design_scores_gemma":[0.0038965633,0.0008477558,0.00088255847,0.052042637,0.0023078262,0.000012764174,0.0004066306,0.000008432268,0.00019376178,0.00012446822,0.93891007,0.0003665203],"about_ca_topic_score_codex":0.006730221,"about_ca_topic_score_gemma":0.00048779824,"teacher_disagreement_score":0.98079896,"about_ca_system_score_codex":0.0027803879,"about_ca_system_score_gemma":0.0011085321,"threshold_uncertainty_score":0.9999468},"labels":[],"label_agreement":null},{"id":"W4388049965","doi":"10.1016/j.ctrv.2023.102649","title":"Molecular profiling in cholangiocarcinoma: A practical guide to next-generation sequencing","year":2023,"lang":"en","type":"review","venue":"Cancer Treatment Reviews","topic":"Cholangiocarcinoma and Gallbladder Cancer Studies","field":"Medicine","cited_by":54,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"Agence Nationale de la Recherche; Sociedad Española de Oncología Médica; European Commission; Incyte","keywords":"Medicine; DNA sequencing; Computational biology; Targeted therapy; Bioinformatics; Liquid biopsy; Molecular diagnostics; Profiling (computer programming); Disease; Gene; Internal medicine; Cancer; Genetics; Biology","score_opus":0.40081382377839403,"score_gpt":0.4724980599402206,"score_spread":0.07168423616182656,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4388049965","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00016664898,0.9905579,0.00003321864,0.00042855993,0.00043761666,0.0071938266,0.000042680265,0.000103437,0.0010361281],"genre_scores_gemma":[0.0000125984725,0.983999,0.0018785072,0.0004627929,0.0010456106,0.010768767,0.0003711251,0.0001526616,0.0013089022],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99616975,0.00028456465,0.0014591742,0.001130126,0.00032496944,0.00063142466],"domain_scores_gemma":[0.9982959,0.00009450891,0.0003900867,0.00083381875,0.000083747706,0.00030194022],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00044278026,0.00087386084,0.003909405,0.00048222463,0.00008402025,0.000078535704,0.00014074515,0.00026409634,0.000041238764],"category_scores_gemma":[0.00022853093,0.00060638064,0.0010831964,0.0012050091,0.00003172675,0.000118919575,0.00010535385,0.00037686818,0.00048316465],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000015723588,0.00009758199,0.00029412983,0.015926717,0.0005931274,0.0010716707,0.0002768555,0.0000034117006,0.0000844765,0.000038913582,0.0063205995,0.97527677],"study_design_scores_gemma":[0.0006839458,0.000276117,0.000023583938,0.025443373,0.003448538,0.00012186519,0.00004093984,0.000017620474,0.00006312312,0.0000014190523,0.9694145,0.0004650016],"about_ca_topic_score_codex":0.00069731247,"about_ca_topic_score_gemma":0.0005676513,"teacher_disagreement_score":0.9748118,"about_ca_system_score_codex":0.005224793,"about_ca_system_score_gemma":0.0017280368,"threshold_uncertainty_score":0.99963874},"labels":[],"label_agreement":null},{"id":"W4388341977","doi":"10.1016/j.ctrv.2023.102652","title":"Vascular endothelial growth factor-targeted therapy in patients with renal cell carcinoma pretreated with immune checkpoint inhibitors: A systematic literature review","year":2023,"lang":"en","type":"review","venue":"Cancer Treatment Reviews","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":19,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"Ipsen; Ipsen Fund","keywords":"Medicine; Cabozantinib; Tolerability; Pazopanib; Renal cell carcinoma; Oncology; Internal medicine; Vascular endothelial growth factor; Adverse effect; Systematic review; Regimen; Cochrane Library; Sunitinib; MEDLINE; Randomized controlled trial; VEGF receptors","score_opus":0.03545536927305138,"score_gpt":0.285767195707976,"score_spread":0.2503118264349246,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4388341977","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0019210845,0.956133,9.907291e-7,0.000022615823,0.00015244019,0.041011278,0.0004749904,0.00015219735,0.0001314217],"genre_scores_gemma":[0.00029512853,0.9728078,0.00011194915,0.000069292364,0.00023392885,0.02198227,0.0032236925,0.00046398427,0.0008119178],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.9910867,0.0014432238,0.0034519914,0.001888357,0.0011009376,0.0010287856],"domain_scores_gemma":[0.99410367,0.00019175625,0.0025127102,0.0022752143,0.0004344609,0.00048218836],"candidate_categories":["metaepi_narrow"],"consensus_categories":["metaepi_narrow"],"category_scores_codex":[0.0004743125,0.0027538976,0.012618325,0.0007286567,0.0001104536,0.000104120656,0.00040818643,0.0005162502,0.0001435281],"category_scores_gemma":[0.000073428804,0.0012740119,0.0025943727,0.0028227011,0.00010174457,0.00018698614,0.0000682721,0.00078831834,0.00019464966],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00031509835,0.0013329586,0.0043512504,0.9177094,0.0026805662,0.0009826593,0.00031554923,2.4443622e-7,0.000002864402,6.0487565e-7,0.000116073046,0.07219274],"study_design_scores_gemma":[0.0088801095,0.0057438016,0.00163251,0.88946354,0.013724352,0.000083019986,0.0000053116555,3.360594e-7,0.00013494701,5.9602525e-7,0.07919182,0.0011396616],"about_ca_topic_score_codex":0.00029233762,"about_ca_topic_score_gemma":0.000055984932,"teacher_disagreement_score":0.07907574,"about_ca_system_score_codex":0.0044684247,"about_ca_system_score_gemma":0.0010368223,"threshold_uncertainty_score":0.99935323},"labels":[],"label_agreement":null},{"id":"W4388461381","doi":"10.1016/j.ctrv.2023.102653","title":"Pharmacotherapy for leptomeningeal disease in breast cancer","year":2023,"lang":"en","type":"article","venue":"Cancer Treatment Reviews","topic":"Brain Metastases and Treatment","field":"Medicine","cited_by":29,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Sunnybrook Health Science Centre","funders":"Seagen","keywords":"Medicine; Breast cancer; Trastuzumab; Clinical trial; Oncology; Metastatic breast cancer; Systemic therapy; Cancer; Internal medicine; Disease","score_opus":0.0922318840725777,"score_gpt":0.43915167979962827,"score_spread":0.34691979572705056,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4388461381","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.40931216,0.5413665,0.00006496248,0.032960013,0.0010199632,0.011855872,0.0027798573,0.00030253318,0.00033814955],"genre_scores_gemma":[0.116381094,0.8481423,0.00043260827,0.0022901117,0.0008257448,0.025794104,0.00048208638,0.00008993137,0.0055619744],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9987198,0.00005478062,0.0003252972,0.00039952408,0.00011989791,0.0003806813],"domain_scores_gemma":[0.9993049,0.000044103672,0.00009162577,0.00026874227,0.000028879267,0.00026178756],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00015153816,0.00027374388,0.00061999116,0.00012489874,0.00005901895,0.000013239146,0.000052275336,0.000029423827,0.00094590575],"category_scores_gemma":[0.000004366712,0.00017585464,0.00032281724,0.00041156518,0.00002809777,0.00005149366,0.000009800124,0.000046015808,0.00009253776],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0007218376,0.0005235433,0.15460183,0.0004317531,0.00028908302,0.000108193664,0.00019146153,0.000073051,0.00031432748,0.000027887805,0.017449703,0.8252673],"study_design_scores_gemma":[0.008547332,0.00023158324,0.055370443,0.00070673705,0.0007435921,0.0000053242206,0.0000149240195,0.00039552982,0.00035930055,0.000035495672,0.9333889,0.00020084539],"about_ca_topic_score_codex":0.00044086945,"about_ca_topic_score_gemma":0.00008921087,"teacher_disagreement_score":0.9159392,"about_ca_system_score_codex":0.0007331359,"about_ca_system_score_gemma":0.00021364908,"threshold_uncertainty_score":0.99996734},"labels":[],"label_agreement":null},{"id":"W4389001294","doi":"10.1016/j.ctrv.2023.102663","title":"A systematic review of the role of chemotherapy in retroperitoneal sarcoma by the Australia and New Zealand sarcoma association clinical practice guidelines working party","year":2023,"lang":"en","type":"review","venue":"Cancer Treatment Reviews","topic":"Sarcoma Diagnosis and Treatment","field":"Medicine","cited_by":12,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"Australia and New Zealand Sarcoma Association","keywords":"Medicine; Sarcoma; Chemotherapy; Clinical Practice; Oncology; General surgery; Internal medicine; Family medicine; Pathology","score_opus":0.22139979854696398,"score_gpt":0.4828110196235043,"score_spread":0.26141122107654036,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4389001294","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00006195016,0.9869261,1.023195e-7,0.0035385082,0.00017914394,0.009166709,0.000060341306,0.000012611952,0.00005456962],"genre_scores_gemma":[0.0000058307933,0.9948475,0.00017323106,0.0007336108,0.00023074343,0.0022475037,0.00006338789,0.000056165376,0.001642037],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99322146,0.0016097109,0.0038856636,0.0005013092,0.00048757353,0.00029428245],"domain_scores_gemma":[0.99322945,0.0014218221,0.0040791896,0.00096287037,0.00018869185,0.000117995325],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0025596656,0.0005752514,0.006099499,0.00005909806,0.00004873559,0.000022757427,0.0002635393,0.00025397394,0.000040154904],"category_scores_gemma":[0.0021877817,0.00023572659,0.0013489726,0.0006962707,0.00006258373,0.00004557197,0.00006208854,0.00030613085,0.0000169238],"study_design_candidate":"systematic_review","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000016674818,0.00042023003,0.009851341,0.3139159,0.0017708307,0.000007703195,0.000059484857,1.5808478e-8,2.705407e-7,0.000008252871,0.027812105,0.6461372],"study_design_scores_gemma":[0.00060078636,0.00010833191,0.00021427355,0.44064862,0.008887301,0.00002405635,0.000010275699,4.6807128e-7,0.000002312596,0.000003782176,0.54940677,0.00009301618],"about_ca_topic_score_codex":0.0018308457,"about_ca_topic_score_gemma":0.00019327804,"teacher_disagreement_score":0.64604414,"about_ca_system_score_codex":0.0009721745,"about_ca_system_score_gemma":0.00046243664,"threshold_uncertainty_score":0.96126515},"labels":[],"label_agreement":null},{"id":"W4389248415","doi":"10.1016/j.ctrv.2023.102666","title":"Reporting of post-protocol therapies in metastatic breast cancer registration clinical trials: A systematic review","year":2023,"lang":"en","type":"review","venue":"Cancer Treatment Reviews","topic":"Advanced Breast Cancer Therapies","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto","funders":"","keywords":"Medicine; Protocol (science); Clinical trial; Breast cancer; Population; Metastatic breast cancer; Research design; Clinical study design; Internal medicine; Oncology; Cancer; Alternative medicine; Pathology","score_opus":0.5415218340859154,"score_gpt":0.6121691677018806,"score_spread":0.0706473336159652,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4389248415","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[2.9906283e-7,0.7496174,0.00001559435,0.00035092124,0.00022786729,0.2493046,0.0003696671,0.000078922574,0.00003474372],"genre_scores_gemma":[1.046977e-7,0.5825173,0.0002325772,0.00020493679,0.0002590075,0.41596815,0.00012670357,0.00012444147,0.0005667601],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.9667934,0.0057250387,0.02505883,0.0012356902,0.0006204536,0.00056657323],"domain_scores_gemma":[0.9589699,0.0016023885,0.036888693,0.0018710742,0.00042806822,0.00023991159],"candidate_categories":["metaepi_narrow","metaepi_broad"],"consensus_categories":["metaepi_narrow"],"category_scores_codex":[0.016811524,0.0013456536,0.031672798,0.00040867992,0.00005858627,0.000031536478,0.0003503964,0.00030172785,0.00042975685],"category_scores_gemma":[0.0064845844,0.00073184527,0.0047154934,0.0015046019,0.00017544335,0.00017005687,0.00005517072,0.0005577294,0.00007385369],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000065201355,0.00018987163,0.000026013868,0.51537216,0.0017109776,0.0000583216,0.00004524514,3.5216726e-7,3.741228e-7,0.0000051600537,0.00010544892,0.48242086],"study_design_scores_gemma":[0.0012834679,0.00022756522,0.00001554493,0.6150916,0.018349515,0.00021841346,0.000027668526,0.000001766803,4.7144377e-7,0.000010735668,0.36445123,0.0003220165],"about_ca_topic_score_codex":0.0007178752,"about_ca_topic_score_gemma":0.00044640456,"teacher_disagreement_score":0.48209885,"about_ca_system_score_codex":0.0021245703,"about_ca_system_score_gemma":0.0032128287,"threshold_uncertainty_score":0.9999294},"labels":[],"label_agreement":null},{"id":"W4396847506","doi":"10.1016/j.ctrv.2024.102753","title":"Oncological outcomes of local excision versus radical surgery for early rectal cancer in the context of staging and surveillance: A systematic review and meta-analysis","year":2024,"lang":"en","type":"review","venue":"Cancer Treatment Reviews","topic":"Colorectal Cancer Surgical Treatments","field":"Medicine","cited_by":9,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"Department of Health and Social Care; National Institute for Health and Care Research","keywords":"Medicine; Meta-analysis; Context (archaeology); Relative risk; Colorectal cancer; MEDLINE; Surgery; Internal medicine; Cancer; Confidence interval","score_opus":0.2657512587046783,"score_gpt":0.4697405175223402,"score_spread":0.2039892588176619,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4396847506","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00011934498,0.9857547,0.000008645844,0.00039250246,0.00012563326,0.01272229,0.0008322484,0.000013850782,0.000030756164],"genre_scores_gemma":[0.0017458079,0.9801669,0.000033003576,0.00013542632,0.000029111508,0.017608846,0.00008682753,0.000041464973,0.0001525899],"study_design_codex":"systematic_review","study_design_gemma":"meta_analysis","domain_scores_codex":[0.99434125,0.0013394413,0.002680891,0.00085671287,0.00043756652,0.00034413833],"domain_scores_gemma":[0.99344474,0.004316171,0.0013000193,0.0006797248,0.000103575396,0.00015574563],"candidate_categories":["metaepi_narrow","metaepi_broad"],"consensus_categories":[],"category_scores_codex":[0.0019129579,0.0008644894,0.022601938,0.00033169836,0.000039247116,0.00002388344,0.00016947438,0.00024007172,0.00016583261],"category_scores_gemma":[0.00033047437,0.0003497404,0.005392753,0.0012664893,0.0002745109,0.00004616097,0.00007127158,0.00025067275,0.0000026547323],"study_design_candidate":"meta_analysis","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00015049928,0.0001998171,0.00066657376,0.6816417,0.09825631,0.000049096896,0.00010629087,1.0330224e-7,1.5012857e-8,0.000010471436,0.00014745319,0.21877167],"study_design_scores_gemma":[0.0009638996,0.0007007444,0.00020461073,0.07383859,0.84076715,0.00001906363,0.000035507495,0.0000032887801,2.8217758e-7,0.0000027554595,0.08319095,0.00027313596],"about_ca_topic_score_codex":0.00064545224,"about_ca_topic_score_gemma":0.00065529847,"teacher_disagreement_score":0.74251086,"about_ca_system_score_codex":0.001000239,"about_ca_system_score_gemma":0.00045020427,"threshold_uncertainty_score":0.99989545},"labels":[],"label_agreement":null},{"id":"W4404367648","doi":"10.1016/j.ctrv.2024.102853","title":"Expert recommendations on treatment sequencing and challenging clinical scenarios in human epidermal growth factor receptor 2-positive (HER2-positive) metastatic breast cancer","year":2024,"lang":"en","type":"review","venue":"Cancer Treatment Reviews","topic":"HER2/EGFR in Cancer Research","field":"Medicine","cited_by":9,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"BC Cancer Foundation; Spinal Cord Injury BC; BC Cancer Agency","funders":"Seagen; Pfizer","keywords":"Medicine; Human Epidermal Growth Factor Receptor 2; Metastatic breast cancer; Breast cancer; Oncology; Cancer; Internal medicine; Epidermal growth factor receptor; Lapatinib; Cancer research; Trastuzumab","score_opus":0.3394679420235394,"score_gpt":0.5386860887968553,"score_spread":0.1992181467733159,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4404367648","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00012977066,0.9836787,0.0000070724614,0.0033235284,0.00077227707,0.009197165,0.002233796,0.00009361215,0.0005640515],"genre_scores_gemma":[0.00013525253,0.98063165,0.0003113353,0.00041427457,0.0012272691,0.014339766,0.0008914865,0.00026996786,0.0017789874],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9919002,0.0019011575,0.0025715795,0.002093254,0.00048336122,0.0010504468],"domain_scores_gemma":[0.99682933,0.0007328927,0.00069658464,0.0008797464,0.00014982942,0.0007115992],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":["metaepi_narrow"],"category_scores_codex":[0.0007927395,0.0016927148,0.0064467047,0.0007107217,0.00027240068,0.0001347516,0.00024846234,0.00040732374,0.0019729992],"category_scores_gemma":[0.000080111444,0.0010439474,0.0015693902,0.0007894149,0.00023226508,0.00016414473,0.00012046788,0.001124091,0.00026485615],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00005259789,0.0006411179,0.00018925774,0.010011463,0.0021050824,0.0003112518,0.001311632,7.6545234e-7,0.0000037203627,0.000034753673,0.0026074576,0.9827309],"study_design_scores_gemma":[0.0017302153,0.0017850404,0.00011466747,0.13493828,0.0044198562,0.00015543547,0.00012536207,0.000021526075,0.000021206946,0.0000054505485,0.85590994,0.0007730319],"about_ca_topic_score_codex":0.006522052,"about_ca_topic_score_gemma":0.0014045893,"teacher_disagreement_score":0.98195785,"about_ca_system_score_codex":0.026079793,"about_ca_system_score_gemma":0.0027965636,"threshold_uncertainty_score":0.99958193},"labels":[],"label_agreement":null},{"id":"W4404452346","doi":"10.1016/j.ctrv.2024.102860","title":"Expert consensus on the prevention of brain metastases in patients with HER2-positive breast cancer","year":2024,"lang":"en","type":"review","venue":"Cancer Treatment Reviews","topic":"Brain Metastases and Treatment","field":"Medicine","cited_by":9,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Sunnybrook Health Science Centre","funders":"Seagen","keywords":"Medicine; Breast cancer; Oncology; Internal medicine; Cancer","score_opus":0.07654962218260253,"score_gpt":0.39905532278408096,"score_spread":0.32250570060147843,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4404452346","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00016971999,0.986426,0.0000011064002,0.0013834599,0.00018418081,0.008648589,0.0029601068,0.00001963191,0.00020722202],"genre_scores_gemma":[0.000070768,0.9904279,0.00011128162,0.0003201153,0.0001349099,0.00705564,0.00075013284,0.000093932926,0.0010353196],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9967244,0.0008047048,0.0010230335,0.0007520012,0.0003510538,0.00034475827],"domain_scores_gemma":[0.9980537,0.0002989439,0.00068741775,0.00074594526,0.000086833454,0.00012710111],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0003173904,0.00090048555,0.0035047005,0.00020474919,0.000052033454,0.000023281464,0.00011895577,0.00013090704,0.00056978717],"category_scores_gemma":[0.000021954047,0.00036249618,0.0010849495,0.0006031284,0.00013121279,0.000026935106,0.00003395747,0.00025220582,0.00006316777],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00018778948,0.0014852984,0.00018729747,0.0077444334,0.0028163155,0.000064039195,0.000098145734,7.484881e-7,6.2502316e-8,0.000065651984,0.0075350367,0.9798152],"study_design_scores_gemma":[0.0017797076,0.0016286694,0.00029048682,0.11671477,0.010893316,0.000025206706,0.000017554932,4.7574045e-7,0.0000052617147,0.000005071277,0.86836934,0.00027015267],"about_ca_topic_score_codex":0.0009885662,"about_ca_topic_score_gemma":0.00035215018,"teacher_disagreement_score":0.97954506,"about_ca_system_score_codex":0.0016188221,"about_ca_system_score_gemma":0.00070994365,"threshold_uncertainty_score":0.9998827},"labels":[],"label_agreement":null},{"id":"W4406788450","doi":"10.1016/j.ctrv.2025.102889","title":"Diagnosis and management of bispecific T cell–engaging antibody toxicity: A primer for emergency physicians","year":2025,"lang":"en","type":"review","venue":"Cancer Treatment Reviews","topic":"Monoclonal and Polyclonal Antibodies Research","field":"Medicine","cited_by":11,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Micropharma (Canada)","funders":"University of Texas MD Anderson Cancer Center","keywords":"Medicine; Primer (cosmetics); Bispecific antibody; Toxicity; Antibody; Medical emergency; Family medicine; Immunology; Internal medicine; Monoclonal antibody","score_opus":0.14107790887362762,"score_gpt":0.469043019803262,"score_spread":0.32796511092963443,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4406788450","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00004782065,0.9879369,0.000033153432,0.00017440943,0.00027709902,0.00815646,0.0004345186,0.000017547638,0.0029220593],"genre_scores_gemma":[0.000001797365,0.97247887,0.00081666815,0.00004007783,0.00024635863,0.007914216,0.00043251412,0.00004647051,0.018023046],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9975209,0.00014249564,0.000998141,0.0006962027,0.00022478656,0.00041746045],"domain_scores_gemma":[0.99866056,0.00016028642,0.0004541649,0.0005254813,0.00007247697,0.00012704356],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0002010186,0.0006253108,0.0033951993,0.00022631114,0.00012721229,0.000012674315,0.00016817274,0.00012378432,0.00024070112],"category_scores_gemma":[0.00000909414,0.0003970583,0.001294449,0.00048355674,0.00007162813,0.000034165474,0.00010644021,0.0001582295,0.000018787347],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000021341824,0.0003653552,0.00023167772,0.23714647,0.00086604315,0.000013771547,0.00003408113,3.4845886e-8,0.0000054422767,0.000071649956,0.0041673575,0.7570768],"study_design_scores_gemma":[0.0004911908,0.00027821853,0.00005316938,0.082416475,0.006103615,0.0000030139936,0.000012717704,0.0000012315636,0.000083080595,0.000008431429,0.91029435,0.00025451035],"about_ca_topic_score_codex":0.00008880167,"about_ca_topic_score_gemma":0.000012235605,"teacher_disagreement_score":0.906127,"about_ca_system_score_codex":0.00027178865,"about_ca_system_score_gemma":0.00015811397,"threshold_uncertainty_score":0.9998481},"labels":[],"label_agreement":null},{"id":"W4408014611","doi":"10.1016/j.ctrv.2025.102909","title":"First versus second-generation molecular profiling tests: How both can guide decision-making in early-stage hormone-receptor positive breast cancers?","year":2025,"lang":"en","type":"review","venue":"Cancer Treatment Reviews","topic":"Breast Cancer Treatment Studies","field":"Biochemistry, Genetics and Molecular Biology","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université Laval; Centre hospitalier de l'Université Laval; Centre hospitalier universitaire de Québec","funders":"Fonds de Recherche du Québec - Santé; Génome Québec","keywords":"Medicine; Oncology; Hormone receptor; Profiling (computer programming); Stage (stratigraphy); Internal medicine; Breast cancer; Gynecology; Cancer research; Cancer","score_opus":0.033526328969651076,"score_gpt":0.35042296870750844,"score_spread":0.31689663973785737,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4408014611","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0004101575,0.99008936,0.00010487026,0.00011922505,0.0008947437,0.004042514,0.0037777708,0.00003083682,0.0005305412],"genre_scores_gemma":[0.00054660556,0.9859624,0.0015621025,0.000110294975,0.00071965286,0.0077324524,0.0022081148,0.00013053058,0.0010278694],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99576753,0.00034422905,0.0010909704,0.001757099,0.0002748723,0.0007652663],"domain_scores_gemma":[0.99756753,0.00016514493,0.00084486953,0.0011189881,0.0001396877,0.00016379467],"candidate_categories":["metaepi_narrow"],"consensus_categories":["metaepi_narrow"],"category_scores_codex":[0.0002125343,0.0014387442,0.0027403992,0.00027023,0.00025973306,0.00013758111,0.00046224752,0.00050159154,0.000068037916],"category_scores_gemma":[0.000121692654,0.0011376513,0.0010506391,0.0006480165,0.00010948583,0.000022322714,0.00023605187,0.000249148,0.000015094647],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00018648239,0.00015976503,0.000267921,0.0035657326,0.0015772287,0.00005675061,0.0001108265,0.000048413604,0.00011217755,0.000018714074,0.0041539287,0.98974204],"study_design_scores_gemma":[0.0018581068,0.000356227,0.00012362073,0.019197749,0.0016021031,0.000015095457,0.000029847966,0.000003559042,0.00017486162,0.0000016777708,0.975695,0.0009421238],"about_ca_topic_score_codex":0.0012884145,"about_ca_topic_score_gemma":0.020139039,"teacher_disagreement_score":0.9887999,"about_ca_system_score_codex":0.005048567,"about_ca_system_score_gemma":0.0018552147,"threshold_uncertainty_score":0.99983627},"labels":[],"label_agreement":null},{"id":"W4409613307","doi":"10.1016/j.ctrv.2025.102944","title":"Adjuvant CDK4/6 inhibitors in breast cancer: Interpreting trial design, evidence, and uncertainty","year":2025,"lang":"en","type":"review","venue":"Cancer Treatment Reviews","topic":"Advanced Breast Cancer Therapies","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"Medicine; Adjuvant; Oncology; Breast cancer; Palbociclib; Internal medicine; Clinical trial; Cancer; Metastatic breast cancer","score_opus":0.11247059329814481,"score_gpt":0.43692024393763434,"score_spread":0.32444965063948955,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4409613307","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0000115237945,0.9842971,0.00007072248,0.0005832236,0.0011386846,0.013427589,0.00024494217,0.00009261592,0.00013359259],"genre_scores_gemma":[0.000015810732,0.977601,0.0004593344,0.0003312291,0.0009998523,0.019379742,0.000068325484,0.00011641094,0.001028303],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99421054,0.00091925927,0.0021989853,0.0015407035,0.00033950552,0.00079102017],"domain_scores_gemma":[0.99660826,0.0008196484,0.0011763,0.00095792493,0.00011374416,0.00032411772],"candidate_categories":["metaepi_narrow"],"consensus_categories":["metaepi_narrow"],"category_scores_codex":[0.00073791674,0.0014908006,0.0073044137,0.00059764093,0.00011795988,0.0000652382,0.00030254363,0.00043712472,0.00032051333],"category_scores_gemma":[0.000175908,0.00096685265,0.0010992554,0.0011982131,0.0002142702,0.0002326882,0.00015053056,0.00063329353,0.00002409864],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0040371004,0.00020204285,0.0001451429,0.031478386,0.00047587263,0.000058422713,0.00015580676,0.000011982785,0.0000010635416,0.0000049136847,0.0005042122,0.9629251],"study_design_scores_gemma":[0.008801113,0.0004381318,0.000008322205,0.31875223,0.0030988047,0.0000829039,0.000018028064,0.0000095564355,0.0000020165846,0.000011256748,0.66829497,0.000482651],"about_ca_topic_score_codex":0.0012878247,"about_ca_topic_score_gemma":0.00031058813,"teacher_disagreement_score":0.9624424,"about_ca_system_score_codex":0.006031201,"about_ca_system_score_gemma":0.0030845487,"threshold_uncertainty_score":0.9997841},"labels":[],"label_agreement":null},{"id":"W4413364870","doi":"10.1016/j.ctrv.2025.103015","title":"Advances in the management of locally advanced rectal cancer: A shift toward a patient-centred approach to balance outcomes and quality of life","year":2025,"lang":"en","type":"review","venue":"Cancer Treatment Reviews","topic":"Colorectal Cancer Surgical Treatments","field":"Medicine","cited_by":10,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"MSD Italia; Genentech; Foundation Medicine; Sierra Oncology; Daiichi Sankyo Europe; Servier; European Society for Medical Oncology; FibroGen; Astellas Pharma; Fundación Científica Asociación Española Contra el Cáncer; Sirtex Medical; Natera; Seagen; Sociedad Española de Oncología Médica; BeiGene; INCLIVA Instituto de Investigación Sanitaria; GlaxoSmithKline; G1 Therapeutics; Takeda Pharmaceuticals U.S.A.; Instituto de Salud Carlos III; Amgen; Pfizer; Les Laboratories Pierre Fabre; AstraZeneca; Eli Lilly and Company; Bristol-Myers Squibb","keywords":"Medicine; Quality of life (healthcare); Colorectal cancer; Balance (ability); Cancer; Intensive care medicine; Gerontology; Oncology; Internal medicine; Physical therapy; Nursing","score_opus":0.1135901835730734,"score_gpt":0.41248256483886775,"score_spread":0.2988923812657943,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4413364870","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00030363153,0.980966,0.000014279443,0.000151039,0.00022648633,0.012375346,0.00039390905,0.000022697934,0.005546646],"genre_scores_gemma":[0.0010348245,0.9817106,0.0010921721,0.0001960744,0.00003202075,0.015593935,0.00010682645,0.000038001952,0.00019552714],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9950892,0.0006006268,0.0022323942,0.0010514446,0.0005452479,0.0004811287],"domain_scores_gemma":[0.9972112,0.0003443707,0.001193668,0.0009484255,0.000074974865,0.00022736411],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00025096632,0.0009340387,0.0064893193,0.00023254029,0.000041462026,0.000014771969,0.00036681077,0.00017332143,0.00004209006],"category_scores_gemma":[0.00007448249,0.00050344004,0.0010423103,0.0012882388,0.0001252891,0.000091262984,0.00015841193,0.00021694541,0.0000037310679],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00043589273,0.0009584703,0.0036211978,0.093677446,0.00083177834,0.000012346558,0.00070884364,0.000004881906,8.3962284e-8,0.000098917306,0.000031713116,0.89961845],"study_design_scores_gemma":[0.0036962102,0.0007963846,0.002281619,0.07401231,0.0033028391,0.0000028928666,0.00023154938,0.0000013002979,0.0000024489907,0.000012395106,0.9152285,0.00043159706],"about_ca_topic_score_codex":0.00052517524,"about_ca_topic_score_gemma":0.00021102132,"teacher_disagreement_score":0.9151967,"about_ca_system_score_codex":0.0011910055,"about_ca_system_score_gemma":0.00061105384,"threshold_uncertainty_score":0.99974173},"labels":[],"label_agreement":null},{"id":"W4413758373","doi":"10.1016/j.ctrv.2025.103017","title":"Radioimmunotherapy for lung and head and neck cancers: A comparative review of clinical trial results and sequencing strategies","year":2025,"lang":"en","type":"review","venue":"Cancer Treatment Reviews","topic":"Lung Cancer Diagnosis and Treatment","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hôpital Maisonneuve-Rosemont","funders":"","keywords":"Medicine; Radioimmunotherapy; Head and neck; Oncology; Clinical trial; Lung cancer; Internal medicine; Medical physics; Surgery; Immunology","score_opus":0.33177876822560887,"score_gpt":0.5618173600734572,"score_spread":0.2300385918478483,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4413758373","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000085746164,0.97970045,0.000005369996,0.000262639,0.00035292283,0.018363044,0.00063707976,0.00001852226,0.0005742313],"genre_scores_gemma":[0.0000048380657,0.98770773,0.00093506917,0.00030007403,0.00036606047,0.009940919,0.00029784194,0.00003496616,0.00041249764],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99551946,0.00041776214,0.002602752,0.001010319,0.00015389435,0.00029578913],"domain_scores_gemma":[0.9965979,0.0009695758,0.0015149923,0.00060856476,0.000116386516,0.00019257229],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0007880092,0.0008002877,0.008799564,0.00011129817,0.00009524276,0.00004613301,0.00007801775,0.00023615979,0.000020475467],"category_scores_gemma":[0.00010738553,0.00047095033,0.000938087,0.00024062686,0.0002104934,0.00009391374,0.00003631015,0.00019263962,5.0866873e-7],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0019544808,0.00012726615,0.000041011943,0.26130646,0.0017266076,0.0000055529044,0.00013902967,5.065756e-8,3.3985696e-8,0.000045517518,0.0031658409,0.73148817],"study_design_scores_gemma":[0.02499414,0.002090398,0.000013318438,0.36519703,0.009048748,0.00001278808,0.000016829823,0.0000027332767,5.993278e-7,0.00000432429,0.5984269,0.0001922383],"about_ca_topic_score_codex":0.00063786673,"about_ca_topic_score_gemma":0.00023942706,"teacher_disagreement_score":0.7312959,"about_ca_system_score_codex":0.0014767048,"about_ca_system_score_gemma":0.0034067994,"threshold_uncertainty_score":0.9997742},"labels":[],"label_agreement":null},{"id":"W4414521801","doi":"10.1016/j.ctrv.2025.103024","title":"Impact of brain metastases on systemic renal cell carcinoma treatment outcomes: A systematic literature review","year":2025,"lang":"en","type":"review","venue":"Cancer Treatment Reviews","topic":"Brain Metastases and Treatment","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Alberta Cancer Foundation","funders":"Ipsen Biopharmaceuticals","keywords":"Systemic therapy; Renal cell carcinoma; Systematic review; Kidney cancer; MEDLINE; Carcinoma; Chemotherapy","score_opus":0.06955937531142792,"score_gpt":0.417139175122783,"score_spread":0.34757979981135506,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4414521801","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000014370881,0.96428233,0.0000045474176,0.00011709615,0.0002720762,0.030359348,0.0043362537,0.00006258615,0.00055137527],"genre_scores_gemma":[0.000015615411,0.96769106,0.00018101712,0.00031851168,0.00015304741,0.020270005,0.0029611166,0.00014157941,0.0082680695],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.99071234,0.0025852981,0.0038558026,0.001517384,0.0005654539,0.00076369604],"domain_scores_gemma":[0.9919031,0.0012321443,0.003009226,0.0031613507,0.00019693152,0.0004972105],"candidate_categories":["metaepi_narrow","metaepi_broad"],"consensus_categories":["metaepi_narrow","metaepi_broad"],"category_scores_codex":[0.0007496763,0.0027629375,0.021617187,0.0007223425,0.00011140461,0.0000591345,0.00036597374,0.00039912458,0.0003355959],"category_scores_gemma":[0.0002275002,0.0012268039,0.011731372,0.0014816561,0.00006925401,0.000075522425,0.000060140337,0.000332976,0.00017473771],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00003068645,0.0014698631,0.00006648414,0.6474111,0.004954312,0.0004260316,0.000045380773,5.71647e-7,3.0878516e-7,0.000011042235,0.004487424,0.3410968],"study_design_scores_gemma":[0.0018038368,0.003751857,0.000008051537,0.58034897,0.057048716,0.0003163161,0.0000033033148,2.491456e-7,0.000003026248,5.2163193e-7,0.3563151,0.00040003256],"about_ca_topic_score_codex":0.00024177086,"about_ca_topic_score_gemma":0.000017653712,"teacher_disagreement_score":0.35182768,"about_ca_system_score_codex":0.0070500267,"about_ca_system_score_gemma":0.0025357779,"threshold_uncertainty_score":0.9990182},"labels":[],"label_agreement":null},{"id":"W7117422237","doi":"10.1016/j.ctrv.2025.103073","title":"Targeted therapies in optic pathway gliomas","year":2025,"lang":"en","type":"article","venue":"Cancer Treatment Reviews","topic":"Neurofibromatosis and Schwannoma Cases","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"Ministero della Salute","keywords":"Targeted therapy; Disease; Disease control; Radiation therapy; Glioma; MEDLINE","score_opus":0.04199492782811227,"score_gpt":0.33495590207131193,"score_spread":0.29296097424319967,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W7117422237","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.66440725,0.32842126,0.0000036577926,0.0012380964,0.0001710061,0.0009785426,0.000008762299,0.000035125806,0.004736327],"genre_scores_gemma":[0.8950043,0.09386168,0.00074819464,0.0012132665,0.00010543355,0.0017361167,0.000035088906,0.000026320142,0.0072696498],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99904954,0.00007698126,0.00034818164,0.00026778263,0.0000705775,0.00018695844],"domain_scores_gemma":[0.9994922,0.00003483074,0.00006465428,0.00033142185,0.000019228972,0.00005762485],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00007797203,0.00019216807,0.0006004716,0.0001329391,0.000036664635,0.000015924687,0.00004950404,0.000040824994,0.00027959936],"category_scores_gemma":[0.000019951414,0.00011831467,0.00017505304,0.00040240822,0.000029391862,0.000041435003,0.000013012307,0.00005319441,0.00004804896],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00029109366,0.0011724598,0.14521827,0.0010389606,0.00033636944,0.0009528346,0.00063233223,0.0000030805957,0.040009048,0.0019905965,0.0094729895,0.79888195],"study_design_scores_gemma":[0.0022850395,0.00043206124,0.03368565,0.0014115137,0.00015856605,0.000026765261,0.000040025807,0.00001613289,0.021197928,0.00006541901,0.9405396,0.00014127615],"about_ca_topic_score_codex":0.00012731522,"about_ca_topic_score_gemma":0.00005269724,"teacher_disagreement_score":0.93106663,"about_ca_system_score_codex":0.00024518877,"about_ca_system_score_gemma":0.00014907237,"threshold_uncertainty_score":0.48247322},"labels":[],"label_agreement":null}]}